ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000703.1|Kanamycin_1 # 1 # 3405 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.742	BGC0000703.1|Kanamycin_1 	1	3405	-	Loose	400	26.9498	TxR	21.46	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGCTTGACCGGCTCAGGGACGCGCTGGAGGCACTCGGTCCACCGGTCACCCCGCTGGAACTGGCGGAGATGCTGTGGCTGGCGGAGCGGTTGCCCGTGGGGGAGGGCGGTGACGCCGGGGCTTCGGCGTCGGGCCGGTACGGCGGTGACCACGTGGACTTCCAAGGGGGTACGTTCCACGGTCCGGTGACGGTCCGCCTTGACCACCCCGACGGGAGCGAGGAGGGCGACGCGGACGCGGAGCGCGTCGACCCGGCGGAGGCGGAGGGCGACGCCGGTCCACCCCCCGACGCCGGGCGCAGGCCCCTGCACGTGCCGCACGGCGCCGCGAGCCCCGGCACCGACGCCGACGACGTCCTCGTCCCCGCCCCACAGGCCCTGCGCCAAGAACTCGCGATCCAGCGCTCCCTGCGCCCGCTCAAGCGGCACGTCCCCGACCGGCGCCGCCGCGTCCTGGACGAGGAAGCCACCGCGGCGCGCGCCGCGCGCCACTCGGGCCCGCACCCCTGGACCCCCGTCATGGTCCCCGTCACCGACCGGCTCCTGAGCCTGGCCCTGGTCGTCGACACGGGCCCGGCGATGACGGTGTGGCGTCCGCTCGCCCGCGAACTGCGCGAGGCCACCCAGCGCACCGCCGCCTTCCGCGACGTACGCGTCTGGCACCTGGCCGACCTCGGATCGCGCGTCGGCGTCCGCAGTTCGGCCGCGGGACCCGCACTCGACCCGGCGGCCCTCGTCGACCCGACGGGGCGCCAGATCGTCCTGGTGCTCAGCGACTGCTCGGGCCCGCACTGGTGGGGCGGTCGCGCGGATCCCGCACTGCGCCTGTGGGCAGGGCGCGGCCCCACCGCGATCCTCCAGCCGCTGCCCGAACGCCTCTGGCGCAGGACCGCCGCACCCGCCGTCCCCGGCCGGGCCATCGCCTCGCGCGCGGGCGCGCCCAACACGGCACTGCGGTTCACCCCGCACGACGGCCGCGCGGGCCTGCCCGCGCCCGACGCGATCCCCGTGCCGGTCCTCGAACTGGCCCCCGAGTGGCTCGCCGACTGGGCGGGCCTGGTGACGGCGTCCGGCGACCGGCGCAGGGACACGGCCATGACGTACGTGAGCGCGACGCGGCCACCGCACGACCAACCCCTCGCCAGCGAAGGGGACTTGCCGATCACTGAGCGGCTCCTCCGCTTCCAGGCGGCGGCCTCGCCCACGGCGGCGGACCTGGCCGCGCACGTCGCGCTCTCCGTCCCCGCGCTGCCGGTGATGCGGCTCATCCAGCAGCGAGTGACGCGCGGCTCGCGCCCCAGCGACCTCGCCGAGGTCCTCCTGAGCGGCCTCCTGGAGCCGGTCGACCCGGAGCGCGGCCTGTACGCATTCGTGCCGGGAGCCAGGGCCGCGCTCCTGGAGACCTTGCCCCGCCCCGAGTCCCTGGCGGTCGCCGAGCTGCTCGGCCGCCTCGGTGCGGAGATCGAGGCGAGGGCGGGTTCGGCGACCCGGGCGTTCCGGGCGGTCGTGCCGGTGGCGGAGGGGTCGGGCAGCCGGGGCCTCGGGGCGGCGGGGCAGCCGTTCGCGCTGGTGAGCGAGGAGGCGTTGGGGGTGTTGCGGGGGCGGGCCATACGGGTCGTGGAGCGGCCATCGGTGAGCATCCCGGATACGGATACGTGGAAACTCGCCGTGGAGGAAGAGCCCGTCCCTCCGGAGGTGGCGCGGTTCGATCCGCCCGGCTCTGTGACGGCCCCGGCTGGCTTCTCCAACGTCACCGTCCCGGACCCGTTCATCGGCCGGGCACATGAACTCGACGGTCTGGACAGGACGTTCTCCGACCTCCACGGGGCCGAGCGGGTCGTCCTGCACGGCGCGGCGGGCGTCGGCAAGACCACGCTGGCGATGGCGTGGGCGCGCCGCTGGAGCGGCCGTGACCAGGAGCGCCTGGTGTGGTGGGTCACGGCGGACTCGTTCGCGGCGGTGGTCGCGGGGCTCTCCGGCCTTGCCGGTGCCCTGCAGCCGTCGGTGACGGATCCTCGCGTGCTGCGGGAGAGCTGGGAATGGGCTCTTGAGTGGCTGAGTTCCCACACCAGCTGGGCACTCGTCCTCGACGGCGTCAGGAAGCCCGCCCACGTACGCGTCCTGCTGTCCCGGCTCGGCCGCGGCGGTGCCGTTCTGGTCACCAGCCGGGAGGCGGAGGGCTGGCCGGACGATGTCTTCCGGCTCGGACTCGACGTGCCCGCGCTGTCGGAGGCGGTCCAGATGTTCAAGGCCCACGTGGGCCGCGATGTCGCGGGCGCCGTGCGCCTGTGCGAGGAGCTGGGGCGCCTGCCGAGCGCGGTGGTGCGGGCGGCGGGGGCCGTCGCGGAGACGGGCGTGACGGTGGACGAATACCTTGCCCTCTCCGCACAGGAGGCGGCCGGACCGATCGATCCGGAGGCACCGGGCCCGGAACCGGCGGAGGGTCCGGTGCAGACGGACGCGATCGGCGACGCGATCAGGGAGTCGCTGCGCGGCCTCGCCGACGAGGAGGCCGCCCAACTACTGCGAATCCTCGCCTGGTTGGGCGAAGGTCCCGTTCCTTACGAGCTGCTGGCAGCTCTGTCCCCGGCGTACGACGTGACACGCTCGCTGGTTGCCCTGGCGGAGCGGGGCCTGGTCGATCGCGACCGGGCGACGGACACGGTGACGCTCCCGGCGAGGGTCGGAGCCATTGCTCTCACCCCGAACGAGTCCCTGCTGCCGCGCGAGGCCAGAGCTGTTGCCGTCGCCCGCAACATGGCCGTCGGCTGTCTCGCCGCCGCGTTTCCGAAGTCTGTCGACGACCCGGCGAACTGGCCCCGATGCCGTCAACTCTTCCCGCTCGTCGAGGGGTTGTGCAAACGGGTCAGGACCGAGGACGGCACCGAGGTGCTGGCGCAACTCTTCACGCGGGCAGGGCAGTTCCTCATCAGTCAGGGGAGGGTGGGGTGGGCCATCGACCTACTGGAAAGGGCGCTGTCGTGCAGGCGACGGCTTTCGGGCCACCGGTCGCCGGAGGCGGTGGAAGCCCTGAAGGTCCTGGCGGCGGCTCACCTGGCGGCGGGGCGAGCCGGGAACGCGATCGATCTCTTCAAGGAGGCGCTGGACGGTGTGGCCACCAGGGGGAGGCACCTGGACCCCGCGTCACTCGAGCTGCGCGCCCGGCTCGCCGACGCCTATGCCGCGTCGGGCGATACGCGGTCGGCCGTACGGGAACTGAAGGACGTCCACACGACGGCGGCCGTTTCCCTGGGCGTCGAGCACCCCGACACCTTGCGGCTGCGGTCTCGTCTCGCGGGCGCGTACGCGGTGGCGGGGCGCCCGGGCGAGGCCGTGGAGACGTACGAGGAAACGCTGACCGGCTGCCGCAGGGTGTGGGGCGGCGATGCCCTGGAGACGATC	MTLDRLRDALEALGPPVTPLELAEMLWLAERLPVGEGGDAGASASGRYGGDHVDFQGGTFHGPVTVRLDHPDGSEEGDADAERVDPAEAEGDAGPPPDAGRRPLHVPHGAASPGTDADDVLVPAPQALRQELAIQRSLRPLKRHVPDRRRRVLDEEATAARAARHSGPHPWTPVMVPVTDRLLSLALVVDTGPAMTVWRPLARELREATQRTAAFRDVRVWHLADLGSRVGVRSSAAGPALDPAALVDPTGRQIVLVLSDCSGPHWWGGRADPALRLWAGRGPTAILQPLPERLWRRTAAPAVPGRAIASRAGAPNTALRFTPHDGRAGLPAPDAIPVPVLELAPEWLADWAGLVTASGDRRRDTAMTYVSATRPPHDQPLASEGDLPITERLLRFQAAASPTAADLAAHVALSVPALPVMRLIQQRVTRGSRPSDLAEVLLSGLLEPVDPERGLYAFVPGARAALLETLPRPESLAVAELLGRLGAEIEARAGSATRAFRAVVPVAEGSGSRGLGAAGQPFALVSEEALGVLRGRAIRVVERPSVSIPDTDTWKLAVEEEPVPPEVARFDPPGSVTAPAGFSNVTVPDPFIGRAHELDGLDRTFSDLHGAERVVLHGAAGVGKTTLAMAWARRWSGRDQERLVWWVTADSFAAVVAGLSGLAGALQPSVTDPRVLRESWEWALEWLSSHTSWALVLDGVRKPAHVRVLLSRLGRGGAVLVTSREAEGWPDDVFRLGLDVPALSEAVQMFKAHVGRDVAGAVRLCEELGRLPSAVVRAAGAVAETGVTVDEYLALSAQEAAGPIDPEAPGPEPAEGPVQTDAIGDAIRESLRGLADEEAAQLLRILAWLGEGPVPYELLAALSPAYDVTRSLVALAERGLVDRDRATDTVTLPARVGAIALTPNESLLPREARAVAVARNMAVGCLAAAFPKSVDDPANWPRCRQLFPLVEGLCKRVRTEDGTEVLAQLFTRAGQFLISQGRVGWAIDLLERALSCRRRLSGHRSPEAVEALKVLAAAHLAAGRAGNAIDLFKEALDGVATRGRHLDPASLELRARLADAYAASGDTRSAVRELKDVHTTAAVSLGVEHPDTLRLRSRLAGAYAVAGRPGEAVETYEETLTGCRRVWGGDALETI	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	356.92	gnl|BL_ORD_ID|4724|hsp_num:0	3753			234	786	tetracycline
BGC0000703.1|Kanamycin_2 # 3395 # 4450 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.700	BGC0000703.1|Kanamycin_2 	3395	4450	-	Loose	1100	28.1054	tetA(60)	30.95	3004035	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTCTGAGGCGTCCGAGACGGCCGAGATGTCCAACTGGCTTATCTACAACGGCAGTCGGATCCCGCACGACGGCATCGAACGGCTCCCGGCCCCACCCCCCTGGCGCACCTTCACCGGAGGACCCGCCCTGCCCATCCCGCCCGGCGACTCCGGCAACCCGCACGCGGCCGTCAGCTACCGCCCAGGCGAGGACGCGGTCCGCCAGGTCAACGCCGCGCTGTACCTTCGCAGACCGCTCCTGGTGACCGGCGCCCCCGGCACCGGCAAGTCCTCCCTCGCGTACGCGGTGGCGCACGAACTCGGCCTCGGCAAGGTCCTGCACTGGCCGATCACCAGCCGGGTCGCCCTGCGCGAAGGACTCTACGAGTACGACCCGCTGACCCGCCTGTACGCCGCCGAACGCGCCCGCGGCGACGGAGACGCGGGCGTCGGCGACGACATCGGCGACTATCTGCGCCTCGGCCCCCTCGGCACCGCGCTGCTCCCGTACGAGCGGCCCCGCGTGCTGCTCGTCGACGAGATCGACAAGAGCGACATCGACCTGCCCAACGACCTCCTCACCATCTTCGAGAAGGGCTCCTACGAACTCGTCGAACTGGCCAGGCGCGCCGCGCCCACCGCCAGGGTGATGACCGCCGACAGCACCACCGACCGAGTGGAGATCCGCGACGGCACCGTCACCTGCCGCGCCTTCCCGCTCGTCATCATGACCAGCAACGGCGAGCGCGAGTTCCCGCCCGCGTTCCTGCGGCGCTGTGTGACCGTGGACCTGAAGCAGCCCGCCAGCGTGGCCGAGCTGACCGCGATCGTCCGCGAACATCTCGCCCCGGTGATCGGGGGTGCGGGCGGTGAACTCCCGCCGGGCGCCCAGCAGATCATCGACCGTTTCTTCGAGCGGCGTGGTGGCGGCCTGCTCGCCAACGACCAGCTCCTCAACGCCATTTACATGTGCCATCACGCGTCGTTCAGCGAAGAGCCGGAGAACGTACGGAAGTTGGCGGACCAGGTGATGCCGTACCTGAGCGGCGAGGCGACCCGGCACGATGACGCTTGA	MSEASETAEMSNWLIYNGSRIPHDGIERLPAPPPWRTFTGGPALPIPPGDSGNPHAAVSYRPGEDAVRQVNAALYLRRPLLVTGAPGTGKSSLAYAVAHELGLGKVLHWPITSRVALREGLYEYDPLTRLYAAERARGDGDAGVGDDIGDYLRLGPLGTALLPYERPRVLLVDEIDKSDIDLPNDLLTIFEKGSYELVELARRAAPTARVMTADSTTDRVEIRDGTVTCRAFPLVIMTSNGEREFPPAFLRRCVTVDLKQPASVAELTAIVREHLAPVIGGAGGELPPGAQQIIDRFFERRGGGLLANDQLLNAIYMCHHASFSEEPENVRKLADQVMPYLSGEATRHDDA	MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE	60.62	gnl|BL_ORD_ID|2310|hsp_num:0	2645			1035	1161	tetracycline
BGC0000703.1|Kanamycin_3 # 4514 # 6241 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.744	BGC0000703.1|Kanamycin_3 	4514	6241	-	Loose	700	28.4906	LpsB	34.21	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGGCGGGCATGCACTGGCGTGCCCGGATCGGCACGGTCGACGGCGCCCCCAGAGGGGCGGGCGTACTGGTCGACGGTGCGCGACTGATCACCTGCGCCCACGTCGTCGAGGGCCTCGACGAGGTCTCCGTGACGCTGCCGGGACTCGACGAGACGCTGCGCGGGACCGTGGCGTGGGTCGGGGACTGGCGGCGCGTGGGGGACCGCGGCGACGTGGCCGTGGTCGCGCTCGACCGGGTGCCCGACGCGGCGCCGTGCGCGTTCGCCCCGCTCGACGTCCTGCGGCCGCGCCCGGGGCGCGCCGCCCCCGAACTGCGCGCGCTCGGCTTCCCGTTCGGCCACGACGAGGTGGGGACGCACGTCACGCTGCGCACCAGCGCGGACCGGCTGCTCGGCCAGGAGTGGCTGGAGATCGACGTGGACCGGGCTCATCTGCAGCGCCTCGACGAGGGGTTCAGCGGCGCCGCCGTCTACGACCAGGCGAGCCGTCTCGTCGTCGGCATCCTCACCGACGCCGTGCTCGACGGCGCCCCCGCGGGACACCTCGGACGGATGCTGCCCCTCGACACCATCCGCCGCCACTGGGAGGAGCTGGACGACCTCCTGCCGCTCGACTGGCTGCCCAGCGCGCCGCGCCGCGAACTGCGCGCGCTGTTCAGCGACGTACGCATCGACGCGGCGAACCTGGAGCTGATCGTCCGGCGGGCCTTCCCCACCTTCCGCCGTCCGCTGCCCGCCTTCCGGTCCGTCTGGCACGCGGTCCGCCACGTCGCCGAGGAGCTGACCGGCGAGGACCGGCTCGTGCGGCTGCTCGACTCGCTGCGTGCGGCAGGGCCGCCCGGCGTGGACATCGGCGCGTGGCTGCGGCGCTGGATGCCCGAGCAGTACGTCGAGGGCCGGGCGACCGGCGCGGCAGGGGGCGCCGCACCCACAGGGTCCGTCATGTTCCGCGCCGAGTCGATGACCCGGGGCGCCGGACTCGACCTCTCGGTCTGCACCGTGGTCGACGGCGTGCCCGTCGCCAGGGCCGGTCCCGTCCGGATCCGGCCCCGCCAGCTGCGTCCGAAGGTGGAGGCACTGCTCGCCGAACAGATCGGCCGCGTCCACGAGTTCGACTGGATGGTGGAGTTCGTGGTGCCCGAACGGCTGATGAGCGAGCCGTACGAGGAGTGGCAGATCCACGAGCCGGGCGCCGCCCGGCCCCGGCCGCTGCGCACGGTGCCCGTCGTGGTCCGGCACATGGACCGCCTCAAACCGCTCACCGTCTCGCGGCTCACCCGCAGGCGCTGGGAGACGGTGCGGGCCCGCGGCGAGACCAGGCCCCGGCGCGTGGAGTGCGGACTGCCGTACGGCTACGAGGAGTTCCACGACTGGCTGGACGCCGACGACGACGTGTGCGCCCTCGCGTACGCCGCGACACCCGTCGGCGACTGGCTCGCCGCCGCACTCGACACCGGTGTGCCGATCATGCTGTGGCGGCGCCACGACTGCGGCGACGAGGGCCACGCCCACTGCGCGCCCGACAAGTTCCTCGACCGGCTCACGGACGCGGTCGCCGCACTCGACCCCGACCGGCTGCCGTTCGAGGTGATGCGGCTGCGCAAGGAGGCCCGCTCCCCGGACAAGGGGGACGCCGAACACTGCGGGCACCGGCTGACCCTGTTCTGGGACGACCCGGAGCGCAAACCGGATCCGCCGCTGGCGATGGGAGCGAGGGGAGCGCCGTGA	MAGMHWRARIGTVDGAPRGAGVLVDGARLITCAHVVEGLDEVSVTLPGLDETLRGTVAWVGDWRRVGDRGDVAVVALDRVPDAAPCAFAPLDVLRPRPGRAAPELRALGFPFGHDEVGTHVTLRTSADRLLGQEWLEIDVDRAHLQRLDEGFSGAAVYDQASRLVVGILTDAVLDGAPAGHLGRMLPLDTIRRHWEELDDLLPLDWLPSAPRRELRALFSDVRIDAANLELIVRRAFPTFRRPLPAFRSVWHAVRHVAEELTGEDRLVRLLDSLRAAGPPGVDIGAWLRRWMPEQYVEGRATGAAGGAAPTGSVMFRAESMTRGAGLDLSVCTVVDGVPVARAGPVRIRPRQLRPKVEALLAEQIGRVHEFDWMVEFVVPERLMSEPYEEWQIHEPGAARPRPLRTVPVVVRHMDRLKPLTVSRLTRRRWETVRARGETRPRRVECGLPYGYEEFHDWLDADDDVCALAYAATPVGDWLAAALDTGVPIMLWRRHDCGDEGHAHCAPDKFLDRLTDAVAALDPDRLPFEVMRLRKEARSPDKGDAEHCGHRLTLFWDDPERKPDPPLAMGARGAP	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	157.10	gnl|BL_ORD_ID|2781|hsp_num:0	3793			798	912	colistin A; colistin B; defensin
BGC0000703.1|Kanamycin_4 # 6241 # 6633 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.715	BGC0000703.1|Kanamycin_4 	6241	6633	-	Loose	760	24.2534	macA	40.91	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACGAGCTGATGCGATGGGAGTCCGACGACGGGCCCGTCGTGGTCGAGATGGACTCCCGCGACCCCGGGTTCAGGTCCGTGTCGCGGCGCGGCGGGGACGGCGAGATCTACGAGGTCGAGGGCCGCTTCGAGTCGGCGCTGAGCAATGTGCGCGGGGCCGCGATGTCCGCGCTGCGGACCTTCCGGGACCGGGCGCTCGACCCCGACGCCATCGAGCTGGAGTTCGGGGTCAAGCTCAGCGCCGTAGCGGGTGCCGTCATCGCCAAGACGGCCGCCGAAGGGCATCTCACCGTCAAGCTCACCTGGTCCAGGCCGCAGGCGACGGGCGACGGCACGGGGCAGGACGGCACCGGACAGGACGGCACCGGACAGGCCGTGCAAGGCGAATAA	MNELMRWESDDGPVVVEMDSRDPGFRSVSRRGGDGEIYEVEGRFESALSNVRGAAMSALRTFRDRALDPDAIELEFGVKLSAVAGAVIAKTAAEGHLTVKLTWSRPQATGDGTGQDGTGQDGTGQAVQGE	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	33.16	gnl|BL_ORD_ID|1546|hsp_num:0	1680			744	810	erythromycin
BGC0000703.1|Kanamycin_5 # 6742 # 7653 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.759	BGC0000703.1|Kanamycin_5 	6742	7653	-	Loose	650	26.9498	EreA	34.48	3000361	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGGCGCACGGACACTCCCACGGGCACGCCCACAAGCACGCCCACGGGCACTCCCACGACACGGCCGACATCGACTGGGCCGACATGGGCGACAAGCTGGAGCGGTACGCGAAGATCGCCGCGCCGATGTACGGAGAGGTGGTCGCGTGGCTGCGCCGGTGGGTGCCGGAGCCGGGGCTCGTGGCCGACGTCGGCGCGGGTCCCGGTGCCGTGGCCTTCCTGCTGGCCGACGCGTTCCCCGGGGCGCGGGTCGTCGCGGCGGACCCCGAGGGGCCGCTCCTGGAGCGCGCCGGTGAGCGCGCCGCCCGCGAGGGCCTCGCCGACCGGCTCAGCGCGGTCCGGGTGGAACTCCCGGACGACGTCGGCCAGTTGCCGCCCGCGGACCTGATGTGGCTGGGCAAGTCCCTGCACCACGTGGGCGACCAGGGCGCCGCGCTCGCCGCCCTCGCGCAGCGGATCGCCCCGGGCGGCGCGATCGCCCTCCTGGAGGGTGGTCTCGGCGCCCGCAGCCTGCCCCGCGACATCGGCTTCGGCAAGCCAGGACTCCAGTCCCGCCTGGAGGCGGTGGACGAGGAGTGGTTCGCCGGGATGCGCGCGAGCCTGCCGGGCGCGAAGGACGTCGTGGAGGACTGGCCCGCCCTCCTCGGCGCCGCCGGCCTGCGGCACGTGGCCACCCGCACCTTCCTCCTCGACCTCCCCGCCCCGCTCCCGCGCGAGGCCCGTACGCACCTGGTGGACGAGCTGGCCCGCCGCCGCGACATGTACGACGAGCTCCTCGGCGCCGACGAGCTGGCCACCATCGACCGCCTCCTGGACCCGTCGGATCCGGGCGGCCTCCTCCTCAGGCCGGACGCGTTCCTGCTGCTCGCGCAGACGGTGCACGTGGCGGTCAAGGACGGGGAGCAGGGCTAG	MAHGHSHGHAHKHAHGHSHDTADIDWADMGDKLERYAKIAAPMYGEVVAWLRRWVPEPGLVADVGAGPGAVAFLLADAFPGARVVAADPEGPLLERAGERAAREGLADRLSAVRVELPDDVGQLPPADLMWLGKSLHHVGDQGAALAALAQRIAPGGAIALLEGGLGARSLPRDIGFGKPGLQSRLEAVDEEWFAGMRASLPGAKDVVEDWPALLGAAGLRHVATRTFLLDLPAPLPREARTHLVDELARRRDMYDELLGADELATIDRLLDPSDPGGLLLRPDAFLLLAQTVHVAVKDGEQG	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	74.63	gnl|BL_ORD_ID|917|hsp_num:0	991			264	351	erythromycin; roxithromycin; clarithromycin
BGC0000703.1|Kanamycin_6 # 7892 # 8464 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.723	BGC0000703.1|Kanamycin_6 	7892	8464	+	Loose	400	38.891	tetR	30.68	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCGCACGCGTAGGACTGACCACGGATCGCCTGGTCAGAGCGGGAGCCGAGCTGGCCGACGAGGTCGGCTTCGCGGAGGTGACCGTCTCCGCGCTCGCCCGGCAGTTCGACGTCAAGGTCGCGAGCCTGTACTCGCACGTGAAGAACTCCCACGACCTGAAGACCCGCATCGCCCTGCTCGCCCTGGAGGAACTCGCCGACCGGGGCTCCGCCGCCCTCGCCGGGCGCGCGGGAAAGGACGCGCTCACCGCTTTCGCGAACGTCTACCGCGACTACGCCCGCGAGCACCCCGGCCGGTACGCCTCGACCCAGTTCCGGCTCGACCCGGAGGCGGCCGCGGCGAGCGCGGGCGGCAGGCACGCGCGGATGACCCGGGCGATCCTGCGCGGCTACGACCTGGACGAGCCGGACCAGACACACGCGGTGCGGCTCCTGGGCAGCGTCTTCCACGGGTACGTCAGCCTGGAGCTGGCCGGCGGCTTCAGCCACAGCGCCCCGGACTCACAGGAGTCCTGGTCCTGGACCCTGGACCGGCTCGACGACCTGCTCAGGACCTGGTCCGCGCCCTGA	MAARVGLTTDRLVRAGAELADEVGFAEVTVSALARQFDVKVASLYSHVKNSHDLKTRIALLALEELADRGSAALAGRAGKDALTAFANVYRDYAREHPGRYASTQFRLDPEAAAASAGGRHARMTRAILRGYDLDEPDQTHAVRLLGSVFHGYVSLELAGGFSHSAPDSQESWSWTLDRLDDLLRTWSAP	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	91.35	gnl|BL_ORD_ID|442|hsp_num:0	276			12	264	tetracycline
BGC0000703.1|Kanamycin_8 # 9678 # 10418 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.767	BGC0000703.1|Kanamycin_8 	9678	10418	-	Loose	600	42.743	emtA	26.5	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCTCGACTACAGCAAAGAGGCCGACCGCTACGACGCGTCGCGCGGCGGCGAGCCCCGCGCGGCGGCCGCGGCGGACGCGGTCATCGGCCTGCTGCCCCCGGACACCGCCACCCTCCTCGACGTCGCCTGCGGCACAGGACTCGTCACGCGGCGCCTCGCCGCGCGGCCGGGGCTGCGGGTGACCGGGGTCGACGCGGCGTACCGGATGGCCCGGATGGCGGCGGGCCGGGTGCCGGGCTCCGTGGTGCTCGGCGACAGCCGCCGACTCCCCTTTCCCGACGGCGCGTTCGACGCCGTGAGCATGGTGTGGCTGTTGCACCTGCTGTCCGGTGCCGAGGAGACGTCGTCGGTCGTCGCCGAGTGCGCGCGGGTGCTGCGGCCCGGCGGGACCCTCGTCACCACCGTCGACAAGGCCACGTCGCACGACGTGGGCAGCGACATCGACGCCGTGCTCGCGCCCCGTCCGATCCGGCCCGCGGTGGACCGCGCCGAAGACATCGAGGCGTGCGCGGCCGCGCACGGGCTCGCGCCCGCGGGGCAGTCCCGGTTCCGGGGCCACGGGCAGGGCCGCTCGCCCCGCTCCGCGGTGGACGACCTGCGCCGCGGCTGGTTCACCCAGATCGCCCCGGACGGACCGCTCGCCGAGCGGTTCGCCGCGGGGCTCGCGGAACTGCCCGACCAGGAAGTGCCCCGCCCCGACCCGTGGTTCACGCTGCGCGCGTTCAGGAAGGGTCGCTGA	MLDYSKEADRYDASRGGEPRAAAAADAVIGLLPPDTATLLDVACGTGLVTRRLAARPGLRVTGVDAAYRMARMAAGRVPGSVVLGDSRRLPFPDGAFDAVSMVWLLHLLSGAEETSSVVAECARVLRPGGTLVTTVDKATSHDVGSDIDAVLAPRPIRPAVDRAEDIEACAAAHGLAPAGQSRFRGHGQGRSPRSAVDDLRRGWFTQIAPDGPLAERFAAGLAELPDQEVPRPDPWFTLRAFRKGR	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	72.14	gnl|BL_ORD_ID|2212|hsp_num:0	3368			522	873	evernimicin
BGC0000703.1|Kanamycin_10 # 10885 # 11664 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=12bp;gc_cont=0.713	BGC0000703.1|Kanamycin_10 	10885	11664	+	Loose	700	30.0314	mef(D)	39.53	3005089	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGTCCCCTGCTGCGCGCCTGGCGCGAGCGCCGCCGCGTCAGCCAGCTGGAACTGGCCCTGCGCGCCGATTCCTCGGCGCGGCACATCAGCTTCGTGGAGACCGGCAGGTCGCGGCCGAGCGAGGAGTTCCTGCTCCGTCTCGCCGACCACCTCGACGTACCGATGCGCGACCGCAACTCCCTGCTCCTGGCCGCCGGTTACGCGCCGCGCTTCCGTGAGACCCCGCTCGACGACCCGTCGATGGGCGCGCTGCGCGAGAGCCTGGACCGGCTCCTGACCGGCTACGAGCCGTATCCGGCGCTGGTCGTCGACGCGACGTACGACGTGATCGCGGCGAACCACAGCCTCGCGACGCTGCTCGGGGGCCTGCCCGAGCACCTGCTCGCGTCCCAGCCGCTGAACGCGATGCGGCTCACCCTCCACCCGGAGGGCCTCGCCCCGCGCATCCGCAATCTGCGCGAGTGGCGCGGGCACCTGCTGCACCAGATGGAGCGGCAGATCGCGCTGCAGCGCTCCGACGCGCTGCGCGCCGTGTACGACGAGGTGGCCGCCTACCCGGTGGCGGATCCGGGGGTCGACGCCTTCGACGCCGACACCGACGTGCCGTACTTCGCGCTGCCCCTGCGCGTCGAGCACGAGGGGCAGATCCTCTCCTTCATCTCGTCCATCTCGACGTTCAACACCCCCATGGACGTGACGGTCGCCGAGCTGGCCATCGAGACGCTGCTCCCGGCCGACCCGGCGACATCGAAGTACCTCCAGTCGATGATGTCCTAG	MGPLLRAWRERRRVSQLELALRADSSARHISFVETGRSRPSEEFLLRLADHLDVPMRDRNSLLLAAGYAPRFRETPLDDPSMGALRESLDRLLTGYEPYPALVVDATYDVIAANHSLATLLGGLPEHLLASQPLNAMRLTLHPEGLAPRIRNLREWRGHLLHQMERQIALQRSDALRAVYDEVAAYPVADPGVDAFDADTDVPYFALPLRVEHEGQILSFISSISTFNTPMDVTVAELAIETLLPADPATSKYLQSMMS	MKNNKWKKKFIAIYIGQFFSLLSSAAVQFSIIWWLTDKTGGSPLVLTLAGLAGFLPQALAGPFAGTITDRYSRKLMMILADMTVALGSLILFISLYFYEINISFVILILAIRSLATAFHMPALQASIPLLVPEDDLTKAAGWGQTVSSISNITGPAVGMSILAASSIEWVLLLDVLGAVIASGILLFIYIPKIQNQNQQSIDSKGFFIEMKDGYNALVNHPILLKLTFVMTSVAVLYIPLGTYFPLITRNHFNKGVVEAGIVEIIFAVGLIIGGSFLGILGDKFNKINTMTTGILLMGIALFLTGILSPSLFYFFVVLAGLVGFSGPLFSAPFYALIQSEIEPHLLGRVFSFVTSISLLATPLGYVIAGLLIEITNVSTLFSIIGVLIIFNGIIINRLK	64.91	gnl|BL_ORD_ID|2806|hsp_num:0	3823			993	1119	
BGC0000703.1|Kanamycin_11 # 11661 # 12083 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.738	BGC0000703.1|Kanamycin_11 	11661	12083	-	Loose	1500	25.409	rphB	45.16	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGTCCGCGTTCCAGCTCACCGCCCTGGCCCGCACCACTGACCCGCAGACGATGCTACGCCGCTTCCTCGCGCTCGACGCGGTCGTGACCGCGGGAAACGGGCTCGCCTACGCCGCCGCGTCAGGCCCTCTCGGGCGCTTCCTCGGCGTCGACTCGGGACTGCTGCTCACCCTCGGAGTCTTCCTGACCCTGTACGCCGCGGGTGTCGGCTTCCTCGCCGCGCGCAAGAGTCCGCCGGTACTGCCCGTCCGGGCGGTGATCGAGGTGAACGCGGCCTGGGCGGTGCTCAGCTTCGTCGCCCTCGCCCTGTGGCTCTCGCCCGGCGCGGCGGGCGCCGTGTGGATCCCGCTGCAGGCCGTGGCGGTGGGCGGTTTCGCGGCGCTCCAGTACGCGGCGCTGCGCGCCATCGGGGGCGCGCGCTAG	MSAFQLTALARTTDPQTMLRRFLALDAVVTAGNGLAYAAASGPLGRFLGVDSGLLLTLGVFLTLYAAGVGFLAARKSPPVLPVRAVIEVNAAWAVLSFVALALWLSPGAAGAVWIPLQAVAVGGFAALQYAALRAIGGAR	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	15.84	gnl|BL_ORD_ID|2235|hsp_num:0	2528			582	663	rifampin; rifaximin; rifabutin; rifapentine
BGC0000703.1|Kanamycin_12 # 12336 # 16019 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.699	BGC0000703.1|Kanamycin_12 	12336	16019	+	Loose	750	28.4906	adeF	27.55	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACAGAGACGACCGAGCCCGCCGCCGCCCTGTTGCGGGCGGGCAAGTTCTTCCGGCGCGGCACCACCGCCCCCGACCTGCACAGCATCGGGCTCACCGGTGGCCGGGACGCGGACGCGTTCTACCGCGACCGCTGGAGCCACGACAAGGTCGTGAACTCCACGCACGGCGTGAACTGCACCGGCTCCTGCCGCTGGAAGGTGTACGTCAAGGACGGCATCATCACCTGGGAGACCCAGCAGACGGACTATCCGAGCGTGGGCCCCGACCGCCCCGAGTACGAGCCGCGCGGCTGCCCCAGGGGCGCCGCGTTCTCCTGGTACACGTACTCCCCCACCCGCGTCCGCTACCCGTACCTGCGCGGCGTGCTCCTGGAGATGTACCGCGAGGCGAAGTCCCGCCTGAAGGACCCGGTGCTCGCCTGGGCGGACATCCAGGGGGATCCGGAGCGCAGGAAGACCTACCAGCAGGCGCGCGGCAAGGGCGGTCTGGTGCGGGCGACGTGGGACGAGGCCGTCGAGATCATCGCGGCCGCGCACGTCCACACCATCAAGACGTACGGCCCCGACCGCGTCGCGGGCTTCTCCCCCATCCCCGCGATGTCGATGGTGTCGCACGCGGCGGGCGCCCGCTTCATGGGGCTCATCGGCGCGCCCATGCTGTCCTTCTACGACTGGTACGCGGATCTTCCGGTGGCTTCGCCGCAGGTGTTCGGTGACCAGACCGACGTGCCGGAGTCGGGCGACTGGTGGGACGCCGCGTATCTGATGATGTGGGGCTCGAACGTCCCGGTGACGCGGACGCCCGACGCGCACTGGATGGCGGAGGCGCGCTACCGCGGCCAGAAGGTCGTGGTCGTCGCGCCCGACTACGCCGACAACGCCAAGTTCGCCGACGAGTGGCTGCACCCGCACCCGGGCACCGACGGGGCGCTCGCCATCGCGATGGGGCACGTGATCCTCAAGGAGTTCTTCGTCGACCGGCAGACGGACTTCTTCACGGACTACGTACGCAAGTTCACCGATCTGCCCTTCTTGGTGACGCTGACCGAGCGCGACGGCGCGTACGTCCCTTCGAAGTTCCTGCGCGCCACCGACCTCGGCGAGGACGGGGAGGGCGGCGAGTGGAAGACGGCCGTGCTCGACGGGAACACCGGGCGGCCCGCCGTCCCCAACGGCTCGCTCGGCTTCCGCTGGACCGAGTCCGGCAAGGGCAAGTGGAATCTTGAGCTGGGCGACATCGAACCGGTGCTCACCCTGCACGGCTCCGACGTCGCGGCGGGCACCGAGGTGCTCCTTCCGCGCTTCGACACCGAGGGCGGCACGCACGGTCAGGGCCGCGGCGAGGTGGTGCGCCGCGGCGTTCCCGCCACACGGCTCGGCGGGCAGGACGGGCCGCTCGTCACGACGGTCTTCGACCTGCTGCTCGCGCAGTACGGCGTGGCGCGCGAGGGGCTGCCCGGCCAGTGGCCCGCGTCGTACGAGGACGCCGACTCGCCCGGCACGCCCGCCTGGCAGGAGGCGCACACGTCCGTGCCCGCCGCCAAGTGCGTGAAGATCGCCAGGGAGTTCGCGCGGACGGCGGAGAAGTCGCAGGGTCGGTGCATGATCCTGATGGGCGCCGGGACCAACCACTGGTTCCACTCCGAGACCATCTACCGCGCCTTCCTCGCGCTGCTCCAGCTCACCGGCTGCCAGGGCCGCAACGGCGGCGGCTGGGCGCACTACGTGGGGCAGGAGAAGTGCCGTCCGTCCACCGGCTGGGCGACGCTCGCGAGCGCGAACGACTGGAGTAGGCCGCCGCGCCAGATGATCGGCGCCGCGTACTGGTTCCTCAACACCGACCAGTGGCGCTACGACAAGTTCGCGGCGGACGTCCTCGCCTCACCGCTGGGCGAGGGCCGGTTCACGGGCATGACCGGCGCCGACTGCCTGGCCCTCTCGGCACGCTCCGGCTGGATGCCGTCGTACCCGACGTTCGACCGCAACTCCCTCGAACTCGGCGACACCACCAGCGACCCGGTCGCCAATGTGGTGGACGAACTCAAGGCGGGCACCCTCAAGTTCGCCTGCGAGGACCCCGACGCGCCGGAGAACTGGCCGCGCGTCCTCACCCTGTGGCGCGCCAACCTGCTGGGCTCCTCCGCCAAGGGCGCCGAGTACTTCACCAAGCACCTGCTCGGCACGCACTCCTCGCTGCGCGCCGAGGAGGCGGCCCCGAACGAGCGCCCCTCGACGGTGACTTGGCGCGAGGAGGCCCCCGAGGGCAAGCTCGACCTGCTCGTCTCGCTCGACTTCCGCCAGACGTCGTCGACGCTGCTCTCCGACGTGGTGCTCCCCGCGGCCACCTGGTACGAGAAGCACGACCTGTCGACCACGGACATGCACCCCTACGTGCACTCCTTCACCCCGGCCGTCGACCCGCCCTGGCAGGCCCGCACCGACTTCGACACCTTCCGCGTGATCGCGGACCGGCTGAGCGAGCTTTCGGTCGACCACCTCGGCGTACGCAAGGACGTCGTCGCCACCGCGCTCCAGCACGACACCCCCGGGGAGACCGCGCAGCCCGGCGGGGTCGTCCTCGACTGGCGCAAGGGCGAGTGCGAGGCGATCCCCGGCAAGACCATGCCGAACCTGGCGGTCGTGGAGCGCGACTACACCGCGATCGGCGCGAAGTTCGCCTCGCTCGGGCCGCTCGTGGAGAAGCTCGGACTGCCGGTCAAGGGCATCTCCTTCAACCCCGACCAAGAGGTCGAGGAACTCAAGGAGCGCAACGGCGTCGTGCGTGGCGGGCCCGCCGACGGACGGCCCGCCCTGGACACCGCGGTGAAGGCCGCCAACACCATCCTCGCCCTGTCCGGCACGACCAACGGGCGCCTCGCCACCCAGGGCTTCCACACCCTTGAGGCGCGCACGGGCCAGGAGATGGCACACCTCGCCGCCGAACACGAGGGCAAACGCATCACCTACGCCGACACACAGGCCGCCCCCGTCCCCGTGATCACCTCACCGGAATGGAGCGGCAGCGAATCCGGCGGGCGCCGCTACACCGCCTTCACGCTCAACACCGAACACCTCAAACCCTGGCACACCCTCACCGGACGGCAGCACTTCTTCATCGACCACGACTGGATGCACGAACTGGGCGAGGCGATGCCCGTCTACCGGCCGCCCCTGGACATGAACCGGCTCTTCGGCGAGCCACGCCTCGGCCCTGACGGCGAGAAGGAAGTGACGGTCCGTTACCTCACGCCGCACAACAAGTGGTCGATCCACTCCGAGTACCAGGACAACCTGTTCATGCTCTCCCTGTCGCGCGGCGGCCAGTGCATCTGGATGGCGCCGCAGGACGCGGAGTCGATCGGCGTCAAGGACAACGACTGGATCGAGGCGGTCAACAGGAACGGCGTGGTGGTGGCGCGCGCCATCGTCTCGCACCGGATGCCCGCGGGCACGGTCTACATGCACCACGCGCAGGAACGCACGGTGAACGTCCCCAAGACGGAGACCACCGGCAAACGCGGCGGCATCCACAACTCGCTGACCCGGCTCATCCTCAAGCCGTCCCATCTCATCGGCGGATACGCGCAGTTGTCATGGGCGTTCAACTACCTGGGCCCGACGGGCAACCAGCGCGACGAGGTGACGGTCATCCGCCGCCGCAGCCAGGAGGTGCAGTACTGA	MTETTEPAAALLRAGKFFRRGTTAPDLHSIGLTGGRDADAFYRDRWSHDKVVNSTHGVNCTGSCRWKVYVKDGIITWETQQTDYPSVGPDRPEYEPRGCPRGAAFSWYTYSPTRVRYPYLRGVLLEMYREAKSRLKDPVLAWADIQGDPERRKTYQQARGKGGLVRATWDEAVEIIAAAHVHTIKTYGPDRVAGFSPIPAMSMVSHAAGARFMGLIGAPMLSFYDWYADLPVASPQVFGDQTDVPESGDWWDAAYLMMWGSNVPVTRTPDAHWMAEARYRGQKVVVVAPDYADNAKFADEWLHPHPGTDGALAIAMGHVILKEFFVDRQTDFFTDYVRKFTDLPFLVTLTERDGAYVPSKFLRATDLGEDGEGGEWKTAVLDGNTGRPAVPNGSLGFRWTESGKGKWNLELGDIEPVLTLHGSDVAAGTEVLLPRFDTEGGTHGQGRGEVVRRGVPATRLGGQDGPLVTTVFDLLLAQYGVAREGLPGQWPASYEDADSPGTPAWQEAHTSVPAAKCVKIAREFARTAEKSQGRCMILMGAGTNHWFHSETIYRAFLALLQLTGCQGRNGGGWAHYVGQEKCRPSTGWATLASANDWSRPPRQMIGAAYWFLNTDQWRYDKFAADVLASPLGEGRFTGMTGADCLALSARSGWMPSYPTFDRNSLELGDTTSDPVANVVDELKAGTLKFACEDPDAPENWPRVLTLWRANLLGSSAKGAEYFTKHLLGTHSSLRAEEAAPNERPSTVTWREEAPEGKLDLLVSLDFRQTSSTLLSDVVLPAATWYEKHDLSTTDMHPYVHSFTPAVDPPWQARTDFDTFRVIADRLSELSVDHLGVRKDVVATALQHDTPGETAQPGGVVLDWRKGECEAIPGKTMPNLAVVERDYTAIGAKFASLGPLVEKLGLPVKGISFNPDQEVEELKERNGVVRGGPADGRPALDTAVKAANTILALSGTTNGRLATQGFHTLEARTGQEMAHLAAEHEGKRITYADTQAAPVPVITSPEWSGSESGGRRYTAFTLNTEHLKPWHTLTGRQHFFIDHDWMHELGEAMPVYRPPLDMNRLFGEPRLGPDGEKEVTVRYLTPHNKWSIHSEYQDNLFMLSLSRGGQCIWMAPQDAESIGVKDNDWIEAVNRNGVVVARAIVSHRMPAGTVYMHHAQERTVNVPKTETTGKRGGIHNSLTRLILKPSHLIGGYAQLSWAFNYLGPTGNQRDEVTVIRRRSQEVQY	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	115.86	gnl|BL_ORD_ID|132|hsp_num:0	153			618	888	tetracycline
BGC0000703.1|Kanamycin_13 # 16019 # 17674 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.673	BGC0000703.1|Kanamycin_13 	16019	17674	+	Loose	600	26.9498	OprZ	25.49	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGCGTGGCGAAGCCACTCAACGACGTGTGATGGCACAGATCGCGATGGTGATGAACCTCGACAAGTGCATCGGGTGTCACACCTGCTCGGTCACCTGCAAGCAGGCGTGGACCAACCGCGACGGCATGGAATACGTCTGGTTCAACAACGTCGAGACCCGCCCGGGACAGGGCTATCCGCGCCGCTACGAGGACCAGGAGAAGTGGCGCGGCGGCTGGGAGCTGAACAAGCGCGGCGCCCTCAAGCTGAAGAACGGCGGCCGCGTCAAGTCCCTCCTCGAAATCTTCTCCAACCCCAAACTGCCGGAGATCAAGGACTACTACGAGCCCTGGACGTACGAGTACAAGAACCTCACCGACGCCCCGCTCGGCGACGACTACCCGGTGGCCGAGCCGCGCTCGCTGATCTCCGGCAAGCCGATGAAGATCGAGTGGTCGTCGAACTGGGACGACAACCTCGGCGGCGCCACCGAGCACGGCGACCTCGACCCGATGGTCGCCAAGACCCGCCAACAGGCTGCCGACAAGGTGAAGTTCGCCTTCGAGCAGACCTTCATGTTCTATCTGCCGCGGATCTGCGAGCACTGCCTGAACCCGGCGTGCGTGGCGTCCTGCCCGTCGGGCGCGATGTACAAGCGCGAGGAGGACGGCATCGTCCTGGTCGACCAGGACCACTGCCGCGGCTGGCGCAAGTGCGTGACGGGCTGCCCGTACAAGAAGGTCTACTTCAACCACCGCACCGGCAAGGCCGAGAAGTGCACGATGTGCTACCCACGCGTCGAGGTGGGCCTGCCCACCGTCTGCTCCGAGACCTGCGTGGGGCGCCTGCGCTACCTCGGGGTGATCCTCTACGACCCCGACAAGGTGACGGAGGCGGCCTCCGAGCCCGACGAACACAAGCTGTACGAGGCGCAGTTGGGCGTCTTCCTCGACCCCGACGACCCGGAGGTGCGCCGCGACGCCGAACGCTGCGGGATCTCGTACGACTGGCTGGAGGCGGCCCGCCGCTCCCCCGTGCACGCGCTGATCAGCAAGTACAAGGTGGCGCTCCCTCTCCATCCGGAGTACCGCACGATGCCGATGGTCTGGTACATCCCGCCGCTCTCCCCCGTGGTGGACGCGCTGAGCGAGACCGGCCACGACGGCGAGGACCTGGACAACCTCTTCGGCGCGATCGACACCCTGCGCATCCCCCTCGAATACCTCGCGGAGATCTTCACGGCCGGTGACGTCGGCCCGGTGCGGTCCTCGCTGGAGAAGCTCGCGGCGATGCGGGCGCACATGCGGTCCATCAACCTCGGTGACCTGCCGGACAGTTCGGTCGCGCGGTCGGTGGGCATGTCGGCGCAGGAGATCGAGAAGATGTACCGGCTGCTCGCCATCGCCAAGTACGAGGACCGGTACGTCATCCCCACCGCCGCGGTCGGCGACGCCCGGCGCCTGGAGGAGTCGGCGCTGCCCGACTCGTGCAGCCTCGACTACGAGGACGGGCCAGGGATGGGCGGCGAGGGCCCCTTCGGTCAGGACTCGGGACGCAAGCAGCTGCCGCTGGTCACCATCGAGAACTTCCACGCGCTGCGGGCCAGGCAGACCGCCGACGAACAGCCGAGCGCGACCGAGGAGGCCCACGCGGCCAGGGAGGACGACAAGTGA	MPRGEATQRRVMAQIAMVMNLDKCIGCHTCSVTCKQAWTNRDGMEYVWFNNVETRPGQGYPRRYEDQEKWRGGWELNKRGALKLKNGGRVKSLLEIFSNPKLPEIKDYYEPWTYEYKNLTDAPLGDDYPVAEPRSLISGKPMKIEWSSNWDDNLGGATEHGDLDPMVAKTRQQAADKVKFAFEQTFMFYLPRICEHCLNPACVASCPSGAMYKREEDGIVLVDQDHCRGWRKCVTGCPYKKVYFNHRTGKAEKCTMCYPRVEVGLPTVCSETCVGRLRYLGVILYDPDKVTEAASEPDEHKLYEAQLGVFLDPDDPEVRRDAERCGISYDWLEAARRSPVHALISKYKVALPLHPEYRTMPMVWYIPPLSPVVDALSETGHDGEDLDNLFGAIDTLRIPLEYLAEIFTAGDVGPVRSSLEKLAAMRAHMRSINLGDLPDSSVARSVGMSAQEIEKMYRLLAIAKYEDRYVIPTAAVGDARRLEESALPDSCSLDYEDGPGMGGEGPFGQDSGRKQLPLVTIENFHALRARQTADEQPSATEEAHAAREDDK	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	119.01	gnl|BL_ORD_ID|2408|hsp_num:0	2796			981	1134	erythromycin; cefepime
BGC0000703.1|Kanamycin_14 # 17671 # 18267 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.727	BGC0000703.1|Kanamycin_14 	17671	18267	+	Loose	500	25.0238	APH(3')-IIa	33.33	3002644	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGACGCGCCACGCGGTCCTTTACCAGGCGGCGGCGCTCTGCCTGGCCTACCCCGACGACGAGTTCCGCGCGCGCCTGCCGCTGCTGAGGGCGGCGGCCCCCGCGGAACTGACCGGCTTCCTGGACCACGCGGAGGCGACCGGGCAGCGCGAACTGGCCGCGCACTACGTCCAGGTCTTCGACTTCAAGAACCGGCACAGCCTCTATCTGAGCTGGTGGCGGGACGGCGACACCCGGCGGCGCGGCATGGCCCTGGTGCGCTTCAAGGAGGTGTACCGCGAGCACGGCCTGGAGTTCAGCGGCGAGGAGCTGCCGGACTTCCTGCCCGCGGTCCTGGAGTTCTCCGCGCACGCGGGCCCGGTGCTCCTCACGGAGAACCGCAGCGGCATCGAACTGCTCCGCCTGGCCCTGACCGACTTCGGTACGCCGTACGCCGCCGTCCTCGACGCCGTCTGCGCCTCGCTGCCCGGGCCCTCGCCCAAGGACCGCGCCGAGGCGCTTGCCCTGGCCCGCTCGGGGCCGCCGCGCGAGGACGTCGGACTCGAACCGTTCGGCGGCATGGAACCCTTCGCACTCATCGGGGAGCGACCCGCATGA	MTRHAVLYQAAALCLAYPDDEFRARLPLLRAAAPAELTGFLDHAEATGQRELAAHYVQVFDFKNRHSLYLSWWRDGDTRRRGMALVRFKEVYREHGLEFSGEELPDFLPAVLEFSAHAGPVLLTENRSGIELLRLALTDFGTPYAAVLDAVCASLPGPSPKDRAEALALARSGPPREDVGLEPFGGMEPFALIGERPA	MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	75.00	gnl|BL_ORD_ID|1912|hsp_num:0	2114			45	252	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000703.1|Kanamycin_15 # 18264 # 18989 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=9bp;gc_cont=0.665	BGC0000703.1|Kanamycin_15 	18264	18989	+	Loose	700	25.0238	tet(D)	42.86	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGACCCTGCTCTGGGGCGCACTCCCCTACGTCGCCTTCGTCCTGCTCGTCGCGGGCGTCGTCTGGCGCTACCGCTACGACAAGTTCGGCTGGACAACCCGCTCCTCGCAGGTCTACGAGTCCAAGCTCCTCAACATCGCCTCGCCGATGTTCCACTACGGCATCCTCTTCGTGCTCGTGGGCCACCTCATGGGCCTGTTCGTGCCGGAGTCGTGGACGGACAAGGTCGGCCTGACCGAGAGCACGTACCACAAGCTGTCGCTGTGGGGCGGCACGGCGGCGGGCGCGCTCGCCGTGCTCGGCATCCTGATGCTGCTCTACCGGCGCCGCACCAAGGCGCCGGTCTTCCGCGCGACCACCGCGAACGACAAGGTGATGTACGTCGTGCTGCTCGCGGCGATCGTCATGGGCATGTGGGCCAAGCTCACCAACTCCGGCCTCGACGAGGGCTACAACTACCGTGAGACGATCGCGCCTTGGGCCCGCAGCCTCTTCACTCTGCAGCCGGACGTGGACCTGATGGTGGGCGTCCCGCTCACCTTCCAGATCCACGCGGTGATCGGGCTCCTGCTGTTCGCGCTGCTGCCCTTCACTCGGCTGATCCACATGTTCAGCGCGCCGGTGCAGTATCTCTTTCGGCCGTATGTGGTGTATCGGAGCCGGGACCCCAAGCGGGTGGGGGCTCGTCCGGACCGGCGGGGGTGGGAGCGGACCGGTTCATGA	MKTLLWGALPYVAFVLLVAGVVWRYRYDKFGWTTRSSQVYESKLLNIASPMFHYGILFVLVGHLMGLFVPESWTDKVGLTESTYHKLSLWGGTAAGALAVLGILMLLYRRRTKAPVFRATTANDKVMYVVLLAAIVMGMWAKLTNSGLDEGYNYRETIAPWARSLFTLQPDVDLMVGVPLTFQIHAVIGLLLFALLPFTRLIHMFSAPVQYLFRPYVVYRSRDPKRVGARPDRRGWERTGS	MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPLLGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICLLIRKPAPVAATC	61.17	gnl|BL_ORD_ID|1187|hsp_num:0	1138			123	207	tetracycline
BGC0000703.1|Kanamycin_16 # 19079 # 20941 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=7bp;gc_cont=0.690	BGC0000703.1|Kanamycin_16 	19079	20941	-	Loose	400	27.335	tetR	34.78	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCACGTGCGGTCGGGATCGATCTCGGGACGACGAACTCAGTGGTGGCCGTGCTGGAGGGCGGTGAGCCCACCGTCGTCGTCAACGCGGAGGGCGCGCGCACCACGCCGTCGGTCGTGGCGTTCGCGAAGAGCGGCGACGTTCTGGTGGGCGAGGTCGCCAAGCGGCAGGCGGTCACGAACGTGGAGCGGACCGCGCGCTCCGTCAAACGCCACATGGGCGACGGCGGTTGGCGCTTCCCGGAGAGCGGCTCCGTGGACGGCACCCGCTACACCGCGCAGGAGCTGTCCGCGCGCGTCCTGCAGAAGCTCAAGCGCGACGCCGAGTCCTACCTGGGGGAAGACGTCACCGACGCGGTGGTCACCGTGCCCGCGTACTTCGACGACACCCAACGCCAGGCCACCAAGGAGGCCGGTGAGATCGCGGGCCTGAAGGTCCTGCGCATCATCAACGAGCCGACGGCCGCGGCCCTCGCGTACGGCCTGGACAAGGGCGACGACCAGACCGTGCTCGTCTTCGACCTCGGCGGCGGCACCTTCGACGTCTCCCTCCTGGAGATGGGCGACGGCGTCATCGAGGTCAAGGCCACCAACGGCGACACCCAGCTCGGCGGCGACGACTGGGACCAGCGGATCGTCGAGCACCTGGTGCGGCAGTTCAAGAACGGCCACGGCGTGGACCTCGCCAAGGACAAGATGGCGCTCCAACGCCTGCGCGAGGGCGCGGAGAAGGCGAAGATCGAGCTGTCCTCGTCGAGCGAGACGGACATCAACCTGCCCTACATCACCGCATCCGCGGACGGACCGCTGCACCTGGCCGAAAAACTGACGCGCGCTCAGTTCCAGGAGCTCACCTCGGACTTGCTCGACCGCTGCAAGCAGCCCTTCCACCAGGCGGTCAAGGACGCGGGCGTCAAGCTGTCCGCGGTCGACCACGTGATCCTGGTGGGCGGCTCCACGCGGATGCCCGCGGTGAGCGAGCTGGTCAGGGAGCTCACCGGCAAGGACCCGCACAAGGGCGTCAACCCCGACGAGGTGGTGGCACTCGGCGCGGCCTTGCAGGCCGGGGTGATCCGCGGCGACGTGAAGGACGTGCTGCTGCTCGACGTGACCCCGCTGTCCCTGGGCATCGAGACCAAGGGCGGCATCATGACCAAGCTCATCGAGCGCAACACCACGATCCCCACCAAGCGTTCGGAGACCTTCTCGACCGCCGAGGACAACCAGCCGTCGGTGGGCATCCAGGTCTTCCAGGGCGAGCGGGAGATCGCCGCGTACAACAAGAAGCTCGGCGTCTTCGACCTCACCGGACTGCCGCCCGCCCCGCGCGGCGTCCCCAAGATCGAGGTCACCTTCGACATCGACGCCAACGGAATCATGCACGTGTCCGCGAAGGACGAGGCCACCGGGCGCGAGCAGCGCATGACGGTGACCGGCGGTTCCGCGCTGCCCAAGGACGACATCAACCGCATGGTCCGCGAGGCCGAGGAACACGCGGAGGAGGACCGCAGGCGCCGCGAGGCCGCGGAGACCCGCAACCAGGCGGAGCAGCTCGTCTACCAGACCGAACGCTTCCTGCGCGACAACGAAGAGCGGATCCCCGCCGACACGAAGACCGAAGTGGAGGCGGCCGCGGCGGAGTTGAAGGACCTCCTGAAGAACCGGGCGGAGGACACCGCGGCCCTGCGCACGGGCGCCGAGAAGCTCGCCTCGGTCAGCCAGAAGATGGGCCAGGCGATGTACGCGAACTCTGGCGGGGGCGCCTCGCAAGAACGGACAGCCTCGGAGCCCGCGGCCGAGGAGGGCGTGGTGGACGCGGAGATCGTGGACGAGGACGACAAGAACGAGAAGGGCGGGGCGTAG	MARAVGIDLGTTNSVVAVLEGGEPTVVVNAEGARTTPSVVAFAKSGDVLVGEVAKRQAVTNVERTARSVKRHMGDGGWRFPESGSVDGTRYTAQELSARVLQKLKRDAESYLGEDVTDAVVTVPAYFDDTQRQATKEAGEIAGLKVLRIINEPTAAALAYGLDKGDDQTVLVFDLGGGTFDVSLLEMGDGVIEVKATNGDTQLGGDDWDQRIVEHLVRQFKNGHGVDLAKDKMALQRLREGAEKAKIELSSSSETDINLPYITASADGPLHLAEKLTRAQFQELTSDLLDRCKQPFHQAVKDAGVKLSAVDHVILVGGSTRMPAVSELVRELTGKDPHKGVNPDEVVALGAALQAGVIRGDVKDVLLLDVTPLSLGIETKGGIMTKLIERNTTIPTKRSETFSTAEDNQPSVGIQVFQGEREIAAYNKKLGVFDLTGLPPAPRGVPKIEVTFDIDANGIMHVSAKDEATGREQRMTVTGGSALPKDDINRMVREAEEHAEEDRRRREAAETRNQAEQLVYQTERFLRDNEERIPADTKTEVEAAAAELKDLLKNRAEDTAALRTGAEKLASVSQKMGQAMYANSGGGASQERTASEPAAEEGVVDAEIVDEDDKNEKGGA	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	298.08	gnl|BL_ORD_ID|442|hsp_num:0	276			297	429	tetracycline
BGC0000703.1|Kanamycin_17 # 21092 # 21517 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.711	BGC0000703.1|Kanamycin_17 	21092	21517	-	Loose	600	24.6386	OprZ	29.0	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCAACCACGCGCTCCGCGCACACGGTCTGGGAAGGCTCGCTGACGGAGGGTTCGGGCACCGTCACCTTCGACTCCTCGGGCATCGGGGAGCAGGCGGTGTCCTGGCCGTCGCGCGCCGAGGAGGCGAACGGCAAGACCAGCCCGGAGGAGCTGATCGCGGCCGCGCACTCCAGCTGCTTCTCCATGGCCCTGTCGCACGGCCTGACCGGTGCGGGCACCCCGCCCACCCGGCTCACCACCTCCGCCGACGTGACCTTCCAGCCGGGCACCGGCATCACCGGCATCCACCTCACCGTCGAGGGCACCGTGCCGGGTCTCGACGAGGCCGCCTTCACCTCGGCAGCCGAGGACGCCAAGGCCAACTGCCCGGTGAGCCAGGCGCTCACGGGTACGACCATCACGCTTTCGGCCAAGTTGGCCTGA	MATTRSAHTVWEGSLTEGSGTVTFDSSGIGEQAVSWPSRAEEANGKTSPEELIAAAHSSCFSMALSHGLTGAGTPPTRLTTSADVTFQPGTGITGIHLTVEGTVPGLDEAAFTSAAEDAKANCPVSQALTGTTITLSAKLA	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	30.45	gnl|BL_ORD_ID|2408|hsp_num:0	2796			228	507	erythromycin; cefepime
BGC0000703.1|Kanamycin_18 # 21830 # 23461 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=7bp;gc_cont=0.704	BGC0000703.1|Kanamycin_18 	21830	23461	+	Loose	175	28.4906	vanT gene in vanG cluster	36.36	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGCGCATGAACTATTCGGACCGCGGTCCTTCTCCGCTCGAACCGGAGAAGCCCGGTGCGGCGGGCGACCGCGACTCGACCTTCGGCTGGTGGGGTGCCTTCAGCATCCAGAAGTTCGTCAACCAGGCGACGCTCTACCACACGCACGAGGATGCCACCGGCTGGCTGGCGTACCTCCAGCAGTTCTACGACCGCAACTTCTGGTTCGCCGACGGCGGCGCGCAGGTGTGGGCGTACGAAGAGACGTACGACAACTGGCAGGACCGCTACGGCATGGACGCGGTGTGCGCCGTGTACCACTCGGGGCACGGCGGCATGGACGGCAACGGCGTCTTCTTCGCGCCACTCGGCGCCGTCTGGGACGGCCGCAGCGACGCGATCTCCAACCGGATGGCCCTCGGCAACGAGAAGGTCAACTACGTCTTCTGGTCGACCTGTGACTCGCTCAAGGTCACCGGCGGCCACTCCCCGATCCGCACCTGGGCCGGTCCCAACATCGGCTTCCGGATGATCTTCGGGTTCGAGACCACCAGCATCGACAGCGGCGACTACGGCAAGAAGTTCTGGGAGAAGTGGCGGGCCGGGCAGACGTACTGCGACGCCTGGCTGAACGCCAGCTGGGACATCTACCACGGGCAGGCACCCTCGGTCGCCGCTGTCGGCACCACCCAGGCCGAGGCCGTCAACCGGCTCAACACCGAACGCAACTTCTACCGCGACCACGTGCCGGACACCTGGTACGCATGGCGCTGGTACTACGCGCGCGAAGGCGTCAGGGAACCGCTCACCCAGCTCCCCGGGCCCCAGCAGATCGTCCAGCTCGCGCCCCGCGACCCGAGCGCGGAACTCACCGCACTCGGCCGGCAGGCCGGGTTCCCGACGGCCGCGCTGCAGGAGGTGCAGGTCGAACGGCAGGGCGTCATCAGCGCGACCTCCGGCGACCGCGTCATCTCCACCGCCCCCGGTGCCAGCCGCTGGGTCAAGCTCGCCGAGCCCAACCACCGCAACACCCAGCAGCTGCCCACCGACCGGGCGATCCAGGCGGCGCGCACCTTCGCCGAGCAGTACGCCGAGGGCGCCGAGCTCGTCGTCGACAGCGTGCACGACCTGATGCAGAACTCCGGCACCAAGGACGGCTCCGAGGTCGGGCGCCCGGTGTCCCTGCAGACGCACGTGACGTTCCGGCAGGTCTTCGACGGCGTGCCCGTCATCACCCCCGGGCGCGGCCTGATCCGGGTCGGCCTGGACAACGACGGCACCGTCGTCCAGTCGCAGATCGCCACGCGCCAGGCCACCGGCGTCACGCGCGAGCCGAGCACGGAGGTCTCGCCGCCACCGCCCAAGGGCGGCAAGGCGACGGCCGCGCCGCTGGAGCGCGACCCGCGCAAGGCGCTCGACGCGGCGCAGCGCAAGCTGCTCGCCGAGCTCGCGGCGGTCACCGCGGGCGAGAGCGGACAGGGCGCGGCGCAGCAGCGTCAGCCCGAGGTCAAGGACGTGCCCGGCACGTTCGAGGTCGGCTACGAGGTCGAGGGCAACGAGGCGTACCCCGCGGCCCGCAAGCTCATCGAGATCGGCCAGCGGGACAGCATGTTCCGCACGCAGCGCTGGGTCGTCGCGCCGCTGGCGAGGTAG	MRMNYSDRGPSPLEPEKPGAAGDRDSTFGWWGAFSIQKFVNQATLYHTHEDATGWLAYLQQFYDRNFWFADGGAQVWAYEETYDNWQDRYGMDAVCAVYHSGHGGMDGNGVFFAPLGAVWDGRSDAISNRMALGNEKVNYVFWSTCDSLKVTGGHSPIRTWAGPNIGFRMIFGFETTSIDSGDYGKKFWEKWRAGQTYCDAWLNASWDIYHGQAPSVAAVGTTQAEAVNRLNTERNFYRDHVPDTWYAWRWYYAREGVREPLTQLPGPQQIVQLAPRDPSAELTALGRQAGFPTAALQEVQVERQGVISATSGDRVISTAPGASRWVKLAEPNHRNTQQLPTDRAIQAARTFAEQYAEGAELVVDSVHDLMQNSGTKDGSEVGRPVSLQTHVTFRQVFDGVPVITPGRGLIRVGLDNDGTVVQSQIATRQATGVTREPSTEVSPPPPKGGKATAAPLERDPRKALDAAQRKLLAELAAVTAGESGQGAAQQRQPEVKDVPGTFEVGYEVEGNEAYPAARKLIEIGQRDSMFRTQRWVVAPLAR	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	76.26	gnl|BL_ORD_ID|1522|hsp_num:0	1561			564	663	vancomycin
BGC0000703.1|Kanamycin_20 # 24977 # 27232 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.737	BGC0000703.1|Kanamycin_20 	24977	27232	-	Loose	600	31.9574	BKC-1	26.49	3004757	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BKC Beta-lactamase	GTGGTGTCCGGTTCGGGTGGAAACGTGAGGTGGCACGGCGTGACGCAAGGGCGATGGCGCAGAATCGGCAGCACGCTCTGGCGCGTGGTGGCCGTATGGGCCGTCAGCACGCTGACGATGCTCGTACTCGCCGGCATCCTGCCGGACTTCAAGCTCCAGTCGGACGACGGCGACAGCGCCACCCGCATCGCCGTCACCGCGGCCCTCGGCGCCGGCGCCTTCGGTGTGCTCTCGGCCGTCGTGTGGCCGCTCCTCGTGCGTGCCCTGCTCCTCGTACCCGCCCTCGTGCTCGGGCTGCTCGCCTTCTTCCTCAACGGGTCCCTGCTGCTCATCGCCCTGCGGCTGATCCCCGAGGGACGGGGCGAGGTCGGTGCGGAGACCGCCGTCGTCGTGGCCGCCGTGATGTCCGCCGTCGCGTCCGCCACCGGCGGCGCGCTCGCCGTCCGGGACGACGACGCCTACCGGCGCCGCCTCTACCGGCTCTCCGACCGGCGGCGCAGGCGGAACAGCGGCCGTGACGACCAGGACGGCGGCGGGCCCGTCACGCCCGGCACCGTGTTCATCCAGCTCGACGGCGTCGGCCACGACGTCCTGCGCGACGCGGTCGACAAGGGCCTCATGCCGACCGTCGCGGACTGGCTGGGCGAGGGGAAGCGCGGCGCCACGCACCGGCTCACTCCCTGGCGTACCGACTGGTCAAGCCAGACCGGCGCCAGCCAGCTCGGCATCCTGCACGGTTCCAACCACGACGTGCCCGCCTTCCGGTGGTACGAGAAGGACACCGGCGAGGTCATGGTCAGCAACCGGCCCGCCTCCGCCGTGGAGCTGCAGCGCCGCGCCATCGAACGCACCGGTGACGGCGGACTCCTCACCGTGGACGGCGCGAGCCGCGGCAACCTCTTCAGCGGGGGCGCCGAGCAACTTGCGCTCGTGCTGTCCATGGCGGCCAGGCGCGGCAAGGAGAACCGGTCGCGGGCCGGGTACTTCGCGTACTTCTCCGACCCCGCCAACGCCGTACGCACCGCGCTCTCCTTCGTCGCCGAGGTCTTCAGGGAGATCGGGGAGTCGACGCGGGCCCGCGTGAAACGGCGGCGGCCGCGCATCGGCCGCGGCGGGCTCTATCCGTTCATCCGCGCCTTCGCGACCGTCGTCGAGCGGGACGTCGTGGTCGCCGCCGTCATAGGGGACATGCTCGCAGGGCGCAGCGCGGTCTACGCCGACCTGGTCGCCTACGACGAGGTGGCGCACCACTCCGGGCCCACGGGACCCGACGTGGAGAAGGTGCTCGCGCGCCTGGACCGGTCGCTCGCGCTGCTCGCGCAGGTCGCCGAGCACGCCCCCCGCGCGTACCGGATCGTGCTGCTCTCCGATCACGGGCAGAGCCCGGGCGAGACGTTCCGCGCGCGGTACGGGCTGACCCTCGGCGACCTGGTGCGGGCGGGCTGCGGGCTGCCCGTGCCGCGCAGGGCGCAGCGCACGCACAGCGGCGCCGAGGCCAGGGCGTCGGTGCGGGCCGCGCTGCGCCGCCCGGTGGAGGAGGGCGCCGACGAGCGGCGTCCCGCGCGCCGGGCCGAGCCGATCGTGCTGGCATCGGGCAATCTCGGCCTGGTCTCCTTCCCCGACGTGCCGCACCGCATGACCCGCGAGGAGATCGACCGGCGGCATCCCGCGCTGCTGCCCACGCTCGCCAACCATCCGGGCATCGGCTTCCTGCTCGTACGCAGTGCGGAGCGCGGTCCCGTGGTGCTCGGGGCGCGCGGCGTCGAGGTGTATCTGGCCGAGGAGCCCGCGGAGCTCGGGCCGCTCGCCGATTTCGGGCCCGGCGCCATGGAGGCCGTACGGCGTACCGACGGCTTTCCGCACACCGCCGACATCATGGTCAACTCCTGGTACGACCCGGCGGAGGGCGAGGTGCTCGCCTTCGAGGAGCAGATCGGCTCGCACGGCGGGCTCGGCGGGGCGCAGGCCAGGCCGTTCCTGCTGTCGCCGCTCGCGCTGTCCGAACCGGTGGCGCCGGGGCAGGAGCTGGTCGGTGCCGAGCAGGTCCACCACGTACTGCGGTGCTGGCTCGGCGAGGAGCTGGGGCCGGAGGTTCCGGTGGGCGACGCGGGTGCGGTACGCGCGGAGAACCCGCAGGTCACGGCGCGGGAAGCCGTCGCGGAGGCTGCGGTTCCGGTGGATGATTCCCGGCCGAATGCCGCTGGCGGCACAGCATTTGCGGCCGCCGACGCCGCCGGGCAGGACAAAACACACTGA	MVSGSGGNVRWHGVTQGRWRRIGSTLWRVVAVWAVSTLTMLVLAGILPDFKLQSDDGDSATRIAVTAALGAGAFGVLSAVVWPLLVRALLLVPALVLGLLAFFLNGSLLLIALRLIPEGRGEVGAETAVVVAAVMSAVASATGGALAVRDDDAYRRRLYRLSDRRRRRNSGRDDQDGGGPVTPGTVFIQLDGVGHDVLRDAVDKGLMPTVADWLGEGKRGATHRLTPWRTDWSSQTGASQLGILHGSNHDVPAFRWYEKDTGEVMVSNRPASAVELQRRAIERTGDGGLLTVDGASRGNLFSGGAEQLALVLSMAARRGKENRSRAGYFAYFSDPANAVRTALSFVAEVFREIGESTRARVKRRRPRIGRGGLYPFIRAFATVVERDVVVAAVIGDMLAGRSAVYADLVAYDEVAHHSGPTGPDVEKVLARLDRSLALLAQVAEHAPRAYRIVLLSDHGQSPGETFRARYGLTLGDLVRAGCGLPVPRRAQRTHSGAEARASVRAALRRPVEEGADERRPARRAEPIVLASGNLGLVSFPDVPHRMTREEIDRRHPALLPTLANHPGIGFLLVRSAERGPVVLGARGVEVYLAEEPAELGPLADFGPGAMEAVRRTDGFPHTADIMVNSWYDPAEGEVLAFEEQIGSHGGLGGAQARPFLLSPLALSEPVAPGQELVGAEQVHHVLRCWLGEELGPEVPVGDAGAVRAENPQVTAREAVAEAAVPVDDSRPNAAGGTAFAAADAAGQDKTH	MTITFSRRQAIAGALLAVPAVSTLAASAGALLAVPAVSTLAASAGAATGGPLEKRLAELEGRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVGKSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGDDVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKTGDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERNAVIAEIGRIAAEA	239.94	gnl|BL_ORD_ID|2537|hsp_num:0	3563			435	858	
BGC0000703.1|Kanamycin_21 # 27751 # 28215 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=5bp;gc_cont=0.727	BGC0000703.1|Kanamycin_21 	27751	28215	-	Loose	450	27.7202	tsnR	32.56	3003060	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (A1067)	ATGGAAGACGCCGCGGGCATCGGCATCGGCACGGGCGCCGGAACCGGTTCCGGCACCGGCGTCGCCGTGGTGCGGGTCGCGGCGATCGCCAGCCTGACGCCCCTGGAGGAGCTCGAGGCCGACCCCTTCCTCGTCGACTCCCGCAGCCAGCACGCGATGTGCGCGCGGTGGGCCGCCGAACGGGGCTACGTGGTCACGCGCGAACTCGTCGTACGAGGACTGCGCGCCGACCACGTCGTGCTGTGGGGGGACGTCGAGGCGGGACTCGTGGACCTCTTCGTCGTACCGAGCCGACGCGTCCTGGAACGGGCGCTGCGCTCTGCCGACGAGTTCACCGCGGAGTGTGCGCGGCGGGGGGTGCGGGTGGAGACGGCGGGGCTCGCGGAGCCCGCGTACGACTCGGAGATGAAGGCGCATGTGCATCGGCGGCTTTCCATGCCTACGGCGGGGTACGACGGGCGATAG	MEDAAGIGIGTGAGTGSGTGVAVVRVAAIASLTPLEELEADPFLVDSRSQHAMCARWAAERGYVVTRELVVRGLRADHVVLWGDVEAGLVDLFVVPSRRVLERALRSADEFTAECARRGVRVETAGLAEPAYDSEMKAHVHRRLSMPTAGYDGR	MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVPFPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDEALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPMNPAAESLNVSVSAGIALHRRARRNLSRPRG	57.04	gnl|BL_ORD_ID|148|hsp_num:0	49			189	318	thiostrepton
BGC0000703.1|Kanamycin_23 # 29179 # 30159 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.675	BGC0000703.1|Kanamycin_23 	29179	30159	+	Loose	900	25.409	basS	29.31	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	GTGTGGACAACGGCTGTGACTTGCTTCACGTGGGCATATGCGTCGGTGACACATGAAGGCATTTCCGGGTGCGTCGTCGCCCGAATTCAGAGCCCCAGGCTGAGCCGGGTCGGAATATCTCCACGGACAGGCTGCCGCTTGATGCCAGAATCACGCCGCTCGGGCACCGCCGGATTCATTCCGACCTGGAACCTGATCGACGCCAGCAGCTCCCTCCTGGAGCCCGCCCGACGGCGGGCAGATCGTCCCACCCCGCGACCTTGCAGTCCGCCTCGAATTGCAGGGACCACTTTCCGCAAACAGCGCTCGGACAGAAATGCCGGTCTACCGGCTGGACCACTCTCCCTGGAGAAAATCTCACCGAAGGATCGATCGAACCGGCACCGACGCCCAGGTGGTTTGCCCGCCTCGTCACCGCGGTACAGCACGCCGTCCGCGTGCTGTGCGGTCATGGAACCTCCGGTTCACCTCCGCTCGCGCGGAGAGCACGCACAGCGGTGCGCCAAGTCCATCCTCGGCCGCGGTTCACCTCCGCTCACGCGGAGAGCACCCGTCGATCTGCCGGATGACGGACGCGTACTTCGGTTCACCTCCGCTCGCGCGGAGAGCACGCGGCGCGCAGCAGCACGTGGTGGGCGTGGACCGGTTCACCTCCTCTCGCGCGGAGAGCACCACACCGGGCGTCTGCTGCCGCCGGACAAGATCGGTTCACCTCCGCTCGCGCGGAGAGCACGCGGCGCGCAGCAGCACGTGGTGGGCGTGGACCGGTTCACCTCCGCTCGCGCGGAGAGCACTGTGCCGTTCACCTCGTGCTCGTCCTGCGCGGCGGTTCACCTCCGCTCGCGCGGAGAGCACCTTGCTCATGCCTGCGTCGCCCCCGTCCGGGACGGTTCACCTCCGCTCGCGCGGAGAGCACCCCAACTTCTGCATCGCCCGGTACTGGAGCGTCGGTTCACCTCCGCTCACGCGGAGAGCACCTGA	MWTTAVTCFTWAYASVTHEGISGCVVARIQSPRLSRVGISPRTGCRLMPESRRSGTAGFIPTWNLIDASSSLLEPARRRADRPTPRPCSPPRIAGTTFRKQRSDRNAGLPAGPLSLEKISPKDRSNRHRRPGGLPASSPRYSTPSACCAVMEPPVHLRSRGEHAQRCAKSILGRGSPPLTRRAPVDLPDDGRVLRFTSARAESTRRAAARGGRGPVHLLSRGEHHTGRLLPPDKIGSPPLARRARGAQQHVVGVDRFTSARAESTVPFTSCSSCAAVHLRSRGEHLAHACVAPVRDGSPPLARRAPQLLHRPVLERRFTSAHAEST	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	68.34	gnl|BL_ORD_ID|2350|hsp_num:0	249			1032	1206	polymyxin B
BGC0000703.1|Kanamycin_24 # 33347 # 33658 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.667	BGC0000703.1|Kanamycin_24 	33347	33658	-	Loose	600	24.2534	oleC	40.62	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCATCCATGATCGTGCTCTCCGCCACAGCCGTCCCCGACCACCTTCGCGGAGCCCTCTCCCGCTGGCTTCTGGAAGTCACCCCCGAGCTGTACATCGGTACGGTCTCGGCCCGCGTACGCGAGGAACTCTGGGCCTCCGTGACGGCGTGCGCAGACGACGGCACGGCTGTCCTGGCCTACCCGAGCGACAACGAACAGGGCTTCGAACTCCGCACCGCGGGGACGCAGCGCCGCCGCCCGGCGGACTTCGACGGGCTGACCTTGATCGCCTTCCGCCGAGAGAGTAAAGAAGATGCAAACCTCGTCTAA	MASMIVLSATAVPDHLRGALSRWLLEVTPELYIGTVSARVREELWASVTACADDGTAVLAYPSDNEQGFELRTAGTQRRRPADFDGLTLIAFRRESKEDANLV	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	31.69	gnl|BL_ORD_ID|2050|hsp_num:0	2264			492	588	oleandomycin
BGC0000703.1|Kanamycin_26 # 34679 # 35350 # -1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=AGGGA;rbs_spacer=7bp;gc_cont=0.726	BGC0000703.1|Kanamycin_26 	34679	35350	-	Loose	200	25.409	vanT gene in vanE cluster	29.55	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	TTGAGCATCTGGCTGACCCGCATCGTCCCCGACCTGCGCTCACGCGACGCCCGCCGCGACCTCACCGGCACCGCGACAGCCGTCGGCCTGCACCGCCGCCTGATGGCCCTGTTCCCCCAGGACGCCGGGCCCGACCCGCGCGCCCAATTCGGCGTCCTGTTCCGCATCGAGGACACCACCACCGGACCGCACGTCCTCCTGCAGAGCACCCACGAACCCGACCTCACCCGCCTGCCCGACGGCTACGGCACCTCCCTCAGCCGACCCCTGGACCCCCTCCTGGACGCCCTGGAACCCGGCCTGACGGTGCGCTACCGCTGCGTAGCCAGCCCCGTCCGCAAACCCGGAGCCACCACCCGCGAGGTCTACAACCTGCCCGCCGTCGTCCCGCTCAGCGGCGCCGCCGCCGACGAATGGTGGCTGCGCCAGGCCGACACCGCCGGACTCAAATCCCTCACCCACCACGCCCAGCCCCTGGACCCAGCCCAAGGGACACGCGGCCCGCACACCCCGGGCAAGGAACAACGCGTCCGCCACGCCCGCACCCGCTTCGACGGCTCCGCGATCATCAACGACCCCGACCTCCTCCGCCAGAAGATCACCGAAGGCATCGGCCGCGGCAAGGCATACGGCTGCGGCCTCCTCAGCATCGCCCCCGCCAAGGCCCTGTGA	MSIWLTRIVPDLRSRDARRDLTGTATAVGLHRRLMALFPQDAGPDPRAQFGVLFRIEDTTTGPHVLLQSTHEPDLTRLPDGYGTSLSRPLDPLLDALEPGLTVRYRCVASPVRKPGATTREVYNLPAVVPLSGAAADEWWLRQADTAGLKSLTHHAQPLDPAQGTRGPHTPGKEQRVRHARTRFDGSAIINDPDLLRQKITEGIGRGKAYGCGLLSIAPAKAL	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	31.77	gnl|BL_ORD_ID|4680|hsp_num:0	1308			1029	1161	vancomycin
BGC0000703.1|Kanamycin_27 # 35347 # 36189 # -1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.732	BGC0000703.1|Kanamycin_27 	35347	36189	-	Loose	1850	25.409	mdtF	28.07	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCCACACACCTGCCCGGCCTGCCCCCGAGCCCGGACTGCTGCTGCGACTGAGCGGGCCTCTGCAGTCCTGGGGCGAACGCAGTCACTTCAACGAACGCGACACCGCCCGCTTCCCGACCCGTTCCGGCATCATCGGGATGCTCGCCGCCGCGCTGGGGCGACGCCGCGGTGAACCGGTCGACGACCTCGCCCGGCTCTCGCTGACCGTGCGCACCGACCGGCCCGGCATCCTCCTGCGTGACCTGCACACCGTCGGCGGCGGCCTGCCCGCCAAAGCCACCGTCACCACCGCCGAGGGCAAGAAGCGCCCCGGGACCACCGGCACCCTGCTCACTCACCGCACCTACCTCGCCGACGCGGCCTTCACCATCGCCCTCACCAGCACCCCCGACGACAGGCCCCTGCTCGATCAGGCGGCCCAGGCCCTGAACACCCCGTGCTGGCCCCTTTTCCTCGGCCGCCGCTCGTGCCCGCCCGAAGGCCCCCTCCTGCTGGGCGCCTCCGAAGACGCCCTGCACCACCTGGTGCACCTGCCGCTCGCCGCCCATCCCGGCCGCGGGCAGCAGGACACCGAATTCCTCGCGGACCGCCCCCTGAACCGTCTTCCGTACGGGACGGCCACCCCGGTCGGCGCGGACGGCACACACCCTTCCGGCGAGGTCAACGACCAGCCGCTCTCCTTCGACCCACGCCGCCGCTCCTACCGTGCCCGGCCCCTGTACCGGCGCAGCCTGCGCCTCCCCACAGAGCAGTACGCCGGACTGGGCACCGAGCACGTCCAGGCACTGGGCGCCTACCTGCGCCAGCACCTGAACCAGCCGGAAGGGAGCCACCGTTGA	MTHTPARPAPEPGLLLRLSGPLQSWGERSHFNERDTARFPTRSGIIGMLAAALGRRRGEPVDDLARLSLTVRTDRPGILLRDLHTVGGGLPAKATVTTAEGKKRPGTTGTLLTHRTYLADAAFTIALTSTPDDRPLLDQAAQALNTPCWPLFLGRRSCPPEGPLLLGASEDALHHLVHLPLAAHPGRGQQDTEFLADRPLNRLPYGTATPVGADGTHPSGEVNDQPLSFDPRRRSYRARPLYRRSLRLPTEQYAGLGTEHVQALGAYLRQHLNQPEGSHR	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	27.00	gnl|BL_ORD_ID|103|hsp_num:0	121			693	864	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000703.1|Kanamycin_28 # 36186 # 37367 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.701	BGC0000703.1|Kanamycin_28 	36186	37367	-	Loose	200	26.1794	vanH gene in vanD cluster	39.13	3002944	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCCCGCTCCCGCCCGGTTCATCGACGTCCACATCGTGCAGTCCGTCCCGTTCGCCAACCTCAACAGGGACGACACGAACTCCGTGAAGACCGTGCAGTACGGCAACACCCTGCGTACCCGCGTCAGCAGCCAGTCCTGGAAGCGCGCCACCCGCGAGGTCTTTCAGGAGCGGATCGGCCAGGCGGCCCTGCGCACCCGGCGCATCGGCGAGCGCGTCACCCAGGAACTGGAAGGGCGCGGCTGGCCCCCGGCGCTCGCGCAGCGCGCCGGGGGCCACGCGGCGGCCGCCAGCAGCATCAAGTTCGAGCTGGCCAAGGACCCGGCCGACAACAAGCAGTTCCTGCCCAACACGGTGCTGACCAACGCGATGGTGTACGTGCCGGAGGCGGCGGTCGCCGAACTGGCCGATCTCGCCGAGCAGCACCGCCAGGAGCTGGAGAGCGCCAAGGACATCAAGAAGCCCGCCGACAAGAGCGTGCTGCCCAAGGACGCGGTCGAGGCCGTGCTGCGCTCGCGCAACGGCGTCATCAACCTCTTCGGCCGGATGCTCGCCGAGGTCGACGACGCGGGTGTCGACGGCGCCGTCCAGGTCGCCCACGCCATGACCACCCACGAGACGGACGTCGAACTGGACTACTTCAGCGCCGTCGACGACATCACCGCCGCCTGGAAGGACTCCACCGGCAGCGGCCACATGGGGCACACCGAGTTCAGCGCGGGCACCTTCTACCGGTACGCCACCGTCGACCTGCGTGATCTCGCCACGAACATCGGCGGCGAGGTGCGGGCCGCACGCGAACTAATCGCAGCGTTCCTGGCCTCCTACATCGAGTCGCTGCCGCAGGCGAAGAAGAACTCCACCGCCCCGCACACCATCCCCGACCTCGTCCACATCTCGGTGCGCTCCGACCGCCCGCTGTCCTATGCGGCCGCGTTCGAAAAGCCCGTCCGCGCGGGCGCTCCGGGCGGCTTCGGAGAGGTGTCCCGCGCCGAACTCGCCACGTACGCGCAGGCCGCGAACACCCTGCTCGGCACCGGACGCATCGTGACCTCCGGCTGGGCCAGCCTGGAGACCAAGGACCTGACCGGCCTGGGCACCCGCCATGAGTCCTTCGACGACCTCATCACCGCCGCCCTGGACGCCGCCCTGCACCCGGCCCACGACGGGGCGGCGGCGTGA	MPAPARFIDVHIVQSVPFANLNRDDTNSVKTVQYGNTLRTRVSSQSWKRATREVFQERIGQAALRTRRIGERVTQELEGRGWPPALAQRAGGHAAAASSIKFELAKDPADNKQFLPNTVLTNAMVYVPEAAVAELADLAEQHRQELESAKDIKKPADKSVLPKDAVEAVLRSRNGVINLFGRMLAEVDDAGVDGAVQVAHAMTTHETDVELDYFSAVDDITAAWKDSTGSGHMGHTEFSAGTFYRYATVDLRDLATNIGGEVRAARELIAAFLASYIESLPQAKKNSTAPHTIPDLVHISVRSDRPLSYAAAFEKPVRAGAPGGFGEVSRAELATYAQAANTLLGTGRIVTSGWASLETKDLTGLGTRHESFDDLITAALDAALHPAHDGAAA	MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAELSEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV	121.67	gnl|BL_ORD_ID|1348|hsp_num:0	1333			450	582	vancomycin; teicoplanin
BGC0000703.1|Kanamycin_29 # 37440 # 38186 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.736	BGC0000703.1|Kanamycin_29 	37440	38186	-	Loose	500	24.6386	mphF	43.75	3003071	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGACAGCGCAGAGCATCACCGAAGACAAGGCCGCGGCCCGACGTAGGCACCGGCAGGGGTTCACAGCGCACGTCGAGAAGCTGTGCCAGGACGCCGGGGCGCGCACGGCGCTGCGCAGCGGGCTGGGCCGCGGCATGGACGACGTACGGCGCATGCACCGCTTCATCGCCCCCCGGCTGCCCGGGGACCGGGTCGGCGAGGCCGAACAGCGGGCCTACTACGCGGTGGCCGCGATGATCGCGGCGCAACCCCGCCAGAGCCCCGCCGGGCCTGAAGACCCCGCCGAGACGGGAGCCGACACCGAGCCCGACACCGGGACCGAGCCCGCCGCGGGCCCCGAACCCGGGCGCTCCGCTGCGCCGGGCACGGCCACGACCGCCTCCGCACGGTACGGAACCAGTCTGGGCACCGCTTTCGCCCTCGCCGTCACCCAAGGCCCCGGCCGGGACCGGAAGATGCGGGAGTCCACAGCCGAGTCCCGCCTCAACCTGCTGACACGGCAGAGCATCACCGGCCTGCACCGTCACCTTCCCGCCTCCGTCCGCTACTTGCGCTCCCTGGGCGTTCCGCTCGACTGGGCACAGCTGCTGGACGACCTGATCGCCTGGCCCGAGTACTCCGGGCGGATCGCACGGCGCTGGCTGCAGGACTACTACCGCCTGAGCAGCCGGGCCCTGCGCGAGCACGCCGACCTGGCCGACCGACAAGAAGCCGAAGCAGCCGAAGCGGCCGCCCCCGGCGCGTAA	MTAQSITEDKAAARRRHRQGFTAHVEKLCQDAGARTALRSGLGRGMDDVRRMHRFIAPRLPGDRVGEAEQRAYYAVAAMIAAQPRQSPAGPEDPAETGADTEPDTGTEPAAGPEPGRSAAPGTATTASARYGTSLGTAFALAVTQGPGRDRKMRESTAESRLNLLTRQSITGLHRHLPASVRYLRSLGVPLDWAQLLDDLIAWPEYSGRIARRWLQDYYRLSSRALREHADLADRQEAEAAEAAAPGA	MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAAVKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVYVETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAWLADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEASLRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI	82.94	gnl|BL_ORD_ID|444|hsp_num:0	473			198	291	erythromycin; roxithromycin; clarithromycin; tylosin; azithromycin
BGC0000703.1|Kanamycin_31 # 39961 # 43137 # -1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000703.1|Kanamycin_31 	39961	43137	-	Loose	660	28.1054	MexS	34.57	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACGGGGAGGAGTATCTGGGTCACGTGGAGAGACTCTACGCGTCCGGCGCCAGTTCGCTGGATCTCGTGCTGCTGTGCTTCGCCGCAGACTCCGGCTGTCCGTCGAGCCGCCTCACAGGTGATTCGCTGGCCCGTGTCCTATCCCAACTCGACTACCTCACCGCCGTGTTGGCATGTTTCGGTAAGTGGAGCGCATTGTCAGTGGCGACTGCTATTCCTTGCCTCATGACGAATCACGGAGAGGCAACGCCCGGATGCGTTCCGCTCGATGCCCGGTTCTGGGGCAAGGAGCGGGAGCTCCCGCATCCCTATCCGGTCGTGTGTCATCTGCTGGACACTGCCGCTGTTTTCGGGGTCCTGTGGGATGTCCTGCTCGGTGCCGAGGTGCACGAGCGTGTGTCCGAGGCTCTCGGACTGCGGGTGGAGCAGGCACGGTCCGTGCTGTCGTTTTGGGCGGGACTGCACGACTTGGGGAAGATCACTCCGCCGTTCCAGGCGCAGGTGCCAGAGAGTTTCGCCGGGCTGCGGGCGGATGCCGCGTACCGGTTCGCTCCGGGGGCGGAGAAGGAGCGGGCGTTCCGTCATGAGATGGCGACGCACTGGTCCCTGACCCAACTGCTGGGCGAGGCCGGGTATCCGGCGGACGGCCGGTTGATGCGGCGGGCGGTGAGTCATCAGGTCGCTCAGCTGCTCGGCGGGCACCACGGGAGTTTCGGCGCGGTCCTCCTGTCCAAGGAGCTGTCTCGGGCGAGTGAGTATCGGCCCGGCCTTGGGGAGGAGGGCTGGGCCGCACAGCGGCGGGCGCACTTCGCGGAGTTGCGGCGCGTTACTGGAGCCGACGCGGTGCCGACGCAGGGGCTGCCTGCCGAACTGGCCGTGAGCGTCACCGGGTTGGTAGTCGTCGCGGACTGGCTGGCCAGCCAACGGGGCGCGATCGTGCCGCTGATGCCGCCGGTGGGCTGGCAGGGCAGGCCAGAGGAGCTGGATGCGCATTGGAGCCGCACGCAGGCGGCGGCGGTCGGGCTGGTGGCGAAGGCGCGTCTGGGGCGGGCCCGGTTTGACGCCGAGCGGTTCGAGGAGATGTTCCCGTTCTCACCCAACGCCCTGCAAGGTGACCTTGCTGAACGCCTTCCGCGGCTCGTGGGGGAGAGGGGGCCGGGACTGTTGCTGGTCACCGCGCCGACCGGGGACGGCAAGACGGAGGCGGCGCTGTACGCGGCCTCGGTTCTGGGGCGGGCCGCCAACGCGCGCGGCCTGTACTTCGCCCTGCCCACGATGGCCACGGCCGATGCGATGTTCCCGCGGGTCAGGGACTTTGCCGCCGAAGCCCTGGAGGGGGAGCGTGCTCTGACGCTGTTGCACTCCATGGCCTGGCTCAGCCCCGCCTATGCCCAGGACGAGCAAGCCCCCGAAGTCTCGGACGGAGCCGTCAGCGCCGACCCGGCCACGGCGACCGAAGCGGGGACATGGCTGCGCGGCTCCAAGAGGGGGCTGCTCGCACCGCTCGGTGTGGGCACGATCGACCAGACGCTCGCTGCGGTTCTGCCCCTGCGGTACAACGCACTGCGGCTGTTCGGCCTGTCCGACAAGGTCTTCGTCGTCGATGAGGCGCACGCCTACGGCCCGTGGATGCACCAGCTCCTCTCGCGCCTGCTGGAGTGGCTCGGCGCCTTTCGCGCGCCCGTGGTTCTGCTCTCGGCGACGCTGACCGGCCGCACGGCCGCCTCCCTGGTCGACGCCTACCGGCGGGGCGCCGGGTTCCTGGAGCCTTCAGCGGTCGAACCCGCCTATCCGGGCTGGCTCTTCACCGACTCCAGGACCGGCAAGATATCCAGGCCCCGCACCGTCACCAGCCAGCGTGCCCGCACCCTCGACATCGACCTGCGGCCGGTGGCGTGGGATGCGATGGAAGGGCCCGCCGCTACACCCCGGACAGAGGGTCGCCGCGCAGCCCTGCGAGAGGTGCTCCGCCCGGTGGCCGAGGAGGGCGGTACGGCGCTGGTGTGCTGCACCACCGTCGCCGAGGCCCAGCAGACCTTCCGCGATCTGTGCACAGCCTTCCCGGAACTGGCCCTGAGAGAGGGTGGGTTGCGGCTGCTGCACTCCCGGTATCCGGCCTTTGCCCGGCAGCGCATCACCGCCGACTGCGAGGAGGCCTACGGCAAGCTGCGCGGCGACCTTGAGGCAGCCCCGCCCCGCCCGGCATCAATCCTGGTAGCCACCCAGGTCGTTGAGCAGTCCCTCGATTTCGACTTTGACGTGGTCGTCAGTGATCTCGCACCCGTGGCCCAGCTCCTCCAGCGTGCCGGACGCGGACGCCGCCATGCACGCGGGAAGGCGGGGCGCCCACCGTGGGCCCACCTCGAGGACCGGCCGCTCCTGGTCGTGTTGGAGCCGGTCGACGGTGACGGCAAGACCGCAGTGCCCCGAACCTGGGGGGCGGTGTACGACGCCGGTCTGCTCCGGCGCACCGCTCTCCTACTCGCCGAGCAGACACGCACCGGCATCGCCATCCCCGATGGTGTCCAGAGCTTGGTCGACGCGGTGTACGCCGAGGACTTCGTCGACGGCCTGGATGCCGCCGCACGACTGGAGCTGCGCCGCATGGACTCCGAGCGCGCCGCCGGAGAGATAGCCGAGGAGCACCTCGCCGGCATGGTCGGCATCTGCGCTCCGGCCGATGTGGCCGGTGATCTCCATAAGCTCAGCCGCCAGGAGGCAGGGGTCACCGAGGAACTCCTGACGACCCGCCTGGGCGCGGACAGCGGCCGTGTCCTGTGTCTGTATGAGCAGCAGGACGGTGCCTTGACGCTGGACGACGCCGGAGCGCTGCCGCTGCCCCAAGGGGGCAAGCGGGGCCCCTCCCGGCAGGAGCTGGTGCAGATCATGGCGCATGTTGCCCCGGTGCCGGGCAGCTGGCTGCGCGGAGCCGAGGGGCACCCCGCCCCTCGGGGATGGAGCGAACAGGTGCCCCTCCGCGATCTCGTCTTGCTGACGGTGCGTCCCGACGACGCCGAGGGCACGACGTGGACTGGCCGCCACGGCAACCGGTCCATCCGGATCTCGGACATCGGCTTGGAGGACGTACCGCACGTCAGTTCACCGCAACGGGAGCCTGGCCGTTGGCAGCCAGCTTCCGCTAGCTTCAATGTGCCGCCCCAGCAGTGGCCCTGA	VNGEEYLGHVERLYASGASSLDLVLLCFAADSGCPSSRLTGDSLARVLSQLDYLTAVLACFGKWSALSVATAIPCLMTNHGEATPGCVPLDARFWGKERELPHPYPVVCHLLDTAAVFGVLWDVLLGAEVHERVSEALGLRVEQARSVLSFWAGLHDLGKITPPFQAQVPESFAGLRADAAYRFAPGAEKERAFRHEMATHWSLTQLLGEAGYPADGRLMRRAVSHQVAQLLGGHHGSFGAVLLSKELSRASEYRPGLGEEGWAAQRRAHFAELRRVTGADAVPTQGLPAELAVSVTGLVVVADWLASQRGAIVPLMPPVGWQGRPEELDAHWSRTQAAAVGLVAKARLGRARFDAERFEEMFPFSPNALQGDLAERLPRLVGERGPGLLLVTAPTGDGKTEAALYAASVLGRAANARGLYFALPTMATADAMFPRVRDFAAEALEGERALTLLHSMAWLSPAYAQDEQAPEVSDGAVSADPATATEAGTWLRGSKRGLLAPLGVGTIDQTLAAVLPLRYNALRLFGLSDKVFVVDEAHAYGPWMHQLLSRLLEWLGAFRAPVVLLSATLTGRTAASLVDAYRRGAGFLEPSAVEPAYPGWLFTDSRTGKISRPRTVTSQRARTLDIDLRPVAWDAMEGPAATPRTEGRRAALREVLRPVAEEGGTALVCCTTVAEAQQTFRDLCTAFPELALREGGLRLLHSRYPAFARQRITADCEEAYGKLRGDLEAAPPRPASILVATQVVEQSLDFDFDVVVSDLAPVAQLLQRAGRGRRHARGKAGRPPWAHLEDRPLLVVLEPVDGDGKTAVPRTWGAVYDAGLLRRTALLLAEQTRTGIAIPDGVQSLVDAVYAEDFVDGLDAAARLELRRMDSERAAGEIAEEHLAGMVGICAPADVAGDLHKLSRQEAGVTEELLTTRLGADSGRVLCLYEQQDGALTLDDAGALPLPQGGKRGPSRQELVQIMAHVAPVPGSWLRGAEGHPAPRGWSEQVPLRDLVLLTVRPDDAEGTTWTGRHGNRSIRISDIGLEDVPHVSSPQREPGRWQPASASFNVPPQQWP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	312.09	gnl|BL_ORD_ID|1039|hsp_num:0	1041			48	291	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000703.1|Kanamycin_32 # 43604 # 44845 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.729	BGC0000703.1|Kanamycin_32 	43604	44845	+	Loose	500	26.9498	SCO-1	47.22	3004856	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	SCO beta-lactamase	GTGCTCGCCGGGCGGGTGTCCGGCGCCGCACTGGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCCGCCAACCGGTTCGACCTCGCCGACCCCGAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCCGCCGGATACCTCGCCAAGACCGTGCCCGAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCACAGGGCTGATCGACTCCTCGTACGTACGGGTGCTCTCCGCGCGAGCGGAGGTGGGTCTGCCTCGCGGCCGCCCAGGCCATCCCTGGCGGAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCAGATCGTCATCGGTGTGCGGTCAGCTGGATGTGCTCTCCGCGCGAGCGGAGGTGGGTCGTAGCGCACCACCACGGCCCACCGGGGGTACACGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGTGGTCTCGATCTGGGGGCGGCCGTCCTCGTCGTGCTCTCCGCGCGAGCGGAGGTGGGTCGCAACTCGTGGTTCAGCGCCGCCTTGATGCGCTGTGCTCTCCGCGCGAGCGGAGGTGGGTCGATGCTCCACGCCCGAAGTACCGAAACGCACGGGTGCTCTCCGCGCGAGCGGAGGTGGGTCGTTCACCGCCGAGGAGTTCGCCGACCGGCTGGAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCCACCGCCCCGGTTCGGGTGGTGGCCTCTCAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGTCGTCCAGGTCCACGACGACGACCAGCACGTCGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGCTGCTCGCCGCCGCTTCCCCCGACCGTCAGGGTGCTCTCCGCGCGAGCGGAGGTGGGTCGCCGCCCGCCGTCGCCACGGCGTACATGACGGCGTGCTCTCCGCGCGAGCGGAGGTGGGTCGCGCAGGACCGTGTTCTGCGGGAGGAGTTCGCCGTGCTCTCCGCGCGAGCGGAGGTGGGTCGTGGCCTTCGCCAGCGGGCCCAGCTTCTTCAGAGTGCTCTCCGCGCGAGCGGAGGTGGGTCGCCGGGCGTGGAGATAGCGCCCCCGGCCACGTTGTGCTCTCCGCGCGAGCGGAGGTGGGTCGTACGGGCGCGTCCGGGCGGGCTGGTGCTCCTCGTGCTCTCCGCGCGAGCGGAGGTGGGTCGCACCTTGGCCCGGATCGTCGACCAGTTGGAGGGTGCTCTCCGCGCGAGCGGAGGTGGGTCGGTCATCGTGTTCCGTGTCTGA	MLAGRVSGAALVLSARAEVGRPPTGSTSPTPSALRASGGGSAAGYLAKTVPECSPRERRWVGTGLIDSSYVRVLSARAEVGLPRGRPGHPWRSALRASGGGSADRHRCAVSWMCSPRERRWVVAHHHGPPGVHVLSARAEVGRWSRSGGGRPRRALRASGGGSQLVVQRRLDALCSPRERRWVDAPRPKYRNARVLSARAEVGRSPPRSSPTGWSALRASGGGSATAPVRVVASQCSPRERRWVVVQVHDDDQHVVLSARAEVGRLLAAASPDRQGALRASGGGSPPAVATAYMTACSPRERRWVAQDRVLREEFAVLSARAEVGRGLRQRAQLLQSALRASGGGSPGVEIAPPATLCSPRERRWVVRARPGGLVLLVLSARAEVGRTLARIVDQLEGALRASGGGSVIVFRV	MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWFHRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADLCSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTTPRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGTRGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE	143.40	gnl|BL_ORD_ID|2627|hsp_num:0	3653			636	744	penicillin; cefepime; ceftazidime; cefuroxime; amoxicillin; piperacillin; cefotaxime; cefalotin; ticarcillin
BGC0000703.1|Kanamycin_34 # 45675 # 46310 # -1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.665	BGC0000703.1|Kanamycin_34 	45675	46310	-	Loose	1100	25.0238	mecR1	27.03	3000215	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGACCACCCTGCACGATGCGCCTGACTTGGCTGTCACCCCCACCGCCATCAGCAGCAGGCGGGCACGGGTAGCGCGGCGCATCACCGACGGACTCGACCCGAAGAACGTCATCATCGCCGTCAGCCTCTTGACCGGCCTTGCCCAGGACCGCCCACTGATGGGTCTCGCCTGGGGCGTCGAGGCGATCGTCTTCGCCGCGGTGATACCCGTCGCCTACATCAAGTACGGGATCAAGTCCGGGAAGTGGAGCGACCGGCACGTCGGCAACCGCCAACGACGCCTTCTCCTGATCCCCGTCATCATGGCGTCCGTCAGCATCGGCATCGGCACCATGCTCTGGCTCGGTGCCCCACGCCAGATGCTCGCCCTGGTCGTCGCGATGCTCACCACACTCGCTGTGCTTCTGCCGATCACCGCGTTCTGGAAGATCTCGGTGCACACCAGTGTCGCGGCCGGTTCGCTCGCGATCCTCGCGTGTGCGTACGGGCCCATGGTCTGGCTGGCCGTGCCGCTGGTGGGGGTGATCGCATGGTCCCGCGTGTTCCTGAGCGCTCATACGCTGGCTCAGACCGTCGCTGGAGGGGGCGTTGGTGCCATCGTGGCGGGGGGCGCATTCAGTGTGCTGAGTTCGTGA	MTTLHDAPDLAVTPTAISSRRARVARRITDGLDPKNVIIAVSLLTGLAQDRPLMGLAWGVEAIVFAAVIPVAYIKYGIKSGKWSDRHVGNRQRRLLLIPVIMASVSIGIGTMLWLGAPRQMLALVVAMLTTLAVLLPITAFWKISVHTSVAAGSLAILACAYGPMVWLAVPLVGVIAWSRVFLSAHTLAQTVAGGGVGAIVAGGAFSVLSS	MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI	36.07	gnl|BL_ORD_ID|586|hsp_num:0	645			72	183	methicillin
BGC0000703.1|Kanamycin_35 # 46307 # 47575 # -1 # ID=1_35;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0000703.1|Kanamycin_35 	46307	47575	-	Loose	500	26.5646	AIM-1	40.48	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	TTGACCTCCGATGACCACATAGCTCTCCTGACGATCATCCCGCTGTGGGCGGTCGTCGTCGTCCGCGCCAACGCCCGGCGCAAGCGCACCGAACCCAACGCGGGTAAGGACGCACTGTTCTGGACGTTCGTAGCCCTCGCCATCGGCACCACGCTGCGACTATCGCCGCTCGAACACGCCCTGGCCTCACTCACCGGGATACGCGACTCCGCCGTGTTGCCGAAGCACCTCTCCCTCGTGGTGGCGTGTCTTCTCCTGGTGGGCTGGGTCGACTCCGCCGTACCACCACGCAGTCCCGAACCGCGCTGGCGCCGCCTCGCTGCGTTCAAGCCGCGACTTGTCCTCGGCGCTGTCGCCGTCACCGCGGCCGTCGCGACTTTCCCCGGCGCCGCTCCCGCTCGGCTGGCCCCCAACGGGGACACGGACTTCATCAACGGCCAGTTCGGCGACGGGTGTGGCACCGCCTACCTCTTCGTCTACCTCATGCTCATCGGCGTCGCGCTGGCGCTGTCCGCCGCCTTGTGCACGGCGGCCGCCAACCGTAGCCCGGCGGGCGCTTTCCGCCGCTGCATGCAGCTCATGGCCATCGGTTGCGGGCTCGGCGTCAGCTACCCCATCTACCGGCTCACCTACCTCGGCTACGGTCTCGTCGGTTCCGATTTCCCGTTGACCGAGGACCAGTTCGACATGGGAGGAAACCTCCTCCAGGTCTCGACGATCCTCCCCGTCATCGCGGGCTCCAGCGTCCGCGCCATCGACCTCGTCGCCCGCGGCCTGCGCAACCGCCGCGCCCTCATCGACCTGCGCCCGCTGTGGATCGACCTCGTGTGCGTCCTCTCCCCGGACACTGTCCGCAAGCACCTGGACCAGGGCACTTCCTCATTCCGCGACTGGTGGAGCGTGCGCGACACCTACGACCGGCTCGACCAACGCGTCGTCGAGATCTGGGACGCCGCCTACGAACTGCTCCCGTGGATCGACGAGGACCTGCCCGCTCGCGCGCTGGCCGCAGCACGCGTCGAAGGCTTCACCGGCGACGACGCGGAAGCCGCCGCCGAGGCCGTGTGCCTGCGCATCGCCCGCCGCCGCGCGGTAGACGGCGAACCCCAGGCCTTTCCCGCGACCGTCGAGCCGCTGTTGGCGCTGCGCGACGACCAAGAGGCCAATGCCCGCTGGCTGACCCGTGTCGCAGCCGTCTACACCTCCACGCGCCTGGACTCCGTCGAGAAGGCGCTGGCGAACGAGAACGAAATGGTAGGAACAGCGTGA	MTSDDHIALLTIIPLWAVVVVRANARRKRTEPNAGKDALFWTFVALAIGTTLRLSPLEHALASLTGIRDSAVLPKHLSLVVACLLLVGWVDSAVPPRSPEPRWRRLAAFKPRLVLGAVAVTAAVATFPGAAPARLAPNGDTDFINGQFGDGCGTAYLFVYLMLIGVALALSAALCTAAANRSPAGAFRRCMQLMAIGCGLGVSYPIYRLTYLGYGLVGSDFPLTEDQFDMGGNLLQVSTILPVIAGSSVRAIDLVARGLRNRRALIDLRPLWIDLVCVLSPDTVRKHLDQGTSSFRDWWSVRDTYDRLDQRVVEIWDAAYELLPWIDEDLPARALAAARVEGFTGDDAEAAAEAVCLRIARRRAVDGEPQAFPATVEPLLALRDDQEANARWLTRVAAVYTSTRLDSVEKALANENEMVGTA	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	139.27	gnl|BL_ORD_ID|652|hsp_num:0	707			303	423	
BGC0000703.1|Kanamycin_36 # 47614 # 48141 # -1 # ID=1_36;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.655	BGC0000703.1|Kanamycin_36 	47614	48141	-	Loose	600	25.409	SFC-1	30.0	3006985	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SFC beta-lactamase	GTGATCCACTACGCCGACAGCCAAATATGCCGAGCTCTCGCGAGTTTCCCGGTTCCTGAACCACTGACCATCGACTCGCTGTTCGCCGTCATTCAGGATCGATACCCGCGGCCACTGGAACTGTGGCGAGAGGACCCGCCCCTCGCCGGTCTCCGGGCCAATGGCCTGTGGCTGACTCGTCCCGAGGCGGAGAGCGATGCCATCTGGGTCGCGCCGGAGCTCACCGGAGCCGCCGCCGTGCACACCCTTGCCCACGAAGTCGGGCACATCGCGCTGAGTCACAAGCCCGTTGTGCTGCCCGCGGAGCCAGAACCCGAGCCGTACCAATTCTTGTCAGCCGACTTCCTGGCCGGTTGCTTGATGGGCCGTACTCGATCCCAAGACGGCCCTCAGGACCCTGAGCACGTCAAGGTCGAGGACCAGGCGGAAAGGTTCGCGTTCGCCCTACGCCGGAAGGCGCTCGATCGCGCCCGCGAGAACCAGCACAGCGGCGATCCGCTCCTTGACCGCCTCTACAAGGCGCTCTAA	MIHYADSQICRALASFPVPEPLTIDSLFAVIQDRYPRPLELWREDPPLAGLRANGLWLTRPEAESDAIWVAPELTGAAAVHTLAHEVGHIALSHKPVVLPAEPEPEPYQFLSADFLAGCLMGRTRSQDGPQDPEHVKVEDQAERFAFALRRKALDRARENQHSGDPLLDRLYKAL	MSRTGRLSVFFSAIFPLLTLTNMAEAASQPPQVTVDKLKRLENDFGGRIGVYAIDTGSNKTFGYRANERFPLCSSFKGFLAAAVLSKSQQQEGLLNQRIRYDNRVMEPHSPVTEKQITTGMTVAELSAATLQYSDNGAANLLLEKLIGGPEGMTSFMRSIGDNVFRLDRWELELNSAIPGDDRDTSTPKAVAESMQKLAFGNVLGLTERHQLMDWFKGNTTGGARIRASVPANWVVGDKTGTCGVYGTANDYAVIWPVGHAPIVLAVYTSKPDKNSKHSDAVIADASRIVLESFNIDALRMATGKSIGF	56.63	gnl|BL_ORD_ID|4572|hsp_num:0	5642			645	795	
BGC0000703.1|Kanamycin_37 # 48175 # 48471 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.670	BGC0000703.1|Kanamycin_37 	48175	48471	-	Loose	700	27.7202	OmpA	38.89	3005044	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to peptide antibiotics	ATGTCGGTGCTTGCCGACTTCTTCGGGGTCCCGCTCGACGTCTTCAATCTGACCAGTACTGCGGCGAACACGACCGCGGGCGGTGTCATCGCCGAGCTCGAGCGCTTCCTCGACGAGCGACGCCAGCGCCAGGAGCCGGAGGGGAACGAGACCCTTGCCGTTCTCGCTCGATCTGCCAGCCGGTTGTCCCCTCAGGGCCAGGCACGTGTTGTCCAGTACGCCGACCGGCTAGGGGAAGTCGAGCAGATGGAGCACGAGGCCGGGGCAGGAGAGGCGAAGCGGCCCGACCACGACTGA	MSVLADFFGVPLDVFNLTSTAANTTAGGVIAELERFLDERRQRQEPEGNETLAVLARSASRLSPQGQARVVQYADRLGEVEQMEHEAGAGEAKRPDHD	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	26.20	gnl|BL_ORD_ID|2774|hsp_num:0	3787			774	882	polymyxin B; defensin
BGC0000703.1|Kanamycin_38 # 49089 # 49448 # -1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=AGCGA;rbs_spacer=11bp;gc_cont=0.689	BGC0000703.1|Kanamycin_38 	49089	49448	-	Loose	1900	24.6386	acrB	26.92	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGGTCGGCACTGTCGGCCGATGGGTCACGGGCAAGGGGGCGCCCAGCTCCCGCAAGTTCGCTGCACTGGTCGAGGAGCTCAAGGTCCCTCGGTCGCAGCTGCTGCTACCCCTCTCCGCTGACGCCGACCTCGCCGTGCTGCGAACGCGCGCCGGCCTCCGTCAGGAAGATGTCGCTGAACGTCTGGCCGTCCAGGCGTCGGACGTTTCGGAATTGGAACAGGGGGTTGGGCGCATGAGGGTTGAGTGGGTCGAGCCGCTGTCTGCCCTTTACGACGTTCCGCCGGAGCGGCTGGCCGCGGCCGTGGAAGTCGTGGAGGGGCGCTGGCGCGCGAACCTAGATGCCAAGCGCCAGTGA	MTVGTVGRWVTGKGAPSSRKFAALVEELKVPRSQLLLPLSADADLAVLRTRAGLRQEDVAERLAVQASDVSELEQGVGRMRVEWVEPLSALYDVPPERLAAAVEVVEGRWRANLDAKRQ	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	11.34	gnl|BL_ORD_ID|1011|hsp_num:0	1104			417	570	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000703.1|Kanamycin_39 # 49899 # 50273 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.632	BGC0000703.1|Kanamycin_39 	49899	50273	+	Loose	700	24.2534	oleD	36.0	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGGACACCCCGCAGGGACACCTGCCGTCGGCGGCACCCTTAACCTGCAAGGACTCACTGCGGTGCTGCGACTCATCGCAGACAGCGGCGACGTCGATGCCCTACTGCGTCAGCTGGACACGCTCCACGTCGATTACACAGAGGCCGCCAGGCGACTGAACATCCCGGAGAAGTGGCTCCGCGGACGCATAGGGTCACTCCCCCACCGGAAGATGGGCAAGTTCGTCGGCTTCACCGATGATGACCTCAGGGCCATTTCCGAGATGTACGCCGTGCGGCCTGATCTCGACGCGATCCCCATCGGTAACGGCCAGAGCGAGAGGGTCACAAACCTCACGCCGTCGCGACGTTCACGCGTTTCTTCACACGCCTGA	MGHPAGTPAVGGTLNLQGLTAVLRLIADSGDVDALLRQLDTLHVDYTEAARRLNIPEKWLRGRIGSLPHRKMGKFVGFTDDDLRAISEMYAVRPDLDAIPIGNGQSERVTNLTPSRRSRVSSHA	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	29.88	gnl|BL_ORD_ID|1253|hsp_num:0	1367			975	1122	erythromycin; tylosin
BGC0000703.1|Kanamycin_40 # 51663 # 52496 # 1 # ID=1_40;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.615	BGC0000703.1|Kanamycin_40 	51663	52496	+	Loose	300	26.9498	AAC(3)-IIc	35.59	3002535	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGTGACATCATGACCGATCTCGTATGGAATTCATCGCGGTCAAAGCGGGGATCCTTTACCGTCCTGCTCGCCCTTGCGCGTGAGGCCGATGAGCTGGGGCAAGCGACGTTGGCCCTGAAGGACATATCCAAGCTCACTCGGCTTTCTCCACGGTCTATCACCACGTGCCTTAGGGAACTGTCCGGCCTCGGTGAGCTGACCTACAGCTCTGGAGGCGGCAGGGGGCACCAGAACCAATACTCCATACGTCTCGGCCACCCTGCCGAACTGGCTCCATGCGGCGACGCCGTTTCGCAAGACGCAGGAAGCAATTACTCGGAAGCTACTTCTGGAAACAGGAAGCTTGACGCAGAAGGCAGGAAGTTCTTGCCACAGAACGAGGAAGTTTCTTCCTCGGGCGTACACGGTGTTATTACTCCCTACGGGAGTAATAACACCTCTCAAAAGCAAGCTAGCTCGCCCTCCTCCAAGTCGAGCCAGCAGGGATTGGAAGCCGCCGATATCCCGACTGGCGCCCAGGAAGTCGTTGCGGCACTGACCCACGCGGGGATGCTCGTGGGCTGGCGACTCTCGGACGACGAATGGAACCGGGTAACAGTCTTGTCGGCCCGCTGGGGCGCTGAACGGCTCGTGGAGCTCATCGCGCGGCGGTGGGATCCGGGTCGGCCACCTCAGTCAGCCCGCTACCTGCTCCGCATCTGGGACGACCTGCCATCCCATGTCCCCGCTGAGGCTCCGCAAGGCAACGTCGTCCCGCTTCGGCGTGAGCCCGGCGGCTGGAAGCCCTTCCGTAACTCGGCCAAGCCCAGCGCCTACCAGAACGGATTCTGA	MSDIMTDLVWNSSRSKRGSFTVLLALAREADELGQATLALKDISKLTRLSPRSITTCLRELSGLGELTYSSGGGRGHQNQYSIRLGHPAELAPCGDAVSQDAGSNYSEATSGNRKLDAEGRKFLPQNEEVSSSGVHGVITPYGSNNTSQKQASSPSSKSSQQGLEAADIPTGAQEVVAALTHAGMLVGWRLSDDEWNRVTVLSARWGAERLVELIARRWDPGRPPQSARYLLRIWDDLPSHVPAEAPQGNVVPLRREPGGWKPFRNSAKPSAYQNGF	MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETRNGARLDDKTRRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHKLGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRRVTYEMPMLGSNGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEVAECSCEPSG	96.85	gnl|BL_ORD_ID|1263|hsp_num:0	1378			108	282	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000703.1|Kanamycin_41 # 52535 # 53227 # 1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.674	BGC0000703.1|Kanamycin_41 	52535	53227	+	Loose	400	24.6386	aadA27	34.15	3004682	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGTGCCATCGACCGCATCCTCGCGGCGAAGGGACTACCTCTCTTGTCCAGCTCCGGCACTACGCCGATTCCCGACGAAGGGGGCCCCGGCGATCCCGGTTGGCATCACGGTGCTCGTGTCGAGTACGCGCTGACGCGCTGGGAGACTGCTACCCCGCCCCGATTCCGCACAGCTGAGGCGACGTTCCCTGATGTCAGGGCCTGGGCCGAGCGAGCTCTCGATGACCCTTCGAAGGCGGGGACGATGCTTCTTACCGGCCTGACCGGTACGGGCAAGACGCATCAGGCGTACGGGGCCCTGCGCCACATCGCGGCGGGCGGCCCCGACCGGTTCGAGCTGCTCGCGGTGAACAGCGCGGACATGTACGGGCATCTGCGGCCAACGCATGTGGTCGGGTCCTCGGAGCGGGAACTGAGGCGGTTGTCCACCGTGCAGTACCTGTTCCTCGACGACTTCGGGACGTCCAAGACGTCCGAGTGGACCGAGGAGATCACGTACCGGCTGATCAACTATCGCTACAACCACTGCCTCCCGACGATCATCACGTCCAACCTCCCCGCCCGCGACGCAGACGGCCCGGACCTGACCGACTTCGTGGGTGACCGCGTGGCCAGCCGCCTGGCCGAGATGGTCACGGCACTGGTCCCGATGATCGGGGACGACCGACGCCGGAGTCGGGGGGCCGCATGA	MGAIDRILAAKGLPLLSSSGTTPIPDEGGPGDPGWHHGARVEYALTRWETATPPRFRTAEATFPDVRAWAERALDDPSKAGTMLLTGLTGTGKTHQAYGALRHIAAGGPDRFELLAVNSADMYGHLRPTHVVGSSERELRRLSTVQYLFLDDFGTSKTSEWTEEITYRLINYRYNHCLPTIITSNLPARDADGPDLTDFVGDRVASRLAEMVTALVPMIGDDRRRSRGAA	MSETLQLEQLTESLQQLLGESLFAIYLYGSAVDGGLGPESDLDVLVVVNQALTLHQRQQLAETLLKISYPIGAAQRALEVTIVLKEQILSGSYPLSYELQFGEWLREELNQGALLRAHTDPDLSILLKKAQMHHRSLLGPSLTQWSTAIPEQHLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLITNEIVPKDQAAHWVIAQLPSLHQPILQRMIQEYKGEIRKQNWQQQHQALGPVVDFLSSKIDEQFNKKSSLIK	87.79	gnl|BL_ORD_ID|2241|hsp_num:0	3381			396	519	spectinomycin; streptomycin
BGC0000703.1|Kanamycin_42 # 53224 # 53577 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=5bp;gc_cont=0.703	BGC0000703.1|Kanamycin_42 	53224	53577	+	Loose	700	23.8682	CMY-143	31.58	3005204	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGATGCCGGTCCGCCTCCAAGGCTCCGCTCGTACCGCCGGGAGGTCGCCCGCCTCCTGCATCTACGTCGGCGGGGGCACCCGCTACGCCAACCCCTTCCGCGCCGGTCACCCAAGTCCCTTCGTGCGCCGGAGAGCGATGACTGCGCACGAAGCCGTGCACCTCTTCGACGCCATGCTCCGCGGGCCTGTGGGGCGCTACTACGCCGAGCGGTTCGCCCGCTCCCTCTACGGCCTCGACCTCATGTGCACCTGCCCCCTCGATGCCCCCTGCCATGCCGACGTCCTGCTCCGCCTGGCCAACCGCACCGAACCGCGCCTCGCCACCTGCTCTCTGGAAGGACCTGCTCGATGA	MMPVRLQGSARTAGRSPASCIYVGGGTRYANPFRAGHPSPFVRRRAMTAHEAVHLFDAMLRGPVGRYYAERFARSLYGLDLMCTCPLDAPCHADVLLRLANRTEPRLATCSLEGPAR	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFDALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	30.71	gnl|BL_ORD_ID|2873|hsp_num:0	3891			486	594	
BGC0000703.1|Kanamycin_44 # 53975 # 55117 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.668	BGC0000703.1|Kanamycin_44 	53975	55117	+	Loose	1900	30.4166	MuxB	32.79	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACGTGGAGCGCACTGCGGTGGCCCAGGCAACGTTGGCGAGGGGCTCGCACGAGCTGCGCAGGATGTGTGTCTGGGACCGCGCAGCGATCATCCTGCTCGGTGCGGCTGGCTTCGCCTTCTCCTACGACGCACTGCGACAGGTGGCCATCGCGATACACGCACGTCCGTCGCTCTCCTACCTGTTCCCGGTCTTCATCGACGGGTTCATTGCGTACGGCGTGCGGGCGCTCGTGCTGCTTCGTCACAGTGGTTTTGGTGCGCGCATGTACGCCTGGTTCCTCTTCCTGGCAGCCACGGGATCGAGCCTGTGGGCCAACGCGTTGCACGCGATCACGCTCAACCGCGGTCCGCAGTCCGGCTCGTCCGCGCTGCACTTGGAGGACCGTGTCGTCGGTGTCCTTTCCACGCTCGCGCCGCTGGCACTCGCGGGTTCGGTCCACCTCTACATCATCATGGCGCGGACGGCCGAGTCGTCCGTCCCGGACCGTTTCAAGACCCGTCCGGAGCCTGTCCGCGAGGCCGTCCGGACAGAGCGGACAAGCGCCACGGAAGATCAGTTCGAGCGTGGCTGGTCCGGCGCTGCACCAGCTTCTGAGTCGGTCGCAGTCCCCGGTTCGTCTGCAGCGGACGGTCGTGATCCGGGTTCAACGGATGGGCAACGAGCCAGTCTGGACAAGGGGAACCCGCCCGCCTCAGTCCACCCTAGGGACGCGGAGGGTTGGCCCTCCGCAAGCCGGGAGCATGTGGAGAGCGTCCCGGACGGACGACCCCGACCCGCCGGTCCCGAAGGTACTTCCGTCCCGGACGGTTCACCGGTCCCCGCTGACCGAACGGAAGATCAATCACCGGACCACGGGACGGCCAACCCCCTCGCGGACGAAGACATGGTTCCCGTCCCGGACGGTGGTGAAGCTTCAGAGGACCGTGAGATCGCGGACGACTGGAAGGAGCGGCTGCTTCCCGTCGCCCGAGAGGCTGCCCAGCAGGCCGGAAAGATCACGCGTGACGCGATCAAGTACGCCGTCCGCGCTCGCGAGCAGGTCGGCAATGACCGGATGGGCGAGCTACTCGCGGCACTACACGAAGAGGCGGAAGCAGCGCAGAATCGCGCTCCCGTCACTGTCTCCAGCGTCCTGTGA	MNVERTAVAQATLARGSHELRRMCVWDRAAIILLGAAGFAFSYDALRQVAIAIHARPSLSYLFPVFIDGFIAYGVRALVLLRHSGFGARMYAWFLFLAATGSSLWANALHAITLNRGPQSGSSALHLEDRVVGVLSTLAPLALAGSVHLYIIMARTAESSVPDRFKTRPEPVREAVRTERTSATEDQFERGWSGAAPASESVAVPGSSAADGRDPGSTDGQRASLDKGNPPASVHPRDAEGWPSASREHVESVPDGRPRPAGPEGTSVPDGSPVPADRTEDQSPDHGTANPLADEDMVPVPDGGEASEDREIADDWKERLLPVAREAAQQAGKITRDAIKYAVRAREQVGNDRMGELLAALHEEAEAAQNRAPVTVSSVL	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	36.43	gnl|BL_ORD_ID|2364|hsp_num:0	2718			819	999	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000703.1|Kanamycin_45 # 56327 # 58900 # 1 # ID=1_45;partial=00;start_type=TTG;rbs_motif=AGCGA;rbs_spacer=11bp;gc_cont=0.605	BGC0000703.1|Kanamycin_45 	56327	58900	+	Loose	500	27.335	mphF	33.33	3003071	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTGCGGACGTGCAGAAAACCCAAGAGACGAAGACCAGTTTGGCTGGGGGTGCTCATCGCCGCCCTTCTGTCATCCCTGATCGCGCCAGCAGCGCAGGCTCAGGGCAGCGGCGAGCGAGCCGGCCGGTTCGTCGTCACGAGCCCCGACGGGACCCCGCTCAAGAACCCCGGCAAGCCCCCGCAGACCCTCGATGAACGCCGGAAGCGCATACAAAAGGAGACCCCGGAACAGGTTCGCACCAGAAGCAACCACCTCAACAAGATCAAGAAGAACGAGAAGGTTGGGCCTCGGCTGGCGGGAGATTTCCCTCCCGCAGCCATGACGGAGTGCTACGACGCCGACTACAACGGCGCAAACACGGTGACGCTCAGCCACTGGAAGTGGTGCAAGAAGGCCCTCGGGAGCTACTCCTCCTACGAGAACTGCAAGGGCCCGCCTCCAGGAAATGGCTGCGTAGAAATCGGCAGCGTCCAGTTCCGTATCGGGATCATGGGGCAGGGATACCAGGACAAGAACGATCGCAGCGCCCGCAAGGCTCGGTACTGGATGATGCTCGACCAGCCCCAGACCTTCGGCGCCCCACGCATCACCGACCAGCTCGGCTTCACGGGGGTATGCACTTCGTTCAACTCGGGAGCTGCATGCGATGCCGCCGCAGGAAACGGTCGAATCGACTCGATCGCGGGGTGGATGCAAGCCGGCTATGTGGATTGGAAATACTCGTCCCCTGAGGGTTCGCTGTCCGGCGACAAGATAGCTTACATGGATTTCACCCTGAACTCAATGGTGTTCCAGGAGTATCCAGTACCGGGAATCATGATCCCGCCCGGTGAGGCGGGATTCCGTTGCGACTCGGCCACCTACATGAAATGGCCTGTCGGTGTGCCATCGTACGGATGCGTATTCGACGGGGTCACATCCATCTGGAACTTCAAGGCGGAGCCTGGTGTTGCACAGACCGCCAAGCATGTATGGACCGCGCAATTCAAGCCGAACTCGACTCGACCGCCAACGGTCGGCGACAAGGACATCCCAGGTTCGATTCAGAGTGGTGAATCACTGGAACGGTTGGCAGGTGCGGCCGGGAGTGAAAACGACGTACTGCACAAGAAGAACAGGGATAAGTCGACTGCGGCTTGCGTAACGAACTTCGGTAAATCCTACTCCAGGGGTGCGACACTCGACTGTGACGAATACCCCATGGCATCGACACGGGAAGGCGCTTCGACAGGAGGCGTCGAGGACGACTCGACGGGGCATTTCTCCGTCAGACCTCTGAACGGAGGCGACAACCAGGCGGCTGGCCGTCTCCTTAATACGTTCTATCTCGATGAACGGATCATCAACACAGACACCTTCTTCGTCAATGTGCTCGCAGCAGACGGCGGGAAATACCCTGGGGTGGATGAACCGGACGGCGTCTCCTCACCAGTCTCCAACCGGTCGTGTGATCTTCGCCAGCCAGAGGTACACGACGTGAAAACCAGCGCCGCTCCCGAAAAGACCTTCCTGAACTACGCGAAGAACACACCCGACGGATGGACCGGAGGTGACTCAACCTTCTCCGCCAAGCTCCCGGACGGCCGCATTCTCTGGCTCTTCTCCGACACCTTCCTGGGACCTCTCAACAGCAACGGCACCAGGCCTACGAGCGCACAGCTCGTCAACAGCACCTTCGTGGTCCAGGACGGCGACAAAATGACCACGCTCCGGGGCGGGACCAAGACCAAACCCGAGGGCCTCATGAAACCGGCCGCGGACAAACACTGGTACTGGCTGGGAGACGGGCAACTGCACAAGGAGGGGAACACCACCTACCTGCAGGTCATCTTCCAGGAGTACTACAAGTTCGGTCCAGGGAACTGGGACTTCAAGCACAAGGCCAACTTCGTCGCCACGTTCTCCCTCGACGACTTGGGCACGGCACACGGACACGAGCCCCTGTACATCGAGCCCGTGCCCTCAACGCCTGGCGTCGGGTGGGGATCAGCTCTGCTTCCCGCCGGCCTCAGCGGCGACCGCTACACCTACATCTATGGAGTGGACGATGCTCCGCTGAACAAGAAGATGCGCATCGCACGCGTGGAGGGCACCGATCTCACCGGAAAATGGGAGTACTACAACCCCGGTGCCGGCGGCTGGATGCGCAGCGAGAAGCAGGCAGCGAACGTTCACACCGGGATCGCCAACGAGTACAGCGTGACGCCATGGAATGGTGGCTTCATGGCAGTCAGCCAAACAAGCAAGGAAGGCTTCAGCGGGCAGATCAAAGCATCAGTTTCCTGCTCCCCGCATGGCCCCTTCCAGCTTGAGACAGACGTCTACCGCATGCCCGAACCCGGCCCCTGGGGCAGCTACGCAAACCCGAACGTGATCAGCTACAACGCTCACGTCCACAGAACGAAGCTGCCAGACGGGCTCGGCCCCTACACCCTCTCCTACAACGTGAACAGCATGGACAACCGCGTGAATCCGAACGCCGATCACTACAGTGACCCCAGTATCTACAAGCCACGCTTCATCACGTTCCAGATGTCGCCACGCGGCGGGACCGTCAGACCTCCTGGCCGCTAG	MRTCRKPKRRRPVWLGVLIAALLSSLIAPAAQAQGSGERAGRFVVTSPDGTPLKNPGKPPQTLDERRKRIQKETPEQVRTRSNHLNKIKKNEKVGPRLAGDFPPAAMTECYDADYNGANTVTLSHWKWCKKALGSYSSYENCKGPPPGNGCVEIGSVQFRIGIMGQGYQDKNDRSARKARYWMMLDQPQTFGAPRITDQLGFTGVCTSFNSGAACDAAAGNGRIDSIAGWMQAGYVDWKYSSPEGSLSGDKIAYMDFTLNSMVFQEYPVPGIMIPPGEAGFRCDSATYMKWPVGVPSYGCVFDGVTSIWNFKAEPGVAQTAKHVWTAQFKPNSTRPPTVGDKDIPGSIQSGESLERLAGAAGSENDVLHKKNRDKSTAACVTNFGKSYSRGATLDCDEYPMASTREGASTGGVEDDSTGHFSVRPLNGGDNQAAGRLLNTFYLDERIINTDTFFVNVLAADGGKYPGVDEPDGVSSPVSNRSCDLRQPEVHDVKTSAAPEKTFLNYAKNTPDGWTGGDSTFSAKLPDGRILWLFSDTFLGPLNSNGTRPTSAQLVNSTFVVQDGDKMTTLRGGTKTKPEGLMKPAADKHWYWLGDGQLHKEGNTTYLQVIFQEYYKFGPGNWDFKHKANFVATFSLDDLGTAHGHEPLYIEPVPSTPGVGWGSALLPAGLSGDRYTYIYGVDDAPLNKKMRIARVEGTDLTGKWEYYNPGAGGWMRSEKQAANVHTGIANEYSVTPWNGGFMAVSQTSKEGFSGQIKASVSCSPHGPFQLETDVYRMPEPGPWGSYANPNVISYNAHVHRTKLPDGLGPYTLSYNVNSMDNRVNPNADHYSDPSIYKPRFITFQMSPRGGTVRPPGR	MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAAVKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVYVETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAWLADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEASLRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI	286.62	gnl|BL_ORD_ID|444|hsp_num:0	473			357	501	erythromycin; roxithromycin; clarithromycin; tylosin; azithromycin
BGC0000703.1|Kanamycin_46 # 58937 # 59380 # -1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.597	BGC0000703.1|Kanamycin_46 	58937	59380	-	Loose	1250	25.0238	mecA	28.57	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGCCCAGTCTGGTCAGTGCTGTTGACGTCCGCCCGTGTGTCTCATACCGGACCATCCAAGTCGGCCCCATCCTCTTCGAAGAGGCGCCGGCAGAAGACGAAATCATCCAGATCCCCGGTGACGGTCTGACGCTGACTTCCAGCGACAATGACTTCTTCCCTCTGGTACGGCTGGAAGTATGGGACGGCACCCCAGCGAAGCCGGATGAGGCCTGGGAGTACGAGCGATCCTTCTGCGCCCCCCTGACGGATAACTTCGTCGTCATCGACCTAAACGGCAGAACGCAGGGTGAGATCACAGTCGAGCCAAGAAAGCACCACATCCGTGTGCTGTGCCGGGGGCGGGATCACTATGAGGCATCCCTGGCCCTTGACCCCTTCCCTCCAGTGGGCCCTCATGAGGACCCACTGGAGTTCTGGGTTATTCAATTGTGGCCTGCCTGA	MPSLVSAVDVRPCVSYRTIQVGPILFEEAPAEDEIIQIPGDGLTLTSSDNDFFPLVRLEVWDGTPAKPDEAWEYERSFCAPLTDNFVVIDLNGRTQGEITVEPRKHHIRVLCRGRDHYEASLALDPFPPVGPHEDPLEFWVIQLWPA	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	22.01	gnl|BL_ORD_ID|1216|hsp_num:0	1321			1374	1584	methicillin
BGC0000703.1|Kanamycin_47 # 59849 # 60577 # -1 # ID=1_47;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.628	BGC0000703.1|Kanamycin_47 	59849	60577	-	Loose	700	27.7202	tet(41)	29.03	3000569	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGCCACAGCAACGAGCTCTCCATACATGGCGCATCAGGCTCCGCCGCGCCGCGCGTGAACGATGTACTGGCCCACCTGGAACAGGTGGGCGAAGGACACACAGGAACCGCCGACGGGCTGAACCGGCTGATGGCCTGGATGGACGGCCATGTCGGTCCCGTTGCGGAGGACAGCACCTATGCGGCATCGGCCGAACAGTATGGCCTCCATGGCATGGTCCTCGGCGGATACCGGGCCGGAGCGGGGGCATTCGTTCAGTCCGTGACACTCCAGCTCTGGGGTCAGCGGAGCGAGTCGTTCGGGATCTTGTCTACCGACGCTGGCAGCCTCAAGTTGTTCGCGCCCGGTGACACATGGCCTACAGAGGAATGGGATCGCTGGGCTGAGGGGAGCGTGGGGGCAGTGATCGTCGCCAACACTCAGCACTTGGAGGATTGCTTCGCAGCGCTGAGGTACGTGGAGACCCGAGGGATTCAACACGTTGTGGCAGTTCCCCACGTTGCGGGTGCTCCGACATACGAGGAGGAAGACATCCGGTCGGCTCTGGGAGTGCCCGCTACCGTCCCGCTGACGCGTTTCAGTACGCAGGAAAAGGCGACAGTGGGCAACACGTTGATCGTTCTGGTCGAACACCACTTGCGACGCCTGAGGGCCCAACACCCCGATGTCTTGGAAGAGCTGAGGACCTTCCTCGATTCGATGGAGAGGGAGAGTCTGCTGCAGTAG	MSHSNELSIHGASGSAAPRVNDVLAHLEQVGEGHTGTADGLNRLMAWMDGHVGPVAEDSTYAASAEQYGLHGMVLGGYRAGAGAFVQSVTLQLWGQRSESFGILSTDAGSLKLFAPGDTWPTEEWDRWAEGSVGAVIVANTQHLEDCFAALRYVETRGIQHVVAVPHVAGAPTYEEEDIRSALGVPATVPLTRFSTQEKATVGNTLIVLVEHHLRRLRAQHPDVLEELRTFLDSMERESLLQ	MKKPMLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPILGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTDITPVGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLPESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFGWSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWAPFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYAATRDVWPGLVWALAAALYLVVPPLLARSRARDAAP	61.58	gnl|BL_ORD_ID|1486|hsp_num:0	1584			912	1092	tetracycline
BGC0000703.1|Kanamycin_48 # 60574 # 61173 # -1 # ID=1_48;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.638	BGC0000703.1|Kanamycin_48 	60574	61173	-	Loose	700	24.6386	Klebsiella pneumoniae KpnH	35.9	3004597	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAATCGGACGCCTCCCGACTACCGGATACCTCCCCACTACAAGGTTGAGATCGCAGATCTCTACTGCGAGGCAGCTGGTGAACTGGAAGCCTTTGCCTCGCATCTCATGCTGTACGACCGAGTGCTCGCGCCCGACTTCGTCCAGGACGCCTTCCAAGCCGCAGCACACCAGTGGCAGCGACTGCGTGCACTCGACCGCGGCGCCCAGCGGGCCTGGCTCTTCCGGGTCCTCAAGAACAAGGTGTTCGACCACTGGGGGACGCGGGCAGCGCGAGAGCTTCCGCTGCCCGAGGTGCCCGCTCCGCAAGGGCTCAGCGACCCTCCGCGCCAAGCGTTATCCCACATGCTGCTCCTACGGTGCTGGCACGTGATGGATCAGATGCCGCCTGTCCAGCGGAAGGTGGCGTTGCTCCGGTGGCGCGGGGAGTGGACCAGCCGCGAGATTGCTGAACATCTTGGTATCTGCACCAGCACCGTCCGGGTCCATCTGGGCCGAGCACGGCAAGAGCTGTGGGAGGAACTCGGCAGCGAAATGATTTTTCCATCTGAGTGGTGGGACGCAGCTGTGGAAGACGTGGAGTGGGAGGTATCCCGGTGA	MNRTPPDYRIPPHYKVEIADLYCEAAGELEAFASHLMLYDRVLAPDFVQDAFQAAAHQWQRLRALDRGAQRAWLFRVLKNKVFDHWGTRAARELPLPEVPAPQGLSDPPRQALSHMLLLRCWHVMDQMPPVQRKVALLRWRGEWTSREIAEHLGICTSTVRVHLGRARQELWEELGSEMIFPSEWWDAAVEDVEWEVSR	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH	38.87	gnl|BL_ORD_ID|2732|hsp_num:0	3299			333	432	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
BGC0000703.1|Kanamycin_50 # 63695 # 65728 # 1 # ID=1_50;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.675	BGC0000703.1|Kanamycin_50 	63695	65728	+	Loose	450	27.335	SFB-1	34.92	3003557	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	SHW beta-lactamase	ATGCGTTCACGCATACCAACCCCGTCCCGGCTCGCCGCCGTCGCTGTGGCCGCTGGGGTGATGGGCACCCTGGCCTGGGCCCCGTCCGCTACCGCAGCGGACAAGTACGGGCCAGGCTTCAAGGTCCCAGATTCTGAGGGGCACGCGGCGGCCAGCCATATCGGCGCGTACGGTCCGCCTGGTCTTCAGGTCTGGGGCGACTACGAGACGTATTGCGCGGACCCTTCGCGCCGTGGACCCGACGCGGCTGGCGGGTACTTGGGGCCTCGGCCAGTCTCGCGGTGGGCCTCATCGGAAACCGGGCGGCAGGTCCCGGCCGCGAACTTGGCGTACGCCTCGTACATCATTGGCAAGTACGGACAGACCCGTTCGGATTCTCAGGCAGCCGCTGTTGATGCGGCCACGTACGACCTGCTCGCCGGTGGCGCGTACGGGATCCATGAGGTGCGCGGAAAGGCCCGCCTGAACTATCCGAATGTCTCAGCTAACTCCCGATCTCTCGCGCTTGGTTACCTTGCCGAGGCCAAGAAGCGAGCGGGCCCGTACGAGCTGCATGTCCGGCCGAGATCGAAGGAGGCCACGGAGGGCACGAAGGTCACGGTGGATGTGGACGTCACGTCCAAGCTGTCCGGCGAGCGGGTGCCAGGAGTCAAGGTGGCTCTCAACTCCAGCTCGGCGCAAGGAAGCGTCACCACTGGCAAGGACGGCCGTACGAGCTGGACGTTCACCGCGTCGAAGGCGGGCGCCACCGCGGTCAGGGGCACCGCAGCCGGTCTGCCGGGCTCGCAGCTCAAGGCCCTGGATCCGCACGACAAGCGCGCTCAGCGCATGCTGCTGGCCGGGGACAAGACGACCGCGTGGGATTCCGCGGCCGTCACCGTCAAGCCCGCTACCGGCGGCGTGGAGATCCGCAAGAAGGACCCGGAGGGCTCCCGCCTGGCCGGTGTCACCTTCCACCTTCTGGACTCCTCCGGGAAGGTCGTGAAAGAGGGCAAGACCAACAAGGGAGGTGTCCTGGCCTTCGAGGGGCTGGTGGCAGGTAAGTACCGGCTGCACGAGATCTCGACAGGTGATGAGCTGCACGAACTGGCGGCCGACCAAGACGTGTTGATCGTGGCCGGGCAGTCCGGCTCGGCCAAGCCCATCACAGTGATCGACCCCTTCAAGGACGCTGAACTCGTCCTCGAGAAGGTGGACACGGCCACGGGCAAGCCGCTGGCCAACGCGGTCATCGAGATCGACGCGGACGATGTGGACGCCTCCGGGAAGCACAAGCCGGGCAAGAAGGTCGCCGACTTGACCACCGGCAAGGACGGCCTGGCGAAGGTCAAGCTCGGCGTGGACGTGAAGGCGGGAAACGCGTACTGGGCCAAGGAGATCAAGGCCCCGGCGCACTACCAGCTGAACGGCACTCCGAAGCGGTTCACGGCCAAGCCCGGCGCAGTGGTGAACCTGACCCTGACCAACGACCCGATCCCGGCAACCATGCGCGTCCTCAAGACCGACAAGGACACCGGAAAGGTCCTCGGCGGCATGGGCTTCGACGTCTCGACGGTCAAGGTGGACCCGTCCGGCAAAAAGGTCCCGGGCACGAAGGTGGCCTCCGGTGTGACCAGTGCGGACGGCAACTCGGCGCCGATCAAGCTCGATGCCACGGTGGAATCCGGTATCGAGTACCTGCTCAGCGAGACGAAGGCACCGCAGGGATACGACAAGCTCGCCAAGCCGGTCTCCTTCACCGCACGGGCCGACAGCGAGGTCATCGTCCGGGCGCAGGACAGCAAGACGCCTGTGCCGCCCACGCCGACCCCGACCCCGTCGAAGCCGGGCTCGACACCTCCGACGAAGACCGCGGGCGGCGGTACTCCGCCGGAGACGCCCTCATCGGGCTCCCTGGCCAAGACGGGTGCCGAGATGGCGCCCTGGGCTCTGAGCGGGGCCGCCGCTCTGCTCGTCGCTGGTGGCGGAACGGTGTGGTTCACCCGCCGTCGCCAGCAGGCTCCGGCGAACGCCGGTAACAGCCCGCAGGAGTAG	MRSRIPTPSRLAAVAVAAGVMGTLAWAPSATAADKYGPGFKVPDSEGHAAASHIGAYGPPGLQVWGDYETYCADPSRRGPDAAGGYLGPRPVSRWASSETGRQVPAANLAYASYIIGKYGQTRSDSQAAAVDAATYDLLAGGAYGIHEVRGKARLNYPNVSANSRSLALGYLAEAKKRAGPYELHVRPRSKEATEGTKVTVDVDVTSKLSGERVPGVKVALNSSSAQGSVTTGKDGRTSWTFTASKAGATAVRGTAAGLPGSQLKALDPHDKRAQRMLLAGDKTTAWDSAAVTVKPATGGVEIRKKDPEGSRLAGVTFHLLDSSGKVVKEGKTNKGGVLAFEGLVAGKYRLHEISTGDELHELAADQDVLIVAGQSGSAKPITVIDPFKDAELVLEKVDTATGKPLANAVIEIDADDVDASGKHKPGKKVADLTTGKDGLAKVKLGVDVKAGNAYWAKEIKAPAHYQLNGTPKRFTAKPGAVVNLTLTNDPIPATMRVLKTDKDTGKVLGGMGFDVSTVKVDPSGKKVPGTKVASGVTSADGNSAPIKLDATVESGIEYLLSETKAPQGYDKLAKPVSFTARADSEVIVRAQDSKTPVPPTPTPTPSKPGSTPPTKTAGGGTPPETPSSGSLAKTGAEMAPWALSGAAALLVAGGGTVWFTRRRQQAPANAGNSPQE	MISAPSFAHENEQQTDQSNTDAVKKPQQQPTELFLSPLVPDVYLHQSYKQVSGFGLVESNGLVVVQNKQAFIIDTPWTDSDTAKLVDWITQQGLTVTASISTHSHQDRAGGIGYLNSQGIATWVSDKTQRLLTANKLSTASHTFRTKQHTLQQQLIEVYDLGAGHTVDNLLVWLPKQQILFGGCLIKSLSSRTLGYTGEADLEQWPLTVAKVQAQFIQAKIVVPGHGKIGDTSLLSHTIDLLTQ	277.46	gnl|BL_ORD_ID|561|hsp_num:0	614			318	492	
BGC0000703.1|Kanamycin_51 # 66045 # 66434 # 1 # ID=1_51;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000703.1|Kanamycin_51 	66045	66434	+	Loose	550	23.8682	CAU-1	34.88	3000855	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	CAU beta-lactamase	GTGCGCAAGAGCGCGCGGGCCTTCGCGACCGCCTACGCGCAGCATGACGCCACCAACGACGGTGACCGCTCGTACGCCGATGCGGGCGCCCGTGCGGCGAAGTTCTCCACCGGGGAGCTGAGGAAGGTTCTGGCCCAGAAGCGCGCCGGCCAGGACGCTCCTTGGGCAGCGCTGCGGTCCGAACAGGCCAGGCAGACAGTCAAGATCACCTCTGTTGTCGTGCCAGACGGCGCGCCCGCCGTCACTGCCTCGTCCGCGCTCGTGCGGGTCGGCTACACCCTCACGACGACCCCGAAGTCCGGTCCGGCGCGGCACAGCGGCGAGCAGCTCGCGCTCCGCCTGGAACACACCGCGCACGGCTGGGCTGTCGCAGCGCTGCCGTGGGCGTGA	MRKSARAFATAYAQHDATNDGDRSYADAGARAAKFSTGELRKVLAQKRAGQDAPWAALRSEQARQTVKITSVVVPDGAPAVTASSALVRVGYTLTTTPKSGPARHSGEQLALRLEHTAHGWAVAALPWA	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR	44.64	gnl|BL_ORD_ID|1055|hsp_num:0	1109			360	489	
BGC0000703.1|Kanamycin_52 # 66445 # 67422 # 1 # ID=1_52;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.666	BGC0000703.1|Kanamycin_52 	66445	67422	+	Loose	750	28.1054	tet(X)	25.0	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAAGAAGGCCCTACGCATCACCCTCGGCCTGGCCCTCGCCATGGTCCTTTCCGGCCTCCTGCTGCTGACGGTCTTCGGTGGAGCCGGTGGCGCTTCCGCGGACGAGAGCGGGCCCGGTGGAGGAATCACCTCCGATTCCCCGGTGCCGGGCTGGGTCCGCCCGCTCATCGACAAGCACGCCGGGAAGTGCCCACAGGTCACAGCCTCACTACTCGCCGCCCAGCTCTACACCGAGTCGGGCTTCAACCCGAAGGCGAAGAGCCCCGTGGGCGCGCTGGGAATCGCCCAGTTCATGCCTGGCACCTGGGCCCAGTACGGGATGGACGGCGATGGCGACCACGACAAGGACGTCTTCAACCCTGAGGACGCCATTGCCGCGCAGGCCAACTACGACTGCGTTCTGGCGAAGGAAGTCAAGAACGTCGCCGGCGACTCCACGGACAACATGCTCGCCGCGTACAACGCAGGCGGCGGCGCTGTCATGAAGTACGGCGGCGTCCCGCCCTATCCCGAGACGCGTAACTACGTAAAGAACATCCGGGAGTTGGCCGACAAGTGGACCGATGCGGTCGGCCCGACCTTGCCCGCCGGAAAGGGCGCCGGGAGAGCCATCGCCGCTGCGAAGACCGCGGTGGGGTCCTGGTACCAGTGGGGCGGTGACTGCGTGTCGCCCTTCAAGGGACAGCAGGGCTGCGACTGCTCCTCGCTCACCAAGATGGCGTGGGCCGCAGCCGGGGTGAATCTGCCTCGGGTCACGTACGAGCAGGTCCACGCGGGCAAGCCGGTCAAGAGCGTCTCTCAACTCAAGCCTGGTGACCTCCTGTTCAGCGGGCCCGGCCATTCCGGCCCGGAACACGTGGGGATGTACCTCGGCAATTCCACGGTCATCGACGCTCCGCACAGCGGAGCCACCGTGCGGATCCAGGGGCTCGACGAATGGAAGCCCCGGATCATCGCCATGCGGCATATCGGCTAA	MKKALRITLGLALAMVLSGLLLLTVFGGAGGASADESGPGGGITSDSPVPGWVRPLIDKHAGKCPQVTASLLAAQLYTESGFNPKAKSPVGALGIAQFMPGTWAQYGMDGDGDHDKDVFNPEDAIAAQANYDCVLAKEVKNVAGDSTDNMLAAYNAGGGAVMKYGGVPPYPETRNYVKNIRELADKWTDAVGPTLPAGKGAGRAIAAAKTAVGSWYQWGGDCVSPFKGQQGCDCSSLTKMAWAAAGVNLPRVTYEQVHAGKPVKSVSQLKPGDLLFSGPGHSGPEHVGMYLGNSTVIDAPHSGATVRIQGLDEWKPRIIAMRHIG	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	83.76	gnl|BL_ORD_ID|763|hsp_num:0	776			657	837	tigecycline; tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000703.1|Kanamycin_53 # 67472 # 67810 # 1 # ID=1_53;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.658	BGC0000703.1|Kanamycin_53 	67472	67810	+	Loose	600	25.7942	TriB	33.33	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACAACTTGCTTGCCAGTGCCGCTGACCCGTCCCTTCACACCACCCTCGCGGCGGGCGCCGACGTGGTGACCGGTGTCAAGCCGGACTGGGGCCCGTTCAGCAAGTTCGGCGGCACCTCGAAGGTCCTGCTGAGTGTCCTTGCTGCCCTCGCCATGGTCATCGGGGCGGCATGCTTCTTGATCGGGCTCGGCAAGAGCAAGGGCTGGGTCGGTGACGGCCACTCGACCATGGACTCCTCGCGCGGCAAGGGCATGATGGTGGGCGGCCTGGTGGTCGTCTTCCTGGTCGCTTCTTTCGGCACGATCTTCGCCGTCACCTACGCCATGGGCGTGTGA	MHNLLASAADPSLHTTLAAGADVVTGVKPDWGPFSKFGGTSKVLLSVLAALAMVIGAACFLIGLGKSKGWVGDGHSTMDSSRGKGMMVGGLVVVFLVASFGTIFAVTYAMGV	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	31.46	gnl|BL_ORD_ID|2003|hsp_num:0	2193			792	918	triclosan
BGC0000703.1|Kanamycin_54 # 67814 # 69115 # 1 # ID=1_54;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.693	BGC0000703.1|Kanamycin_54 	67814	69115	+	Loose	950	27.7202	msrE	33.33	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGGCCGTACAGACCCGACGAGGAAACGATCCCTCTCCACGAGGTACGTCCAAGGCGAAGTTCTGGGGCATCGCCGTCGGCGCGGTCGCGGCGCTGACCACCACCGCAATGATCGTGACGCTGGCCACCGGAGACGACTCGGCGCCTACTCACGTCGCTTCGCCGCAGGCCACACCCGAGCCGAAGCCGGGCAAGGCTCGCGGGCAGGTCACCAGTGGCGTGCCCGTCGGCTACCCCCGGACCGAAGCCGGAGCCAAGGCCGCCGCGGCGAACTACACCGTGATCAGCGGCAGCTCGGCATTCCTCACCAGCAAGGACGCACGCCACCGTGCCGTATCGGTCATGTCCGCTGGCAACAGGACGTCAACGGCCATGAAGGAGGCCGACCACGAGGCCAGACGGGCGAGGGCTGAGCTGAAGGGGGACAAGTCCAAGCTCGCCCCGCGCCACGTCATCGCCCGGACCGGCATCCTCTCCGCCCATACGCTCGGTGCCGATATCCACAAGGCCACGGTGCGCCTGTGGACAACGACGGCGCGAGGCAGCGCCACGGGGCATGCGACGCCGAAGGCGGCGTTCCGTTCGGTGACGGTCAGCCTCGTCTGGGAGCGCAACGACTGGAAGATGTCCGGGAGTTCGTCCAGCAGCGGCCTGGTAGCACCGGTCGATACCCGGCAGGCGACCAACGTCACGAGCGACTTCGCCGATTATGTACCGGCCCGCGCCTCCGATCCCGTCCTGAGCGGCGCCGAGACGAAGGACGGTCTTCCGGGAGCGTACGAACGTACCGAGCGGGGGGCCCACGCCGCCGCGACGAGTGCGGTGATGCTGCGCGGTGACCCGCGGTTCTTCTCGGACGCGGAGTGGCGGAACAAGATGCTGACCGCCACGACGGCGTCCAGCGTCCTGGGCACGGCCAAAGCGGACGCCGACTCGATGACTCAGCTCGTCGTGGAGAACCGGTCGCTCGGCGACGACGGCAAGACTGCGGATGGCGGGCTGCTGGTCACGCGGACTGCCGTCCTCGGCTCCCGAGCCGTGGCGTACTCCGGCCAGACCGCGAGCATGGAGCTGTGGACCGCCTCCGTCGGCGGGGTCGCGGGGAAGAACGAGAGCGAGCGCCCGCAGATCGGCTTCATCCGGATGACCGTCGACCTCATCTGGGCTGACGGCACGTGGAAGACGACGGCTGTCACGCCGTCGGAGCCGCTGGTGCCCTCCCCGCCCGCGGCGGAAGAAGCCGCTCCGGCCAGCAGCTTCGCAGATGTCGGAGGTGTCAGCGATGCGCCTTCGCTTGCGTGA	MAVQTRRGNDPSPRGTSKAKFWGIAVGAVAALTTTAMIVTLATGDDSAPTHVASPQATPEPKPGKARGQVTSGVPVGYPRTEAGAKAAAANYTVISGSSAFLTSKDARHRAVSVMSAGNRTSTAMKEADHEARRARAELKGDKSKLAPRHVIARTGILSAHTLGADIHKATVRLWTTTARGSATGHATPKAAFRSVTVSLVWERNDWKMSGSSSSSGLVAPVDTRQATNVTSDFADYVPARASDPVLSGAETKDGLPGAYERTERGAHAAATSAVMLRGDPRFFSDAEWRNKMLTATTASSVLGTAKADADSMTQLVVENRSLGDDGKTADGGLLVTRTAVLGSRAVAYSGQTASMELWTASVGGVAGKNESERPQIGFIRMTVDLIWADGTWKTTAVTPSEPLVPSPPAAEEAAPASSFADVGGVSDAPSLA	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	88.19	gnl|BL_ORD_ID|27|hsp_num:0	33			537	699	erythromycin
BGC0000703.1|Kanamycin_55 # 69096 # 70745 # 1 # ID=1_55;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.690	BGC0000703.1|Kanamycin_55 	69096	70745	+	Loose	1020	26.9498	tlrC	35.14	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCGCCTTCGCTTGCGTGAGGACGCCCCGGGGCTGCTGGCCGTCGAGCGGAGCGGGCCGGGCCGTGGATGGGGGCGGCGTCTTCAGACGGTCGCCTGGGTCAACGTGGTCATCGCCTTCGTCTTCGTTCCGTCCGCGGTGGCCAACCCGTTCTGCTACATCCCGATGGTCTGCGAGGCCAAGGCGGCCATCGACTTCATCTCGGACCCGCTCGGCTTCCTGCTGCAGAAGCTCACCGAGGCCAACATCTGGTTCCTGCGGAAGATGCTGGAGCTGATCCAGAACACGACCAAGGTCGACCTGACAAGCCCCGGCTTCTTGAAGCAGTACGCGATCATCTTCGCTGCTTCCTCGCTGATCACGGCGGCGCTGTGGCTCGTCGCCGTCGCGAAGCGGGCGGTCCGCGGAGTTGCGCTCACCACGGCAGTCAGCGAGGCGATCGGCTTCCTCGTGCTCCAGTTCTTCGTCAATGCGCTGACCCCCGGTGCCATCGCGCTGTTGATGAAGGCGATCGACGAGGTCACGGCCGTGTTCGAGCCGTATGCCGTCAACAACTTCAAACCGTTCCTGGAGAACATCCTCAAGATCATGGCGGCGAGCCCCTCCGATGGAGTGGGTCAGCTGATCGTCGTCAACCTGATCATGATGGCTGGCGCGTTGTTGATGTGGGTCGAGATGCTCATCCGCGGTGCGGCCATCTACGTGGCCGTGGCCCTGGGCCCGGTGGTCAACGCCGGTCTCGTGGACCGGGACTTGTGGGGCAAGAGCAAGAAGTGGTTCGGCGCGCTCTTCGCCATCGGCCTGTCGAAACCGGTCCTGTTCGCCCTGCTCGGGCTGGGTGGAGCGATCCTCAGTGACTCGACCGGCAGCATGTCGGATGCCGTGTCCAAGACGCTGGTCGGCGCGCTGATCCTTCTCCTCGCCGTGTTCGCCTCGGCCACGCTCTACAAGTGGGTGCCCGCTTTCGGCGACGAGATGGCGCAGCTGCACCACGACCGGAAGGCCGCGCAGTCCTCCGGCCCCGCGTCGGTGGTGGACGGCCCCGCCCAGCACGCCAATCGCGCTCTGAACACGCATATCCAGGACTCGCTGGTCGGCGGCGGGAAGCCCGCAAGTAAGGCCTCGGCTCCGGCGGCCGGCGGAAAGGGCGCCCCCTCGCCGAAGGTCGGTGGTCAGGCCGGGACGGCGAGCGCCAAGGCCGCTTCCGGTTCAGGTGTTGCGGCCAGCGCGGCTGGACCGCTCGGTGCCGCCGGTGCTGCGGTCAAGGCCGGTGGCGACGCTGCGAAGAACAGGGCGATGGGATCCCCCGGAGCGCAAGGAGCCGATGCCTCGAGCGACAGCGGCGAGCAGTCCCCGGGCGCCAGTGCCTCTGGCACTCCGGTCGCGGCTCGTTCACGCGCGGCAGGTCCGGGCTCGGTCATCGGATCCGACACCCAGCCCCCGGGCGCCGGAAGCACTCCCGCCTCCAGCGGTGCTCCCGCTGCGGCACCCGGCCAGGGCGCCCCTTCGGGTCCGGTCGTCGCCCCGAAGGGCACCGCGTCCGCCCCGCCGCCCGCGACCGCGCGCCCCGCATCGTCTCCGTACTCGCCACCTGGGCCCCCGTCCGGCGCCGGAACGCCCGTCAAGCCCCCCACCAGCAAGGACCAGTGA	MRLRLREDAPGLLAVERSGPGRGWGRRLQTVAWVNVVIAFVFVPSAVANPFCYIPMVCEAKAAIDFISDPLGFLLQKLTEANIWFLRKMLELIQNTTKVDLTSPGFLKQYAIIFAASSLITAALWLVAVAKRAVRGVALTTAVSEAIGFLVLQFFVNALTPGAIALLMKAIDEVTAVFEPYAVNNFKPFLENILKIMAASPSDGVGQLIVVNLIMMAGALLMWVEMLIRGAAIYVAVALGPVVNAGLVDRDLWGKSKKWFGALFAIGLSKPVLFALLGLGGAILSDSTGSMSDAVSKTLVGALILLLAVFASATLYKWVPAFGDEMAQLHHDRKAAQSSGPASVVDGPAQHANRALNTHIQDSLVGGGKPASKASAPAAGGKGAPSPKVGGQAGTASAKAASGSGVAASAAGPLGAAGAAVKAGGDAAKNRAMGSPGAQGADASSDSGEQSPGASASGTPVAARSRAAGPGSVIGSDTQPPGAGSTPASSGAPAAAPGQGAPSGPVVAPKGTASAPPPATARPASSPYSPPGPPSGAGTPVKPPTSKDQ	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	100.18	gnl|BL_ORD_ID|1841|hsp_num:0	1997			1425	1536	lincomycin; tylosin; mycinamicin
BGC0000703.1|Kanamycin_56 # 70749 # 72275 # 1 # ID=1_56;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.710	BGC0000703.1|Kanamycin_56 	70749	72275	+	Loose	850	25.7942	OpmH	33.33	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTACGCGTACGTATCAGTTCGGAAAGCACCGGCCGACCGGCCTGGTGGGCCGCCGCGATCTCGGCGAACAGGTCGTGCTGGGCTGCGGAGCCGGTAGCGGCATCCTGCTGGGCTTCCTCTCCAGCAGTGCCCCGGTGCTGGCCGTGATCGGCATGGTCGTGCCCATCGCGTTGGCCGTGGTCGTGGTGTACGCGCCGTACCGGCCCAAGGGCACCTCGCAGCGGCGCACGATCTACCGCTGGTGGCGGATCAAGCAGTACCACCGCCGGGCCTTGGCCCGCACCGGCGGTGTCTGGGTCTCCCCAGCGGTCGAGGCCGGTGTACGCCGGGACGGCACTCCACCGGACGCGGCGCTGTCCGAGCCCGAGGGCGTCGCCGGGATGACGTGGGTGCCGGTGACCGTGCGCGGTCAGCAGGCCGTCGTGGTCCTTCAGCCCGCAGCGGGCTGCGTCACCGCGGCCCTGGAGGTCGCCTCGCCCGGTCTGGGCGGCAAGGAGGTCGGGGAGCAGGTCGTGGCCCTGGAGCGGTGGGGCGAACTGCTCGACGCGTTCGGCAATACCGAGGAGCACCCGGTCAAACGGATTCAGGTGCTCGCCCGGCAGATGAAAAGCGACCCGCACGCACACCAGCGGTTCGTCGCCCACCGCGACGAATCGGCGGCGACCGCCGGGGCGCCCCAGTGGCTCAGGGACTCCTACGACACGTTGGCGAAGGCCGTGTCCACCTCGGCGGAGGAGCACCGGTACTACATCACCGCGCACGCGAAGTTCACCCGCGACCTGGCAGCGGACGGAGCGGCCCGGGGCACCGGGGACGAGGGGGTGGCCGCCGCGATGGCCGCGTACGTGGAGGAGCTGTGGGCCCGCTGCGAAGACGCCGACCTCTCGGTGATCGCTCCCCTCGATGAGGGCCGGATGACCGCTCTCATCCGCAACAGCTACGACCCCGATCACGCGATCTGGGACACCGACCTGCCGCGCGCGCACGCCTTCCCCCGCAACGTCGACGTCCGCGACGGCGCGTTCGTCGCCACCCGGGCCGCGGGGACGACGGACAGCTGGTTCCACGCGACGGCGGCCGTCGTCTCCTGGCCCACCACACCTGTGGGCCCCGACTTCCTCTCGCCCCTACTCATCGGCATGCCGGACGTGATCCGGACCATCAGCATCACCCAGAACCTGGAGCCGAACGACAAGGCCGTGGAGCGGATGCTCGACGAGGACACCAACAACCAGGCCGAGATGCACCGTGACCGGCAGCGCGGCAAGAACGTGGACCCCCGCGACATGATCGCCGCCACCGCCACCGGCTCGCGCGGCATGGCCCTGGCCACTTCCGGCGCGGCCGGGTCCGCGGTCGTCGGATACATCACCATCTCCACGCGCAGCGCCGCCGCACTGGAGAAGACCAAGCGCACGACCGCCTCCCGGGCGCGCAATGCCCATCTGCGGATCGAATGGCTCGACCTTGAGCACGCCCGTGCCTTCGCCACGACGCTCCCCTTCGCCGGGGGCATCAAGTGA	MSTRTYQFGKHRPTGLVGRRDLGEQVVLGCGAGSGILLGFLSSSAPVLAVIGMVVPIALAVVVVYAPYRPKGTSQRRTIYRWWRIKQYHRRALARTGGVWVSPAVEAGVRRDGTPPDAALSEPEGVAGMTWVPVTVRGQQAVVVLQPAAGCVTAALEVASPGLGGKEVGEQVVALERWGELLDAFGNTEEHPVKRIQVLARQMKSDPHAHQRFVAHRDESAATAGAPQWLRDSYDTLAKAVSTSAEEHRYYITAHAKFTRDLAADGAARGTGDEGVAAAMAAYVEELWARCEDADLSVIAPLDEGRMTALIRNSYDPDHAIWDTDLPRAHAFPRNVDVRDGAFVATRAAGTTDSWFHATAAVVSWPTTPVGPDFLSPLLIGMPDVIRTISITQNLEPNDKAVERMLDEDTNNQAEMHRDRQRGKNVDPRDMIAATATGSRGMALATSGAAGSAVVGYITISTRSAAALEKTKRTTASRARNAHLRIEWLDLEHARAFATTLPFAGGIK	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	105.39	gnl|BL_ORD_ID|2005|hsp_num:0	2195			1314	1413	triclosan
BGC0000703.1|Kanamycin_57 # 72272 # 73708 # 1 # ID=1_57;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.683	BGC0000703.1|Kanamycin_57 	72272	73708	+	Loose	900	28.8758	lsaD	43.24	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	GTGACCGGCCTCCTCGACCTCAATCCGATGGCCCCGATGGACGAGACCGCGCGGCGCCCGCTGTACACCGAGACCACAACCAGCCAGGCCCTGTACCTGCCCATCGCGCCGCCCACGTTGGGCACGGCGGGCGCCGTCATCGGCCGTGAGCTGTACTCGGGCAAGGCGTTCATCTACTGCCCCTTCAGCGCCTTCGGCGATGGCCTGCCCGGCGGCAACATGATCGCGATGGGCGACACCGGCCGCGGCAAGAGCTCGCTCGTCAAGACCTATACCGCCCGGCAGATCCGTCTGGGCCGCAAGGTCGTCGTGCTCGACACGAAGGAGCAGAAGGAGCGGGAGGAGGGCGAGTGGGCCGCCCTGGGCCGCTCCCTCACCGGTAGGGCCCCGGTGAAGTTCACCCCGGGCGGCGGGGCGAAAGCCTCCTGCATCAATCCGATGGACCCCGCGATCGCGGGCAAGCGGCAGATCGAGCTGGTCCGCACGATCGTGGAACTCGGTTTGGGCAGGCCACTGGGTGAGTTCGCCGGGTCCGCCCTGCGCCTGGCGATCCGCCGGGCCCACCAGCGCGCGACCGCCGATAGCCGCTCTCCGGTGCTGGCCGATGTCGCGGCCGCGCTGCGGTCCCCGGACGCGACGGACGCCGTGGCCAAGAAGCGTTCGGAGGAGGAACTCCTCAACGACGGCCTCGAAGCCTCCTATGTCCTGGACCGGCTGTGCGGGACCGAGCAGGACGCGAGCGGCGATCTGCTCGGCATGCTCGACGGACCGACCAGTCTCAGCGTCGACCTCGACGCCGACATGGTCGTCTTCGACCTGACCAAGGTCCCCTCGGGCGGCGTCGCCATGACGATCCTCGTCGCGGTGATCTCCGTGTTCCTCGAAGAGGTCTGGCTGCGTCCGCTGTGCGAGTGCGGCGCGGAACCCAGCCAGCACGAGCGCAGGGTCGTGGACACAAGCTCGGGGGCCTGGGAACTCGGCGCGAACCCTGACTCCGGCTGCCACCGCTACACCCAGCGCAAGCGCATCCTGGTGTGCGAGGAGGCATGGCACATCCTGGGCACTCCCCAACTCGCCGCGCTGTTGGAGAAGTTCCTCAAGTTCGCCCGTGGCTACGGCCTGAGCTGCATCTTCATCGTGCACCACCTGAGCGACATCGACGACAGTCCCGAGACGCAGGCCGCGTTGAAGATGGCGGACACCGTCGTCGTGTACTCGATGAAGAAGTCCGAAGCCGAGGACACCGTCAGGCGGCTCGGACTCCCCGCCTGGACGGCGGAGCACATCATGCGCCTGCGCCGCGGTGTCGCCCTGTGGAAGGTCGGCGAAGTCATCTACCCCGGCGTCCAGCACCTGCTGACCGAAGCAGAGCAGCACCTGTGCTTCTCCAGCGGCTCCATGACGGACCTGACCACCAGCTCCCCGGATCTCGAATGA	MTGLLDLNPMAPMDETARRPLYTETTTSQALYLPIAPPTLGTAGAVIGRELYSGKAFIYCPFSAFGDGLPGGNMIAMGDTGRGKSSLVKTYTARQIRLGRKVVVLDTKEQKEREEGEWAALGRSLTGRAPVKFTPGGGAKASCINPMDPAIAGKRQIELVRTIVELGLGRPLGEFAGSALRLAIRRAHQRATADSRSPVLADVAAALRSPDATDAVAKKRSEEELLNDGLEASYVLDRLCGTEQDASGDLLGMLDGPTSLSVDLDADMVVFDLTKVPSGGVAMTILVAVISVFLEEVWLRPLCECGAEPSQHERRVVDTSSGAWELGANPDSGCHRYTQRKRILVCEEAWHILGTPQLAALLEKFLKFARGYGLSCIFIVHHLSDIDDSPETQAALKMADTVVVYSMKKSEAEDTVRRLGLPAWTAEHIMRLRRGVALWKVGEVIYPGVQHLLTEAEQHLCFSSGSMTDLTTSSPDLE	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	96.18	gnl|BL_ORD_ID|4773|hsp_num:0	3847			966	1068	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0000703.1|Kanamycin_58 # 73705 # 74091 # 1 # ID=1_58;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.752	BGC0000703.1|Kanamycin_58 	73705	74091	+	Loose	400	24.2534	ErmW	36.67	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGTACGTCCGCGCAGCCCAGCCCCGACGCCACCGGCCCCGAGACGGAACACACCCCTGCCATGACGACCCTCGCCCTCGACCCCGCCGTGCTGCCGACGTATGGCCGCTCCTTCCGGGACGACATCGACCAACTGCACGCCGACTACCTCGACCTCGCCCAGCGCACCGCCCGGCTCGCCGCCCTGCTCGACCACGGCGACTACTGCGCCGCGGGCGGTCGCGCACGAGCAGCGGTCGGCGCCGCCTGGCGCGGTGCGGAGGAACTCCACGCCGCCTTCCACACCGCTCCGCCGCGCTGCTCCGGGCCGGACGCCTCGCTCGCCCGGCTGTGCGGCCGGCGGATGCGCTACCTCGCTGCCCGCATCGCGCGGAGGGCCGAGTAA	MSTSAQPSPDATGPETEHTPAMTTLALDPAVLPTYGRSFRDDIDQLHADYLDLAQRTARLAALLDHGDYCAAGGRARAAVGAAWRGAEELHAAFHTAPPRCSGPDASLARLCGRRMRYLAARIARRAE	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	41.16	gnl|BL_ORD_ID|1572|hsp_num:0	1714			210	300	erythromycin; josamycin
BGC0000703.1|Kanamycin_59 # 74091 # 74360 # 1 # ID=1_59;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.693	BGC0000703.1|Kanamycin_59 	74091	74360	+	Loose	400	22.7126	ErmN	31.48	3000592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCTTCGCCTCGGACGCCCTGTCCCTCGCCCTGTATGCCATCGTCGCGGTCTGCGGGCTCGCACTGCTGGCGTTGCGGCACACATCGAACCGCAGTCGACGCAACGCCGGATTCGCCTCGAAAGCCCAGCTCAAGCGCCAGTTGTCGGCCAAGTCGGCCCTGCGGGCATCCGAGATCCGGCCGTCCCTGGCCGACCGTGACACCCGGTCCCGCCCGACCGCGGATCTCTCCCATCTCTCCAAACGCCCGCGCTCCCACGCGTCCTGA	MAFASDALSLALYAIVAVCGLALLALRHTSNRSRRNAGFASKAQLKRQLSAKSALRASEIRPSLADRDTRSRPTADLSHLSKRPRSHAS	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	30.58	gnl|BL_ORD_ID|232|hsp_num:0	260			684	840	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000703.1|Kanamycin_60 # 74389 # 75837 # 1 # ID=1_60;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.696	BGC0000703.1|Kanamycin_60 	74389	75837	+	Loose	1190	28.1054	novA	36.17	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCACCACACGCTCGACCCGCTCGACTTCGGCTACTCGCTGGGCGTCTCCCAGCGCCCCAAGGGCATCCCCCTGTACTCGCGGGCGGACAAGGCAACCCGCGTCATCGGCCCCATGGGCAGCGGCAAGACGCTGCGGTTCTTCGCCCCGCTCATCCGACGATGGCAAGGCCCGGTCCTGGCCACCTCGACCAAGCCGGACCTGGTCGAACTCACCCTGGACGCACGACGTCGTGCCGACCGCCCGGTCCTGGTCTTCGACCCGCAGAACATCGCACCCTCGCTGCCCCGCTTCCGCTGGCTCCCGATCACGGGCTCGCAGGACACGGAGGTCGCGATGATGCGGGCCAAGGCACTCGTGGCCGGGTCGCGCACCCCCGGCTCTGCAGCCCAGTCCTCCGAGGGCAGCGCCTTCTACAAGGGACAGGCCGCCAAGGTGCTCGCCGCGCTCCTGCACGCAGCGGCGCTCGATGGCGCCAGCCTCGACCAATTCCTGAAGTGGGCCCGGAAGTTCGCTGATCCGGCGCCGCTCGGCATCCTCACCGCGCACCCCGGCGCCGGTCCGGGCTGGGCGGACATGCTCCGCACCTCCACCACAGGTGACAGCCGTACCGTCGGCAACACCGCGGTCACCTTGGACGCGGCCCTGGAACCCTTCATGCACCAAGCCGTGATCGAGTCACTCCAGGGCAAGAGGGGCGAGGCGCCCACGGACTTCCGCGAGTTCCTCGACGCGGGCGGCACCATCTACCTCCTGGGCAAGGACTCCGAGGTCAACTCGGTCGCCCCGCTGACCACGGCGGTCACGGAAGACCTGCTGGACATCGCGGAAGCTCACGCCATCACCTCTCCTGCCGGGCGCCTGGACCCGCCACTCCTGGCGGCTCTCGACGAGGCGCCGAACATCGCGCCGATCCCCTCGCTCCGCCAGCGCGTAGCCGACGGCCGGGGACGCGGCATCACGGTCGTCTACGGCCTCCAGGGCTGGGCGAGCGCCCGGGCCCGCTTCGGCGAGGACACCGCCAACGAACTGGCGAGCTTCACCAACAACGTCGTCGTGTTCGGCGGGGCCAAGGACCCCGACTTCCTCAAGGAGATGTCCGAACTCTGCGGGCAAGTCGAACGGCTGCGTACGACGCGGACCACCACCAGCGGTGACCGTGGCGGCGAGTCGACCGCGACGCACGCAGTGCTGGAATCCGTCCTGCGCAGTGACGAGATCAAGGGCCTCGACGAAGGGTGCGCGCTCGTCCTCGCGGACAACCTGCCGCCGGTCATCACCCGCCTCGACGGCATGTGGACCTGGGACTCATGGACTGAGATCGAGGGCCACACACGGGACCTGCGCCAGGCGAACGAGACGGAGCGGCTACGACAGCAAGAAGCGAGGAGCCGACAGGCTGAGGCGCATGCGGCTGCCTGGGCGGACCGTCAGGACGTGTCGGCATGA	MHHTLDPLDFGYSLGVSQRPKGIPLYSRADKATRVIGPMGSGKTLRFFAPLIRRWQGPVLATSTKPDLVELTLDARRRADRPVLVFDPQNIAPSLPRFRWLPITGSQDTEVAMMRAKALVAGSRTPGSAAQSSEGSAFYKGQAAKVLAALLHAAALDGASLDQFLKWARKFADPAPLGILTAHPGAGPGWADMLRTSTTGDSRTVGNTAVTLDAALEPFMHQAVIESLQGKRGEAPTDFREFLDAGGTIYLLGKDSEVNSVAPLTTAVTEDLLDIAEAHAITSPAGRLDPPLLAALDEAPNIAPIPSLRQRVADGRGRGITVVYGLQGWASARARFGEDTANELASFTNNVVVFGGAKDPDFLKEMSELCGQVERLRTTRTTTSGDRGGESTATHAVLESVLRSDEIKGLDEGCALVLADNLPPVITRLDGMWTWDSWTEIEGHTRDLRQANETERLRQQEARSRQAEAHAAAWADRQDVSA	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	78.37	gnl|BL_ORD_ID|1112|hsp_num:0	1210			1086	1227	novobiocin
BGC0000703.1|Kanamycin_62 # 76800 # 76910 # 1 # ID=1_62;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.604	BGC0000703.1|Kanamycin_62 	76800	76910	+	Loose	500	21.557	OXA-779	52.17	3005315	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAGAACGTCCAAGACATCAGACGCGCGACCCGTCTCTCCCGAACCACTGTCTACGAAGTCCTCCGCGCCGCTGATATTGATCCCGCCACGCGCGATTCCGAGCAGTGA	MENVQDIRRATRLSRTTVYEVLRAADIDPATRDSEQ	MAIRFFTILLSTFFLTSFVYAQEHVVIRSDWKKFFSDLQAEGAIVIADERQAKHTLSVFDQERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQNQDLRSAMRNSTVWVYELFAKDIGEDKARRYLKQIDYGNVDPSTIKGDYWIDGNLKISAHEQILFLRKLYRNQLPFKVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWVGWIEWPTGPVFFALNIDTPNRTDDLFKREAIARAILRSIDALPPN	13.53	gnl|BL_ORD_ID|3019|hsp_num:0	4047			330	396	cloxacillin; oxacillin; cefalotin
BGC0000703.1|Kanamycin_63 # 76945 # 77694 # -1 # ID=1_63;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000703.1|Kanamycin_63 	76945	77694	-	Loose	650	25.409	otr(C)	29.82	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCGCCCAAGGAGTCGGCCGACCGGGTCGTCGAGCGGATGCTCGGCACCTCATTCCCGGAGGCCTCCTACAGCGTGATCCAGGACGCCGCTCGCGCCACAGCTGATGTCGCACTACGCCGTGAGCCAACGGAAGCCGATGCGCGCGCCTTTGCGGCCCGCTTCCAGGACCGGCTCCTGCCCGTCGAGCAGCCGCCTACCGCCACGCCCCGCTCCGGGCGCACCCGCCAGCGCCGACCCGACTCCGGGCGGCGCCCATGGTCGCCGTTCTGGCGGAGCGCGGAGCGGGATGTGCGGCAGGGCGAGCTGCTGAGGGAGGAGCGCGAACGGCGGGAGGCCCGCCGGCAAGAGGCCTTGATCGCGGCTGGCCAGCGCAGCATGGAGCTGCTGTCCAGGGCCATGGACGACCCCTACTTCGCAGCGACCATGTTCATTGGCGATGCCGTCGTGCCACCAGAGAAGCAGCGCCAGTTTCTCTACGTGCGGGCGATGTACGAAAACATGGTCCTCGCGTGGGCCACAGGCGCCGTGCTGTGGGAGAACCTGTTCGTGCACGTGCGGGCCTTCCTACAAAACCCATTCGTCCGGGAGTACTGGGAGGTCACCCGCGCCGAGCGGGTCGGCCTGGCGGCCGACAGCCCGGAAGCAAGAGTAGCCAGCATGATTGACAGCCTGCTCCGGGACCTCGAAGAGTCCGAAACCGACGAGTGGTGGGTCGTAGGCCAGCCCCCTGGCGAGCAGGACTTCTGA	MAPKESADRVVERMLGTSFPEASYSVIQDAARATADVALRREPTEADARAFAARFQDRLLPVEQPPTATPRSGRTRQRRPDSGRRPWSPFWRSAERDVRQGELLREERERREARRQEALIAAGQRSMELLSRAMDDPYFAATMFIGDAVVPPEKQRQFLYVRAMYENMVLAWATGAVLWENLFVHVRAFLQNPFVREYWEVTRAERVGLAADSPEARVASMIDSLLRDLEESETDEWWVVGQPPGEQDF	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	70.94	gnl|BL_ORD_ID|1952|hsp_num:0	1991			189	345	tetracycline
BGC0000703.1|Kanamycin_64 # 77717 # 78346 # -1 # ID=1_64;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.692	BGC0000703.1|Kanamycin_64 	77717	78346	-	Loose	2030	25.409	ceoB	66.67	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCGCGCGATCCTTCTTTGACCGGGCAGCGCACTGGCTCCTCACCGGAGCTCCCTGGTGGCTGCTGGCCTTCGTGCTGCTGTATACGGCAGGGGGTGCATTCCTCGGCTGGCGCGCGGCGTACGAGGTTCTCGTCGGGCTGACGGCCCCGGGCCAGACCCAGCATTCGGCCTTCGCCTATGTGTTGAGCCTGTCCGGCTGGCTGCTCGTGCCCGCGATCATCGGTGGCGCCGCGGGCTACTTCCTGGGCCGCCAGATTGATGCCCGTCGCCCGCTATCAGAAGAGCAGGTCCGCGAGCGGGTCGCCAACCCGGAGCCACCGGCGACGCCGGAACCCGACCGCGACCGGGGGCTCCGCATCCGGTCGCTCGCCGAGCTGGAGGCCGAGGGCGGGGAAGGGCGCCGCTTTGTCGAGAAGTACGTCGCCGGCCCGCACACCAGGAACCGCGAGGTAGCTGAGGAGCACTGGAGCGCCACCGTTCAGTTCGTCGCGGACAACTGGGCGCGACTTGAAGGACTCACGCCCGTGGAAGCCGCAGTTGAGGCGGAACGACTCGCGCGTGCAGCCGCGTTCAACGCAGCCCAGATGGACCGGTGCTTCGTCTGCGATCAGAACCACCGGGCGTAG	MGARSFFDRAAHWLLTGAPWWLLAFVLLYTAGGAFLGWRAAYEVLVGLTAPGQTQHSAFAYVLSLSGWLLVPAIIGGAAGYFLGRQIDARRPLSEEQVRERVANPEPPATPEPDRDRGLRIRSLAELEAEGGEGRRFVEKYVAGPHTRNREVAEEHWSATVQFVADNWARLEGLTPVEAAVEAERLARAAAFNAAQMDRCFVCDQNHRA	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	20.35	gnl|BL_ORD_ID|1148|hsp_num:0	1252			2886	2931	
BGC0000703.1|Kanamycin_66 # 79253 # 80419 # -1 # ID=1_66;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=10bp;gc_cont=0.647	BGC0000703.1|Kanamycin_66 	79253	80419	-	Loose	1800	28.8758	Staphylococcus aureus ileS with mutation conferring resistance to mupirocin	25.2	3003729	protein variant model	V631F	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGCGTTGAAACGACACCGCCTGGAGCGCCGACGTAAAGCAGTGGGTTTCACCCACGAAGCTCTGGCGGACGAACTGCATGTGGAGCGGTCCACTGTCGTGCGATGGGCTGCCGGAAAATCTGCGCCCCGCCCCTATATGAGGCCGCGCCTCGCGCAGTTGCTCCAAGTGACCGTTGAGGAACTGGACGACCTTCTCGCCATCACGTCAGACGACGATCAACCGGTCGGCGAGCGAACTCAGTACGCCATGCGGCATCCGTCGAGCGTCGACCTCGCCACTGTCGCCGAGCTGCGAGATGACATGCAAAAGCTTGGTGAGCGCTATGACCGTGAGCCGTCAGCCGTGCTTCTGGCCAGCGCGGCTGAGCACGCCAGCGCCGTCGGGTTCATTGCCGGAGACGCACCTGCGGGCCGAGTCCAGAGAGAGATGCGAAGCCTCCAAGCGGACGCCGCGACCTTCATGGGGCAGCTCGTCTGGGACGCCTCCCAGCGACATGACCACGAGACAGCTAAGACGTACTACTTGGAGGGCGCGGAGGTCGCGCGCCATCTGCGGGACCCCAACGCAGAGGGGCACGCGCTCTTGCGCATCTCCTATGTCGCCCTCTACGGAGCGGCGAACTACCGGGAGGGTCTCGGCCTAGCGCGCCAAGCCGCACGCACGTCTCGACGTACGAGTCACGTCATCACCGGACTATCGCTCTTGCACGCGGCAGAAGCGCACGCGTACTTGGGCGAGGCGCGGGATTGCGAGCATGCCCTTGTGGATGCCGAGAAGCACTTGGAGCGGAGTCACGACACCGATGCCGCACACGAGTTGTTCTCGCCCACGCACATCAGCCGCCTCGCCGGATCTTGCTACCTGTCACTGGGCGACTTCCGCCGAGCCGAACGGCTGCTGGCCCAGACCGCGGACGAGCTGCACGACCGGCGGAAGTCGCGGGCTATCGTCCTAGGCAATCTGGCCCTGGCCAGGATCCGGCAGGGCGAACTCGACGCGGCGCTCGTCGCATTCAGTACTGCCGTAAACGAACTGCACAGCACACGTGGAGGTGGTGGGATGAACGTTGTCTTCCGTGCCGCCCGAGAGCTGCGTCCGTGGCGCAACGAGCTGACGGTTCAGGAAGCCCAGGATCAGCTCATGGCGTTGATGGAAGCGACGTGA	MALKRHRLERRRKAVGFTHEALADELHVERSTVVRWAAGKSAPRPYMRPRLAQLLQVTVEELDDLLAITSDDDQPVGERTQYAMRHPSSVDLATVAELRDDMQKLGERYDREPSAVLLASAAEHASAVGFIAGDAPAGRVQREMRSLQADAATFMGQLVWDASQRHDHETAKTYYLEGAEVARHLRDPNAEGHALLRISYVALYGAANYREGLGLARQAARTSRRTSHVITGLSLLHAAEAHAYLGEARDCEHALVDAEKHLERSHDTDAAHELFSPTHISRLAGSCYLSLGDFRRAERLLAQTADELHDRRKSRAIVLGNLALARIRQGELDAALVAFSTAVNELHSTRGGGGMNVVFRAARELRPWRNELTVQEAQDQLMALMEAT	MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETFILHDGPPYANGNLHMGHALNKILKDFIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSTAEFREKCKEFALEQIELQKKDFRRLGVRGDFNDPYITLKPEYEAAQIRIFGEMADKGLIYKGKKPVYWSPSSESSLAEAEIEYHDKRSASIYVAFNVKDDKGVVDADAKFIIWTTTPWTIPSNVAITVHPELKYGQYNVNGEKYIIAEALSDAVAEALDWDKASIKLEKEYTGKELEYVVAQHPFLDRESLVINGDHVTTDAGTGCVHTAPGHGEDDYIVGQKYELPVISPIDDKGVFTEEGGQFEGMFYDKANKAVTDLLTEKGALLKLDFITHSYPHDWRTKKPVIFRATPQWFASISKVRQDILDAIENTNFKVNWGKTRIYNMVRDRGEWVISRQRVWGVPLPVFYAENGEIIMTKETVNHVADLFAEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKETDIMDVWFDSGSSHRGVLETRPELSFPADMYLEGSDQYRGWFNSSITTSVATRGVSPYKFLLSHGFVMDGEGKKMSKSLGNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNINDFNPDTDSIPESELLEVDRYLLNRLREFTASTINNYENFDYLNIYQEVQNFINVELSNFYLDYGKDILYIEQRDSHIRRSMQTVLYQILVDMTKLLAPILVHTAEEVWSHTPHVKEESVHLADMPKVVEVDQALLDKWRTFMNLRDDVNRALETARNEKVIGKSLEAKVTIASNDKFNASEFLTSFDALHQLFIVSQVKVVDKLDDQATAYEHGDIVIEHADGEKCERCWNYSEDLGAVDELTHLCPRCQQVVKSLV	42.31	gnl|BL_ORD_ID|2060|hsp_num:0	2276			1638	1977	mupirocin
BGC0000703.1|Kanamycin_67 # 80610 # 81053 # 1 # ID=1_67;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.610	BGC0000703.1|Kanamycin_67 	80610	81053	+	Loose	1950	24.2534	MexB	30.19	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCAGCAACTCCACCTGAACTGCCTCAATTTGCCCCACAGCAAAGAACGTTCAGCCCCCATTCCGCATCTGTGGGTATGGCGCGGACGTTTGTCCTGAAGACGCTTACGGAATGGGGCGTGGAAGGTCGGTCCGAGGATGTGCAGTACTGCGTCTCGGAGCTTGCGACGAACGCCTTGATTCACGGATCCAGCGCAGCAGGGTTCTCGGTTCAGCTGAACATCGGTGACGACCTGATCCGGATAGAAGTAGGCGATCTCAGCGCGGAGATGCCGCAGACCGCCACCCCGGACTGCGAGAGCGACGGCGGTCGAGGACTACTCCTCGTCGCCTCCTTCGCTGACATGTGGGGGGTGGAACCGGACCCACGGGGCGGCAAGACCGTTTGGACCGAGTTCAAGGTTGCCGGTCTTCAACGTGTGCCGAGTGGAGCGGCTCTGTGA	MSATPPELPQFAPQQRTFSPHSASVGMARTFVLKTLTEWGVEGRSEDVQYCVSELATNALIHGSSAAGFSVQLNIGDDLIRIEVGDLSAEMPQTATPDCESDGGRGLLLVASFADMWGVEPDPRGGKTVWTEFKVAGLQRVPSGAAL	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	14.05	gnl|BL_ORD_ID|1789|hsp_num:0	1925			798	957	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000703.1|Kanamycin_70 # 81743 # 82240 # 1 # ID=1_70;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.675	BGC0000703.1|Kanamycin_70 	81743	82240	+	Loose	600	23.8682	RSA2-1	39.13	3006981	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	RSA2 beta-lactamase	ATGATGCATGACCTCGGGACCAAAGATCACCCGCCTGCGAACGCTGTCGTGATGGCTCCGCGGGAGGCGTACGACTTCGACTACTACGCGCAGCGGATCGCGGACCCGGAACTGCTGGTGAAGAGCGTGGCGGTGCGCATGGTTCGCATGCCGCTGCTTGCGGTCCCGGTCGGTGGGACACGCCGTGGGGGGTACTTCCCGGTGCCATGTTTCTGCCTGGGGCTGGCGGTGCGTGACGTGCTCCAAGGCCAGCCGGGCTTTTGGGACTTGCGGTTGGGTTCGGCGTTGTACCCGGAGGGCGAAGCCGTCGAGTGGGGTGAGCGCCCGCCGGAGTTCCCTCCGTGCCCTGACGCCGATGCGGATTCCGCCTTGGGGCGCTTCTACGGCTACAGCGACGCTGCCATCCAGCAGTACACCGCGGCCCGGCGCGCTCGGGCGCTAATCACTCCCGCCTCCTGCTCAGTGTTCTCGTTCTCGCCCGAGCAGCCCCCTGTCTGA	MMHDLGTKDHPPANAVVMAPREAYDFDYYAQRIADPELLVKSVAVRMVRMPLLAVPVGGTRRGGYFPVPCFCLGLAVRDVLQGQPGFWDLRLGSALYPEGEAVEWGERPPEFPPCPDADADSALGRFYGYSDAAIQQYTAARRARALITPASCSVFSFSPEQPPV	MANTTICRLCAVSQAGLSLGETLIKGQVMSFLRSAAIFAAVLLPLSAHAADLDQTIEALENRLDARIGVAIHDTGTGKVWGHREDERFLMNSTIKVPLCAAVLSRSDVDLSEELPVRAEDILEYAPVTEQHVGGTMTVADLCFATIDQSDNTAANLLFGRLGGPESLTTFLRSIGDDLTRSDRLEPDLNIWSAGDPRDTTTPAAMVRTLEAMLTGDALTATAREQLADWMRPGGVTGALMRPSVPHNWDVADKSGSGSNTRNLIAMLTPPDGAPIFVSLSISEAEVDFATRNAALVELSAAVVRSLHAQN	53.23	gnl|BL_ORD_ID|4568|hsp_num:0	5638			189	258	
BGC0000703.1|Kanamycin_71 # 82263 # 83102 # 1 # ID=1_71;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.712	BGC0000703.1|Kanamycin_71 	82263	83102	+	Loose	700	26.1794	ADC-149	34.48	3006323	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGTCTGTGTACAAGATCCCCAGGGCTGGCCTTGTTGCGGCCGACCGCGACGTCGGCTCGGAGCGTCCCTGGGGGCTGAGCCAGCGGCTGCGCACCGTTGTGCGACGGCGAGCTCGGCGGCCGTCTCTACGTCCCACTCCCCGGCTTGAGGCCGGTGGCCCCGCACCGGTTAGCCCCCAGGGCAGGAGTCGCGTCGGAGGCGCGACGCGGAGGCTGATCCCCTACATCACGGCCCGCGAGGGCGAGGTGGACGAGTCCCTCGTCGACTTACGCGCTTCCTTCACCAGTGCCGGGGGAAGCCGCCTCAGCTACGCGGACGAGCGGCCCGAGGACCGTGACGTCCAGGGCGCTTTGTGGGCGCGGGTCTCCCAGTCCCTCGACGAGCACGGGGTGCCGACTGGCGCGCCGCTCTGGCGGATGGTCAACCCGATCCGGCAGCGCGAGACGATGCTGCGGCTGCGGTGCCAGTTCTGCCGCGAGCCCGCCAGGACCCAGGACGGGATCCTGTTCGTCCTGAGCGCCGAGGAGTGCGTACCCGAGGCCACCACCACGGTCCGCACCGCCCAGCCGCCGTTCTGCCTCAAGCACGCACGCATGGCCCCTCGGCGGTGTTCCCACCTCGCCGAGCACGGACACGTCGCGCTGCTGGCGCAGAGCGCGCCCCTGTATGGCGTCATCGGCACGCCACACCGATATGCCGCCGCCGATCGCAGCATCCACGTCCTGGCGAGCGACGGCGTCCCGGTGCCCTACGGGGGCGCCGCCCTGGACTGGATGATCGCCGCCCAACTGGTGCGCACACTGCGGGCGTTCAAGGTCATCAACCTGGACGACCTGTAG	MSVYKIPRAGLVAADRDVGSERPWGLSQRLRTVVRRRARRPSLRPTPRLEAGGPAPVSPQGRSRVGGATRRLIPYITAREGEVDESLVDLRASFTSAGGSRLSYADERPEDRDVQGALWARVSQSLDEHGVPTGAPLWRMVNPIRQRETMLRLRCQFCREPARTQDGILFVLSAEECVPEATTTVRTAQPPFCLKHARMAPRRCSHLAEHGHVALLAQSAPLYGVIGTPHRYAAADRSIHVLASDGVPVPYGGAALDWMIAAQLVRTLRAFKVINLDDL	MRFKKISCLLLSPLFIFSTSIYADNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	72.85	gnl|BL_ORD_ID|3181|hsp_num:0	4219			63	150	
BGC0000703.1|Kanamycin_72 # 83198 # 83656 # 1 # ID=1_72;partial=00;start_type=GTG;rbs_motif=AGAGA;rbs_spacer=10bp;gc_cont=0.671	BGC0000703.1|Kanamycin_72 	83198	83656	+	Loose	470	39.2762	sdiA	32.79	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGCCAACACCACGATCTCGTTCACCACCCGCGAGAGAGAGGTCGTCCAAGGACTCGCCGAGGGCAGGTACGTCTACGAGATCGCGCATCTCCTTCGCCTCAAGGAGAACACGGTCAAGCACTACATCACCGTCGCCTCGCGGACGCTGGGCGTGAGGGGGCGGACGGTTGTCGTCGACCGCGCCTACGAGCTGGGACTCATTCGGCAGCCTGACCGCGAGCAGGGCACGCTCGACCTGATGCCCCGGCATCTGGAGGTGCTGCCTCTGCTCGCGCAGAGCCTGACCAGGGTCCAAATCGGCCTGTTGACAGGCCGATCGAAGGAGCAGGTCACCAGGGACATCAACGGCCTGATGGCGGAATTGGGGGCTCGGACCCGGCCCCACGTGGTGACCCTAGCCCGGATGTACGGCCTGCCGACGGCGGCGCACGCCCCAAGCGCCGCCCGCACCTAG	MTANTTISFTTREREVVQGLAEGRYVYEIAHLLRLKENTVKHYITVASRTLGVRGRTVVVDRAYELGLIRQPDREQGTLDLMPRHLEVLPLLAQSLTRVQIGLLTGRSKEQVTRDINGLMAELGARTRPHVVTLARMYGLPTAAHAPSAART	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	63.33	gnl|BL_ORD_ID|207|hsp_num:0	228			537	720	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000703.1|Kanamycin_74 # 84132 # 85229 # 1 # ID=1_74;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000703.1|Kanamycin_74 	84132	85229	+	Loose	400	31.9574	vanR gene in vanE cluster	22.81	3002924	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGACGAACCCGCTCGCCCCCAGCAGGCCGCCCGTCCTGCTGCACGGCGCGGCAGCACGCCGGGCCCTGCGTCACGCCATCGCACTGCTGCTGCTCGCGTCCATCGTCCCTGTGGCCAACGCGGCAATCTCGCTCGGCTATCTGTACGGGGTGCCCTGGCCTCCGCGCACAGGTCACTACCTCGGCGTGATGCGTGTCTGCGTGGCCATCGTCGTGTTCTTCTGGCTGCCCTGGGTGGTGATAGGCCGCACCACCCTGGACCGGGTCACCCCGCGACGGCGCCTGGCCCAGCGCGGCGCGGCAGTCGCCTGCGGCTCAGCGGCCATCTTCGCGGCCGATCCCTCGGTGGCTTTCACCCCCCTGGCGATGATCATTTTCTGGGGCACGTTCGCGTGGCTCACGCTGGAGGTGTGCCGGTCCCACGGCATCGTCCTGGAACGCCCCCGCGGTGAGACGGATCCGCGGCGCAGGCGGGCACACACATGGGAGCTCTCGCAGCGCGCCTTCAACTTCTGCGTGGCAGGCGGGTTTCTGGCCTTCCTGAGCGCGCAGGCCCTGCTCTTCCTGGACGTGGATGTGCTGCCCGTCATGGACGATCAGCTCGCCGCACTCGGCATCGAGGGCGACCTCGGCCGCACTCTCGCCGCGGTGACATCGACCGTGGTCCTGGAGGACGTCGTCATCGTGGCGGCCGTCGCAGCCCTGATGACGGCCGCGCGACGGCCCGTCTGGCAGATCTACACCACGATCTGCGTGGTCGAAGTCGCGGTTCACGCCTACTTCGGGCTTCCCGCCCTCGCCATGGCCATCTTCGCCGCAGGCCGTCTCCAGATCTTCCTGCACTACGGCCGCGTCGTACCGCTGATGATCGCCCACGGCATCTTCGACCTGGCGGGCACCCTCCTCAAGCCGGTCCCGCTCCCCTACCGCATCGCGGCGGGTTGTGTGCTCGCTATCGCGCTCCCGATGATCGAGAAGCGTGCGACAGGGGCGGCTGATGCAGAGGAGCAGGCCGATCCGGACCCAGCGGCCCACCCGGACGAGCCGCCTGCCCGGGACCGCGCCAACGCGGTCAGTTCTCCTGCGAAGGACTCGTGA	MTNPLAPSRPPVLLHGAAARRALRHAIALLLLASIVPVANAAISLGYLYGVPWPPRTGHYLGVMRVCVAIVVFFWLPWVVIGRTTLDRVTPRRRLAQRGAAVACGSAAIFAADPSVAFTPLAMIIFWGTFAWLTLEVCRSHGIVLERPRGETDPRRRRAHTWELSQRAFNFCVAGGFLAFLSAQALLFLDVDVLPVMDDQLAALGIEGDLGRTLAAVTSTVVLEDVVIVAAVAALMTAARRPVWQIYTTICVVEVAVHAYFGLPALAMAIFAAGRLQIFLHYGRVVPLMIAHGIFDLAGTLLKPVPLPYRIAAGCVLAIALPMIEKRATGAADAEEQADPDPAAHPDEPPARDRANAVSSPAKDS	MAKILILDDEKEIVSLLSTLLSNEGYEVYEAMSGKESLEIIENNKIDLAILDVMLPDISGFDVLQSIREKQFFPVLMLTARGQDMDKITGLSMGADDYIVKPFNPFEVLARVKTQLRRYQTYNSQSIDETNEYAKNGLNISVNSRKVFLYDEEIKLTPIEFDILWYLCRNEGRVISSEELFEKVWKEDYLENNNTVMAHIAKIREKMHEKPRQPNIIKTVWGVGYTIEK	159.39	gnl|BL_ORD_ID|4674|hsp_num:0	691			378	525	vancomycin
BGC0000703.1|Kanamycin_75 # 85536 # 85838 # -1 # ID=1_75;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=6bp;gc_cont=0.716	BGC0000703.1|Kanamycin_75 	85536	85838	-	Loose	700	26.9498	CMY-137	28.89	3006457	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGACGACGAGCCGCTGTCGGACTGGGTGGATCGCCGGGACGCGAAGATCGGACGCCTTCGAGCCGTCCCGCTGGTGTCCGGCGACGGCCCGAAGGGCTCACATCTCAACCCCGACGCGCCGCGTGCCATCCAGCGGTGGAACGGGTACGCCTGGGAGCCGCACGGGTTCGCGGCGAACCTCGCTGAGGCCCAGCGGCTCTTGCACCCGCGTGACGAGGAGCATCCGACTGTGTCGGCACCCCAGCCTCAGCCGCTCCAGGCGGGACGAGGGCGGCACCGCAAACCCCGGCCAGAGGAGTGA	MDDEPLSDWVDRRDAKIGRLRAVPLVSGDGPKGSHLNPDAPRAIQRWNGYAWEPHGFAANLAEAQRLLHPRDEEHPTVSAPQPQPLQAGRGRHRKPRPEE	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMSKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKADSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	26.25	gnl|BL_ORD_ID|3403|hsp_num:0	4472			510	645	
BGC0000703.1|Kanamycin_76 # 85912 # 87081 # -1 # ID=1_76;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.708	BGC0000703.1|Kanamycin_76 	85912	87081	-	Loose	400	33.113	ErmG	22.43	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCGACACCGCCTATGAGCGGCGCGCCCTCGCCGACCGCCTGACGAAGGCGGGCATCCTCTCCAGCCCTCGCTGGCGGGCGGCGGTGGAGGCCGTTCCCCGCGAGCTGTTCCTGAACCCCGGAGTGTTCCTGCCCGCGGAGGGGGGCCGGTGGCAGCCGGTGACCGCGGTCGGCACCGACCCGGCCCAGTGGGTAAAGATCGCGTACCGCGACGAGTCCCTAACCACCCAGCTTGATGGACACCTCACCGCCGACCAGGCCAGCGGCCCCGTGACCGGCTCCCCGACCTCCTCCTCCACCACGCCGGTCACCGTCGTGGACATGCTGGAGAAGCTGGAAGTGGAGGACGGCCACCAGGTCCTGGAGATCGGCACGGGAACCGGCTACTCCTCCGCCCTGATGTGCTTCCGCCTCGGCGAGGACAACGTCACCACCATCGAGGTGGACCCGGACGTCTCGGCCCGCGCCGACGCTGCCTTGGAGACCGCCGGATACTCCACCTGGACCCTCACCGGAGATGGACTCCTCGGCCACCCCCGCCGCGCGCCGTACGACCGGGTCATCGCCACCTGCGCCGTACGCCGCATCCCCTACACCTGGATCAGGCAGACCAAGCCGGGCGGCATCGTCCTCACCACGGTCGGCGGTTCCTGGCACTACGGCACCGGCCTGGCGAAGGTCACCGTCGCCGACGACGGCACCGCCGAGGGCCAGATCATCGGCCGCAGCTCCTTCATGCAGGCCCGGTCCCAGGCGGAAGTACCCATCGGCGGCGACCTGTCGGCCCGCACCGCCTACGCCGACAGCGAGCACGAAACCAAGGTGTCCCCGCTGCTGCTGGAGGACTGGATGCCAGCGTTCCTGGCCCAGCTCGCTGCCCCGGGGGCGCGCTTCACCCGCGCCACATCGCTGGAGGGAAACCGGCTGCTGCACCTCTTCGACCCGGACCGCGAGTCCTTCGCCTCCTTCACGGAGAACGACGGCACCTGGACCGTCCGCCAGGGCGGCCCCACGGCGCTGTGGGACACGATCGAGCAGGCCCTCACCGCCTGGCAGGACGCGGACCGCCCCGACATCACCGAGGTACGGCTCCGCGTCACGAAGAAGGCCCACACCTACTGGATCGATGGCCACCCCGCGCTCCGCTGGCAGCACGACCTCATCTGA	MTDTAYERRALADRLTKAGILSSPRWRAAVEAVPRELFLNPGVFLPAEGGRWQPVTAVGTDPAQWVKIAYRDESLTTQLDGHLTADQASGPVTGSPTSSSTTPVTVVDMLEKLEVEDGHQVLEIGTGTGYSSALMCFRLGEDNVTTIEVDPDVSARADAALETAGYSTWTLTGDGLLGHPRRAPYDRVIATCAVRRIPYTWIRQTKPGGIVLTTVGGSWHYGTGLAKVTVADDGTAEGQIIGRSSFMQARSQAEVPIGGDLSARTAYADSEHETKVSPLLLEDWMPAFLAQLAAPGARFTRATSLEGNRLLHLFDPDRESFASFTENDGTWTVRQGGPTALWDTIEQALTAWQDADRPDITEVRLRVTKKAHTYWIDGHPALRWQHDLI	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	159.43	gnl|BL_ORD_ID|915|hsp_num:0	989			39	348	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000703.1|Kanamycin_77 # 87078 # 88037 # -1 # ID=1_77;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.701	BGC0000703.1|Kanamycin_77 	87078	88037	-	Loose	500	25.409	OXA-611	33.33	3005832	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGACGAGAGGCCGGTGCTCGTGGCCACCGAGGCGGATGACCTCACCGCCGACATGGTGATCAACGAGCTGAACCGGCGAGGCGTGCCGGTGACCAGGTTCAACCCCGCCGACATCGGGGCGGCCCTGACGGTCTCCGCTCAGTTCGGAAGCTGCCCGGCCCCCGTGGCCGGGCAACTCCGCACCCCGTCGCGGACCGTGGACCTGGCCCAGGTCCGGTCGGTGTACTGGCGCCGCCCGGTGTGGCCCGCCTTCGGCCACCTCGGCCCGGACGACGCGCGGTTCGCGGCGGCCCAGACCCGCTACGGGCTCGGCGGCACCCTGTACGCCCTCGACGGGCCGCTGTGGGTCAACCACCCACTGCACAACGCCGCCGCCGACTACAAGCCCGCCCAGCTCGCCATCGCCCAGCGCCTTGGGCTGACCGTGCCGCCGACGCTCGTCACCAACGACCCGCACGAGGCGCGGGCCTTCGTCGGCAGCCACGATCAGGTGATCTTCAAGACGCTCCGGTGGACGCCCTACCAGCGCGACGGCGTTCCCGTTACCGGGTGGGCCGACCCGGTCACCGCGACCGAGATCAACGAGAGCGTCGCCGTAGTGCCGCACCTGTTCCAGGCCGTGGTCGACAAGGCAGCAGATCTGCGCGTGCTGGTCGTCGGCCGCGAGGTGTTCGCCGTACGGATCGAGTCCGAGATGCTGGACTGGCGCAAGGACTACTCGGCCCTGTCCTACCGCGTGGTGGATCTGCCCGGCCGGGTGGAGAAGGCGCTCCTCGCCTACCTGGAGCACTTCGGGCTGGTGTCGGGGAGCTTCGACCTCGCCGTGGACAAGGCCGGTGATCTCTGGTGGCTGGAGCTGAACCCGAACGGACAGTGGGGGTGGCTGGAAGAATCCACCGACCTCCCGATGTCCGCCGCATTCGCTGACCTGCTGACGCAAGGAGTTGCGCCATGA	MTDERPVLVATEADDLTADMVINELNRRGVPVTRFNPADIGAALTVSAQFGSCPAPVAGQLRTPSRTVDLAQVRSVYWRRPVWPAFGHLGPDDARFAAAQTRYGLGGTLYALDGPLWVNHPLHNAAADYKPAQLAIAQRLGLTVPPTLVTNDPHEARAFVGSHDQVIFKTLRWTPYQRDGVPVTGWADPVTATEINESVAVVPHLFQAVVDKAADLRVLVVGREVFAVRIESEMLDWRKDYSALSYRVVDLPGRVEKALLAYLEHFGLVSGSFDLAVDKAGDLWWLELNPNGQWGWLEESTDLPMSAAFADLLTQGVAP	MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWVSNDFSRAMETFSPASTFKIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIGIKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVKEMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREKILEKYLDELVKKVKNDG	124.12	gnl|BL_ORD_ID|3867|hsp_num:0	4937			81	171	cloxacillin; oxacillin; cefalotin
BGC0000703.1|Kanamycin_78 # 88041 # 88295 # -1 # ID=1_78;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.694	BGC0000703.1|Kanamycin_78 	88041	88295	-	Loose	535	27.335	aadA10	24.56	3004692	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTCCACCGCAGTTGAGCCCCGCGTGCGTCCCTGGGGAGCCGATCGGCTCGCCCCGTACCCGACCGTCACGCACCGCCCGCACACCACGGTCACGCTCGACCCCGACTCCCAGCTCGGCGTCTTCACCGACCACGTCGGCACGGTGATCGAGATGGGCAAGCACGGCACCAGTAAGGGCACCGAGACGAGCACGACCACGAACTCGGACTCCGCGCCCGATCAGGGGAGCGACCAGGACGACGAGCAGGACTGA	MSTAVEPRVRPWGADRLAPYPTVTHRPHTTVTLDPDSQLGVFTDHVGTVIEMGKHGTSKGTETSTTTNSDSAPDQGSDQDDEQD	MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDESVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWIGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLASLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST	30.32	gnl|BL_ORD_ID|2153|hsp_num:0	3398			123	294	spectinomycin; streptomycin
BGC0000703.1|Kanamycin_79 # 88409 # 89512 # 1 # ID=1_79;partial=00;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=4bp;gc_cont=0.685	BGC0000703.1|Kanamycin_79 	88409	89512	+	Loose	1000	26.5646	msbA	33.33	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCCGCGAAGGAAGTGACCCGCGGACGCGCGACCGCGGGCACGATCGCCGGGTTCGTCCTGCGCGTCGCCCGGGAGAGTACGAGCATCCGCACACAGGTCGGCATGGCCGAAGCGATCGGCGTCGATCTCGCCACCTGGCAGGGCTGGGAGACCGGACGACGACCGCTCGCCAACGTGAAGGCCGGGGCCCTCCTCAACATCCGGCGCCGGTTACTCGCGCTCGGCGCGGACCCCCATGTCCTTCACCTTCTCGACCCGGCGATGGACGCGGACCGCGTCATCACCTCCACGATCCATCCGGAGATCAACGACCTTCACCCTCTCGCGAGTTGGGTGCACACCCGCGATACGGCCCACATGATCGCCTGGGCGCTGAACGGGACCGCTCCACGCGCTCTCGTTCGCAGCGCGACGACGGGACGTCGCGGCCCCGTCGCCAAGGCCCCGCTCTTACCCACGTCCGACCGCGACGTGTTCTTCGCGCACCTCCGGGAGACCGCCGAATCCGCGTTGCGCGCCGGAGACGGCGGTTTGCTGCTGCACCGCCAGACCCTCTACCTCTGCTCCTACGACCGAGGCTCCGAGGCGACGTCGTGGATGGTGCACGCGCTACACGGCCGCCGCGACCTGATTTCCGCACGCGGCTGGACCCCGCACTGGGCCACCGCAAGGTCAACCGCCGCCGCGCTGGTACGGCTCGGTGACCGTCAACCGCTGCTCGACTTCATCGAGCGAGGCTTGGCGGACGACGACTCCGCAGAGATCGCGAACCTCAACTACTGGGCCTACTGGCTCGGTTCGATCCGCGAGCCGCAGCCAGACGATGGCTTCATGCGGCGCGGCCCAACCAACTGGGAGCCCGTACGGCTCCTTCGGGGCCTCGCCGCCGGTCTTCAGCAGGCTCCGGCGTACATGGACCTCTACGTCCACTCACTCTGGGCCCTCCTCACTACCAACCGGTGGCTACCCCTGGCAGATCCCGTCCTCGCTGACAAGCTCGCCGCGCACACCGCCCGACTCCTCGATCACGACGGGATCTCCCCGCGAGCCAGGCGGGAACTCAGTTCGGTGCATTACGTTCTACGCGAGAACCGCACATGA	MAAKEVTRGRATAGTIAGFVLRVARESTSIRTQVGMAEAIGVDLATWQGWETGRRPLANVKAGALLNIRRRLLALGADPHVLHLLDPAMDADRVITSTIHPEINDLHPLASWVHTRDTAHMIAWALNGTAPRALVRSATTGRRGPVAKAPLLPTSDRDVFFAHLRETAESALRAGDGGLLLHRQTLYLCSYDRGSEATSWMVHALHGRRDLISARGWTPHWATARSTAAALVRLGDRQPLLDFIERGLADDDSAEIANLNYWAYWLGSIREPQPDDGFMRRGPTNWEPVRLLRGLAAGLQQAPAYMDLYVHSLWALLTTNRWLPLADPVLADKLAAHTARLLDHDGISPRARRELSSVHYVLRENRT	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	63.06	gnl|BL_ORD_ID|2185|hsp_num:0	2423			15	159	metronidazole
BGC0000703.1|Kanamycin_80 # 89533 # 90114 # 1 # ID=1_80;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.668	BGC0000703.1|Kanamycin_80 	89533	90114	+	Loose	400	30.0314	VIM-32	31.48	3002302	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGGCGGACACAGAGCAGGAGCAGGCAAAGGGCACCACGGGCTTCCTGCTGGAGATGGGGATGCTCAAGCGTGCCAAGCGGTCGGGCTGGTGGATCGCCGGGGTCAAGGACCCCGAGACCATCGCCGAGCACAGCTTCAGGGTCGCGCTCATCGGCTCCGTGCTCGCCATGATGGAGGGCGCCGACCCGGCGAAGACCGCCCTCCTCGGCCTGTGGCACGACACCCAGGAGACCCGCGTCAGCGACATCCCCCACATCGGCCGCCGCTACCTCGAAGCCGCCAGCAACGAGAAGGTCACCGCCGACCAAGTATCGGCCGCACACCCGGCGGTGAAGGCCGGGGCCCAACGGATCGTGGAGGAGTACGAGAACGGCGACTCCCTCGAAGTCATCTGCGCGCACGACGCCGACAAACTCGAATGCCTCCTCCAAGCTGTCGAGTACCGCGAACAGGGCTGCTCGAACGTCCAGCCCTGGATCGACAGCAGCGTCGCCAAGCTCAAGACCACCTCCGCGCAGTCCCTCGCCGACGCCGCGCTCACCATGACCTCGATCGAGTGGCAGCAGACGTATCTCCGCTGA	MADTEQEQAKGTTGFLLEMGMLKRAKRSGWWIAGVKDPETIAEHSFRVALIGSVLAMMEGADPAKTALLGLWHDTQETRVSDIPHIGRRYLEAASNEKVTADQVSAAHPAVKAGAQRIVEEYENGDSLEVICAHDADKLECLLQAVEYREQGCSNVQPWIDSSVAKLKTTSAQSLADAALTMTSIEWQQTYLR	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAAGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	72.56	gnl|BL_ORD_ID|1400|hsp_num:0	1521			417	687	
BGC0000703.1|Kanamycin_81 # 90183 # 94628 # -1 # ID=1_81;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=12bp;gc_cont=0.702	BGC0000703.1|Kanamycin_81 	90183	94628	-	Loose	500	29.261	BSU-1	35.9	3006902	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BSU beta-lactamase	ATGGGATGGGTGACCATGATCGGCCCCTCCGACGGGCAGGTTGAGTACCGCCTTACCGGCGGCCACGGATGCGGGAAGTCCGTCGCGGTCGACGCCGCGCCCCTCATTGCCGCCATCGAGGCGAAGGCCGAAGCCGCCGGTGCCCCCGTCGCCTCCCTGCTCGCCAACCGCGAGGCCAAGCGCGCCTTCTTCCGTGCCCGCGGACTCCTCCGCAGCAAGGGCGCTGCGCGGTTCACCGGGTTCGACGCCGTTGAAGTCGCCGCCGCAGCCGGGCTCGACGCCCGCGACCTCTACGGCGAACAGGCCCTTCCCCCGAGAGCCTCCGACGGACAGGTGGACTACCACCTGGACGCCAGCGAAAGGCCCCTGGTCTGGATCGGCGGCGGGCTCACCGAGTTCGACATCACGCCCGGCAGCACCCTCGTCCCCGAGCAGTTCGCGGCCGCCCGGCGCCTCATGCTCGGGGAAGACCCCCGGACCGGGCAGACCCGCGTGGAACCCAAGCTGGCCATCGCCTCGGCCGCCAAACTCCCCGCCGCCCCACTGGCCCGCGCCATCCGTCGCGCCGCCGCCGAACGCAGCGTGAACCCGACCTCCCTGCTCGATTCCAAGCGCAAGCAGGACGCATTCCGCCGGATGGAGAGCCAGCTCAAGCGATTCGGCGAGACGCACCGCGTCCCCGTCTCGACGGTGCTGAAGCTCGCCGATGCCGTCGGCATCAACGCCGTCGACCTCTACGGCGAGGACACGGTGGAGAAGGCCGTCGCCGCCGAGGCGGGCGGTCACCTGGACGCCCGTGCCCTCCTGCGCGCGGTCGAGGCCCGCGCCGCCGAGACCGGACAGCAGCCCGCCGACCTGTTCGACGCGGCGTCCATGAAGCGCCGATACGCCCAGACCGAAGGCGAAGGTGGCCGTCGTCTCCGGGACCTGCCGATGGATGTCCGCGAAGCCGTCGCGATGGCCAAGGCGGCAGGGCTCACGCCCGAGGACGTGTGGGACGCCGAGGAGATCAAGGCCGCCCTCCTCGAAGGTCGCGTGCAGGTCGGCAACCGCGGTGCCGACGTCACCTTGGACCTGGCGAAGTCGAAGTCCGCGTTCCTCGCGTACGCGCCCGAGGAGATCGCCGCCCAGGTCGAGGGCATCTACACGACCGCCGGCCGCGAGTCCATCGGCGCCCTGGAGCGGTGGACCGCGTACGCCATGCGCGGCCACCACGGCGACGGCGAAGAAGCGGAGATCGTGAAGACGAGCGGGTTCTCCGGCTGGATGATGGTCCACCGCGCCGCCCGCCCCGTCGACGGAGCCCCGTACGGGGACCCCCACTTCCACCTGCACTTCACCCTCGCCAACATGGTCAAGGGCGCCGACGGCAAGTGGTCCACGATGGCCAGTGGGGGCCGCGATCTCCACCGGCACACCCGCGCGACCCAGTCCCTCATGAACGCCCGCATCCGCCGCGAGCTGACCGACACGTTCGGCATCAGCTTCCGTCGTGAGGAGCGGACCGGAGCCTGGGAGATCGCAGCGATTCCCGAGGCCACGATCCGGCTGTTCAGCAAGCGCGACAGCCAGGTCCGGGACCTGCTGACGAAACTCGGCATCGACTACGACAGCGCCACGACCCGCGAGCGTACCGCCGCCTCCACCGCGTCCAAGGCCGCGAAGAACGGCGAGGCCGCCGGGGTCGGGGACGATGTTCTCCGCGCCTACTGGCAGGCCGAGGGCCGGGCGGCCGGAGACGACCCCGACGCCATCGCAGCCAGCGCGATGGAACAGGACCGAGCAGACCAGAACCCCACCCTGGACGAGCTGTGCGCCCAGGTCTTCGACCCGAAGACCGGTTTGACCAGCCACTCCAAGGAGTTCACCCACGCCGCCGCCATCGCCGCCGTGCTGGACGCCCTCCCGTACGGCGTCGCGGACGCCGCCGAGGCCGAACAGCTCACCAACTCCGTACTGCGGCAAGCCGGGTACGCGGTCCAGCTCAGCCCGAAGGGCGCCCAGCACTTCGCGCACGCCGAGCGGTACACCACGGCGGATGTCGTGGCGGCCGAAGCGCTGATCGTCTCCGAAGCCACGAACCGGCTCGGGACTCAGGCCGCCGTCGTCAGCAGCGACACGGTCGACATGACGCTGTCCACCGTCGAGGCCCAGCACGGTGGCAGCTTCACGTTCTCCGACGAACAGCGTGCCGTCCTCGAACGGCTGCTCACGGCCGGGCACGGAATCGACGCCGTCGTGGGCATCGCCGGAGCGGGCAAGACCACGATCATGGACACCGCGCGGCAGGCGTGGGAGGCGCACGGTCTCGTCATCGCCGGCGCGAGCACGGCCGCCGTCGCCGCCGCGAACCTGAAGGCCGAGGCGGGCATCGAGTCCCGCACCCTCGCGTCCTGGTTGACCGGCATCCGCAACGGAGGCTCCGGCCTCACCGGCGTGGACGTGTTGGTCGTGGACGAGGCCGCGATGTGCGATGACCGCGACATCGCCGAACTCCTCACCCACGCCGCGGAAACCGACACGAAGATCGTCGGTATCGGTGACCCCAAGCAGCTCCACTCGCCCGGCATCGGCGGTTCCTTCGCTGCCGTGCACCACATCGTCGGCGGACTCACCCTCAGCCAGAATTTCCGCCAGAAGGACATGGTCGAGCGCCGGGCACTGGAGCTCTGGCGCGACGACAACCGCGTGGAATCGCTCCGCATCTTCGCCGGGACCGGGCGCGTGCACGCTCTCGCGGACAAGGACGCCACCCTCGCCGCGATGCTCACCGTCTGGGCCGACAAGCGGGCCGCGCACACCGACGACCACACCGCCGTGCAGCAGCTCCTCATGCTCGCCGCCACCAACGAGATCGTGGAAGAGCTGAACACCGGCGCCCGCGCACTGCGGAAGGAGAACGGCGACCTCACCGGCCCCGAGCACGCATACGCGCTGCCCGGTGGCGGCGAGCTGACCCTGTCCGTCGGCGACCAGGTCCTCCTACGGGTCAACGACTACCGAGGCAAGAAGAGCCGAGGCGCGAGCGAAGACGTCCTGAACGGCTACCGCGGAATCGTGCGAGCCGTGGACGAGGAACGCCGGGTGCTGGTCGAGTGGCGAGAGAAGACCGAGGACGGCCACCGCGACGTTGCCGAATGGATCGACGCCGACTACATCGCACAGGGCGGACTCAGCCTCGGATACGCGATCACCGGCCACAAGTCGCAGGGCCTCACCGTCCAAGAGGCCCTGGTCTACGGACCCGGCGCTCAGGCGAACGCCCTCTACACCATGATGTCGAGGGACAAGGCCGAGTCCCACCTCTTCCTGCCGCTCTCCGTCTACGAGACCGACGCCGACCGCGCCCGCCACGGCGACGCACTCACCGACCAGGAGCAGCTTGACCGCGCCGTCTCGGGCCTCATCCGCGAGATCGAGAACGGCACCGAGGAACGCATGATCCTCACCGAACTCCCCAAGAACGCGGTCCCCGCCCACGTCCGTCAGGCCGTAGCGGACCTCCCGATCCCGCGAGCCCCCGGCGCCGACGAGCACCACGACGCCGACACTCCCGAGGAGACTCCGGACCACGAGGACCGCCCCATACTGGCGAACGCCGAGCCGACCACGGAGTCGGCCACACGTTCGGAACCCGCGCCGACGGCTGACCGTCCATACGCTCACCTCGGTAACTCGGCACTGCGTGACGCCGTGCGCAAGGCTGCCATCGCCGCCCGCGCCACGACGGCGGCGGCGGACAAGGCGGAAGGCGCCGCCGATCGTGCCGAACAGGAGGCTGCTGCCGGAGCAGGCCCCAAGTCGCTCGCGCTCCAACGCCGTCATCAGGACGTTGCCGAACGGGCCGTGGCCATCCGCGAAGTCCTGTTGCTGGACGGCACGATCGCGGAACGCACCGCTCGACTGAACGGCACAGAAGCCCGTATCGGAGGTCTTGAACAGCAGCTGGCCGCGACGGGCCGTTTCGGCCGGGCGGCACTCCGTGGTGACGAGCGTGCTGCGGTCGAGGCAGACCGGGAAGCACTCCTTCGTACCCGTGAGGAGACCGTCCAGGAGCTGGAGCAGATGGACACGCGGCTCCAGGACGTTACCCGGCAGGCCGGACCCGTCAACGAGTACGAAGCAGTGCTGAGGGAAGCGGACATGCCGCAGCAGGAGAAGGCCGCGCTGCTTCGGCGGGCCAAGGCCAAGGACAACGAGGCAGCCAAGCAGCTCCGGGCCGAGGCCATCAAGGCTCGCAGCACTGCTCACGGCGCAGACCACCGCATGTCCGGCCTCCAGAAGGAGGCGAGTCTGCGAGCTGAGCACGGGCGTCAGCACGTCGACGCCGAAGAGGCCGCGGCGCCCTCATCTCCGAAACCCGACTCCTCGTACGCCAACCGAACCGCGATGGGCCACACACAGGCCGCACCGCCGGACAGCGCTCACGACGCACCGCCCGTGTAG	MGWVTMIGPSDGQVEYRLTGGHGCGKSVAVDAAPLIAAIEAKAEAAGAPVASLLANREAKRAFFRARGLLRSKGAARFTGFDAVEVAAAAGLDARDLYGEQALPPRASDGQVDYHLDASERPLVWIGGGLTEFDITPGSTLVPEQFAAARRLMLGEDPRTGQTRVEPKLAIASAAKLPAAPLARAIRRAAAERSVNPTSLLDSKRKQDAFRRMESQLKRFGETHRVPVSTVLKLADAVGINAVDLYGEDTVEKAVAAEAGGHLDARALLRAVEARAAETGQQPADLFDAASMKRRYAQTEGEGGRRLRDLPMDVREAVAMAKAAGLTPEDVWDAEEIKAALLEGRVQVGNRGADVTLDLAKSKSAFLAYAPEEIAAQVEGIYTTAGRESIGALERWTAYAMRGHHGDGEEAEIVKTSGFSGWMMVHRAARPVDGAPYGDPHFHLHFTLANMVKGADGKWSTMASGGRDLHRHTRATQSLMNARIRRELTDTFGISFRREERTGAWEIAAIPEATIRLFSKRDSQVRDLLTKLGIDYDSATTRERTAASTASKAAKNGEAAGVGDDVLRAYWQAEGRAAGDDPDAIAASAMEQDRADQNPTLDELCAQVFDPKTGLTSHSKEFTHAAAIAAVLDALPYGVADAAEAEQLTNSVLRQAGYAVQLSPKGAQHFAHAERYTTADVVAAEALIVSEATNRLGTQAAVVSSDTVDMTLSTVEAQHGGSFTFSDEQRAVLERLLTAGHGIDAVVGIAGAGKTTIMDTARQAWEAHGLVIAGASTAAVAAANLKAEAGIESRTLASWLTGIRNGGSGLTGVDVLVVDEAAMCDDRDIAELLTHAAETDTKIVGIGDPKQLHSPGIGGSFAAVHHIVGGLTLSQNFRQKDMVERRALELWRDDNRVESLRIFAGTGRVHALADKDATLAAMLTVWADKRAAHTDDHTAVQQLLMLAATNEIVEELNTGARALRKENGDLTGPEHAYALPGGGELTLSVGDQVLLRVNDYRGKKSRGASEDVLNGYRGIVRAVDEERRVLVEWREKTEDGHRDVAEWIDADYIAQGGLSLGYAITGHKSQGLTVQEALVYGPGAQANALYTMMSRDKAESHLFLPLSVYETDADRARHGDALTDQEQLDRAVSGLIREIENGTEERMILTELPKNAVPAHVRQAVADLPIPRAPGADEHHDADTPEETPDHEDRPILANAEPTTESATRSEPAPTADRPYAHLGNSALRDAVRKAAIAARATTAAADKAEGAADRAEQEAAAGAGPKSLALQRRHQDVAERAVAIREVLLLDGTIAERTARLNGTEARIGGLEQQLAATGRFGRAALRGDERAAVEADREALLRTREETVQELEQMDTRLQDVTRQAGPVNEYEAVLREADMPQQEKAALLRRAKAKDNEAAKQLRAEAIKARSTAHGADHRMSGLQKEASLRAEHGRQHVDAEEAAAPSSPKPDSSYANRTAMGHTQAAPPDSAHDAPPV	MSKGKVQALFLSLIGAALLMTSSLQTPTEAEAAEKNINSKKLKVDEFFTDLDGTFILRDLKNEKTFVYNDQRAKQRFAPQSTFKVPNALIGLETGAVKDEYDIKYWDGVKRELDVWNQDHTLGSAMRYSVVWYYQAMARDIGEERMKEWIEKTGYGNQDISGGIDQFWLSSTLKISPLEQTDFMESLYKEKLPFDKSVMKTVKRMMIQEDEDHYTLYGKTGSGSGIGWYAGFVKTEHGAYSFVTNIDGTGTEAKSITMDILKKYVLH	554.68	gnl|BL_ORD_ID|3337|hsp_num:0	4406			399	510	
BGC0000703.1|Kanamycin_83 # 95440 # 96093 # -1 # ID=1_83;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.691	BGC0000703.1|Kanamycin_83 	95440	96093	-	Loose	2000	25.409	oqxB	25.0	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCCCGCAAGACCGGCCGCACGCTCTACTCACGCGCGGACCTCCGCAAGGCCCACGGCATCAGCGAGCCCACCCTTCAGAACCTCTGGACCGACCGCGAGAACAACGACCACCCGCCCATCGCAGAGATGATCGACGGCGTCATGCACTGGGACGCCGACGCCTGGGCGAAGTGGCACCACGAGCTCCAGCGCAAGCGAGCCGCCGCGAACACCACGAACCCGCCCAAGCTCGACGGCGACCCCGAAGAGATGGTCGGCCCCGCCGAAGCCGCGAAGGTCTGCGGGTTCGCCAACTCCACCACCGTCTCCCACTACGTCAAGAACCCGCCGGAAGGATGGCCCGAGCCCGACGACTGGGACGAACTCCCCACCCGGCGGCGCCCGAAGTGGAAGCGCTGGAGGCTGTGGCAGTACCTCGCCGACCGGAAGGGCCGCGGCCATGCCGGCGGGCGACCCAAGGGCCGCCGCGGACTGGCCTACCCCTACCAGGGAGACGAACGGCTCACGCTCGCCCGGCAGGCCCTCAACGCCAACCCGGGGGCCAAGAACGCCGACCTGATCGCGGGACTTCAAGCTCAGATGGAGAAGGAGTACTCCCGTACGGTCTGGAACCTGATCCTCAAGACCGCCCGCGAACACCCCGAGGAGTAA	MPRKTGRTLYSRADLRKAHGISEPTLQNLWTDRENNDHPPIAEMIDGVMHWDADAWAKWHHELQRKRAAANTTNPPKLDGDPEEMVGPAEAAKVCGFANSTTVSHYVKNPPEGWPEPDDWDELPTRRRPKWKRWRLWQYLADRKGRGHAGGRPKGRRGLAYPYQGDERLTLARQALNANPGAKNADLIAGLQAQMEKEYSRTVWNLILKTAREHPEE	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	20.67	gnl|BL_ORD_ID|2152|hsp_num:0	2400			633	777	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000703.1|Kanamycin_86 # 97223 # 97621 # -1 # ID=1_86;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.727	BGC0000703.1|Kanamycin_86 	97223	97621	-	Loose	725	26.9498	SRT-3	54.55	3006853	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	ATGGATGAGACGACAGAAGACCGCAGCACCACCAGGACGCCGAGCCGCCGAGGAGCCGCCACTCCCAGCCGGGACGGCGTCCACCGACTCAGCGTTCCCCTCCGCCCCCGGCTCAGCGCGACCGAGCTGATCCGCGTACTCCTCGCGGCCCCCGGGGAAACCGACCTCACCGCCCTCGACCCGGTGCAGGTCCGATCGCTCATCGCCGACGTGCTCACCCAGCACGGCTACGACGTGCTCGACCGCTCGCCGTACTACCCGGAGCTCGACCGCCACCAGGACGCCCGCCGCGCCGTGCGCCGGGCGTATGGGCCCCGGTTCCTCGACGCCCCCGACGAACAGTCCGTGCTCGCGGACCCGCTCCGCGAAGTGCTCGCCGCCGGAAGCAGGACGTCGTGA	MDETTEDRSTTRTPSRRGAATPSRDGVHRLSVPLRPRLSATELIRVLLAAPGETDLTALDPVQVRSLIADVLTQHGYDVLDRSPYYPELDRHQDARRAVRRAYGPRFLDAPDEQSVLADPLREVLAAGSRTS	MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYRIVQALDKR	34.92	gnl|BL_ORD_ID|4594|hsp_num:0	5664			741	807	
BGC0000703.1|Kanamycin_87 # 97707 # 98135 # -1 # ID=1_87;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.751	BGC0000703.1|Kanamycin_87 	97707	98135	-	Loose	1750	23.8682	amrB	48.15	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCGACCCGCCACATCCCCGAGAGCATCGTCATCGCGGACACCCCAGCCGCGATCCTGGAATGGGCCGCCCGCCACATCGAACACGTCGGCATCCACCAGGGCCCGCGTCTGTTCGCTGGTCCCGGCCGTACGGCCACACTGCCGTGCTGGCCGCGCGGCGCCCTCGACGTCGCCGCCGGCCACGGCCGGGGAGCCGCTGGCCGGACGTACGACTGGGACCGCATCAACCACGCCCGCGACCAGGCGTTCGCCATCCTCGCGGAAACCCTCGCCGGGCACCCCGTCGACGCCGACGTGCCCACCGCCGCCAGGACCCTGCACCGCGAGGTCATCGACCGGTGGAGCGCCGAGCCCGGACGTACCGCCGCCGACGCCGCCCGCGCGTTCCGCACTGCCGCCGCCCGCGCCGAACATGCCCTGTTCTGA	MPTRHIPESIVIADTPAAILEWAARHIEHVGIHQGPRLFAGPGRTATLPCWPRGALDVAAGHGRGAAGRTYDWDRINHARDQAFAILAETLAGHPVDADVPTAARTLHREVIDRWSAEPGRTAADAARAFRTAAARAEHALF	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	13.61	gnl|BL_ORD_ID|428|hsp_num:0	476			1881	1962	
BGC0000703.1|Kanamycin_88 # 98199 # 98849 # -1 # ID=1_88;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=7bp;gc_cont=0.702	BGC0000703.1|Kanamycin_88 	98199	98849	-	Loose	575	24.6386	PAU-1	40.74	3006964	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PAU beta-lactamase	ATGACCACGCAACTCCTCGAACGACCCGCGACCATCACCGTCCCCGACACCGAAGTGGGCAGGCTCATCGTCCCCGCGACGGGGGGCAGCACCACCGTCTCGACGTACCGCGTTGGCACCCCCGACATTCAGTGCCGATACTCCGTGATCGTTGGCGAAGACCAGGTCATCGGCCGCGCCTACCGGTGGCACCGGGATTGGCTCGTCCTCACCACCGCGGGCGAACGCAACCTCCGCCGCCCGCCCAAGGGAACCCCCGGCACCGACATGGCCGCCGCCCATCTCGCCGAGGAGTACGCCGCCGGTCGGATCGGCACCGTGCCCCTGGACCAGGTGATCGCCGAGGCCCCGACGCCGTTGTGCGGGCCGGTACCCCTCCTGCACCCGCGGATGCCGGTCAACGATCGCAACATCGAAGGCGCGCAGATCGCGTTCGCCGGACTCGCGGCCCACCACTGGCGGGCAGTCCTCACCGGCTTCCCCGGCAGCGACAACCACTGGTTCCTCAGCTGTGAACTGTGCCCGTGGGAGGGCCCGAAGTTCTGGTCACACCTGCGCGGGCGCAACGGAGAGCCGCCGAGCGCGCGCCGCCACAAGGGCGGGTGCATCGGAGAGGACAAGGTCCGCCGACTGATCCCCGCCTACCACTAG	MTTQLLERPATITVPDTEVGRLIVPATGGSTTVSTYRVGTPDIQCRYSVIVGEDQVIGRAYRWHRDWLVLTTAGERNLRRPPKGTPGTDMAAAHLAEEYAAGRIGTVPLDQVIAEAPTPLCGPVPLLHPRMPVNDRNIEGAQIAFAGLAAHHWRAVLTGFPGSDNHWFLSCELCPWEGPKFWSHLRGRNGEPPSARRHKGGCIGEDKVRRLIPAYH	MKRRNFSVGMAFSAFGFSAIFPKKSFALGEQGQMTAVFQQLEAKAQGRLGVHVIDTATGHEFGYRSDELFMMLSSFKLLASALVLARADRGEESLTRRIRYRKQDLVPWSPVTEAYADGEGLTLAQLCHATITTSDNTAGNLILASYGGPQALTQYARQLGDKITRLDRNEPDLNTRVEGGSLDTTSPRAMAMTMNKLLLGDALSPLSRNLLRQWLLENTTGGKRLKAGTPADWTVGDKTGTNKTDANDIGILLPPQGAPVLVTAYLADSTASSQIKDATLAEVGRLTSIGIR	73.72	gnl|BL_ORD_ID|4169|hsp_num:0	5239			387	468	
BGC0000703.1|Kanamycin_89 # 98921 # 100549 # -1 # ID=1_89;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.708	BGC0000703.1|Kanamycin_89 	98921	100549	-	Loose	450	26.5646	BlaB-20	37.14	3005534	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	GTGCGTTCACCGTCGTCGGCCGGCTCCGCCGCAGGCGGCTCCGCCGACCGACGACGGGCACCGGACCGCAGCGGACGCGCCCCGCGGGGGCGCGACTGCCCCTGTCGTCGCGCAGGCGCGACGACCCGCGAGCCGATCGTCCCTCACGGCCCGCGCCGGTGGTGCAGCGCCGCTGCCAACGCACGGTCCGCCCTGCGGCCGGACCACAAACTCTCACCAGAAAAGACCAGTTCAGTGACTATCGAGATCACCCACACCCGCCGCGAAGGCACCCTCATCGAGGGCACGAGCCGCAACGACGGATCGAAGGAAGTCCTCCGGACCCGCCACTACGCATCCGGATACACCACGCTCGCCAAGTGGTCGCGCAACCTCGGGTGCTGGTACCTCCCCTACAGCCGCGACAAGCGCACCTCCCCGCCGATGCTGGAAGCCCTAGCCGAACGGCTCCGCGCAGAGGGGTTCGAGGTCACCGTCACCATCGACGACACCGACCGCCGCAGCTTCGCCGAGGCCGAGCAAGACCGCGTCGAGCGGGCCGAGGGCCGCGCCGAGCGGTTCGCTGGATACGCCGATGCCGCCGCCCGGAACTCCGAGACCGCGTGGAAGAAGAGCCACGACATATCCGAGCGGTTCGCTGGGGGGCAACCGATCCTCATCGGTCACCACTCCGAGGGCCGCGCCCGCCGCGATCATGCGCGGATGGACGACGCGATGCGCAAGAGCATCGGCGAGCGCGACCGCGCCGCCCACTGGACCGGCCGGGCACAAGCCGCCGCGAATTACCAGCAGTTCAAGAAGGACCCCGGCCGCACGCTCCGCCGTCTCGACAAGCTGCGGGCCGACCTCCGCGCGGTCGAGAAGTGGCAGCGCGGCCAGTCCGCCAAGGGATTCTCCCGGAACCCGGCAGACCCGGAGCTGGAGATCGAGCACCAGGAGCTGACCGAGGAGATCGCCCACTGGGAGAAGGTCATCAAGGACGCCGAAGCCGAGGGCTTCAAGGTGTGGTCGCGGGCCGACTTCAAGCGCGGTGACTTCGTTCTCTACCGAGGCACCTGGTACGAGGTCCTCCGGGCCAACCCGAAGTCCGTGACCATCCCGCACATCCACAACGGCACCGGCAAGCGCATCGTCCGCGCCACCGGCAACCAGCACGACAACTGGACATGGACCGCCCCCTACGACGGAGTATCCGGACGTAAGAGCGCCGACGAGATGCAGCAGCCGCCCCAGGATCCGGCCACTGAACCGCAGTCGCCAGCCGAGCAGTCCCCGGCGGTCGAGGAACCGGTACGAGTCGAGGAGCCGACCGCCGCAGCGGCCCCCGCCCCGGGCGCGAGCTGGCTGGACGGCATGGCGCTGGTGCTGATCGCCTCGAAGAACTCCCCGCGCCGTCGCAAGCGAGCCTTGTGGGCGATGACCCGCCGCGAGGCACAGGCAGTGTGCGGCGACCCCCGCACCTCCGGCCGCTCCTACATGCTCACCTGGACCGAACAGCCCGGCACCGAGGGCGCCGACTGGGAGTGGGTCCCGGACAACGGCAGCCACGCCCCGGTCCTGGACGAGCTGGGCATCACCCCGCGCCGCGAGTGGGCCACTGTCCCGCAGGCCCCGGCCGAGGCCGCGTAA	MRSPSSAGSAAGGSADRRRAPDRSGRAPRGRDCPCRRAGATTREPIVPHGPRRWCSAAANARSALRPDHKLSPEKTSSVTIEITHTRREGTLIEGTSRNDGSKEVLRTRHYASGYTTLAKWSRNLGCWYLPYSRDKRTSPPMLEALAERLRAEGFEVTVTIDDTDRRSFAEAEQDRVERAEGRAERFAGYADAAARNSETAWKKSHDISERFAGGQPILIGHHSEGRARRDHARMDDAMRKSIGERDRAAHWTGRAQAAANYQQFKKDPGRTLRRLDKLRADLRAVEKWQRGQSAKGFSRNPADPELEIEHQELTEEIAHWEKVIKDAEAEGFKVWSRADFKRGDFVLYRGTWYEVLRANPKSVTIPHIHNGTGKRIVRATGNQHDNWTWTAPYDGVSGRKSADEMQQPPQDPATEPQSPAEQSPAVEEPVRVEEPTAAAAPAPGASWLDGMALVLIASKNSPRRRKRALWAMTRREAQAVCGDPRTSGRSYMLTWTEQPGTEGADWEWVPDNGSHAPVLDELGITPRREWATVPQAPAEAA	MMKNIMRALILVFGFMSFFMFGQENPDVKIEKLRDNLYVYTTYNTFNGTRYAANAVYLVTDKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQQKQKASN	217.67	gnl|BL_ORD_ID|3313|hsp_num:0	4382			570	666	
BGC0000703.1|Kanamycin_90 # 100646 # 101065 # -1 # ID=1_90;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=6bp;gc_cont=0.719	BGC0000703.1|Kanamycin_90 	100646	101065	-	Loose	800	26.9498	APH(4)-Ib	48.15	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGCTCGCCACCGACCAGAAGCCCACCGTCCAGGACTTCCCCACCGCGACGCTCGTGATCGCCGGACCCTGGTTCCGTGGCCACCAGCTCGACACCCGCCCCGCCGTCGTCGGCCCGTTCGGCGGTTCGGAGTTCGCGGACGAGGCCACCATGTCCGTGGTCTGGTACTTCACCCTCGGTGCGCCGCAGCCGGGCGACTCGGTCCAGGCGATGTTCCCGCACGAGCTGACCCCGCTGGATGACACGCTCACCACGATGCACCAGGACACGTTCCGCGACATCGTCCGCAGCCTGCGCCGGGGCCGGTTCGCCTACGACGACGGAGACGCGCTCCGCGCCGCCGTCCGCCAGGCATGGCGCGAGCGGACCGGCCTTGCCGACGCCGACCCGACCGCCCGCCACACGCTCCACCGCAGCTGA	MLATDQKPTVQDFPTATLVIAGPWFRGHQLDTRPAVVGPFGGSEFADEATMSVVWYFTLGAPQPGDSVQAMFPHELTPLDDTLTTMHQDTFRDIVRSLRRGRFAYDDGDALRAAVRQAWRERTGLADADPTARHTLHRS	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	33.10	gnl|BL_ORD_ID|1547|hsp_num:0	1681			1023	1104	hygromycin B
BGC0000703.1|Kanamycin_92 # 102167 # 102526 # -1 # ID=1_92;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.614	BGC0000703.1|Kanamycin_92 	102167	102526	-	Loose	450	26.1794	BlaB-28	36.11	3005541	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGAGCGCCGACGTATTCACGATCGAACCGCAATGGATCGTGCAGGCCCCGCACCTACGGTGCACCCTCAAACGCGCCCTTGCGCTCCAGTCCGCATATAACGTGTGGTCCGGTACCGAGCACATCAACAACGCCGTTGGGATGGCCTACGGTAATGAACTCCCGGATTCCGGCCGATGGGAACTCACCCGCTCCCAACTCCGCACACTCAAAATCGCCATTGAGTGGCGCAGGGCCACGCGTGCGGCCAGCGACAAGAAGACCGCCCCCGATATCCTCGAACGCTGGACGCGAATAGAGGACGAGGTTATAGCCGCATACCGCGCCGCGAGCAACGAAGCAGGGCTGTACTGGATTTAG	MSADVFTIEPQWIVQAPHLRCTLKRALALQSAYNVWSGTEHINNAVGMAYGNELPDSGRWELTRSQLRTLKIAIEWRRATRAASDKKTAPDILERWTRIEDEVIAAYRAASNEAGLYWI	MMKRLKGVLVLALGFTGLQVFGQQNPDIKIEKLKENLYVYTTYNTFKGTKYAANAVYMVTDKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGFEYFGKLGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQQKQKASN	47.79	gnl|BL_ORD_ID|3320|hsp_num:0	4389			69	177	
BGC0000703.1|Kanamycin_93 # 102587 # 103219 # -1 # ID=1_93;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.675	BGC0000703.1|Kanamycin_93 	102587	103219	-	Loose	500	27.335	mphJ	25.0	3004544	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAACACGCCTCTCACCGTCGCGAAGCTGTCCCACCCGATCGCCCTCGAACTCGGCGGGAACTGGCGACCGCAGCCCGCGCGCCACGGCATCCAGGAACTGGACCACGCCGCCACGTTCACGCACCTGGACGGCCGACAGCTCCACCTGTCCGAGCGGTTCGACGACCCCGGACACCTGCACATCCGGGGCGCATTCCCCACCACCGACTACCCGTTCCGCAGGGGCGAGCGCGACACGGTCCGAGTCGCCATGAGCGAGGACCCGGCGGACATCGCGGCCCGGATCGCCGCCGATCTCATCCCCGCGCACCGTGACGTTCACGAGCGCGTGAAGGACCACAACCGCGCACAGGCCGAAATGCGCCGGGACGTTGAGGAAGCCGCATGCGATCTCTCCGCCCGACTCCCCGGAGCGCGAACCCGAATCGACGGCACAACCGCTTTTGTCTACATGGATCTTGAGCCGGGCGAAGTCCGTATCGGACTCGACGGCGACACTGTGAGTCTCGTACTCAATGACGCGCCCCGGATCATCGCGGACGCCGTCGTATTCGCGGTGAGTCGATTCCTGCCCCACGTCCAGACCCCCGAGGGGGAGCGCGGCGAGTACGTCGACGGATACACCCTCTAA	MNTPLTVAKLSHPIALELGGNWRPQPARHGIQELDHAATFTHLDGRQLHLSERFDDPGHLHIRGAFPTTDYPFRRGERDTVRVAMSEDPADIAARIAADLIPAHRDVHERVKDHNRAQAEMRRDVEEAACDLSARLPGARTRIDGTTAFVYMDLEPGEVRIGLDGDTVSLVLNDAPRIIADAVVFAVSRFLPHVQTPEGERGEYVDGYTL	MSKNNVEHMLALAKNNGILVDPTTVKVNESGLDFLAIFASTIDGIPWVLRQPRRDDVVETARYEKRVLDLVAKHLRVEVPDWQVHTSEFIAYPILGGTPMATINMETKNYDWYLNPESLPELCIQTWAEALVELHGIHHDLARDAGIRVKQPSYARASLREKMNEIKRVFGVSGALWDRWQKWLADETFWPAHSALVHGDLHPGHILVAENGKVTGLLDWTEAEVSDPAIDFTVVYLLFGDTGLADFIQRYEKAGGRVWSRMHEHIVEMTAAYPVTLATFALKSGLEEFKIMARQALGVDENGKEITS	68.18	gnl|BL_ORD_ID|2691|hsp_num:0	3220			426	714	erythromycin; telithromycin; tylosin
BGC0000703.1|Kanamycin_96 # 106560 # 106982 # -1 # ID=1_96;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.707	BGC0000703.1|Kanamycin_96 	106560	106982	-	Loose	350	25.0238	BcIII	40.0	3007101	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	GTGACCCGTACAGCTCTGTTCGAGACCCACGCCGACGACCACGGTTGCGGATGTGTCCCCGCCCCCGCCGAGCCCGGCCCCGGCACCACGGCCGACATCATGCAGGCCCGCGCCATCGCGGGCGGACTCGCGGAGTTCGGCATCGGGCCCGCCCGCTGGTCCGCCGCCTACGACCACGAGGCCGCCGCCGTCGTGCTGTGGGTGGACACCCCGCGCGGACTGTACGCACTCGCTATCCCCGCACCCGGTCAGCCGTTCCCCGTTCAGCACCGAGGCGAGCGCATCGGAGCCCTGGAATGTCGGCGCACCTACGGCACTGCCGACAGCTGCACCGCCGCCCTGTTCGCCGCGTTCCTGAGAGACCGCGCTGCACTGGACATCCCCGGTCGCGATGTTTGCCCCACACCTCAAAACATGGGTTAA	MTRTALFETHADDHGCGCVPAPAEPGPGTTADIMQARAIAGGLAEFGIGPARWSAAYDHEAAAVVLWVDTPRGLYALAIPAPGQPFPVQHRGERIGALECRRTYGTADSCTAALFAAFLRDRAALDIPGRDVCPTPQNMG	MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK	44.30	gnl|BL_ORD_ID|4780|hsp_num:0	5775			567	657	
BGC0000703.1|Kanamycin_97 # 107048 # 108796 # -1 # ID=1_97;partial=00;start_type=ATG;rbs_motif=AGCGA;rbs_spacer=7bp;gc_cont=0.683	BGC0000703.1|Kanamycin_97 	107048	108796	-	Loose	1000	26.1794	almE	26.09	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCAACGTCAAGACCCAGGCCAGCGTCCAGACTGCCCCTGCCCCGTGGCCGACCCTTGCGGCCGCCGAGCTCGCCGCGCACCCCGGCAACTTCCGCGACATCGAGGCCCCGGCCGATCTGCTCGCCGACGTGAAGGGCAACGGCGTCGTCGAGCCGCTGTACGTCGTGCGGACGCATGGCGACGTGCCGCAGATCATCGACGGTTTCCAGCGTCTCGCCGCCGCACTCGCCGCAGGACTTGAGGCCGTGCCGGTCACGCCTCGCCCGGTCATTCGGATTGACGCGCTCACTCCGCACCCGGAGAACGCCCGCGAAGATCTCGACATCAACGCGCCGTTCGTGGACTCTCTCCGCTGCGAGGGGTGCCGCATTCCCGTCAAGATCCAGCGACTTGACGGCGGAGTCCTCCAGGTCAACGACGGAAACCGTCGCTACTTCGGGGGCCAGGACGCCGGGCTCACCCACCTCCCCTACGAGTGGGAGGATGACGACCGCGACGCCGCCGGGCAGTTCCTCGACATGATCACGACCGCCCAGCACCGCAAGCCCCTGACACAGGGCGAGATGACCGCCGCGATGTTCAGTGCCGCCGAAGCGGGCGCCCAAGTGGGTCGTATCGCCAAGGCCGCAGGGGTGCGGCAGAAGGACGTCAAGACCGTCGTCAAGGTCAAGAACGACAAGGCCCTGAGCGGCGCCGTCGCGAACTCCGCCTACGCATGGACCTTCGACCAATTGGCCGCCCTCAGCGAGTTCGCCGACGACGCCGAGGCGCTCACCGCGATCACCAAGGCCGCAGAAGACGAAGACGCCGCCGACGAGATCGACTGGACCATCCAGATCGAGCGGACCAAGCGCGAGAAGCAGGCGAAGGCCGAGGCTCACCGCGCCGAGCTGGAGAAGGCCGGGCAGAAGGTCCGGGACATGACGGAGCTGTCCGAACGGGCCACCCCGGTATGGAGGCTCAGGACCCCCGACGGGGAGCGCATCACCACCGAGGATCACGCCGAGTGCCAAGGTCAGGTATGGGTGCTGGAGGAGGATGACGACGAGAAGCTGAAGCCGTACTGCACCTCTCCCGTCCTGTACGGCCACGCCGAACCCGGCAGCTCCCTGGGCGGCAACGGGACGAAGAACGCCGCCGAGAAGGAGGCGGAGAAGGCCGCCCGCGCAGCCGTCAAGAAGGGGAACCTGGAATGGGACGCGGCTGAGGGCAGGCGCCGCCAGTGGCTCGCCGACATGGTCAAGCGGCGCAACCTCCCCAAGGACACCACCAACACCTTGACCGCGCACATCAACGCGGCTCTGCTCGCGGGTACTTGGGGCATCTGCGACGACCTGAACAAGGAGCCCACGACCGAGATCCTGGCAACCCTGCTCGGTATCACCGGCGACAAGGCGAAGTACCGCACGAACTTCCCCGACCACGTCGCCAAGGACCCCCGCCGCGCCGTGCAACTCCAGTGGGCCGCCCTCGCGGCAGTGCGGGAAAAGCACGCGACCCGCTCCGCATGGCGGACCGATGCCCAACGGGCCCCGTGGGCACGGAACCCCACCGGAAGGTGGTTCGAGATCCTCGAAGCGCTCGGATACCAGCTCACCCCCATCGAGCAGGCCGTCAAGGACGACGAGCCGTACGACCCGTACAAGAAGAAGCGCGCCGCGATCACGGCCAGCGCTGCACCCGAGCAGGCCGACCAGATGCCCGCCGACGGCGAACAGCCCGCCGCCGATGCGGCCGCCGCCTAA	MTNVKTQASVQTAPAPWPTLAAAELAAHPGNFRDIEAPADLLADVKGNGVVEPLYVVRTHGDVPQIIDGFQRLAAALAAGLEAVPVTPRPVIRIDALTPHPENAREDLDINAPFVDSLRCEGCRIPVKIQRLDGGVLQVNDGNRRYFGGQDAGLTHLPYEWEDDDRDAAGQFLDMITTAQHRKPLTQGEMTAAMFSAAEAGAQVGRIAKAAGVRQKDVKTVVKVKNDKALSGAVANSAYAWTFDQLAALSEFADDAEALTAITKAAEDEDAADEIDWTIQIERTKREKQAKAEAHRAELEKAGQKVRDMTELSERATPVWRLRTPDGERITTEDHAECQGQVWVLEEDDDEKLKPYCTSPVLYGHAEPGSSLGGNGTKNAAEKEAEKAARAAVKKGNLEWDAAEGRRRQWLADMVKRRNLPKDTTNTLTAHINAALLAGTWGICDDLNKEPTTEILATLLGITGDKAKYRTNFPDHVAKDPRRAVQLQWAALAAVREKHATRSAWRTDAQRAPWARNPTGRWFEILEALGYQLTPIEQAVKDDEPYDPYKKKRAAITASAAPEQADQMPADGEQPAADAAAA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	104.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1317	1524	colistin A; colistin B
BGC0000703.1|Kanamycin_100 # 110422 # 110952 # 1 # ID=1_100;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.672	BGC0000703.1|Kanamycin_100 	110422	110952	+	Loose	500	24.6386	GRD33-1	28.57	3006926	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	GRD33 beta-lactamase	ATGGTGGAGCGCCCGGAAGCGCCAACTTCCGGAGGCACGGAGGAAGTTGGCGATCCGGACGTACGACCGTGCGGCCCTGCGGCGCGGTGCGCGAAGCTGGGACGGCCGATCGAGGAGGGAACCCCGCCCTTCACCTCGACCACGACGGCGCCGCAGCCAAACGACTCGCCCCTCCCCCTCCGAGGGAGGACCCGCCGGAGGCATGGAGGTCGTGAGGTCGGCGCCGATGACGCTTTCATGGGACTTCTTCCCGGCCCCGTGCTTACCGTGCGCGCCATGAGCAGGCATTCCGAGCAGTATCGCGTCGAGATCGAGGAAGCCGTCCAGACCCTGATCGGAGAGATGGAGGACGTCGTGCACCACCAGGTCGCCGACAGCCGCTGGCATCCGGCCTTCAAAGAGGTGGAGGACCTGACGGACGACGAATTGCGTGAAGCGGCCGATCAGTTGGCACGGCAGCTGATGAGGTCGGGCCTCAAGGTGCTCGCCGCGACTGCGCACGATCACGACTTCAACGGGGAGGGCCGATGA	MVERPEAPTSGGTEEVGDPDVRPCGPAARCAKLGRPIEEGTPPFTSTTTAPQPNDSPLPLRGRTRRRHGGREVGADDAFMGLLPGPVLTVRAMSRHSEQYRVEIEEAVQTLIGEMEDVVHHQVADSRWHPAFKEVEDLTDDELREAADQLARQLMRSGLKVLAATAHDHDFNGEGR	MAAMAAVAAVLLGVFAFAHAQDQPALWTQPQQPVRIIGNAWYVGTRGLSAILITSPTGAVLIDGAMRESADDIAKNITSLGVRLEDVKLIVNSHAHNDHAGGIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFDTQTPPPDRVPKVKTIRDGEALHAGGVTITAHKTGGHTPGSTSWTWRSCEENRCVDIVYADSITAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAK	60.90	gnl|BL_ORD_ID|3596|hsp_num:0	4665			180	306	
BGC0000703.1|Kanamycin_104 # 112861 # 112986 # -1 # ID=1_104;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.603	BGC0000703.1|Kanamycin_104 	112861	112986	-	Loose	2000	21.1718	oqxB	27.59	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCCGAATGGCTGCGCTCGGCACATGCTTGCAAGGGGCTGACTTCTGCGTACTTCCGTCCTATTCGCAGCTCAGAGCCATGGAGGTGAAGGGGGAGGCGGTCAGTTCGCCTGTGCGGACCTAA	MRRMAALGTCLQGADFCVLPSYSQLRAMEVKGEAVSSPVRT	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	3.90	gnl|BL_ORD_ID|2152|hsp_num:0	2400			1794	1875	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000703.1|Kanamycin_105 # 113752 # 114504 # 1 # ID=1_105;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.598	BGC0000703.1|Kanamycin_105 	113752	114504	+	Loose	750	26.1794	PAC-1	27.27	3005150	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	PAC beta-lactamase	ATGGGGGTGTCGTTCGAGGGAGTTTCGGCACTAGGTACGGACCCGCAGCATTTCCAACTCGAAGTATCGACCGATGGGGTCATCAGGTACCCCGAACCTAGAGCGCCCGAAGGAGGCGTAGAATCCAATAATCCCGCACCTGCAGCAGATCCCGACGCTTGCGATGACGGGGCGAATGCATGGCTGGACTGGTCGGCGTACCCCACCTACAAGTGGTACATCGGCGATGGCGGAATGCCTGGCGCGCTCTCTCGGTCAGCAGCGCAGAAGGCATTCGCAGATGCCATCAATAACATAACTGCGAGCTACAACGACTGCGGACTTTCTGACGAGGTGTCAGTGGGTCACGACTACGCGGGGACGACGACCTACGAGAGCGACATGACCGCTACCGGCTGCGCCGAGCGCGACAAAGTCGGCACCTGGGATGCGGGAGATCTCGCGGTTGGAACTCTGGCAGCGACATGTGCCTGGTATTTCACAGGCGGCGGATCGTTCGGCCAACTCGAAGAGGCTGACGTGCGCTACAACACCAAGGACTACGACTTCACGAACGACCCGGTCGCCGGACCCTGCACCAACAAGTACGACATACGATCCGTCGGCACGCATGAAGCTGGCCATGTATACGGGATGGCCCACGTCGGCAACGGGCATTCGAACCTGACCATGTACACCAACTCCTTCCTCTGCAACACAAAGGCCAGGACCCTGGGCAAGGGTGATGTCCTTGGCCTCCGGAAGCACTACTGA	MGVSFEGVSALGTDPQHFQLEVSTDGVIRYPEPRAPEGGVESNNPAPAADPDACDDGANAWLDWSAYPTYKWYIGDGGMPGALSRSAAQKAFADAINNITASYNDCGLSDEVSVGHDYAGTTTYESDMTATGCAERDKVGTWDAGDLAVGTLAATCAWYFTGGGSFGQLEEADVRYNTKDYDFTNDPVAGPCTNKYDIRSVGTHEAGHVYGMAHVGNGHSNLTMYTNSFLCNTKARTLGKGDVLGLRKHY	MRCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLITAQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAYGLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKETLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANKWYPNDARIEAAYELVQRLKK	65.62	gnl|BL_ORD_ID|2857|hsp_num:0	3875			51	282	
BGC0000703.1|Kanamycin_107 # 115623 # 116969 # -1 # ID=1_107;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.671	BGC0000703.1|Kanamycin_107 	115623	116969	-	Loose	500	33.113	mphK	37.5	3004541	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGGCAGACCAACTCCTCGGGGACCGCTACCGGCTCTTGCGGCAGCTCGGCGAGGGCGGCATGGGCCAGGTCTGGGAAGCTCGGGACGAGACGTTGGGGCGCCTGGTCGCAGTCAAGTTGATCGCCATGCTGGCCGGGGGCAACAACAAAGGCGATGAAGCGCGAGCCAGGTTCCTGCGCGAGGCACGAATCACCGCCGCGCTGCATCACCCGAACGTCGTGACCGTCCACGACCTCGGGCAAGCGAACGGTGAGAACGGCACAGCACCTTTTCTGGTGATGGAGCTCCTGCGGGGTGAGGCACTCGACGCGTTGGTACGCCGCGGACCTGTCTCGCTGCCGGACGCGGCCCGGTGGGGCGCGCAGATCTGTGACGCCCTGGCCGACGCCCACGAGGCCGGAGTGCTGCACCGCGACATCAAACCCTCGAACGTACTCATCACGGCGACTGGCCGTGTGAAGGTCCTTGACTTCGGTATCGCGCGAGCCGCCGACCCCTACGCGACGGCGAACCGGCTCACTCAGACCGGCTTCATTGTGGGCACGCCCCCGTATATGGCCCCCGAACAAGCGCGCGGCTTCCCAGAATCACGCAGCGATCTGTATGCGCTCGGCTGCCTCCTCTTCGAGTTGATCACCGGGCGCCTGCCGTTCCAAGCTCCCGACGCCGTGGGGTACCTCACTGCCCATCTCACCCAGCCCCCGCCAGCTCCCAGCTCGGTTGCTGCGCACATCCCGTCCGACTGGGACGAACTCGTGCTGACCCTGCTACGCAAGGAACCCGAACAGCGCTACGCAACCGCCGCCGACGTCTCCGATGCCCTCCGCAGGCTGGAAAGCGGCCGTCGACCGGGGCCGGGTGCTATGGGCGCCCCAACCGCAACGCGCGCCAGTCTCGGCGCTACCGCCAGGCTTGGCGCGGCGGGCTCCGAACCTGAGCAGGGTCGGAAGCCAGCTGCGATTCCCTCAGCACTCCCGAGGGTGGGGTTTGAGCTGGTTCGGCGTGGCTACGACCGGGAAGAGGTTGACGTCTACCTCTCGCTGCCTGCCGACGAACGGGGACCAATCCCGAGCTTCAATCTGGTTCGCCACGGCTATGACTGTGACCAGGTCGACGAGTACCTCGGCCGTGTCCGCGTCACCACGGCCGATCCCGGCACCAAGGAAGAGGGGGACGCCGATTCACGACGCCCGGTGGGGTTTGAGTTGGTTCGGCGTGGCTACGACCGGGAAGAGGTTGACGCTTACCTCTCGCTGCCTGCCGACGAACGGGGACCAATCCCGGCCTTCAACCTGAGGCGTCGCGGCTACCATCGTGGCCAGGTCGACACGTACCTCGGTCGCTGA	MADQLLGDRYRLLRQLGEGGMGQVWEARDETLGRLVAVKLIAMLAGGNNKGDEARARFLREARITAALHHPNVVTVHDLGQANGENGTAPFLVMELLRGEALDALVRRGPVSLPDAARWGAQICDALADAHEAGVLHRDIKPSNVLITATGRVKVLDFGIARAADPYATANRLTQTGFIVGTPPYMAPEQARGFPESRSDLYALGCLLFELITGRLPFQAPDAVGYLTAHLTQPPPAPSSVAAHIPSDWDELVLTLLRKEPEQRYATAADVSDALRRLESGRRPGPGAMGAPTATRASLGATARLGAAGSEPEQGRKPAAIPSALPRVGFELVRRGYDREEVDVYLSLPADERGPIPSFNLVRHGYDCDQVDEYLGRVRVTTADPGTKEEGDADSRRPVGFELVRRGYDREEVDAYLSLPADERGPIPAFNLRRRGYHRGQVDTYLGR	MTNLNEKQLITEIVGLARSQGLTVHSENAQLNETGMDFQVVFAKDDTGMPWVLRKPRRSDVVERASAEGITLAFLRANLTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMDHQPPSDDFVRTLADILAELHGTDQISAGQSGIEVIRPEDFRQMTADSMVDVKNKLGVSTTLWERWQKWVDDDAYWPGFSSLIHGDLHPPHILIDQNGRVTGLLDWTEAKVADPAKDFVLYQTIFGEKETARLLEYYDQAGGRIWAKMQEHISEMQAAYPVEIAKLALQTQQEEHINMALEALGVTSD	146.41	gnl|BL_ORD_ID|2624|hsp_num:0	3217			525	729	telithromycin; azithromycin
BGC0000703.1|Kanamycin_109 # 118228 # 118446 # 1 # ID=1_109;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.680	BGC0000703.1|Kanamycin_109 	118228	118446	+	Loose	900	22.7126	hmrM	36.0	3003953	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGCCGCCCGTGATCGTGCGCGAGGACAGGGCGGGCCTGTACTCACACCAGGAGCGCATCCGCAGCAAGGGCTCGGGGCAGGACAGCGCGTGGGTGGAGGAGGTGCGGGCCGGCTACCGCATGCTGCTGTCTCTCGATGTGCCCGAGGTGTGGGAGAACGACACCGTTCTGGTGGTCGAGGCGCGCGACGAGCAGGCTGCAGAGCCTACATATCGGTGA	MPPVIVREDRAGLYSHQERIRSKGSGQDSAWVEEVRAGYRMLLSLDVPEVWENDTVLVVEARDEQAAEPTYR	MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWMPLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK	15.52	gnl|BL_ORD_ID|2186|hsp_num:0	2425			243	318	acriflavine; norfloxacin
BGC0000703.1|Kanamycin_111 # 119375 # 122236 # 1 # ID=1_111;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.705	BGC0000703.1|Kanamycin_111 	119375	122236	+	Loose	500	30.0314	cmrA	29.09	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGCACGGCATCAACGAAGGTCTTTCAGATCCTGCCCGCAAGGTGTGGGCGAAGTACGACGCAGGGACGGATGGCTGGCTGCCGTTGTGGCGACACATGGCCGACAGCGCTGCGGTGGCCGGTCTGCTGTGGGATCGATGGTTGCCCGAAGCGGTGCGGCGACTTGTTGCCGAGGTGCTGCCAGAGGGCCTGGCGGATGCGCGTCGACTGGTGGTGTGGCTGGCAGGGGTGCATGACATCGGGAAGGCAACGCCGGCCTTCGCCTGTCAGGTGGAGGGTCTGGCGGAGCCGATGCGCCGGGCGGGTCTGGCGATGCGCTCAGAGCGGGAGTTGAGGCCGGAGCGGAGACTGGCGCCCCACGCGCTGGCCGGGCAGGCGTTGTTACAGGAGTGGCTGGAGCAGGAGCACGGGTGGCCGGGCCGGGCCACCGCGCAGTTCGCCGTCGTGTTGGGTGGGCATCACGGGGCTCCGCCGGAGGATGCTCAAATCTATGACCTGGCCTGTCATCCCGGGCTGCTGCGGACTCCCGGTGGGAGTGCGGCCCTGTGGCGGCGAGTGCAGGTCGAATTACTCGACATGTGTGCCCAAGAGTTCGGCGTACGGCATCGTCTGGCCGACTGGCGGGCGGTCAAACTGCCCCAGCCCGTGCAGGTGCTGTTGTCGGCACTGGTTATCGTCGCGGACTGGATCGCGAGTAACCGAGATCTTTTCCCGTACTTTCCCGAGGCGGCCGGGCAGGGACAGGACGAGCGTGTTGCGGCGGCCTGGCGCGGGCTGGCGCTGCCCGAGCCGTGGCGGCCGGTGGCGCCGGACGGCTCGGCCGCCGAGCTGTTTGCCGCTCGCTTCGATCTGCCCGATGGGGCCGCGCCCCGTCCCGTGCAGGAGGCGGCGGTTCAGGTGGCGCGGGAGATGGCGACGCCCGGTCTGCTGGTCATCGAGGCGCCGATGGGGGAGGGCAAGACCGAGGCGGCGCTGGCGGCGGCCGAGATATTGGCGGCCAGGGCCGGGGCGGGCGGGGTGTTCTTCGCGCTGCCGACGATGGCCACCGGGAATGCGATGTTCCCGCGCCTGCTGAACTGGCTGGACCAGCTGCCCACCCTGGAGGGGAAGCGGCTGTCGGTTCAACTGGTGCACTCCAAAGCCGCGTTGAACAAGGACTTCGAGGTGCTGATGCGCGCCTCGCGGCAGCACATAGCCGCGATCGACGCCGAGGCCGGACAGGAGTTGCCCCGCCCCGGTGCATCGCGGCGTCTGGCGCCCGCGGAGCTGGTGGCGCACGAGTGGCTGCGGGGACGCAAGAAGGCGATGCTGGCGTCGTTCACCGTGGGGACGGTGGATCAGCTGCTGTTCGCCGGGCTGAAGAGCCGCCACCTGGCGCTGCGTCATCTCGCGCTGGCGGGCAAGGTCGTCGTCATCGATGAGGCGCACGCCTACGACACGTACATGAACTCCTACCTGGACCGGGTGCTGTCGTGGCTGGGCGCCTATCGGGTGCCGGTGGTGGTGCTGTCGGCGACGCTGCCCGCCGGGCGGCGCCGAGCCCTGGCGGAGGCCTACGCGGGTGTCGCGGCGGGTGCCTATGAGGTGGTGGAGAAGGCGCAGGAGTATCCGCTGGTGACTGCGGTCGCTCCCGGCCAGGAGCCGCTGCTGGTGCGCCCGGAGGCCTCCGGGCGCACCAGCACGGTGTGCGTCGAGCCGTTGGTGGATCGTCTGGAGGTGCTTGCGGACCGGTTGGAGGATGAACTCGTCGATGGCGGGTGCGTGTTGGTGGTGCGGAACACGGTGAACCGGGTGCTGGAGACGGCGCGGGTGCTGCGGGAGCGGTTCGGCGAGGACGCGGTGACGGTGGCGCACGCCCGGTTCGTGGATGTGGATCGGGCGGCGAAGGACCAGGATCTGTTGGACCGGTTCGGCCCGGACCCCACCCTGCGGCCCCGGCGGCACATTGTGGTGGCCAGTCAGGTCGCCGAGCAGTCGCTGGATGTCGACTTCGACCTGCTGGTCACCGATCTGGCGCCGGTCGACCTGGTGCTGCAGCGGATGGGGCGCCTGCACCGGCATCGGCGTGGGTCACGGCCCGAGCGGCTGCGTACGCCGCGCTGTTTGGTGACCGGTGTCGACTGGAGCACGGGCCCGCCCGATCCGGTGCGCGGCTCGCAGTTGGTCTATGGGCGGCACGCGCTGCTGCGTTCCCTGGCCGTTCTTCAGCCGCATCTTGAGGGTGAGGTGGGCCCGGTGCGGCTGCCGCAGGACATCAGCCCGCTGGTGCAGGACGCCTACGGCGACGGGCCGGTGGGGCCGCGGGGCTGGGGCGAGGTGATGGAGGAGGCGCGGACGCAGCACGAGCGGCAGCAGGACTTGAAGGAACAGCGTGCCGGCGCGTTCCGGCTCGGGGCGCAGGCGAAGGCCGGGCGGGCGCTGACGGGCTGGGTCGCGGGCGGGGCCGGGGATGCGGACGACACCCGGGCCGGGCGGGCGCAAGTCCGCGACAGTCAGGAGAGCCTGGAGGTTCTCCTGGTCCAGCAGCATGCGGACGGCTCGCTGACGACGCCGGAGTGGATTGGCGAGGGCCGGGGCGCTCTGCCGCTGCCCCTGGACGCGGTGCCGTCGGCGCGGGCGGCGAAGGCCGCGGCGGCGTGCGGACTGCGGCTGCCGCTGCAGCTCTCCCATCCCAAGGTCGTCGATCAAGTGATCGCCGAGCTGGAGGAGTTCTGCGTACCGGCATGGCAGACCAAGCAGAGTCCGTGGCTGGCAGGGGAGCTTATTTTGCCTGTTCACAGCGATTGTCAGACCTGCCTGGCAGGGTTCGTCCTCAGCTACTCCCCCAACGACGGGCTTGAGGTGCGACGTGACGCATGA	MTHGINEGLSDPARKVWAKYDAGTDGWLPLWRHMADSAAVAGLLWDRWLPEAVRRLVAEVLPEGLADARRLVVWLAGVHDIGKATPAFACQVEGLAEPMRRAGLAMRSERELRPERRLAPHALAGQALLQEWLEQEHGWPGRATAQFAVVLGGHHGAPPEDAQIYDLACHPGLLRTPGGSAALWRRVQVELLDMCAQEFGVRHRLADWRAVKLPQPVQVLLSALVIVADWIASNRDLFPYFPEAAGQGQDERVAAAWRGLALPEPWRPVAPDGSAAELFAARFDLPDGAAPRPVQEAAVQVAREMATPGLLVIEAPMGEGKTEAALAAAEILAARAGAGGVFFALPTMATGNAMFPRLLNWLDQLPTLEGKRLSVQLVHSKAALNKDFEVLMRASRQHIAAIDAEAGQELPRPGASRRLAPAELVAHEWLRGRKKAMLASFTVGTVDQLLFAGLKSRHLALRHLALAGKVVVIDEAHAYDTYMNSYLDRVLSWLGAYRVPVVVLSATLPAGRRRALAEAYAGVAAGAYEVVEKAQEYPLVTAVAPGQEPLLVRPEASGRTSTVCVEPLVDRLEVLADRLEDELVDGGCVLVVRNTVNRVLETARVLRERFGEDAVTVAHARFVDVDRAAKDQDLLDRFGPDPTLRPRRHIVVASQVAEQSLDVDFDLLVTDLAPVDLVLQRMGRLHRHRRGSRPERLRTPRCLVTGVDWSTGPPDPVRGSQLVYGRHALLRSLAVLQPHLEGEVGPVRLPQDISPLVQDAYGDGPVGPRGWGEVMEEARTQHERQQDLKEQRAGAFRLGAQAKAGRALTGWVAGGAGDADDTRAGRAQVRDSQESLEVLLVQQHADGSLTTPEWIGEGRGALPLPLDAVPSARAAKAAAACGLRLPLQLSHPKVVDQVIAELEEFCVPAWQTKQSPWLAGELILPVHSDCQTCLAGFVLSYSPNDGLEVRRDA	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	243.73	gnl|BL_ORD_ID|1599|hsp_num:0	1744			123	396	chloramphenicol
BGC0000703.1|Kanamycin_112 # 122226 # 123929 # 1 # ID=1_112;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.718	BGC0000703.1|Kanamycin_112 	122226	123929	+	Loose	500	28.1054	GPC-1	28.45	3005096	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	GPC beta-lactamase	GTGACGCATGACCAGAGGGCCGAGACGGCGCAGGGTCCGCTGTCGTTCGACCTGACCGACCGGCCGTGGCTGCCGGTGCAGCTGTTCGATGGCAGCCAGACGGTGCTGTCGTTACGGGAGATCTTCGCCCGGGCTGGCAGCGTCCGGCGGCTGGCCGGTGATGTTCCCACCCAGGACTTCGCTCTGGTGCGGCTGCTGGTCGCCATCCTCCATGACGCGCTGGATGGACCCCAGGACCTGGACGATTGGGCGGAGTTGTGGGAGTCGGACGAGCCGTTCGCGCCGGTGCCCGGCTATCTGGACTCCCATCGACAGCGGTTCGACCTGCTGCACCCGGTCTCCCCGTTCTTCCAGACGCCGGGTCTGCGGACAGCCAAGGGGGAGGTCTTCCCGCTCGACCGGATCGTGGCGGACGTGCCCAACGGCACGCTGTTCTTCACGATGCGACCCCAGGGCGCCAAGAGGATCTCCTTTGCGGAGGCGGCCTGTTGGGTGGTGCACGCGCAGGCGTACGACACCTCCGGGATCAAGACCGGGGTGGTCGGTGACGAGAGGGCCAAGGCTGGCAAGGCCTACCCGCAGGGTGTGGCCTGGGCAGGCAGCATCGGCGGGGTGCTGGCCGAAGGGCCCACCCTCCGCGAGACGCTGCTGCTGAACCTCATCGCCGCCGACGGCCCCATCACGGCGGTGGGCGGCAAGGACCGACCCGCCTGGCGCGGCGGGCCCGCCCGGCCGGGAGCCGCAGCCGACCTCGCGCTACGGCCGTATGGGGTGCGCGACCTGTACACCTGGCAGTCGCGCCGCCTGCTGCTGCACGCGGACGCCGACGGAGTGCACGGCGTCGTACTCACCTACGGTGATCCCCTCCCCCCGCAGAACCGGCAGGGGCTCGAGCCGATGTCCGGCTGGCGGCGCAGCCAGGCCCAGGAGAAGAAGCACCAGCAGGCTTTGGTGTACATGCCGCAGGAGCACGACCCGGCCCGCGCTGCCTGGCGGGGCCTGGCCGCGCTCATCGCCCCGCGCGATCACAACACCGCGCCGCGCGGTGAGCCGCCCTCCCGGCTGCGGCCCGGCCTGGTCGACTGGATCGCCCGTCTGATCAATGAACGGGTGCTGCCTGACCGGATGTTGATCCGGATACGCACCTACGGCGTGGTGTACGGCACTCAGCAGTCCGTTGTCGACGAGATCACGGAGGACGCCGTCACGCTGTCCGTGGTCCTGCTCAGCGAGGCCGACCGCGGTCTGGGGCAGTGCGCGGTGGATGCCGTGGCTGATGCGGAGACGGCCGTCACCGCGCTCGGCGCGCTGGCCGCCGCCCTCGCGCAGGCGTCCGGCAGCGAGGTGGAGGCTCCCAAGGACACCGCCCGCGACCTGGGGTTCGGCGCCCTCGATGGCCCCTACCGGGCTTGGCTGGCCGCCCTCCACCCTGGCGATGATCCCCAGCAGGCCCGCGCCCAGTGGCAACAGACGGCGCGCCGGACGCTCGCCCGCATTGGCGCCCAACTCGTCGCGCAGGCGGGCGAGGCCGCCCGGCAGGGGCGGGTCATCGAGCTGGCTAAGGGCGGCCAGCTGTGGCTCAACTCAGCCTCGGCCGACCTGCGTTTCCGCACCAGGCTCAACGCATGTCTGCCGCTCGCCTCACCCCCCGCCCCCGGGTCCGAGGAGTCGCCGGGCGGCCGTCCCCGGAAGGTGTCCGCATGA	MTHDQRAETAQGPLSFDLTDRPWLPVQLFDGSQTVLSLREIFARAGSVRRLAGDVPTQDFALVRLLVAILHDALDGPQDLDDWAELWESDEPFAPVPGYLDSHRQRFDLLHPVSPFFQTPGLRTAKGEVFPLDRIVADVPNGTLFFTMRPQGAKRISFAEAACWVVHAQAYDTSGIKTGVVGDERAKAGKAYPQGVAWAGSIGGVLAEGPTLRETLLLNLIAADGPITAVGGKDRPAWRGGPARPGAAADLALRPYGVRDLYTWQSRRLLLHADADGVHGVVLTYGDPLPPQNRQGLEPMSGWRRSQAQEKKHQQALVYMPQEHDPARAAWRGLAALIAPRDHNTAPRGEPPSRLRPGLVDWIARLINERVLPDRMLIRIRTYGVVYGTQQSVVDEITEDAVTLSVVLLSEADRGLGQCAVDAVADAETAVTALGALAAALAQASGSEVEAPKDTARDLGFGALDGPYRAWLAALHPGDDPQQARAQWQQTARRTLARIGAQLVAQAGEAARQGRVIELAKGGQLWLNSASADLRFRTRLNACLPLASPPAPGSEESPGGRPRKVSA	MTITISRRQAMAGALLAIPAVSALTAGTSRAAGENLAQRLAALEARHGGRIGVAIHNLSTGARLGHNTDERFLMCSTFKALLAGHILVRVDRGEETLDRRIVVKEADLVDWSPVVEKRIGGDVISIAELCEATITLSDNAAANLLLAASGGPKAVTAFLRGLGDEVTRLDRTEPTLNYHETPGDERDTTTPSAMVETLRRLLFTDVLSARSKAQLAAWLIMNKTGDTRLRAGFPADWMTGDKTGTNGDKAGNANDVAVAWSPDRGAVIVAAFCEIPGISGDERNAVIAEIGRIAAEV	190.91	gnl|BL_ORD_ID|2811|hsp_num:0	3828			501	804	
BGC0000703.1|Kanamycin_114 # 124582 # 125778 # 1 # ID=1_114;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.695	BGC0000703.1|Kanamycin_114 	124582	125778	+	Loose	275	26.1794	AAC(6')-Isa	36.11	3002563	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGACCAGCCGCATCATCCTCGACGTGCACGCGCTGCAGAACGTCCCGCCGAGCAACCTCAACCGCGACGACACCGGGGCCCCGAAGTCCGCCGTCTATGGCGGGGTCACCCGCGCCCGGGTCTCCAGTCAGGCCTGGAAACGCGCCACCCGCCGCTACTTCGCCGCCCTCCTGGACCCGGCCGAACTGGGCGTGCGCACCAAGCGTGTCGCCGAGCTGCTCGCCGAGCACATCACCGCCCTGGATGAATCCATCGACCCCGCCCAGGCCCTGAAGATCGCCGCAGAGACGCTCCAGACCGCGACCGGCTCCAAGATCGAACCGCCCAAACGGCAGGCGGAGGCGGCGAAGAAGAACGGCACCGCCGAGCCCGCGCCCGCCTCCTCGTACCTGATGTTCCTCAGCGCCCGCCAGATCGGCGGGCTGGCCGAGCTGGCCGTCGAAGGCGCAGGCGACATCAAGGAGTTCTTCAAGAACAAGGAGCACAAGGCCCGCGCAAAGCAGATCGCCGACACCCAGCACTCCGTCGACATCGCCCTGTTCGGCCGCATGGTCGCCGACTCCACCGACATCAACGTCGACGCCGCGGCCCAGGTCGCCCATGCCCTCAGCGTCCACCGCGCCGAAGTGGAATCGGACTACTTCACCGCGGTCGATGACCGCAACACGGGCGCCGAGCCGGGCGCCGGAATGATCGGCACCGTCGACTTCAACTCCGCCACCCTCTACCGCTACGCCGCCGTCGACGTCGACCTGCTGGAACGCAATCTCGGCAAGGGCCTGGCCGCCGACAAGTCCCCGGCCACCCCCGTGCGCCGGGCCGTTGAGGCGTTCGTGGACGGCTTCGTCGCTTCCCTGCCCACCGGGAAGATCAACACGTTCGGCAACCACACGCTGCCCGACGCCGTCATCATCAAGCTCCGCGCGGCCCGCCCCATCAGCTTCGTCTCCGCCTTCGAAAAGCCCGTGCCCGCCGACGAGTCGGGCGGCCACATGGAGGGCGCCTGCACGCGCCTGGCCGACTACATCCCCGAGCTCGAACGCGCCTACGGCGACGAGAGCGCCGCCACCTGGGTGCTGCGCATCGGCTCGGCCACTGCGAAGATCTCCGGCCTGGGCACCGAAGTCCCCAGCCTGAACAAGCTCGTGGAGAGCGTCGGTGCGGCCGTCGCCGAACGCCTGGAGCAGCGGGGATGA	MTSRIILDVHALQNVPPSNLNRDDTGAPKSAVYGGVTRARVSSQAWKRATRRYFAALLDPAELGVRTKRVAELLAEHITALDESIDPAQALKIAAETLQTATGSKIEPPKRQAEAAKKNGTAEPAPASSYLMFLSARQIGGLAELAVEGAGDIKEFFKNKEHKARAKQIADTQHSVDIALFGRMVADSTDINVDAAAQVAHALSVHRAEVESDYFTAVDDRNTGAEPGAGMIGTVDFNSATLYRYAAVDVDLLERNLGKGLAADKSPATPVRRAVEAFVDGFVASLPTGKINTFGNHTLPDAVIIKLRAARPISFVSAFEKPVPADESGGHMEGACTRLADYIPELERAYGDESAATWVLRIGSATAKISGLGTEVPSLNKLVESVGAAVAERLEQRG	MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEETDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYRKVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT	253.50	gnl|BL_ORD_ID|886|hsp_num:0	967			153	261	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000703.1|Kanamycin_115 # 125775 # 126512 # 1 # ID=1_115;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.730	BGC0000703.1|Kanamycin_115 	125775	126512	+	Loose	700	28.1054	ACC-5	34.04	3001819	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGAGTGTCCTGGCCCTGCAACTGGCCGGTCCCCTGCAGGCGTGGGGGGCCTCGGCCCGCTTCGCCCGGCGCACCACGGAGAACGCCCCCACCAAGAGCGGCGTGATCGGCCTGCTCGCCGCCGCCCAGGGCCTGGAGCGCACCGCCGACCTCACCGCGCTCACCGCCCTACGCTTCGGGGTGCGCATCGACCAACCGGGCACGCGGATAAGGGACTTCCAGACCGCCCACCACCCCGACACCGGCCAGGCGATGCCTATCTCCGACCGCTACTACCTGGCCGACGCGGTCTTCGTCGCCGCCCTGGAAGGCACAGCCGACCTCATCGCGGAGCTGGACGCGGCACTGCGCTGCCCGCACTACCTGCCCTTCCTCGGCCGCCGCTCCTGCCCGCCCTCCCGCCCCCTCAACCTGGGCGTCCACTCCACCGGCGCCCTGGAGGACGTCTTGGCCGCGGAACCGTGGCACGCAGCCGAATGGCACCAAAGGCGGCACCGGCAGGAGACCACGGTGGCCCTGCCCGTCCTCACCGAGACCCGCGGCGGCGACACGGCCGACTCCCTCACCGCAGACACACTGCGCGACCAGCCCCTCAGCTTCGACCCCCGCCACCGCCGCTACGCCCTGCGCACCGTGCAGAACCGCACCGTCACCGTCACCAATCCCCATGCCCAGCCGGCCACCGCCCGCCGCGGCGTTCCGCCGCACGATCCGACCAGCCTCCTGGAAGACGTCTGA	MSVLALQLAGPLQAWGASARFARRTTENAPTKSGVIGLLAAAQGLERTADLTALTALRFGVRIDQPGTRIRDFQTAHHPDTGQAMPISDRYYLADAVFVAALEGTADLIAELDAALRCPHYLPFLGRRSCPPSRPLNLGVHSTGALEDVLAAEPWHAAEWHQRRHRQETTVALPVLTETRGGDTADSLTADTLRDQPLSFDPRHRRYALRTVQNRTVTVTNPHAQPATARRGVPPHDPTSLLEDV	MQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQLSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	63.47	gnl|BL_ORD_ID|1723|hsp_num:0	1865			273	414	
BGC0000703.1|Kanamycin_116 # 126512 # 127231 # 1 # ID=1_116;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.688	BGC0000703.1|Kanamycin_116 	126512	127231	+	Loose	250	27.335	arr-1	27.27	3002846	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGTTCCTGACCCGATTCCGCGTCAACACCGCGCGCCCGGCCAGCAGGCAACTGCTCTCCTCACCGCAGGCCCTGCACGCGGGCGTGATGAGCTCCTTCCCGCAGATCCTGCCCAGTGCCCCCGATGCCCCGCGGATCCTGTGGCGCATCGACCGCAACGCGGCCGCCGAGGTCATGCTCTACGTCGTAGGCCCCCAGCGCCCCGACCTCACCCACCTCGTCGAGCAGGCGGGCTGGCCCGCCGCGGCCGCCGCCGGCACACCGGGCTGGCAGACCTACCACTACGCGCCCTTCCTCGACCGCCTCGAAAACAAGAGCGTGTGGAACTTCCGTCTCACCGCCAACCCCGTACACAGCATCCGCAACCGCGACGGCGTACCCACCAAACGCACCGCGCACCTGACCCCCAAACACCAACTGGGCTGGCTGCTGCAGCGCCAGGAAGCCTCCGGATTCCGCGTGATCACCAAACCCGCCGACCACCGGCACACCGAACACGGCGACGAACACCAGATCACCGTCAGCGACCAGCGCAGCCTCGACTTCGGCAAACGCAGCACCGACCAAAAGCGCCCCAACCGGGTCACCCTCACCACCGTCACCTACAACGGCCGCCTGGAAGTCACCGACCCCCCTGCGCTGCGCCGCATCCTCACCCAAGGCCTGGGCAAGGCCAAGGCGTATGGCTGTGGCCTGATGACGCTCGCCCCGGCGGAGTAG	MFLTRFRVNTARPASRQLLSSPQALHAGVMSSFPQILPSAPDAPRILWRIDRNAAAEVMLYVVGPQRPDLTHLVEQAGWPAAAAAGTPGWQTYHYAPFLDRLENKSVWNFRLTANPVHSIRNRDGVPTKRTAHLTPKHQLGWLLQRQEASGFRVITKPADHRHTEHGDEHQITVSDQRSLDFGKRSTDQKRPNRVTLTTVTYNGRLEVTDPPALRRILTQGLGKAKAYGCGLMTLAPAE	MVANPPKPFEVHESGAYLHGTKADLKVGDRLVPGRESNFEAGRIMKHVYITQTLDAAVWGAELAVGEGRGRIYIVEPEGEIEDDPNVTDKKLPGNPTRSYRTREPVRIVGELTDWEGHSPEQIAAMREGLEDLRRKGLAVIYD	167.13	gnl|BL_ORD_ID|1801|hsp_num:0	1950			147	339	rifampin; rifaximin; rifabutin; rifapentine
BGC0000703.1|Kanamycin_117 # 127236 # 127637 # 1 # ID=1_117;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.719	BGC0000703.1|Kanamycin_117 	127236	127637	+	Loose	400	23.8682	IMP-75	45.0	3005480	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	GTGAACACCCCCGGCCAGCGCCCGGCCAGCGGTCCGCGCGACCTCACCCGCATCGCCGACCGAGCTTCCTTCGTCTACCTGGAACGCTGCACCATCCACCGCGACGCCAACGCCATCACCGCCAAGGACGCGGACGGCACCACCCACATCCCCTCCGCGACCATCGGCACACTCCTCCTCGGCCCCGGCACCCGCATCACCCACCAGGCAATGAGCGTGCTCGGCGAGAGCGGCGCGGGCGTGGTGTGGGTCGGTGAACAGGGCGTGCGCTACTACGCCTCCGGGCGGGCCCTGACCAGCTCCTCCCACCTCACCGAGGCTCAAGCGGCACGCTGGGCCAACCGCCGCAGCCGCCTGGACGTGGCCCGCGCCATGCACCGACTGCGCTTCCCCGACGACTAA	MNTPGQRPASGPRDLTRIADRASFVYLERCTIHRDANAITAKDADGTTHIPSATIGTLLLGPGTRITHQAMSVLGESGAGVVWVGEQGVRYYASGRALTSSSHLTEAQAARWANRRSRLDVARAMHRLRFPDD	MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVFAKHGLVVLVKNDAYLIDTPITAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELTNELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGNLGDANLEAWPKSAKILMSKYGKAKLVVPSHSEIGNASLLQRTWEQAVKGLNESKKPLQPSS	54.07	gnl|BL_ORD_ID|3631|hsp_num:0	4700			291	351	
BGC0000703.1|Kanamycin_118 # 127784 # 128575 # 1 # ID=1_118;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.755	BGC0000703.1|Kanamycin_118 	127784	128575	+	Loose	700	25.7942	PDC-158	30.56	3006536	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGCTGCTCCCCGCGCCCGCGGGGTTGGTCCCCGAACTGGAGTGTGACCATGCCCGACCCGCGCCTGCTCCCCGCGCCCGCGGGGTTGGTCCCTCGCCAAGAGCGTTGCGAACGCGGCCGCCTCCCTGCTCCCCGCGCCCGCGGGGTTGGTCCCCAACTGCAGCACCTGTTCCGTGTGCACGACCCTTGCTCCCTGCGCCCGCGGGGTTGGTCCCGGCGCGCACTACGCGGAGATCGTGCGGGCCAACTGCTCCCCGCGCCCGCGGGGATGGACCCGCCCTCTCCGTCTGGCACGACAAGACCGGCGGCTGCTCCCCGCGCCCGCGGGGTTGGTCCCGCATCACCCTCAACGAGGCCGCCGCGAACAAGCTGCTCCCCGCGCGCGCGGGGCTGGTCCCAGCGGGGACAGCCTCAGCGCCGCCCTGCCCGCCTGCTCCCCGCGCCCGCAGGGTTGGTCCCCAGTCCGTGCGCGGCCTGCGGGACAACGCCCGCTGCTCCCCGCACCCGCGGGATTGGTCCCACGGCGGGCGGCACCGTCGGGTCCCAGATGCGCTGCTCCCCGCGTCCGCGGGGTTGGTCCCGGTCGAGGAAGAGCCGAACTCAACCTCGATGTCTGCTCCCCGCGCCCGCGGGGTTGCTCCCGCCCTTACCCTCCAGGCAACCCGCTGGTGGGTCTGCTCCCCGCGCCTGCGGGGTTGGTCCCGGCGGGGTGGTGTATGTCCACGCGTGGGTACGCTGCTCCCCGCGCCCGCGGGGATGGCCCCCATTCCCACCAGGTGGTGCCGGGGGTGA	MLLPAPAGLVPELECDHARPAPAPRARGVGPSPRALRTRPPPCSPRPRGWSPTAAPVPCARPLLPAPAGLVPARTTRRSCGPTAPRARGDGPALSVWHDKTGGCSPRPRGWSRITLNEAAANKLLPARAGLVPAGTASAPPCPPAPRARRVGPQSVRGLRDNARCSPHPRDWSHGGRHRRVPDALLPASAGLVPVEEEPNSTSMSAPRARGVAPALTLQATRWWVCSPRLRGWSRRGGVCPRVGTLLPAPAGMAPIPTRWCRG	MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVSEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	66.25	gnl|BL_ORD_ID|4226|hsp_num:0	5296			618	819	
BGC0000703.1|Kanamycin_119 # 128384 # 129532 # -1 # ID=1_119;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.744	BGC0000703.1|Kanamycin_119 	128384	129532	-	Loose	400	26.1794	ErmE	50.0	3000326	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TTGGAGGCGGGACCAACCCCGCGGGCGCGGGGAGCAGACCCCGGGCACCACGCGCGTGCGGATCCAGCAGGGTCCATCCCCGCAGGCGCGGGGAGCAGTCGATCTCTGAGAAGGACCGGCGCTCTTCCTCGGGTCCATCCCCGCGGGCGCGGGGAGCAGGGTGGTTCCCCAGCGTCTCACTCGTCACGACAGGGTCCATCCCCGCGGGCGCGGGGAGCAGAGCCGGAATCCGCGGCCGCCCTCGGAGGGCGGGGGACCAACCTCGCGGGCGCGGGGAGCAGGACACCGGGATCGAAGACGAGGACCTGTGGCGGGGACCAACCCCGCGGGCGCGGGGAGCAGCAGATCGAGGCGGGACAGATCCAGATGCCGAAGGGTCCATCCCCGCGGGCGCGGGGAGCAGTCGACGAGGTCTCCGCCGCGCGTGCGCACCGTGGGTCCATCCCTGCGGGCGCGGGGAGCAGTTGCCCGTCAGCAGGCCCTGCGCGAGGGGCTTGGGACCAACCCCGCGGACGCAGGGAGCAGACTCTGAGTGATATCCACGATCCCACCTGCAAGGGACCAACCCCGCAGGCGCGGGGAGCAGTAGCTCGCCGAGTGGCACGCCGCCCTCGATCAGGGACCAACCCTGCGGGCGCGGGGAGCAGCTCCTCCGCCTCGGCTCCGCACCGGCGGCATTCGGGTCCATCCCCGCGGGTGCGGGGAACAGCCGAACCCTCCGGGGCCGGACGCGGAGGTCTTGGGGACACCCCCGCGGGCGCGGGGAGCAGATCTACGAGGACGGCGAGACCGAGCAGTTCTGGGGACCAACCCCGCAGGCGCGGGGAGCAGGGGCTGGTGCCGGAGCAGCGGCGGCCGGTGGTGGGACCAACCCCGCGGGCGCGGGGAGCAGGCAGCGGCCATCGTCGCCGTCATCAGCGCCGTGGGACCAACCCCGCGGGCGCGGGGAGCAGCTCCTCACCCCCGGCACCACCTGGTGGGAATGGGGGCCATCCCCGCGGGCGCGGGGAGCAGCGTACCCACGCGTGGACATACACCACCCCGCCGGGACCAACCCCGCAGGCGCGGGGAGCAGACCCACCAGCGGGTTGCCTGGAGGGTAAGGGCGGGAGCAACCCCGCGGGCGCGGGGAGCAGACATCGAGGTTGA	MEAGPTPRARGADPGHHARADPAGSIPAGAGSSRSLRRTGALPRVHPRGRGEQGGSPASHSSRQGPSPRARGAEPESAAALGGRGTNLAGAGSRTPGSKTRTCGGDQPRGRGEQQIEAGQIQMPKGPSPRARGAVDEVSAARAHRGSIPAGAGSSCPSAGPARGAWDQPRGRREQTLSDIHDPTCKGPTPQARGAVARRVARRPRSGTNPAGAGSSSSASAPHRRHSGPSPRVRGTAEPSGAGRGGLGDTPAGAGSRSTRTARPSSSGDQPRRRGEQGLVPEQRRPVVGPTPRARGAGSGHRRRHQRRGTNPAGAGSSSSPPAPPGGNGGHPRGRGEQRTHAWTYTTPPGPTPQARGADPPAGCLEGKGGSNPAGAGSRHRG	MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELRPDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAEPPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTWPLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGRPGRRGGPGQR	100.26	gnl|BL_ORD_ID|94|hsp_num:0	109			3	105	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000703.1|Kanamycin_121 # 131229 # 131558 # -1 # ID=1_121;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.639	BGC0000703.1|Kanamycin_121 	131229	131558	-	Loose	500	23.483	cfrC	26.19	3004146	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGCTCGGCCAACGGGCACGTCCGGTTCGGCGGGCGGGGATGGGAAAACCGACACCGGAAACGGTGCACGGCGTCTCGTCCCCGACCCAACACATGGAACTCGACCGGCGAGGCGCCGAACTCCTCTTTCAGGTCCTAACCGAACGCGAGGAGAAGAACAGCGTCGCTATCGCCTCCAACGAATCCTTCTCCGGCTGGACCAAGACCTTCACCGACCCACGACTCTGCGGCGCCATCGTCGACCGCCTCACCTTCGGCAGCAACATCATCGAGACCGGAACCGACTCCTACCGCCTCGCCCAGACTCGAGCCCAACAAGCCGACGGCTAA	MLGQRARPVRRAGMGKPTPETVHGVSSPTQHMELDRRGAELLFQVLTEREEKNSVAIASNESFSGWTKTFTDPRLCGAIVDRLTFGSNIIETGTDSYRLAQTRAQQADG	MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGKNVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCATGSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGLSQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLDEHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFKFQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL	31.69	gnl|BL_ORD_ID|2412|hsp_num:0	2800			183	408	chloramphenicol; florfenicol
BGC0000703.1|Kanamycin_122 # 132250 # 132543 # 1 # ID=1_122;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.646	BGC0000703.1|Kanamycin_122 	132250	132543	+	Loose	500	23.0978	GRD33-1	29.73	3006926	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	GRD33 beta-lactamase	ATGGGACTTCTTCCCGGCCCCGTGCTTACCGTGCGCGCCATGAGCAGGCATTCCGAGCAGTATCGCGTCGAGATCGAGGAAGCCGTCCAGGCCCTGATCGGAGAGATGGAGGACGTCGTGCACCACCAGGTCGCCGACGGCCGCTGGCATCCGGCCTTCAAAGAGGTGGAGGACCTGACGGACGACGAATTGCGTGAAGCGGCCGATCAGTTGGCACGGCAGCTGATGAGGTCGGGCCTCAAGGTGCTCGCCGCGACTGCGCACGATCACGACTTCAACGGGGAGGGCCGATGA	MGLLPGPVLTVRAMSRHSEQYRVEIEEAVQALIGEMEDVVHHQVADGRWHPAFKEVEDLTDDELREAADQLARQLMRSGLKVLAATAHDHDFNGEGR	MAAMAAVAAVLLGVFAFAHAQDQPALWTQPQQPVRIIGNAWYVGTRGLSAILITSPTGAVLIDGAMRESADDIAKNITSLGVRLEDVKLIVNSHAHNDHAGGIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFDTQTPPPDRVPKVKTIRDGEALHAGGVTITAHKTGGHTPGSTSWTWRSCEENRCVDIVYADSITAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAK	33.56	gnl|BL_ORD_ID|3596|hsp_num:0	4665			180	291	
BGC0000703.1|Kanamycin_124 # 133654 # 133839 # 1 # ID=1_124;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.565	BGC0000703.1|Kanamycin_124 	133654	133839	+	Loose	400	23.483	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin	26.67	3003470	protein variant model	A138E	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic resistant gidB	ATGCCTCGCGGTGGTTCAAATTCATTGTTGAGCTTCGAAACGATTGCCGAGCGGATGGAAGTAACAAAGCGCACCGTCCTCGATAACTACAGGAATTGGGACATCCCCGTCGTGCGCATCAGCGACCGCATTCTCCGCGTGCGGGAGCGAGATTTCGAGGCATGGATCGACACGCGCACGGAGTGA	MPRGGSNSLLSFETIAERMEVTKRTVLDNYRNWDIPVVRISDRILRVRERDFEAWIDTRTE	MSPIEPAASAIFGPRLGLARRYAEALAGPGVERGLVGPREVGRLWDRHLLNCAVIGELLERGDRVVDIGSGAGLPGVPLAIARPDLQVVLLEPLLRRTEFLREMVTDLGVAVEIVRGRAEESWVQDQLGGSDAAVSRAVAALDKLTKWSMPLIRPNGRMLAIKGERAHDEVREHRRVMIASGAVDVRVVTCGANYLRPPATVVFARRGKQIARGSARMASGGTA	27.23	gnl|BL_ORD_ID|1934|hsp_num:0	489			384	489	streptomycin
BGC0000703.1|Kanamycin_127 # 136397 # 137011 # 1 # ID=1_127;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.725	BGC0000703.1|Kanamycin_127 	136397	137011	+	Loose	500	25.0238	Rhodococcus fascians cmr	30.88	3002701	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTGGGCGGCGGCGTCCCAGGTGACGCCGGAGAGCACGCAGCAGGCGGTGGGCTATCCCTCGCTGTTCCTGTTGGTGGTCATCGGCGCGCTGGTGCCCGTGGTGCCGACGGGCGCGCTGGTGAGTTCGGCGGCGGTGGTCGCCTTCCATCAGACGGCGCCGTTCGCGCTGCTGATCGTCTTCGGTGTGGCGGCGCTCGCGGCGTTCATCGGCGACATGGGCCTGTACTGGCTCGGGCAGCGCGGCATGCGTTCGAAGAACGGCTCGCGCTGGCTCGCGGCGATCCGCGACCGGGCGCCGGAGGAGCGTCTGCGGCAGGCGCAGGAGAAGCTCGACGACCACGGCGTGCTCGTCCTCGTGCTGTCCCGGCTCGTCCCCGCGGGCCGGATCCCGGTGATGCTGGCGTGCCTGATGGCGAAGCTGCCGCTGCGCAGGTTCGCGCGCGGCAACGCGCCCGCGTGTCTGGCCTGGGCGGCGACGTACCAGCTGATCGGCATCCTGGGCGGCTCCCTGTTCGAGGAGCCGTGGCAGGGCGTCGCGGTGGCGATCGGCCTGACGGTCCTGATCAGCGTGGCGCCCTCGGTGTGGCGCAGGCTCCGGAGGCACACGGCCTAG	MWAAASQVTPESTQQAVGYPSLFLLVVIGALVPVVPTGALVSSAAVVAFHQTAPFALLIVFGVAALAAFIGDMGLYWLGQRGMRSKNGSRWLAAIRDRAPEERLRQAQEKLDDHGVLVLVLSRLVPAGRIPVMLACLMAKLPLRRFARGNAPACLAWAATYQLIGILGGSLFEEPWQGVAVAIGLTVLISVAPSVWRRLRRHTA	MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAIVSMRWQRRRALLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMVPADMKGRATSVLLGGVTIACVVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPADSPTDSVPNATRELSSLRQRKLQLILVLGALINGATFCSFTYLAPTLTDVAGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLVAGSAALLVGWIVFAITASHPVVTLVMLFVQGTLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALGPALGGVAIGIGMGYRAPLWTSAALVALAIVIGAATWTRWREPRPALDTVPP	52.17	gnl|BL_ORD_ID|294|hsp_num:0	250			264	462	chloramphenicol
BGC0000703.1|Kanamycin_128 # 137053 # 138225 # -1 # ID=1_128;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.735	BGC0000703.1|Kanamycin_128 	137053	138225	-	Loose	425	32.7278	VAM-1	22.76	3007062	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam; tetracycline antibiotic	antibiotic inactivation	VAM beta-lactamase	GTGACTCAGCAGGCGCAACGGACGCAGCAGATGCAGCAGGCGCAACAAGCGCAGCAGGCGCAAGAGGCACAGCGAGTGCAGGAGACACAGCAGGCGCAGCAGATGCAGCAGATGCAGCAGACGTGGCAGACACAGGGGGCGCAAGAGGCACAGCAGGTGCAAGAGGCGCAGCTGCAGACGGCCGTGCGGCCGGTCTCCCCGCACGCGCCCGCCCCGCCGCACGCCCCCGGCGGGATCCGCCGGTGGCCGAAGTCGTTCGCCGACCGGCTCACCGCCCCCCTGCCCGGCCTTCGCGCCTTCGCGCGCTTCGCCCGTGAGGGCGCCCTGCGGCCCCGCCCCGACGGGCTCGCCGACATCCAGCGACTGCCCTACGACCCCGGCCCGCTGCCGCGCGTCGACGCGGGCACCGTCGCCGTCACCTGGGCGGGCCACGCCAGTTGGGTGCTGCGCGTCGGCGGGCTCACCGTCCTCACCGACCCCGTCTGGTCCCGCAAGATCCTCGGCACCCCGGCCCGGGTCACCCCGGTCGGCGTCGCCTGGAGCGCCCTGCCGCGCGTCGACGCGGTCGTCATCAGCCACAACCACTACGACCACCTGGACGCCCCGACCCTGCGCAGACTCCCCAGGGACACCCCCGTCTTCGTACCCGCGGGACTCGGCCGCTGGTTCACCCGCCGCCGCTTCAGCAGGGTCACCGAACTCGACTGGTGGGAGGGGGCCGAACTGGGCGGAGTGCGCTTCGACTTCGTGCCCGCGCACCACTGGTCCAAGCGGAGCCTCCTGGACACCTGCCGCACGCTGTGGGGCGGCTGGCTGCTCACCGACGCGCGAGGGCAGCGGGTCTACTTCGCGGGCGACACCGGATACGGCCACTGGTTCGAGCGGATCGGCGCCCGCTACCCCGGCATCGACCTCGCGCTCCTTCCGATCGGCGCGTACGACCCGCGGTGGTGGCTCAGCGACGTGCACTGCGACCCGGAGGAGGCGGTCCGCGCCGCCATCGACCTCGGAGCGCGGCGGATGGCGCCCATGCACTGGGGTACGTTCCTGCTCTCCGCCGAGCCGGTGCTCGAACCGCTCACCAGGGTGCGTACGGCATGGGAGAAGGCGGGCCTGGACCGCGAGGACCTGTGGGACCTGCCGGTGGGGGCGTCGCGGGTGCTTGCCGCTTGA	MTQQAQRTQQMQQAQQAQQAQEAQRVQETQQAQQMQQMQQTWQTQGAQEAQQVQEAQLQTAVRPVSPHAPAPPHAPGGIRRWPKSFADRLTAPLPGLRAFARFAREGALRPRPDGLADIQRLPYDPGPLPRVDAGTVAVTWAGHASWVLRVGGLTVLTDPVWSRKILGTPARVTPVGVAWSALPRVDAVVISHNHYDHLDAPTLRRLPRDTPVFVPAGLGRWFTRRRFSRVTELDWWEGAELGGVRFDFVPAHHWSKRSLLDTCRTLWGGWLLTDARGQRVYFAGDTGYGHWFERIGARYPGIDLALLPIGAYDPRWWLSDVHCDPEEAVRAAIDLGARRMAPMHWGTFLLSAEPVLEPLTRVRTAWEKAGLDREDLWDLPVGASRVLAA	MNFLIKNILLITLFVPFVTAANNTDTKTLEVKQLTDNIYQHISYKHVEPWGFIGASGLIVVDGDAAYLIDTPWTTKATNQLIEWIEDRGLVLKSAIVTHFHEDASGDLPLLNDLKVNTYATSLTNQLLKLNNKEISNTEISSNELKIFNGIATVYYPGPGHTEDNIVVWLPNEKLLFGGCFVKSLRNKSLGYTGDANIGEWSNSIQRVLQRYPDIVTVVPGHGQVGDVSLLLHTQKLASSDKTSDK	158.54	gnl|BL_ORD_ID|4764|hsp_num:0	5761			279	645	tetracycline; ceftriaxone; ampicillin; cefotaxime
BGC0000703.1|Kanamycin_129 # 138222 # 139469 # -1 # ID=1_129;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.782	BGC0000703.1|Kanamycin_129 	138222	139469	-	Loose	920	25.7942	OpmD	34.15	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGCGGACGGACCCCGAAGGGCACGGGCCCGTCCGGTACGGGCCGCCCCCACCGGAGCCGGGCCTTCCGGTCCTGCCCGAGCTGGCGGCGGCCGCCGCCGCGGCCGCGGGCAGGTCCCACGGCGAACCACCGGGCGGGAGCCCCGTACTCCTCGACGCCGCCTGCGGCTACTGGGCCAGGCGCGGCCTGCCCGCCGAGCGCGACCACGTCGTCGCGGCCCCCGGCGCCCCCACCCTGCTGCTCGCCCTGACCGCGGCCATCGGCGGCGACGTCCTGCTGCCCCGCCCCTGCCCGGCCTGGTGGGCGCCCCAGGCACGGCTGCTCGGCCGCGCGGTCTACCACGTGCCGACCCCCGCGGAGTGCGGCGGCGTCCCCGACCCGTACGCACTCCTGGAGACCGTCCGCCGCGTCCGCGCCGAAGGCGGCAGACCCCGGCTCCTCGTGCTCTCCGTCGCCGACGACCCGACCGCCACCGTGCCGCCCCCCGACGTCCTGCACGAGGCCGTCGAAGCGGCCGCCGACGAGGGCCTGCACGTGATCAGCGACGAGACCTGGCGCGACACCCTGCACCGGCCGCGCGACACCGTCCTGATCGGCCCGGCGGAGATGGACCACGCGCGCGTGACCGTCCTCTCCGACCTCTCCGGCGCCTTCCTGCCCCCGGCACTGCCCGCGGCCGTGGCGCGCTTCCCCGACACCGCGGCGGGCAGCGCCCTTCGGGCCCGCACCCTGGACGTCCTCGCCGCGCTCGGCGCCGTGCCCGGGGGCCCGGCCGCCGCGGCCGCGACGTACGCGCTCGGGGAACCGGACGAGATCGGCGAACGCCTCACCTCGGCCGTCCGCCTGCACGCGCGCGTGGCCGCCGCCGCGCAGCGCGCCGTGCTCGCCGCGGGGGGCCTGGCCCGGCCCCCGCAGGCGGGCCGTCACCTCTACGCCGACCTCGGCCCGCTGCGCCCCGCGCTCGCCGCACGCGGCGTCGGCGACGCGCAGGACCTGGAGGACTTCCTCGGCGAACGGCTCGGCATGCCCGCACCGGGCGGCCACCGCTTCGGCGACGAGATCGACGCCCTGCGCGTACGCCTGGTCACGGGGCCGCTGCTCGGCTCGACACCCGACGAACGCATGGCGTCCCTCGCCGCACCCGACCCACTGGAATTGCCGCATGTGGAACGGGCGTTGAGCAGGTTCGGATCGGCCTTCGACGATCTCCGCGCAGAAGCCCAGCGAATGGAGCCTCCTCGGTGA	MRRTDPEGHGPVRYGPPPPEPGLPVLPELAAAAAAAAGRSHGEPPGGSPVLLDAACGYWARRGLPAERDHVVAAPGAPTLLLALTAAIGGDVLLPRPCPAWWAPQARLLGRAVYHVPTPAECGGVPDPYALLETVRRVRAEGGRPRLLVLSVADDPTATVPPPDVLHEAVEAAADEGLHVISDETWRDTLHRPRDTVLIGPAEMDHARVTVLSDLSGAFLPPALPAAVARFPDTAAGSALRARTLDVLAALGAVPGGPAAAAATYALGEPDEIGERLTSAVRLHARVAAAAQRAVLAAGGLARPPQAGRHLYADLGPLRPALAARGVGDAQDLEDFLGERLGMPAPGGHRFGDEIDALRVRLVTGPLLGSTPDERMASLAAPDPLELPHVERALSRFGSAFDDLRAEAQRMEPPR	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	85.22	gnl|BL_ORD_ID|450|hsp_num:0	442			600	717	acriflavine; tetracycline; norfloxacin
BGC0000703.1|Kanamycin_130 # 139663 # 140370 # 1 # ID=1_130;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=6bp;gc_cont=0.702	BGC0000703.1|Kanamycin_130 	139663	140370	+	Loose	275	29.6462	dfr22	36.23	3005354	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGCCGATCGTGCGCAGCGGGGGGCCGGTCCCGATTCCTACGCTGGTGGTCATGAACGACGCGATCATCCATGCAGTCGAAGGCTTCGTCACCTCTCCGTGGGTGTACGCGGTGCTCTTCGGCATCGCCGCACTGGACGGCTTCTTCCCGGTGGTCCCCAGCGAGACGCTGGTGATCACCCTGGGAGTGTTCGCCGCCTCGACCGGTGATCCCCAGCTCGTGCTCGTGATCGTCGTGGCCGCGCTCGGTGCCTTCACCGGTGACCACATCTCCTACTGGATCGGGCGCAAGTCCGGACAGAAGATCTTCGCCAAACTCAAGCCCGAGAGCCGCAGCCGCAAGGCGTACGACCGGGTGGGCAAGATGCTGGAGGAGCGCGGCGGCCTCGTCCTCGTCGTCGCCCGCTACATCCCCGGCGGCCGCACCGCGGCGACGCTGACCACCGGCGCCACCGGCTTCCCGCGCCGTTCCTTCACCTTCTTCGACGCGATCGCCGCGTCGTCCTGGGCGATCTACTCGGCCTGCCTCGGCTACGTCGGCGGCGCCGCCTTCGAGGACACGCCCCTGCTCGGTGTCGCGCTCGGCCTCGGCATCGCCTTCTCGATCACGCTGCTGCACGAGGGCGTCCGCTGGCTCCGGCACCGCCGCGCGCCCCAGCCCGAGGCACAGGAGACGCCCGCCGCGCAGGAGACGCGGAGCGCCGCCTGA	MPIVRSGGPVPIPTLVVMNDAIIHAVEGFVTSPWVYAVLFGIAALDGFFPVVPSETLVITLGVFAASTGDPQLVLVIVVAALGAFTGDHISYWIGRKSGQKIFAKLKPESRSRKAYDRVGKMLEERGGLVLVVARYIPGGRTAATLTTGATGFPRRSFTFFDAIAASSWAIYSACLGYVGGAAFEDTPLLGVALGLGIAFSITLLHEGVRWLRHRRAPQPEAQETPAAQETRSAA	MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFLSEVHQTFEGDAFFPVLDEAEFEVVSAETVQATITYTHSVYARRNG	142.42	gnl|BL_ORD_ID|3058|hsp_num:0	4085			3	204	trimethoprim
BGC0000703.1|Kanamycin_131 # 140445 # 141281 # -1 # ID=1_131;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=13bp;gc_cont=0.707	BGC0000703.1|Kanamycin_131 	140445	141281	-	Loose	260	26.9498	FosD	26.32	3004674	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGCGATCCCACACGACCACTGTCCAGGCGACCAGGACCGCGGCCGCCGCCCCTGCCAGGACCAAGCGACATCCGCACGACGACGCCCCGGACACGGCGGCCGCCTTCGAGCGGCTCGTCGAGATGGAGGAGGGTCCCGAGCGGGACACCCTGCGTCAGGAAGTCGTCGAGGTCTGGCTGCCCATGTCCGAGCGTCTCGCGGGGCGCTTCCGCAACCGCGGCGAGTCCCTCGACGACCTGCGCCAGGTCGCGGCCCTCGGGCTCGTCAAGGCCGTGGACCGCTACGACCCGCGCCGCGGCACCGCGTTCGAGAGCTACGCCGTACCCACCGTCACCGGTGAGATCAAGCGTCACTTCCGCGACCACATGTGGACCCTGCACGTACCGCGGCGCGTCCAGGACCTGCGCAACCGCGTGCGCTTCGCCCGCCAGGACCTCGCCCAGACGGTGTCGGGGCGCGCCCCGACCACCGCCGAGATCGCCGAACGCGCGCAGATGAGCGAGGAGGACGCGAAGGCGGGCCTGGAGGCGCTCGACAGCTTCACCGCCCTCTCCCTTGACGCGGAACTCCCGGGCAGCGAGGACGGCTACTCACTGAGCGACGCCCTCGGCGGACCCGACCCCGCGCTCGACGTCGTCATCGACCGCGAGTCCGTCAAACCGCGCATCGCGCAGCTGCCAGAGCGCGAACGCACCATCCTCTACATGCGGTTCTTCGGCGACATGACCCAGAGCCGCATCGCCGATGAGATGGGCATCTCGCAGATGCACGTCTCGCGGCTGATCAGCCGCTGCTGCGACCGGCTGCGCGACCAGGTCATGCGGGACGCCGCGTAA	MRSHTTTVQATRTAAAAPARTKRHPHDDAPDTAAAFERLVEMEEGPERDTLRQEVVEVWLPMSERLAGRFRNRGESLDDLRQVAALGLVKAVDRYDPRRGTAFESYAVPTVTGEIKRHFRDHMWTLHVPRRVQDLRNRVRFARQDLAQTVSGRAPTTAEIAERAQMSEEDAKAGLEALDSFTALSLDAELPGSEDGYSLSDALGGPDPALDVVIDRESVKPRIAQLPERERTILYMRFFGDMTQSRIADEMGISQMHVSRLISRCCDRLRDQVMRDAA	MIQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQYSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTLENRLNYYKETKPHMVFYK	200.00	gnl|BL_ORD_ID|2251|hsp_num:0	3373			18	195	fosfomycin
BGC0000703.1|Kanamycin_132 # 141545 # 141985 # 1 # ID=1_132;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.717	BGC0000703.1|Kanamycin_132 	141545	141985	+	Loose	700	32.7278	oleI	37.14	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGCTGATTACGTAAGGGACGTCATGACGACCGGCGTCGTGGTGGTGCGTCCCGATGCCTCACTCGTCGAAGCCGCCCAGCTCATGCGCGCACAGGACATCGGCGATGTGCTCGTCGCCGTCGGGGGCCGGATCCTCGGTGTGCTCACCGACCGGGACATCACGCTGCGCGCCGTGGCCGACGGCGCCGACCCGCTGACGGTCAGCGCACAGGCGATCTGCACGCCCAATCCGGTGGTGGTGACGCCCGACGACGCGGTGTCCGCCGCCGTCGATCTGATGCGCGACCACGCCGTCCGCAGGCTGCCCGTCGTCGAGGACGGCCGCCCGGTGGGCATGGTCAGCCTCGGCGACCTGGCGCTCGCCCGGGATCCGTCCTCCGCGCTCGCCGACATCAGCGGCGCGGATCCGGACACCTGGCCGGACATCGCGCGACCCTGA	MADYVRDVMTTGVVVVRPDASLVEAAQLMRAQDIGDVLVAVGGRILGVLTDRDITLRAVADGADPLTVSAQAICTPNPVVVTPDDAVSAAVDLMRDHAVRRLPVVEDGRPVGMVSLGDLALARDPSSALADISGADPDTWPDIARP	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	34.43	gnl|BL_ORD_ID|1684|hsp_num:0	1824			105	309	oleandomycin
BGC0000703.1|Kanamycin_133 # 142044 # 142685 # -1 # ID=1_133;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=12bp;gc_cont=0.751	BGC0000703.1|Kanamycin_133 	142044	142685	-	Loose	500	25.7942	OXA-621	37.04	3005842	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGACGAGCGGCACGACACGAGCAGCGCGAGCGGCACGGGTGAGGCGAGCGACACGGGCGGGGCGGCCGATCCGGCGCTGCTCGACCGGCACGCGGCGGCCCTCGACCTCTTCACCGACCGGGTGCACGCCGTCCGCGCCGACCTGTGGGACGCGCCGACGCCCTGCACGGACTGGACCGTGCGGGACCTCGTCGCCCACCTCACCGGCGAACAGCTGTGGGTGCCCTCGCTCGTCCGCGACGGCGCCACCACCGCCTCGGTCGGGGACGCCTTCGACGGCGATGTGCTCGGCCCCGACCCCGTCGCCTCCTGGGACACCGCGGCCGCCGCGTCCCGCGCGGCGTTCCGCGAACCGGGCGCCCTGGACCGCACCGTGCACCTCTCCTTCGGCGACACCTCCGCCGCGTTCTACTGCGGGCAGATGACGACCGACCTCGTGGTGCACGCCTGGGACCTCTCCCGGGCGATCGGCTCCGACGAGGCGCTGCCCGCCGCGCTCGTCGACTTCTCCGTACGCGAAGTCGAGCCGTACGCGGCCGAGTTGGCGAAGAGCGGCCTCTTCGCCCCCGCGGTCGAACCGCCCCCGGAGGCCGACGCGCAGACGAGGCTGCTGGGACTCCTCGGCCGCCGAGCGTGA	MTDERHDTSSASGTGEASDTGGAADPALLDRHAAALDLFTDRVHAVRADLWDAPTPCTDWTVRDLVAHLTGEQLWVPSLVRDGATTASVGDAFDGDVLGPDPVASWDTAAAASRAAFREPGALDRTVHLSFGDTSAAFYCGQMTTDLVVHAWDLSRAIGSDEALPAALVDFSVREVEPYAAELAKSGLFAPAVEPPPEADAQTRLLGLLGRRA	MRDFIVFIWFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPVFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY	82.88	gnl|BL_ORD_ID|3877|hsp_num:0	4947			6	87	cloxacillin; oxacillin; cefalotin
BGC0000703.1|Kanamycin_134 # 142682 # 142921 # -1 # ID=1_134;partial=00;start_type=ATG;rbs_motif=AGCGA;rbs_spacer=12bp;gc_cont=0.717	BGC0000703.1|Kanamycin_134 	142682	142921	-	Loose	2300	24.6386	evgS	41.18	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACGGAGTCGACCCGGTACGGCTGGACGACAAGGAGCTCATCAAGGAGCTGGAGACGATCCACCGCACCCGCCACACCACGCTGCTGCACGGCTCGAACGACGCCCTGCGGGCGCACAACGAACGCATGGCGGTGCTCGAGGGCGAGTACCTGCGCCGCCACCCGCGCAGGTCGGTCGCGGCGGGGCGGACGCGCGCGGGCGCGCGGGAGCGGGAGAGGGGAAACGGCGACTCATGA	MNGVDPVRLDDKELIKELETIHRTRHTTLLHGSNDALRAHNERMAVLEGEYLRRHPRRSVAAGRTRAGARERERGNGDS	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	6.60	gnl|BL_ORD_ID|1214|hsp_num:0	1318			114	216	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000703.1|Kanamycin_135 # 143041 # 144720 # -1 # ID=1_135;partial=00;start_type=GTG;rbs_motif=AGGGGG;rbs_spacer=5bp;gc_cont=0.717	BGC0000703.1|Kanamycin_135 	143041	144720	-	Loose	1100	179.874	oleB	33.33	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGCGTCCCCGCAGGGAAACGGTTTGCCCGAGCGGCGTCCGGACACGGAGAATCACCGCCATGGGACATCTGGAAGCCGCGCACCTCGAGTACTACTTGCCGGACGGGCGGGCGCTGCTCGGTGATGTCTCCTTCCGGGTCGGCGAGGGCGCGGTCGTCGCCCTGGTCGGGGCGAACGGCGCGGGCAAGACCACGCTGCTCCGGCTGATCTCCGGTGAGCTCCAGCCGCACGGCGGCAGCGTCAACGTCAGCGGCGGGCTCGGCGTGATGCCGCAGTTCGTCGGCTCCGTGCGCGACGAGACCACCGTGCGCGACCTGCTCGTCTCCGTCTCCACGCCGCGCATCCGCGAGGCCGCGAAGGCCGTGGACGCCGCCGAGCACAAGATCATGACGGTCGACGACGAGGCCGCCCAGCTCCAGTACGCCCAGGCGCTCTCGGACTGGGCGGAGGTCCAGGGGTACGAGGCCGAGACGCTGTGGGACATCTGCACCACGGCCGCGCTCGGCGTCCCCTACGACAAGGCGCAGTTCCGCGAGGTCCGCACGCTCTCCGGCGGTGAGCAGAAGCGGCTCGTCCTGGAGTCCCTGCTGCGCGGCTCCGACGAGGTCCTGCTCCTGGACGAGCCGGACAACTACCTCGACGTACCCGGCAAGCGCTGGCTGGAGGAGCGGCTCAAGGAGACCCGCAAGACCGTCCTCTTCGTCTCCCACGACCGGGAACTGCTCGCCCGAGCCGCCGAGAAGATCGTCAGCGTCGAGCAGAGCCCCGGCGGCGCCGACGCGTGGGTGCACGGCGGCGGCTTCGCGACGTACCACGAGGCCCGCAAGGAGCGCTTCGCGCGCTTCGAGGAGCTGCGCAGGCGCTGGGACGAGAAGCACGAGCAACTGAAGAAGCTGGTCCGCAACCTGCGCCAGGCCGCCGAGATCAGCCACGAGCTCGCATCGCGGTACCAGGCGGCCCAGACCCGGCTGCGCAAGTTCGAGGAGGCGGGACCGCCGCCCGAGCCGCCGCGCGAGCAGGACATCACCATGCGCCTCCAGGGCGGCCGCACCGGCGTGCGCGCCGTGACCTGCCAGGGCCTGGAGCTCACCGGGCTGATGAAACCCTTCGACCTGGAGGTCTTCTACGGCGAGCGGGTCGCCGTCCTCGGCTCGAACGGCTCGGGCAAGTCGCACTTCCTGCGGCTGCTCGCGGGCGGCGAGGTGGCGCACACCGGCGCCTGGAAGCTCGGCGCGCGCGTCGTGGCGGGCCACTTCGCGCAGACCCACGCCCACCCCGAGCTGCTCGGCCGCCCGCTGCTCGACATCCTGTGGCGCGAGCACGCACAGGACCGCGGGGCCGCCATGTCGCGCCTGCGGAGGTACGAGCTGACGGCCCAGGCCGAGCAGAACTTCGAGCGGCTCTCCGGCGGCCAGCAGGCCCGCTTCCAGATCCTGCTCCTGGAACTGGAGGGCTGTACGGCCCTGCTCCTCGACGAGCCGACCGACAACCTCGACCTGGAGTCGGCCGAGGCGCTGCAGGACGGCCTCGAGGCGTTCCAGGGCACGGTCCTCGCCGTCACCCACGACCGCTGGTTCGCCCGCTCCTTCGACCGGTACCTGGTCTTCGGCAGCGACGGCAAGGTCAGGGAGACCCCCGAGCCGGTGTGGGACGAGCGACGGGTCGAGCGCAAGCGGTAG	MRPRRETVCPSGVRTRRITAMGHLEAAHLEYYLPDGRALLGDVSFRVGEGAVVALVGANGAGKTTLLRLISGELQPHGGSVNVSGGLGVMPQFVGSVRDETTVRDLLVSVSTPRIREAAKAVDAAEHKIMTVDDEAAQLQYAQALSDWAEVQGYEAETLWDICTTAALGVPYDKAQFREVRTLSGGEQKRLVLESLLRGSDEVLLLDEPDNYLDVPGKRWLEERLKETRKTVLFVSHDRELLARAAEKIVSVEQSPGGADAWVHGGGFATYHEARKERFARFEELRRRWDEKHEQLKKLVRNLRQAAEISHELASRYQAAQTRLRKFEEAGPPPEPPREQDITMRLQGGRTGVRAVTCQGLELTGLMKPFDLEVFYGERVAVLGSNGSGKSHFLRLLAGGEVAHTGAWKLGARVVAGHFAQTHAHPELLGRPLLDILWREHAQDRGAAMSRLRRYELTAQAEQNFERLSGGQQARFQILLLELEGCTALLLDEPTDNLDLESAEALQDGLEAFQGTVLAVTHDRWFARSFDRYLVFGSDGKVRETPEPVWDERRVERKR	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	98.24	gnl|BL_ORD_ID|1272|hsp_num:0	1388			123	1665	oleandomycin
BGC0000703.1|Kanamycin_136 # 144820 # 146376 # 1 # ID=1_136;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=13bp;gc_cont=0.766	BGC0000703.1|Kanamycin_136 	144820	146376	+	Loose	350	53.5286	bcrC	28.91	3003250	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	undecaprenyl pyrophosphate related proteins	ATGCGCCCTGACTCCTCGGACGTCTCCGACCTCGATCTGTCCCTGTCCCTGCCCCCGTCCTCAGCCGGGCACCGCCCGGTCAAGTCCCGCCTGGTCGGGCTCGACCGCCGCCTGTTCGAAGCGGTCGCCGCCCGGCACTGGCCCGGCGGCGACCGCGTGCTGCCCGGGCTCAGCCGGAGCGCCAACCACGGCGTGCTGTGGTTCGCCGCGGCGGCGGGCATCGCCGCGACCCGCACCCCGCGGGCCCGGCGTGCCGCGCTGCGCGGTGTGGCCTCGCTGGCCCTCGCCTCCGCTGCCATCAACACCCTGGGCAAGCGTTCGGTGCGCCGCCCCCGGCCGCTGCTCGACGCGGTACCGCTGATCAGGCAGCTCAAGCGCCAACCGATCACCACGTCCTTCCCCTCGGGCCACTCGGCGTCCGCCGTCGCCTTCGCGACCGGTGTGGCGCTGGAGTCGCGGGCCTGGGGCGCGGCCGTCGCGCCGCTCGCGGCCGCCGTCGCGGCGTCCCGCGTCTACACCGGGGCGCACTTTCCGAGCGACGTCCTGGTGGGCGGGGCGCTCGGCGCGGGCGCGGCGTTCGCGGTGCGCGGTCTGGTGCCGACGCGGTCCCAGCTCGCGCCGCCGGGACGACCCCGCGTCGCGGCTCCCGCCCTGCCGGGCGGCGCGGGCCTCGTCCTGGTCGCCAATGCCGGGGCGGGCACCGCGGACCGCGTCAAGTCGCTCCACGCCGCGCTGCCGGACGCGGAGGTCGTCCTCGCCGAACCGGACGAGCTGGTCGCCGAGTTGGGCAAGGCGGCGGCCCGCGCGCGGGTCCTCGGCGTGTGCGGCGGCGACGGCACGGTCAACGCCGCGGCGACGGTCGCCCTGCAGCACGGGATACCGCTCGCGGTGCTGCCCGGCGGCACGCTCAACCACTTCGCGTACGACCTCGGGGTCGAGGACGCCCGCGATCTGTCGAGCGCGGTGGAGGGCGGGGAGGCGGTCGCCGTCGACGTGGGCCGCTTCAGGAGCGATGGCCCGGAGGGGGCCACCGCGACGGAGGACGCCGTGGAGGGGTACTTCCTCAACACGTTCAGCCTGGGCGTGTACCCGGAGCTGGTGCGGCTGCGCGAGCACTGGTCGCCGCGCATCGGCGGCAAGCCCGCGTCCGTACTCGCGGCGCTGAAGGTGCTGCGCTCCGACGAACGGCCGATGGTCGCCCAGTTCCGGGGCAAGGACCGGGCGTTGTGGCTGCTCTTCGCGGGCAACTGCACCTATCACAGGCCCGGCTTCACCCCGGGCCGCAGGCTCGACCTGGCGGACGGGCTGCTCGACGTGCGGATCGTGCACGGCGGGCGCAGGCCCGGCACGCGGCTCCTCGCCGCCGCCCTGACGGGACCCGAGGTGCGCTCCCCCGCGCAGGCGGCCTCGCGGCTGCCCCGGCTGCGGGTGGACGGCCTCGGCCCGGGCACGGCGGTCGCGTACGACGGTGAGGTGCGGCACGTCCACGGCTCGCTGCTCCTCGACAAGCTGCCGGAGGCGCTGACCGTCTACCGGCCGCTGACGGCCACCCGCTGA	MRPDSSDVSDLDLSLSLPPSSAGHRPVKSRLVGLDRRLFEAVAARHWPGGDRVLPGLSRSANHGVLWFAAAAGIAATRTPRARRAALRGVASLALASAAINTLGKRSVRRPRPLLDAVPLIRQLKRQPITTSFPSGHSASAVAFATGVALESRAWGAAVAPLAAAVAASRVYTGAHFPSDVLVGGALGAGAAFAVRGLVPTRSQLAPPGRPRVAAPALPGGAGLVLVANAGAGTADRVKSLHAALPDAEVVLAEPDELVAELGKAAARARVLGVCGGDGTVNAAATVALQHGIPLAVLPGGTLNHFAYDLGVEDARDLSSAVEGGEAVAVDVGRFRSDGPEGATATEDAVEGYFLNTFSLGVYPELVRLREHWSPRIGGKPASVLAALKVLRSDERPMVAQFRGKDRALWLLFAGNCTYHRPGFTPGRRLDLADGLLDVRIVHGGRRPGTRLLAAALTGPEVRSPAQAASRLPRLRVDGLGPGTAVAYDGEVRHVHGSLLLDKLPEALTVYRPLTATR	MSFSELNIDAFRFINDLGKEYSMLNPVVYFLAEYMMYFLALGLVVYWLTRTTKNRLMVIYAVIAFVVAEILGKIMGSLHSNYQPFATLPNVNKLIEHEIDNSFPSDHTILFFSIGFLIFLFHKKTGWLWLVLAFAVGISRIWSGVHYPLDVAAGALLGVLSALFVFWTAPKLSFIHQMLSLYEKVEQRIVPSKNKSNDKSKNF	255.17	gnl|BL_ORD_ID|196|hsp_num:0	215			144	519	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000703.1|Kanamycin_137 # 146458 # 147267 # 1 # ID=1_137;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.728	BGC0000703.1|Kanamycin_137 	146458	147267	+	Loose	400	31.187	ErmE	29.49	3000326	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCGAAGGAGACCGCCGTCTACACGCACGGGCACCACGAGTCCGTGCTGCGTTCGCACACCTGGCGCACGGCCGCCAACTCAGCCGCGTACCTGGTCGGTTCGCTCAAGCCGCACATGCGGGTCCTCGACATCGGCTGCGGCCCCGGCACCATCACCGCCGACCTGGCGGCGCTCGTCCCGGAGGGGCACGTCACGGGCGTGGACCACGCGCCGGGGATTTTGGACCAGGCGCGCGCGACCGCCGCCGAACGCGGCCTGGACAACGTGGAGTTCGCCGTCGCCGACGTGCACGACCTGGACTACCCCGACGACAGCTTCTGCGTGGTCCACGCGCACCAGGTGCTCCAGCACGTGGGCGATCCGGTGCGGGCGCTGCGCGAGATGCGGCGGGTCTGCAAGCCGGGCGGCATCGTGGCCGTGCGCGACTCGGACTACGCGGCGATGACCTGGTACCCCAACACCCCGGCCATGGACGACTGGCTGGACCTCTACCGGCGCGTGGCCCGCGCGAACGGCGGCGAGCCCGACGCGGGGCGCCGCCTCAAGTCCTGGGCCCTGGAGGCCGGTTTCACGGACATCACCGCCACGGCGGCCACCTGGTGCTATGCCTCGGAGGAGGAGCGCGCCTGGTGGAGCGGCCTGTGGGCGGACCGCACCCTCGCCTCCGCCTACGCCGAGCGCGCGGTCGAGGGCGGCCACGCGGACGGGGAACTCCTGCGGACCGTCTCCGACGCCTGGCGGGAGTGGGGGAAGCAGGACGACGCCTGGTTCGCGGTGCTGCACGGCGAGATCCTCTGCCGGAAGTAG	MPKETAVYTHGHHESVLRSHTWRTAANSAAYLVGSLKPHMRVLDIGCGPGTITADLAALVPEGHVTGVDHAPGILDQARATAAERGLDNVEFAVADVHDLDYPDDSFCVVHAHQVLQHVGDPVRALREMRRVCKPGGIVAVRDSDYAAMTWYPNTPAMDDWLDLYRRVARANGGEPDAGRRLKSWALEAGFTDITATAATWCYASEEERAWWSGLWADRTLASAYAERAVEGGHADGELLRTVSDAWREWGKQDDAWFAVLHGEILCRK	MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELRPDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAEPPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTWPLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGRPGRRGGPGQR	70.60	gnl|BL_ORD_ID|94|hsp_num:0	109			171	393	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000703.1|Kanamycin_138 # 147364 # 147534 # 1 # ID=1_138;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.626	BGC0000703.1|Kanamycin_138 	147364	147534	+	Loose	730	23.0978	tet(G)	29.55	3000174	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTTCCTATTCTGCTGGTCCTTCTGCTGGCGCTGCTCCTCTTCGGAGCGGGATTCGCCGTGAAGGTTCTCTGGTGGATCGCCATCGCCGTGCTCGTCATCTGGCTGCTCGGCTTCGTGATGCGCAGTTCGACCGCCACGGGGTCGAGGTCCCGCTGGTACAGGTGGTAG	MVPILLVLLLALLLFGAGFAVKVLWWIAIAVLVIWLLGFVMRSSTATGSRSRWYRW	MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPLLGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIADSTGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQWDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATIGAWTGWVWIVGAILYLICLPILRRPFATSL	14.32	gnl|BL_ORD_ID|893|hsp_num:0	957			267	399	tetracycline
BGC0000703.1|Kanamycin_139 # 147548 # 147637 # -1 # ID=1_139;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.722	BGC0000703.1|Kanamycin_139 	147548	147637	-	Loose	600	20.7866	mdtN	60.0	3003548	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCGAGCTCAGGGACCGGTACGGGCTGCGGCCCGAGGACCTGAATCTGGTCCTCGGGCCGCTGGGCCCCCTGCTTCCCAGGGGCTGA	MAELRDRYGLRPEDLNLVLGPLGPLLPRG	MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ	8.45	gnl|BL_ORD_ID|1321|hsp_num:0	1442			855	900	acriflavine; puromycin
BGC0000703.1|Kanamycin_144 # 151763 # 152368 # 1 # ID=1_144;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.710	BGC0000703.1|Kanamycin_144 	151763	152368	+	Loose	1100	25.7942	tetA(46)	32.26	3004032	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAGAACCCGCGCGTGGAGAACGCAGAAGTACTGCTCATCGGGGGCCGGTCCGGGGTCGGCAAGACGTCCGTCGGCCTGGAAGTCGCGGCACGGCTCCGGGCCGCGGACATCGGCCACGCGCTGATCGAGGGCGACCTGCTCGACCTGGTCCACCCGGCGCCGAGGGACGATCCGGACCGCTCGCGGATCACCGAGCGGAACCTGGCGGCGCTCTGGGCCAACTACACGGAGCTCGGCTGCCGTCGGCTCGTGTACACGAACACGGCGAGCGTGCTCGGCAGCGAGGAGCGGCTGTTCACACGTGCCCTCGATGGACCGCGCATCATCCGCGTCCTGCTCACGGCCACGGACGCGACGGTGGAACAGCGTCTGACGGCCCGCGAGCAGGGCTCGGAACTCGAACAGCAGCTGCGCCGCAGCGAGTTCATGGCCCGCCACCTGAGCGCGCACACTCCACCGGACGCCCACCGCATCGCCACGGACGGCCGCGACGTACGCGACATCGCGGCGCGGGTGGTGGCGGCGACGGGCTGGGCAACGGGAAGCACCCCACGGGGAACATGTGACGAAGGCCACACCATGGGCGGGTTTCCTCCGGGGTAG	MENPRVENAEVLLIGGRSGVGKTSVGLEVAARLRAADIGHALIEGDLLDLVHPAPRDDPDRSRITERNLAALWANYTELGCRRLVYTNTASVLGSEERLFTRALDGPRIIRVLLTATDATVEQRLTAREQGSELEQQLRRSEFMARHLSAHTPPDAHRIATDGRDVRDIAARVVAATGWATGSTPRGTCDEGHTMGGFPPG	MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVLLVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTTDVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQEEYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYSFGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMTDLILVYQTGQMSYKKLKEVIDETDDLEPDGTHYLEQIDSVEFKDYSFSYPGAERKSLSGIDWTIQRGQTVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFSKSIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISLARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVLDQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE	35.02	gnl|BL_ORD_ID|2308|hsp_num:0	2643			1065	1224	tetracycline
BGC0000703.1|Kanamycin_145 # 152689 # 153045 # 1 # ID=1_145;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=10bp;gc_cont=0.717	BGC0000703.1|Kanamycin_145 	152689	153045	+	Loose	250	31.5722	FosM2	22.43	3007098	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGAGATCCTGGGAACCACGCTGCGGATCTGCGTCGAGGACCTGGAGTCCTCGGTCGTGTTCTACGAGCGGCTCGCGGGCGGCAAGGCCATGCGCTTCGAACGCGGCGGCGTGTCCGTGGCCGCGGTCGGCTGCTTCCTGCTGATGAGCGGGCCCGAGGCGGAGCTCGAAGTGCTCCGCAAGGTCTCGGCGACCATCGCGGTGCGGGACGTGGACGAGGCGTACGCCGTCCTGAACGCCTCCGGCGCGCGCGTCATCGCGGGCCCGGTCCCGACCCCGGTCGGCCGCAACCTGATCGCGATGCACCCGGACGGCGCCGTCTTCGAGTACGTGGACCGCCGCGGCGGCACGGACTGA	MEILGTTLRICVEDLESSVVFYERLAGGKAMRFERGGVSVAAVGCFLLMSGPEAELEVLRKVSATIAVRDVDEAYAVLNASGARVIAGPVPTPVGRNLIAMHPDGAVFEYVDRRGGTD	MIKGINHFLFSVSDLEKSIQFYQEVFEAKLLVKGKNTAYFDLNGLWLALNMEKDIPRNEIKQSYTHIAFSIEETAFDRMYDQLEKLGVNILTGRPRDEKDKKSIYFTDPDGHKFEFHTGTLQDRLNYYKQEKPYMDFYI	84.89	gnl|BL_ORD_ID|4778|hsp_num:0	5773			27	348	fosfomycin
BGC0000703.1|Kanamycin_146 # 153101 # 153835 # 1 # ID=1_146;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.761	BGC0000703.1|Kanamycin_146 	153101	153835	+	Loose	850	25.409	OprM	40.0	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCGAGCGGTACGGCGGGCGGTACGTCAGGCGGTGCGGAACGGACGTCGCTCAGCGCCCAGGCGCGCGAGGCCGTCCGGCAGCGCATCGTCGACCGCCGCTACGCGCTTGGCGCGCGCCTGGTCGAGCGTGAGGTCGCCGAGGAGCTGCGGATGTCCCGCGTCCCGGTCCGGGAGGCGCTGCGGGCGCTGGTCGCCGAGGGCCTCCTCGAACTCCTGCCGCACAGCGGCGTACGGGTGCGGCGCCTCGAACCCGCCGACGTGCAGCATCTGTACGAGGTGTGGGAGCCGCTGGCCGTCCAGGCGTCCCGGCTCGCGGCCCGCCAGGTGGCGGAGAGCTCCCCGGCCGAGCCGCCGGGGCTCGCCGCGCTGCGGGCCACCCTCGACCACGCGGAGGCGGCGTCGCGGGCCGACGACGGCCCGCGCGAGACCGCCGCGCACACGGCGTTCCACGAGGGCATCGTGGCACTCACCGGCAACCCCCTGCTCGCGCGCACCATGGAACAGCTGAGCTGGCAGCTCCAACTACTCTTCGGCATGCACGCGGAACCGGACCACATGCGCTCCCAGCACCGCCTCGTCTACCGGCACATCGCCGCGGGCGACGAGGAAACATCGGCGGCGAGCACGCTGCTACACGTCCGGGACAGCAGGGCGGTGGCGCTGCGGGCGCTGGGCCTGGGCGGGGGCCTGGGCGGCGGGCCTGAGCGGGCGGGCTCCAGCGGCCGGGCCTGA	MASGTAGGTSGGAERTSLSAQAREAVRQRIVDRRYALGARLVEREVAEELRMSRVPVREALRALVAEGLLELLPHSGVRVRRLEPADVQHLYEVWEPLAVQASRLAARQVAESSPAEPPGLAALRATLDHAEAASRADDGPRETAAHTAFHEGIVALTGNPLLARTMEQLSWQLQLLFGMHAEPDHMRSQHRLVYRHIAAGDEETSAASTLLHVRDSRAVALRALGLGGGLGGGPERAGSSGRA	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	50.31	gnl|BL_ORD_ID|2355|hsp_num:0	1305			1065	1155	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
BGC0000703.1|Kanamycin_147 # 154378 # 155814 # 1 # ID=1_147;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.743	BGC0000703.1|Kanamycin_147 	154378	155814	+	Loose	600	31.9574	PRC-1	34.33	3007085	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	PRC beta-lactamase	TTGCGGTATACCAGCGACAACTTCCCCACCTCACCCCTGCCCGGAATTACCTCCCAATACCTCGCAAGCCCCTCCCCCACCCTTGCAGGCACCCCACCATTGGTATACAAACTGGCGGACGCGTCCACTCCGCTCGCCCTCCCCAGGAGTCACCAGATGTGCGTTGAGAACACCCCGCCACCCGCCTCCCGCCTCACCCGGCGCGGCATCCTCGCGGGTGCCGCGGCGCTGGCGGGCACCACGGCGGCGCTCTCGGCGGCGGCGCCGGCCGCATCGGCGAGTCCGCAGCGGGCCGAGCGTCGCGGAGTCGGCGGCGATCTCGTCATCGACGGCGGCACCCTGCTCGACCCCGCGACCGGCGACGTCACCGAGGACGCGGTGGTCGTCATCGTCGGCGGCGTGGTCCGCTCGGCGGGCGCGCGCGGCAGGGCACGGGTGCCCGAGGGCATCGACGTGCTCGACGCGCACGGCACGTGGGTCCTGCCGGGGCTCGTCGAGGCGCACATCCACCTGAACACCGCGGCCGAGGCGCGGGACGCCGTGCTCAAGGGCGCGACCACCGCCCGCAGCGGTTCGACCAACTTCTACCAGGACATCGCCGTACGGGAACTGGCCCGCCAGGCGCCCGAGCTCGCGCCCCGGCTGCGCGCCGCGGGCATCTTCGTCACGCCCGACCTCGGCGACACGATCCTCGCCGACCCGGACCTGACCCCGCTCGCCAGGCTCCGGGACGGCGTGCGCTCACCCGAGGCGCTGCGCCGCGTCGTCGAGGTCAATCTCGCCCGGGGCGCCGACGTCATCAAGACCCGCGTGAACGAGCGCGCCGGGCTGCCCGAGCAGGACCCGCTCGCCCAGGTGTACGACCGCGAGCAGCTGTCCACCGTCGTCGCGGCAGCCCGCCGCGGCGGCAAGGGCGTGCTCTGCCACAGCTACAGCGAGAAGGGCTGTCACGACGCGGTCAGGGCGGGCATCCGCTCGCTGGAGCACGGCGTGTTCGTCGGCGAGCGCACCCTGCGCGAGATGCGGCGCAGGGGTACGTACTTCACGCCGACGCTCACCGCCATCGCCGGTCTCGCCGACTCCGACGACCCCGTGCTCGCCGAGCGCGGCCGCACCTACCTGCCGGTGCTCAAGCGCGCGGTGCGCGCCGCCCACGAGCTCGGGGTGCCGCTCGCCGCGGGCACGGACTCGTCCGGCGGCACCGTGGACCCGATCGGCGGCGAGGTGGAACTGATGCGCGCGGCGGGCCTGCCCGCGCTCGACGCGATCCGCACGGCCACCACGGGCGCCGCGCGCCTCCTGGGTCTGCAGGGCACCTCGGGCCGCATCGCGCGCGGCTTCGCCGGTGACGCGATCCTCCTCGACGGCGACCCCCTGACAGACGTGTCGGTCCTCAAGAAGCCCGTCCGCGTGATCCGCGCGGGCATCCCGGTCTGA	MRYTSDNFPTSPLPGITSQYLASPSPTLAGTPPLVYKLADASTPLALPRSHQMCVENTPPPASRLTRRGILAGAAALAGTTAALSAAAPAASASPQRAERRGVGGDLVIDGGTLLDPATGDVTEDAVVVIVGGVVRSAGARGRARVPEGIDVLDAHGTWVLPGLVEAHIHLNTAAEARDAVLKGATTARSGSTNFYQDIAVRELARQAPELAPRLRAAGIFVTPDLGDTILADPDLTPLARLRDGVRSPEALRRVVEVNLARGADVIKTRVNERAGLPEQDPLAQVYDREQLSTVVAAARRGGKGVLCHSYSEKGCHDAVRAGIRSLEHGVFVGERTLREMRRRGTYFTPTLTAIAGLADSDDPVLAERGRTYLPVLKRAVRAAHELGVPLAAGTDSSGGTVDPIGGEVELMRAAGLPALDAIRTATTGAARLLGLQGTSGRIARGFAGDAILLDGDPLTDVSVLKKPVRVIRAGIPV	MRHLYRPLFVALALLAASHAPAAPSLETQVDAAAKSMMQTHAIPGMAIAISHKGQSHFFEYGVASLENGQTVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPALQGSAFDHISLLDLATYTSGGLPLQFPDTVSNERQMLDYYRNWQAVYPPGTQRLYSNPSIGLFGHLAAASLAKPFQQLMEKDLLPQLSMQESYVRIPTEQMEHYAWGYRDDKAVRVTPGALDAEAYGLKSTAADVLRFIDANLHPDQLPAPLRQAISATHRGYYQVGDMTQALGWERYAYPISLEKLQAGNSAEMALQPQTVARFAAPKPAEGDLLLNKTGSTNGFGAYILLLPARDTGLVILANRNYPNAERVRLALQLLDAIEP	126.12	gnl|BL_ORD_ID|4774|hsp_num:0	5769			150	345	cefazolin; ceftriaxone; amoxicillin; benzylpenicillin; ampicillin; cefotaxime
BGC0000703.1|Kanamycin_148 # 155844 # 157142 # 1 # ID=1_148;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.731	BGC0000703.1|Kanamycin_148 	155844	157142	+	Loose	670	27.335	Escherichia coli acrA	45.83	3004043	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGCCACTGTCCCGCCGCGGCATGCTCGCCGGAGCCGCCGCCCTGGCCGGCACGGGAGCCGCCGCCTCGTCCGCCTCGCCCGCCGCGGCCGCGTCCGGCGCGCGCGACGACAGGCGCCGCAAGGCCGTGGTCTTCCGCGACGTACGCCCCCTCGGCGCGCGGAAGGCCGTGGACCTGACGGTGGTCGACGGCAGGATCACCGGCGGCCGCGCGCCGCACGGCGCCGAGGTGGTCGACTGCGACGGACGCATCGCACTGCCCTCGCTCGTGGACGCCCACATCCACCCGGACAAGACCACCTGGGGCGGGGACTGGGTGACGCGGAAGCCCGCGAGCGGCATCGCCGACTACTGCGCGCAGGACGTGGAGCTGTTCAAGAGCCAGTCCCGTCCGGTCGGCGAGCGCGCGTACGGCCTGATGGCGCACGCCGTGACCCGTGGCACCCGCGCGATGCGCGCCCACGTGGACGTGGCGCCCGCCTACGACCTGGCCGGTGTGGAGGGCGTCAACACGGCCCGTGAACGCCTGCGGCACGCGCTCGACGTACAGATCGTGGCGTTCCCCCAGCACGGCGTCGTACGGACCCCGGGCACGGCCGAGCTCCTAGAGGAGGCGGCCCGCTCGGGGCAGGTCGACCTGGTCGGCGGCATCGACCCGATCAGCTTCGACCACGCCATGGACGAGCAGCTCGACCTGGTCTTCGGCCTCGCGGACCGGCACGGCGTGGGCGTGGACATCCACCTGCACGACCGGGACGAGAAGGGCACGAAGGTCCTGCGGGCCATCATCGACCGCACCCGCGCGCTGTCCCTGCGCGGCAAGGTCACGGTCAGTCACGTCTTCTGCCTGCCGAACCTGTCCGACCGCGAACTGGACGTCATGGCCGCCGACTTGGGCGACCTGGACATCTCCCTGACCACCGTGGCGCCCAACGAGTCACTGGTCCTGCCCATCGCGAAACTGCGCGAGCACGGGGTGCGGGTCGGGCTCGGTTCGGACGGGGTGCGCGACTCGTGGAGCCCGTTCGGCAACGCGGACATGCTGCACCGCACGCACATCCTCGGCTGGGTCACCGACGTGCGCCTGGACGAGGAACTCGCGGACTGCTACCGCGTGGGCGCGCACGGCGGCTCGGACGTCATGGGCCTGGACCGCGCCGACCTGGAGCCGGGCGCCCCGGCCGACTTCGTCCTGGTCCGCGCCGAGTGCCTGCCGCAGGTCGTGGTGGACATGCCGCAGCGGGACATGGTGGTGCACGGCGGCCGCGTCGTGGCCAGGAACGGGAAGCTGGTGTAA	MTPLSRRGMLAGAAALAGTGAAASSASPAAAASGARDDRRRKAVVFRDVRPLGARKAVDLTVVDGRITGGRAPHGAEVVDCDGRIALPSLVDAHIHPDKTTWGGDWVTRKPASGIADYCAQDVELFKSQSRPVGERAYGLMAHAVTRGTRAMRAHVDVAPAYDLAGVEGVNTARERLRHALDVQIVAFPQHGVVRTPGTAELLEEAARSGQVDLVGGIDPISFDHAMDEQLDLVFGLADRHGVGVDIHLHDRDEKGTKVLRAIIDRTRALSLRGKVTVSHVFCLPNLSDRELDVMAADLGDLDISLTTVAPNESLVLPIAKLREHGVRVGLGSDGVRDSWSPFGNADMLHRTHILGWVTDVRLDEELADCYRVGAHGGSDVMGLDRADLEPGAPADFVLVRAECLPQVVVDMPQRDMVVHGGRVVARNGKLV	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	108.82	gnl|BL_ORD_ID|2321|hsp_num:0	2661			879	951	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000703.1|Kanamycin_149 # 157201 # 159177 # -1 # ID=1_149;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000703.1|Kanamycin_149 	157201	159177	-	Loose	700	30.0314	DHA-29	24.19	3006470	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGGTGATCGTGAAGACCACCGTGCGCCGTGACGTACTGACCCTGCCCGCCGCCCCGTTGGGTCCGGAGAACCCCCTGCCCGCGCTGCGGCCGCTCGACGAAGTGCACACACTGGACGAGCGTGCCAAGGAAGGGCTGCCGCGCGACATGGCGCGCCAGCTCGGCTACGAGCCGCTGCGCGGCATCCTGCCCGTGCGGCTCGTCGACGGGTACGGCCGGGACCGCACCGAGACGCCGATCGACACGATCGTCATCGAGAACGACCGGCTGCGCGCCACCGTCCTGCCCGGCTACGGCGGCCGCGTCCACTCCCTCTTCCACAAACCCACAGGGCGCGAACTCCTCTACCGCAACCCGGTGTTGCAGCCCGCCGCCTTCGCGCTCAACGGCGCCTGGTTCTCCGGTGGCATCGAGTGGAACATCGGCGCCACGGGGCACACCACGCTGTCCTGCGCGCCGCTGCACGCCGCGCGTGTGACCGCGCCCGACGGCGGCGAGATGCTGCGCCTGTGGGAGTGGGAGCGGCTGCGCGACGTGCCCTTCCAGGTGGACCTGTGGCTGCCGGAAGGCTCCGACTTCCTGCACGTCGGCGTGCGGATCCGCAATCCGCACGAGAGGGCCGTGCCCGTCTACTGGTGGTCGAACATCGCCGTGCCCCAGGAGCGCAGGGTGCTCGCGCCCGCCGACGAGGCGTGGCGGTTCGCGTACGCGGGCGGCCTCGACCGGGTGCCGGTGCCGGAGTGCGACGGGGTCGACCGGACGTACCCGACGCGCAGCGAGTACCCCGCCGACTACTTCTACGACGTGCCGGACGACACCCGGCGCTGGATCGCCGCGCTCGACGCCGAGGGGCACGGGCTCGCGCAGACCTCGACGGACCGGCTGCGCGGCCGCAAGCTCTTCGTCTGGGGCACCGGCACCGGCGGCGGACGCTGGCAGGAGTGGCTCACCGAGCCGGGCACCCCGGGCTACGCCGAGATCCAGGCGGGCCTCGCGCGCACCCAGCTCGAACACGTACGCCTCGACGCCGAGAGCGAGTTCAGCTGGCTGGAGTCGTACGGGCCGCTGTCCGCGCGGCCCGACCTGGTGCACGGCGACGACTGGGACGGCGCGCGGGGCGAAGCCGCGGCGCGGCTCGCCGAAGCGCTGCCCCGCGAGGCCGTCGACGCCGCCTACGAGGCGTGGCTGACCTGCGCCGACACCGAGCCGGGCGAGTCGCTCGCCACCGGCTCGGGCTGGGGCGCCCTCGAAGTGCTGCGCGCCGAGTACAAGCTGTCGGGCACGCCCTTCGCCGAGTCGACGCTGGGCCCCGAGCAGGCGCCGTGGCTCGAACTGCTGCACACCGGGGCCGTGCCCGAGCCGCGCCGTGTCGCCCCGCCGGGACCGACCCTGGTGTCGCCGCACTGGCGCGACATGCTGGAGACCGCGCCCGCGCGTCCGCAGGCCGAGTACCACCTCGGGATCGCGCAGTGGCACGCGGGCGACCGGGCGCAGGCCGTCCGCAGCTGGGAGCGCGGCCTCGAACTGGCCCCGTCCCGCTGGCCGTTGCTGCGCTGTCTCGCCGTCGCCGACCAGACCGAGGGGCACGCGGAACGGGCCGCGGACAGTTACGCGGCCGCCTTCGACGACCTCTGCGAGGAGCGCAGGGACGACGGCGAACTCTGGACGGCGGCCACCGCGGCGCTCGGCAGGGAGGCGATGGCCGCGCTGCTCGCGGTGGGCCGGACCGAGGCGGCCCGCGCGGTGTGGGAGCGGCTCCACGCGCGGACGCGGACCGAAGGAAGGTTCCGCCTCGCCGAGGCCCAACTGCTCTTCGCCGAGGGCGACATGGACGGCGTGCGGGCGGTCTTCGACGAGGGCTTCGAGGCGGCCGACCTGCGGGAGGGCGCGGAGACCGTGGGCGAACTGTGGGCCGCGGCGACCGGCGAGGAGATAGCGGCGCGGTACGACTTCCGGATGCGGCCGCCGGGGGAGTGA	MVIVKTTVRRDVLTLPAAPLGPENPLPALRPLDEVHTLDERAKEGLPRDMARQLGYEPLRGILPVRLVDGYGRDRTETPIDTIVIENDRLRATVLPGYGGRVHSLFHKPTGRELLYRNPVLQPAAFALNGAWFSGGIEWNIGATGHTTLSCAPLHAARVTAPDGGEMLRLWEWERLRDVPFQVDLWLPEGSDFLHVGVRIRNPHERAVPVYWWSNIAVPQERRVLAPADEAWRFAYAGGLDRVPVPECDGVDRTYPTRSEYPADYFYDVPDDTRRWIAALDAEGHGLAQTSTDRLRGRKLFVWGTGTGGGRWQEWLTEPGTPGYAEIQAGLARTQLEHVRLDAESEFSWLESYGPLSARPDLVHGDDWDGARGEAAARLAEALPREAVDAAYEAWLTCADTEPGESLATGSGWGALEVLRAEYKLSGTPFAESTLGPEQAPWLELLHTGAVPEPRRVAPPGPTLVSPHWRDMLETAPARPQAEYHLGIAQWHAGDRAQAVRSWERGLELAPSRWPLLRCLAVADQTEGHAERAADSYAAAFDDLCEERRDDGELWTAATAALGREAMAALLAVGRTEAARAVWERLHARTRTEGRFRLAEAQLLFAEGDMDGVRAVFDEGFEAADLREGAETVGELWAAATGEEIAARYDFRMRPPGE	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLLVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSLGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	173.61	gnl|BL_ORD_ID|3513|hsp_num:0	4582			585	858	
BGC0000703.1|Kanamycin_151 # 160148 # 160693 # -1 # ID=1_151;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.701	BGC0000703.1|Kanamycin_151 	160148	160693	-	Loose	200	25.409	AAC(6')-Iap	36.51	3007204	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTCCGACCACGCAAGTTATCTCGCCGAAGGCCCCCGCGTGGGCATACGTCACTTCACCCACGCGGACTCCGCCGAGTTCACCGCCCGTACGCGAGAGAGCCAGGACCTGCACAGGCCCTGGCTCTTTCCGCCGTCGGGCGACGACGCCTACCGCGCGTACGCCCGGGTGCTCATCGAGGACCCGACGAAGGCCGGGTTCCTGGTCTGCGAGCGCGACAGCGGCGCCATCGGCGGCTTCATCAACATCAACAACATCGTCCGGAGCGCGTTCCGCTGCGGCGCCCTGGGATACGGCGCGTTCGCGCACGCCGCGGGGCGCGGTCTGATGTCCGAGGGGCTCGACCTCGTCACGGCGTACGCCTTCGGAGCCCTCGACCTGCACCGCCTGGAGGCCAACATCCAGCCGGGGAACGCCGCCTCCATCGCGCTCGTCCGACGCGGCGGCTTCCGGCTCGAGGGCTTCTCGCCGGACTTCCTCTTCATCGACGGGGCCTGGCGCGACCACGAACGCTGGGCCGTCACCGCCGGTCCCGAAAGGTCTTGA	MSDHASYLAEGPRVGIRHFTHADSAEFTARTRESQDLHRPWLFPPSGDDAYRAYARVLIEDPTKAGFLVCERDSGAIGGFININNIVRSAFRCGALGYGAFAHAAGRGLMSEGLDLVTAYAFGALDLHRLEANIQPGNAASIALVRRGGFRLEGFSPDFLFIDGAWRDHERWAVTAGPERS	MSGCAATIRQATPADAAAWSQLRVGLWPDADDPLEELAQSLADPEGAVFLACAADGEAVGFAEVRLRHDYVNGTGSSPVGFLEGWYVTPQWQGRAVGRALLAEVQAWTRDAGCSELASDSRLEDLEAHAAHRACGFVETERVVYFRMPLDAVTRG	116.77	gnl|BL_ORD_ID|4831|hsp_num:0	5817			21	180	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000703.1|Kanamycin_152 # 160737 # 161219 # -1 # ID=1_152;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000703.1|Kanamycin_152 	160737	161219	-	Loose	450	23.483	rmtD	52.38	3002667	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCGCGGCACCGCCGCGCTCGCCTTCGCCGCCCTGCCCCTCCTCGCCACCTCACAGTCCGGCTACGCGGCCGATCACGCGCCGGAACACGCGTCCGCGGCCGGGCCACGGGCCGACTTCGACATCCGCAGCGCCCTGCACGACAAGTGCCTGGCCACCAACGGCGACAACGTAGAAGTGCAGACCTGCCGGGGCACCGGCAATCAGCTCTGGTTCTGGGAGGGCGGAAAGCTGCGCAATCGCGCGGAGCTGCACTGCCTGGACGTACGCAACGGAGAGATCGACGCCCCGGCCCAGGCGGTCGGCGACTGCCACGGCCTGGCCAACCAGCAGTGGAAGCTGGAGGGTTCGTGGCTGCGCTCCGGAGTGAACCGCCAGTGTCTGAGCATCCAGGAGAACGGCGACCCGAGCGAGCACGCGGGAATCAACGTGCGGGACTGCGCGAACGTGGCCTGGCAGTTCTGGAAGATGCCCCCGGAGTGA	MRGTAALAFAALPLLATSQSGYAADHAPEHASAAGPRADFDIRSALHDKCLATNGDNVEVQTCRGTGNQLWFWEGGKLRNRAELHCLDVRNGEIDAPAQAVGDCHGLANQQWKLEGSWLRSGVNRQCLSIQENGDPSEHAGINVRDCANVAWQFWKMPPE	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREYKRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYLAHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQRAGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	64.78	gnl|BL_ORD_ID|1702|hsp_num:0	1843			495	558	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000703.1|Kanamycin_153 # 161373 # 161699 # -1 # ID=1_153;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.743	BGC0000703.1|Kanamycin_153 	161373	161699	-	Loose	725	24.6386	SRT-2	39.29	3002494	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	GTGAGGGTGTCAGTGAAGCCGCGGCTGCGGCGCGCGGGCGTGGTGGTGGGCGGCGCGGCCGCGGCGACCCTGCTGGCGGTGACCACGGCGGCCGCGGCGGGGCCGCCGATGCCGGAGCTCCGGGGGCGGGGCCTGATGCACGTCTTCTCGACCCTCGACTACCGCACGCGCGTCGACGTGCGGGACGTCAGCGGCGCCCACCGGCACGTCCTGTGGCCGCTGAGCTGGAAGGTGTGCACGCAGTCCCCGGCCGCCGGTCAGCAGTTCGACCGAGGTCCCGTCGCCATCGGCGTCGTGAAGAACGGCGAGAGGTGCCCGAAGAAGTAG	MRVSVKPRLRRAGVVVGGAAAATLLAVTTAAAAGPPMPELRGRGLMHVFSTLDYRTRVDVRDVSGAHRHVLWPLSWKVCTQSPAAGQQFDRGPVAIGVVKNGERCPKK	MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYHIVQALEKR	28.57	gnl|BL_ORD_ID|1735|hsp_num:0	1878			891	975	
BGC0000703.1|Kanamycin_154 # 161696 # 161941 # -1 # ID=1_154;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.675	BGC0000703.1|Kanamycin_154 	161696	161941	-	Loose	275	25.0238	AAC(6')-Ii	39.29	3002556	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGCCCCAACACCTCCACGGGCGGCTCCAAGAGCAGCGGCCAGGGCGGCGGGCTGATGACACCCGGCAGGGTGGCCGTCGCCGCGATCGCCGTCCTCACCCTGGTCTTCATCTTCGAGAACACCCGCAGCACCAAGATCCGACTGCTGATCCCCGAAGTGACTCTGCCGCTGTGGATGGCGCTGCTCGGCACGGCCCTGATCGGTGCTCTGTGCGGGGCCTACTTCGTCAGGAGGCGCAAGTGA	MSPNTSTGGSKSSGQGGGLMTPGRVAVAAIAVLTLVFIFENTRSTKIRLLIPEVTLPLWMALLGTALIGALCGAYFVRRRK	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	44.51	gnl|BL_ORD_ID|1042|hsp_num:0	1050			87	171	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000703.1|Kanamycin_155 # 162063 # 162194 # -1 # ID=1_155;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.750	BGC0000703.1|Kanamycin_155 	162063	162194	-	Loose	700	20.4014	OCH-3	42.11	3002516	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	TTGTCCCGTCGCCACGCCCGCACCGGCGGGCGCGACGGGGCGTACGGCGGGAACAAGGGAGTCAAGCCGGTCACGGTGACCGGCGCGCCCGAGGGCACCGGCGTCCTCGACCTGCCCGTCGTCAACCACTGA	MSRRHARTGGRDGAYGGNKGVKPVTVTGAPEGTGVLDLPVVNH	MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAPELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSGGALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFYNYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKIGIVLLANRNYPIDERVKAAYRILQALDNKQ	11.03	gnl|BL_ORD_ID|183|hsp_num:0	201			666	723	
BGC0000703.1|Kanamycin_156 # 162276 # 163220 # -1 # ID=1_156;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.745	BGC0000703.1|Kanamycin_156 	162276	163220	-	Loose	500	29.6462	CTX-M-84	29.24	3001945	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGAGACCGCTCGACCGGCCCGCGCGCCTCGTTCCCGGCGCGCGGGTGGCCGTCGTGGCGCCCAGCGGTCCGGTGCCCGAGGACGCGCTCCAGGCGGGCCTGGACATCCTGCGCGGCTGGGACCTCGACCCGCTCGTCATGCCCCATGTCCTGGACCGGCACCCGGAGTTCGACTATCTCGCTGGCGCGGACGCCGCCCGCGCCGAGGACCTGACGCGGGCGTGGTGCGACCCGTCGGTGTCCGCCGTGTTCTGCGCCAAGGGCGGGTACGGATCGCAGCGGATGGTGGACCTCGTCGACTGGTCCGCGATGCGGGAGGCGACGCGGAGCGGCGGGCCGAAGGTGTTCCTCGGCTACAGCGACATCACCCCGCTGCACGAGGCCTTCGCCAACCGGCTCGGTGTCGCCACGCTGCACGGGCCCATGACGGGCGTGCTCGACTTCCTCAAGAACGCGCGGACCCAGGAGCACCTGCGCACCACGCTGTTCGCGCCGCGGGACGCCCAGGTGATCCGCGCCGCGTCCCCGGACGCCCGCGCGCTGGTCGGCGGCCGGGCCAGGGGCGTCACGCTCGGCGGCTGCGTGTCGCTGCTCGCCGCCGAACTCGCCACCCCGCACGCGCGGGCGTCCGCGCGCGGCGGCCTGCTCTGCATCGAGGACATCGGGGAAGAGGCGTACAGCCTGGACCGAATCCTCACCCAACTCCTGCGCGCCCGCTGGCTGGAGGGCGTCGCGGGCATCGTGCTCGGCTCCTGGAAGGAGTGCGAGCCCCACGACGAGGTGCGGGCGCTCCTCGCCGACCGGCTCGGCGGCCTCGGCGTGCCGGTGCTTTCGGAGTTCGGGTTCGGGCACTGCGACGGGGCGCTGACGGTGCCGTTCGGGGTGCCGGGCGAACTGGACGCGGACGCGGGGACGTTGACGCTGGACGTGCCCGCGCTCGTGTGA	MRPLDRPARLVPGARVAVVAPSGPVPEDALQAGLDILRGWDLDPLVMPHVLDRHPEFDYLAGADAARAEDLTRAWCDPSVSAVFCAKGGYGSQRMVDLVDWSAMREATRSGGPKVFLGYSDITPLHEAFANRLGVATLHGPMTGVLDFLKNARTQEHLRTTLFAPRDAQVIRAASPDARALVGGRARGVTLGGCVSLLAAELATPHARASARGGLLCIEDIGEEAYSLDRILTQLLRARWLEGVAGIVLGSWKECEPHDEVRALLADRLGGLGVPVLSEFGFGHCDGALTVPFGVPGELDADAGTLTLDVPALV	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVAWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	107.90	gnl|BL_ORD_ID|1467|hsp_num:0	1604			309	795	
BGC0000703.1|Kanamycin_157 # 163217 # 165217 # -1 # ID=1_157;partial=00;start_type=ATG;rbs_motif=GGGGGA;rbs_spacer=10bp;gc_cont=0.749	BGC0000703.1|Kanamycin_157 	163217	165217	-	Loose	600	32.3426	EstT	28.99	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGATGCAGACCCGGGCGTACGGATCATGGCCGTCACCCATCGACGCCGAGCTCGCCGCCGCCCACGACGGCGCGCCGGGGTTCGCGGGATTCGTCGGCGCCGAGGCGTGGTGGACCGAGCCACGGCCCGTCGAGGCCGGACGGCGCGCGCTGGTGCGGCGGCTGCCCGACGGAACGGAGCAGTCCGTGCTGCCGGCCCCGTGGAACGTGCGCAGCAGGGTCATCGAGTACGGCGGCCGCCCCTGGGCGGGCGCCGAGGGGCCCGAAGGCCCGCTCGTGGTCTTCGTGAACTTCGCCGACCAGCGCCTGTACGCGTACGAACCCGATGCCCCAGGTGGCGGCCGCGGTGCGGGACCGCGCCCCCTGACCCCGCTCTCCGCCGTGGGCGGCGGGCTGCGCTGGGCCGATCCGGTGCTGCGCGCGGAGCGTGGCGAAGTGTGGTGCGTCCTGGAGGAGTTCACCGGTCCCGCGCCCACCGACGTGCGCCGCGTCATCGCCGCGGTGCCGCTCGACGGCTCGGCGGCCGACGACCGGGGCGCGGTGCGCGAACTCTCCGACGACCGGCACCGGTTCGTCACCGGACCGCGGATCTCGCCCGACGGCACCCACGCGGCCTGGCTCGCCTGGGACCATCCGCGGATGCCGTGGGACGGCACCGAGCTGATGCTCGCCGAGCTGCGGCCCGACGGCACCTTCGGTGCGGCGCGCGTGTTCGCGGGCGGCCCCGAGGAGTCCGTCGCCCAGGTGGAGTGGGCGCCGGACGGGCGGCTGCTCTTCGCCAGCGACCGCACCGGCTGGTGGAACCTGTACCGCGCGGCACCCGACGACAGCGCCCGCGCCCACGCGCTCTGTCCGCGCCAGGAGGAGTTCGCGGGGCCGCTCTGGATGATCGGCCTGAGCTGGTTCGCGCCGCTGGAGAGCGGTCTGATCGCCGTCGTGCACGGCAAGGGCGCCACCGCGCTCGGCATACTCGACCCCGAGACCGGCGAGGTCGTCGACGCGGCGGGCCCCTGGACGGAGTGGGCGGCCACCGTCGCCGCGCACGGGTCCCGCGTCGTCGGCATCGCGGCGAGCCCGCGCAGCGCGTACGAAGTGGTGGAACTGGACACCGGCACAGGACGCGCCCGCGTGATCGGCGCCGCCCACGACGACCCGGTGGACGCCACGTACTACCCGGAACCGCGGATCCGCACCTTCGCGGGCCCCGCGGGACGCGAGATCCACGCCCACGTCTACCCGCCGCACCACCCGGGCCACGTCGCCCCCGACGACGAACTGCCGCCCTACGTGGTGTGGGCGCACGGCGGGCCCACCAGCCGCTCGCCGCTCGTGCTCGACCTGGCCATCGCCTACTTCACCTCGCGCGGCATCGGCGTCGCCGAGGTCAACTACGGCGGCTCCACCGGGTACGGGCGTGCCTACCGCAACCGGCTGCGCGAGCAGTGGGGCAGCGTCGACGTCGACGACTGCGCGGCCGTCGCCCTCGCCCTCGCCGACGAGGGGACCGCCGACCGCAGCCGCCTCGCGATCCGCGGCGGCAGCGCGGGCGGCTGGACCACGGCGGCCTCGCTGACCAGCACCGACGTCTACGCCTGCGGCACCATCATCTACCCGGTCCTCGACCTCACCGCGTTCGCGTCCGGGGAGACCCACGACTTCGAGTCGCGGTACCTGCACTCCATCGTGGGCCCGCTCGACGAGGTGCCGGGGCGGTACGCGGAGCGCTCGCCGGTGACCAGGGCCGACCGGATCACCACGCCGTTCCTGCTCCTCCAGGGGCTCGACGACGTGATCTGCCCGCCCGCGCAGGCCGAGCGGTTCCTCGCCAGGATCGAGGGGCGCGGCGTCCCGCACGCCTACATCGCCTTCGAGGGGGAGGGGCACGGTTTCCGCCGCGCCGACACCATGATCCGCGCCCTGGAGGCCGAACTGTCCCTGTACGCCCAGGTGTTCAGGATCGACCTCGCCGGACGCGTGCCGACCCTGGAGCTCGCCAAGTGA	MMQTRAYGSWPSPIDAELAAAHDGAPGFAGFVGAEAWWTEPRPVEAGRRALVRRLPDGTEQSVLPAPWNVRSRVIEYGGRPWAGAEGPEGPLVVFVNFADQRLYAYEPDAPGGGRGAGPRPLTPLSAVGGGLRWADPVLRAERGEVWCVLEEFTGPAPTDVRRVIAAVPLDGSAADDRGAVRELSDDRHRFVTGPRISPDGTHAAWLAWDHPRMPWDGTELMLAELRPDGTFGAARVFAGGPEESVAQVEWAPDGRLLFASDRTGWWNLYRAAPDDSARAHALCPRQEEFAGPLWMIGLSWFAPLESGLIAVVHGKGATALGILDPETGEVVDAAGPWTEWAATVAAHGSRVVGIAASPRSAYEVVELDTGTGRARVIGAAHDDPVDATYYPEPRIRTFAGPAGREIHAHVYPPHHPGHVAPDDELPPYVVWAHGGPTSRSPLVLDLAIAYFTSRGIGVAEVNYGGSTGYGRAYRNRLREQWGSVDVDDCAAVALALADEGTADRSRLAIRGGSAGGWTTAASLTSTDVYACGTIIYPVLDLTAFASGETHDFESRYLHSIVGPLDEVPGRYAERSPVTRADRITTPFLLLQGLDDVICPPAQAERFLARIEGRGVPHAYIAFEGEGHGFRRADTMIRALEAELSLYAQVFRIDLAGRVPTLELAK	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	217.65	gnl|BL_ORD_ID|4956|hsp_num:0	5948			720	915	tigecycline
BGC0000703.1|Kanamycin_158 # 165241 # 166611 # -1 # ID=1_158;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.709	BGC0000703.1|Kanamycin_158 	165241	166611	-	Loose	500	25.7942	rmtE2	26.19	3004679	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGGCTGACCAGCAGCAGGATCAGGAGCAGGCTCAGGAGTCGGACCACGACCCCTCGGTGGACGCCCGCGCCCTCGACGAGGTCGTGGCGTTCACCTCCGAGCTCATCCGCATCGACACCACCAACCGCGGCAGCGGCGACTGCCGCGAGCGGCCCGCCGCCGAGTACTGCGCCGAGCGGCTCGCCGACGCGGGCCTGGCCCCCGTCCTCCTGGAGCGCACCCCGGGACGCACCAACGTCGTCGCCCGCATCGAGGGCACCGACCCGTCGGCCGACGCGCTGCTCGTCCACGGCCACCTGGACGTGGTGCCCGCGCAGGCCGCCGACTGGAGCGTGGACCCCTTCTCCGGGGAGATCCGCGACGGCGTCGTCTGGGGCCGCGGCGCGATCGACATGAAGAACATGGACGCGATGATCCTCTCCGTCGTACGGGGCTGGGCACGCGCCGGAGTGCGGCCCAGGCGGGACATCGTGATCGCCTTCACCGCCGACGAGGAGGCCAGCGCCGAGGACGGCTCGGGATTCCTCGCCGACCAGCACGCCTCGCTCTTCGAAGGCTGTACGGAAGGCATCAGCGAGTCGGGGGCCTTCACCTTCCACGACGGGCGTGGCAACCAGATCTACCCCATCGCGGCGGGCGAGCGCGGCACCGGCTGGCTCAAACTCACCGCGCGCGGCACCGCGGGCCACGGCTCGAAGGTCAACCGCGCCAACGCCGTGAGCAGGCTCGCCGCCGCCGTCACCCGCATCGGGGAGTACCGCTGGCCGGTGCGGCTCACCCCGACCGTGCGGGCCTCGCTGGTCGAACTCGCCACGCTCTACGGCCTGGAGACCGACCCGGAGGCGCCCGGATTCGACGTCGACGCGCTGCTCGAGAAGCTCGGAACGACCGCCGACCTCGTCGAGCCGACCGTCCGCAACAGCGCCAACCCGACGATGCTGCAGTCGGGCTACAAGGTCAATGTGGTCCCCGGGGAAGCCGTGGCCTATGTCGACGGCCGCTTTCTGCCCGGCGGCGAGGAAGAGTTCCGCCGCACGCTTGACCGGCTCACGGGCCCTGACGTCGACTGGGAGTTCCACCACCGCGAGGTGGCACTGCAGGCGCCGGTCGACTCGCCGACGTACGCGAAGATGCGTGCGGCCGTCGAGGAGTTCGCGCCAGAGGGGCACGTCGTGCCGTACTGCATGTCGGGCGGCACGGACGCCAAGCAGTTCTCTCGGCTCGGCATCACCGGCTACGGCTTCTCGCCGCTGAGGACACCGGAGGACTTCGACTACCAGGCGCTCTTCCACGGGGTCGACGAATGCGTCCCCGTCGACGCACTGCACTTCGGCGTCCGTGTCCTCGACCGCTATCTGCGTACGGCCTAG	MADQQQDQEQAQESDHDPSVDARALDEVVAFTSELIRIDTTNRGSGDCRERPAAEYCAERLADAGLAPVLLERTPGRTNVVARIEGTDPSADALLVHGHLDVVPAQAADWSVDPFSGEIRDGVVWGRGAIDMKNMDAMILSVVRGWARAGVRPRRDIVIAFTADEEASAEDGSGFLADQHASLFEGCTEGISESGAFTFHDGRGNQIYPIAAGERGTGWLKLTARGTAGHGSKVNRANAVSRLAAAVTRIGEYRWPVRLTPTVRASLVELATLYGLETDPEAPGFDVDALLEKLGTTADLVEPTVRNSANPTMLQSGYKVNVVPGEAVAYVDGRFLPGGEEEFRRTLDRLTGPDVDWEFHHREVALQAPVDSPTYAKMRAAVEEFAPEGHVVPYCMSGGTDAKQFSRLGITGYGFSPLRTPEDFDYQALFHGVDECVPVDALHFGVRVLDRYLRTA	MNIDEMAAEVLSSKKYTSVDPAVVRRVCMETAPKYPKKKEAIKAVKNELHIIHEVFLQNECYKNALSFLSQLSLDFNNAQLIDITMQIMQSHTSTKERLGDIEAVCSFLSTHISKEGSVMDIGCGFNPFALPLLHEFPATYYAYDICSEGINILNKYFSILKKGEYRAELLDAVSVTPKEKVDVALLFKLLPLLQQQKKGRGFSILEELDFDKAIVSFPIKSLGGKQKGMETFYSNLFEENLPSSLEIIEKQTFSNEMFYVIQNKTKNGGNQS	167.03	gnl|BL_ORD_ID|2268|hsp_num:0	3378			366	474	amikacin; kanamycin A; gentamicin A; gentamicin
BGC0000703.1|Kanamycin_159 # 166604 # 167437 # -1 # ID=1_159;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.703	BGC0000703.1|Kanamycin_159 	166604	167437	-	Loose	740	26.9498	tet(30)	36.36	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGATCCTCATCAGCGCCGACATGGAGGGCGCCACGGGAGTGACCTGGCCGGCCGACGTGCTGCCGGGCACCGCTCAATGGGAGCGGTGCAGGGCGATGTTCACCTCGGACGTCAACGCCGCCGTGCTCGGCTTCTTCGACGGCGGCGCCGACGAGGTGCTCATCAACGAGGCGCACTGGACCATGCGCAACCTGCTCCTCGAAGAGCTGGACGAGCGGGCCGAGATGCTCACCGGGCGGCACAAGTCGCTGTCCATGGTGGAGGGCGTGCAGCACGGTGACGTGGACGGCATCGCGTTCATCGGCTACCACGCGGGCGCCGGCATGGAGGGCGTCCTCGCGCACACCTACCTGGCCAACCAGATCACCGGCGTGTGGCTCAACGGCGTGCGCGCCAGCGAGGGGCTCCTGAACGCGCGCGTCGTCGCCGAGTACGGCGTCCCCGTCGTGCTCGTCACCGGCGACGACCTCGCCTGCGAGGACGCGCTCGGCTACGCGCCGGGCGCGCTGAAGGTCGCCGTGAAGGACCACGTCTCGCGGTACGCGGCGGTCTGCCGCACCCCGGCCCGCACCGCCGCCGACATCAGGTCGGCGGCGAAGGAGGCGGCGGGACTCGCGGTACGCGGGGAACCGGCGGCCGACGGGCCGTTCACCGTGGAGGTCGAGTTCGACGCGGAACACCTGTCGATGGCGGCGACCGTGGTGCCCGGTGTGCGCCGTACGGGGGAGCGCAAGGTCGCCTATGTCAGCGAGACGATGTACGAGGGGATCCGTACCTTCAAGGCGGTTACCACGATCGCCTCTGCCGCCGTGGAGGAGCAGTATGGCTGA	MKILISADMEGATGVTWPADVLPGTAQWERCRAMFTSDVNAAVLGFFDGGADEVLINEAHWTMRNLLLEELDERAEMLTGRHKSLSMVEGVQHGDVDGIAFIGYHAGAGMEGVLAHTYLANQITGVWLNGVRASEGLLNARVVAEYGVPVVLVTGDDLACEDALGYAPGALKVAVKDHVSRYAAVCRTPARTAADIRSAAKEAAGLAVRGEPAADGPFTVEVEFDAEHLSMAATVVPGVRRTGERKVAYVSETMYEGIRTFKAVTTIASAAVEEQYG	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	70.30	gnl|BL_ORD_ID|1790|hsp_num:0	1917			477	576	tetracycline
BGC0000703.1|Kanamycin_161 # 167984 # 169147 # -1 # ID=1_161;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.729	BGC0000703.1|Kanamycin_161 	167984	169147	-	Loose	600	25.409	rgt1438	29.17	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGAACGACCATCCCACAACACCTCGCCACAAGAGGCCGTCCCCGAGCAGGCGCACGTTCCTGACGGCGGCCGCGGCGGCCACCGCGGGCGCGGCCCTGGTGGGCGCCGAGGCCTGGGCCGGATCCACGCCGGGGCCGCGCGGGGCGGCCCGGGCGGGCTCCTTCGCCGTCCCCGCCGAGGACGTCAGGCACACCAAGACGTGGATGGCCTGGCCGGACAGCAGCGCGATCTGGGGGCGCCAACTCGGCGGGGTCCAGGCCGACATAGCCCTCATCGCGCGGACGGTCGCCAAGCACGAGCCCGTCACCCTGTGCGCCAACCCGGCGAGCGCCGCCAAGGCCCGCTCCCTATGCGGGAGTTCGGTCGAGATCATCACCTCCGTGCCGGTCGACGACTGCTGGATGCGCGACTCGGGACCGGTGTTCCGCACCGACGGCGCGGGCGGCCTCGACGCGGTCGGGCTGCACTTCAACGGCTGGGGCGGCAAGCAGCAGCACGCCAAGGACGCGCGCGTCGCCGAGCGGATCGCCGCCCTGGCCGGGGTGAGGTTCACCGGCGCGGGCCTGGTGGGCGAGGGCGGCGCGATCGAGCAGGACGGCGCGGGCACCCTGATGGCCACGCGCAGCAGCCTCCTCAACGGCAACCGCAACCCCGGGATGTCCGAGGCGCACCTTACCGACGCGATGTGCGAGGCGTACGGCGCCGACCAGGTCATCTGGTTCGACGGCGTGCGCGGCCAGGACATCACCGACGACCACGTCGACGCCACCTCGCGCTTCCTCGCCTCCGGCAGGGCGCTCGTGCAGTGGCCCCTGGACGCGGACGACGACGCGTACGCCAAGGACGCCCGCGCACAGTTCCGGGTCCTGTCCGCCGCCACGAACGCCGAAGGACAGCCGATCGCGGCGACCAAGCTGCAGGGCCCCGACTACGACAAGATCCGTTCCAGGGACCCGAAGTTCCTCGCCTCGTACGCCAACTACTACCTCTGCAACGACGCGGTGATCTGCGCGCACTTCGGCGATTCCACGGCGGACGCGGCGGCGAAGGCGGCGCTCGCCCGGCTGTACCCGGGGCGGACCGTCGAACAGATCGACATCGACAGGCTCGGCGCGGGCGGCGGCGGAATCCACTGCGTCACCCAGCAGCAGCCCGCGCCGTGA	MNDHPTTPRHKRPSPSRRTFLTAAAAATAGAALVGAEAWAGSTPGPRGAARAGSFAVPAEDVRHTKTWMAWPDSSAIWGRQLGGVQADIALIARTVAKHEPVTLCANPASAAKARSLCGSSVEIITSVPVDDCWMRDSGPVFRTDGAGGLDAVGLHFNGWGGKQQHAKDARVAERIAALAGVRFTGAGLVGEGGAIEQDGAGTLMATRSSLLNGNRNPGMSEAHLTDAMCEAYGADQVIWFDGVRGQDITDDHVDATSRFLASGRALVQWPLDADDDAYAKDARAQFRVLSAATNAEGQPIAATKLQGPDYDKIRSRDPKFLASYANYYLCNDAVICAHFGDSTADAAAKAALARLYPGRTVEQIDIDRLGAGGGGIHCVTQQQPAP	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	94.16	gnl|BL_ORD_ID|116|hsp_num:0	134			1002	1194	rifampin; rifaximin; rifabutin; rifapentine
BGC0000703.1|Kanamycin_162 # 169220 # 170053 # -1 # ID=1_162;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.753	BGC0000703.1|Kanamycin_162 	169220	170053	-	Loose	500	95.5153	RanA	28.16	3005091	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCCTGAGCCCACCGAGACCTCTCGGCCCGCCGACGCGCACGTGCTTGAGGTGCGCGGACTGCGGCGCAGCTTCGGCGAGGTCGCGGCCGTGGACGACGTGTCCTTCGCGGTGCCCGATGGCGGGTCCCTCGGCGTCGTCGGGGAGTCCGGCTCCGGCAAGACCACCACGGCCCGGATCATCGTCGGCCTGGAGCGGGCCGACGCGGGGGAGATCCAGGTGCGCGGCAGGCCCCGCACCGCACGCGTCCGCGGCCGCGCGCAGCGTCTGGCCAGGGCCCGCGAGGTGCAGATGGTCTTCCAGGACCCCTACCTCTCCCTCGACCCGCGCACGAGCGTCGAGTCGGTGCTGCGCGAAACGCTGCGCCTGCACTTCCCCCGCATCGACCACGCCCGGCGGGTGCGCGAACTCCTCGACCAGGTCGGCCTCGGCACCCGCGCCGCCGACGCGCTGCCCCGCCAGCTCTCCGGCGGGCAGCGCCAGCGCGTCGCCATCGCGCGGGCCCTGGCCGTGGAGCCCGCGGTGCTCGTCCTGGACGAGGCGGTCGCCGCGCTCGACGTGTCGGTGCAGGCACAGATCCTCAACCTGCTCGCCGACATCCGCGAACGCACCCCGATCGGCTACCTCTTCATCACCCACGACCTCGGCGTGGTCCGCTGCGTCACGGACGACGTCATCGTGATGCGCCACGGCGCCGTGGTCGAGGCGGGCGCCACCGCCGACGTCCTCGCCGCGCCCGCGCACCCGTACACCCGGCTGCTCCTGGACTCCGTCCCGCACCCGGGCTGGGACCCGGAGCGCATCGCGGCGGCCCGCCGGGCCCTCACCCTCTGA	MPEPTETSRPADAHVLEVRGLRRSFGEVAAVDDVSFAVPDGGSLGVVGESGSGKTTTARIIVGLERADAGEIQVRGRPRTARVRGRAQRLARAREVQMVFQDPYLSLDPRTSVESVLRETLRLHFPRIDHARRVRELLDQVGLGTRAADALPRQLSGGQRQRVAIARALAVEPAVLVLDEAVAALDVSVQAQILNLLADIRERTPIGYLFITHDLGVVRCVTDDVIVMRHGAVVEAGATADVLAAPAHPYTRLLLDSVPHPGWDPERIAAARRALTL	MIEVKDLRKSFNDVEVLKGITTTFETGKINLVIGQSGSGKTVFLKCLLNVFDPSSGDILFDGRNLSIMGRTEKQEIRSEIGTVFQGSALFDSMTVEENISFPLDMFTNLTYTEKRKRVKEVIGRVHLENANTKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAIVIDELIKEITEEYNTTTIINTHDMNSVLTIGEKIVYLRKGVKEWEGNKDLIIKAENEHLIDFVYSSALFKQVRETMLRNNQTNL	107.36	gnl|BL_ORD_ID|2808|hsp_num:0	3825			0	711	
BGC0000703.1|Kanamycin_163 # 170046 # 171050 # -1 # ID=1_163;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.745	BGC0000703.1|Kanamycin_163 	170046	171050	-	Loose	650	84.3445	tetA(58)	34.82	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCACCGCGCCCATCCCGGAGCACGTGCTCGACATCCAAGGCCTTCGCATCACCCTGCCCGGCACGGCCCGCCCCGTCCTGGACGGCGTCGACCTCACCGTCGCCGCGGGCGAGACCGTCTCCCTCGTGGGCGAGTCGGGCTCGGGAAAGACCCTCACCTCGCGCAGCGCGCTGCGCCTGCTGCCGCCCGGCGCCGTCACCGAGGGCGCCGTCCGCGTCAACGGCGACGACGTCCTCACGATGGACGAAGGACGGCTGCGGGCCCTGCGCACCGGCACCGCCGCCATGGTCTTCCAGGACCCGCGCGCCGCCCTCAACCCGCTGCGCCGCATCGGCGACTTCCTCACCGAGAGCGTCCGGACCGAGAGCGTCCGCACGACGCGCCGCGCCGACGCCACCGCCCGTGCCACCGAACTCCTCCACGCCGTCGGCCTGGACGCGAGTGTCCTGCACAAGTACCCCGGCCAGGTGTCCGGCGGCATGCTGCAGCGCGTCATGATCGCCGCGGCCCTCATGGGCGACCCCGCCCTGCTGCTCGCCGACGAACCCACCACCGCCCTGGACGTCACCACCCAGGCCGAGGTCGTCGCCCTCCTCGCCCGGCTGCGCGAACGGTTCGGCACCGGACTGCTCTTCGTCACCCACGACCTCGACCTGGCCGCGGCCATCAGCGACCGCGTCTACGTCATGTACGCGGGCCGGATCGCCGAACAGGGCCCCGCCGACGAGCTGTTCGCCCACCCCAGGCACCCCTACACCGCGGCCCTGCTGGCCGCCACGCCGCGTCTGGAGACGGCGAAGGGACGGCTCAGCGCCATCGAGGGCCAGCCACCCGATCTGCGCACGGCCCTGACCGGCTGCGCCTTCGCCGCCCGCTGCGCGATCGCCACCGAGGTGTGCGACGAGCGGGCGCCACGGCCCAGGACCGCCCCGGGACGCCCGGAGCACCTCGCCGCCTGCCACCACAGCGACCGGCTCGAAGGGAGCGCCGCCGATGCCTGA	MTTAPIPEHVLDIQGLRITLPGTARPVLDGVDLTVAAGETVSLVGESGSGKTLTSRSALRLLPPGAVTEGAVRVNGDDVLTMDEGRLRALRTGTAAMVFQDPRAALNPLRRIGDFLTESVRTESVRTTRRADATARATELLHAVGLDASVLHKYPGQVSGGMLQRVMIAAALMGDPALLLADEPTTALDVTTQAEVVALLARLRERFGTGLLFVTHDLDLAAAISDRVYVMYAGRIAEQGPADELFAHPRHPYTAALLAATPRLETAKGRLSAIEGQPPDLRTALTGCAFAARCAIATEVCDERAPRPRTAPGRPEHLAACHHSDRLEGSAADA	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	97.38	gnl|BL_ORD_ID|2243|hsp_num:0	2517			96	705	tetracycline
BGC0000703.1|Kanamycin_165 # 171898 # 172857 # -1 # ID=1_165;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=7bp;gc_cont=0.710	BGC0000703.1|Kanamycin_165 	171898	172857	-	Loose	450	26.1794	SPM-1	25.0	3003793	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPM beta-lactamase	ATGACCTTCCTCAGATTCGCGGCGCGGCGCGTCGCCGAGATGGCCGCCACCCTGCTCGCCGCGTCGTTCGTGGTCTTCGGCGCGATGTACCTGGCGCCGGGCAGCCCCGCGAGCTTCCTGCTCTCGGGCCGGTCGGCGTCGCCGGAAGCGGTGGCGGCGATCAACTCCCAGTACCACCTGGACGATCCGTTCGCCGTGCGGTACTTCGACTGGCTCGGTGGCGTCCTGCGCGGCGACTTCGGCCGGTCCATCACCTACCGCACCGACGTGTCGCGCCTCCTCGCCGACCGGCTGCCCACCACCCTGCTGCTCATCGCCATGGCGCTCGCCGTGGTCGTGGCGGGCGGGCTGCTGCTCGGCAGGATCGCCGCCGTGCGCGGCGGACGCGTCGACTCCGCGATCCTTCTCGCCACGACGTTCGCCGTCGGCACGCCCTCCTTCGTCGCGGCCGTGCTGCTCCAGGGCCTGTTCGCCGTACGCCTCGGCTGGTTCCCCAGCGGCGGCGCGGGCGACGGCATCGGCGACATGATCTGGCACCTGACGCTGCCCGCGCTCGCCCTCGCCCTCTATCTGATCGGGATGCTGGCCCGGGTCACCCGCTCGGCGATGGTCGAGGCGCTCGCCGGTGAGCACGTCACCGTCGCCCGCAGCAGGGGCGTGCCGGAACGCCAGGTGATCCGCCGCCACGTGTTCCGCAACTCGCTCGGCACCGTCCTGACCACCACAGGGCTCGTCGTCTCCACGCTCCTGGTCTGCACGATCCTCGTCGAGACCGCCTTCAGCGTCGGCGGCATCGGCCAGCTCCTCGAACTCTCCACCACCACCAAGGACTTCCCGACCGTCCAGGCCATCGCACTGATCATCGTCGCCCTGTTCATGGCCGTGAACCTGATCGTCGACCTGCTCCTTCCGCTGGTCGACCCGCGGCTCACACTCGGCACCAGGGGGTCCGCCGCATGA	MTFLRFAARRVAEMAATLLAASFVVFGAMYLAPGSPASFLLSGRSASPEAVAAINSQYHLDDPFAVRYFDWLGGVLRGDFGRSITYRTDVSRLLADRLPTTLLLIAMALAVVVAGGLLLGRIAAVRGGRVDSAILLATTFAVGTPSFVAAVLLQGLFAVRLGWFPSGGAGDGIGDMIWHLTLPALALALYLIGMLARVTRSAMVEALAGEHVTVARSRGVPERQVIRRHVFRNSLGTVLTTTGLVVSTLLVCTILVETAFSVGGIGQLLELSTTTKDFPTVQAIALIIVALFMAVNLIVDLLLPLVDPRLTLGTRGSAA	MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL	115.58	gnl|BL_ORD_ID|2076|hsp_num:0	2298			186	330	
BGC0000703.1|Kanamycin_167 # 174547 # 175560 # -1 # ID=1_167;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=6bp;gc_cont=0.725	BGC0000703.1|Kanamycin_167 	174547	175560	-	Loose	750	28.1054	tet(X6)	33.93	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACCGCGTACCGCATGCCCGCCGAATGGTCCGAGCACGAGGGCTGTCTGATGGCCTGGCCCACCCGCGTCGACCTGTGGGACGGCGTGCTCGACCAGGTGCAGGGCGAGTACGCCCAAGTCGCCCGCGCCATAGCCGAGTTCGAGCCGGTCACCATGGTCGCCCCGCCGGGGTACGGGGACGCTGCCCGTGCCCGGTGCGGTGACGGTGTCGACGTGCTCGAACTGCCCCTGGACGACTCGTGGTTCCGCGACTCGGCGCCGCTGTTCGTCCTCGACGGGGACGGCCACCGCGCCGGGGTCGACTTCCGCTTCAACGCGTGGGGCCGCAAGCACCACCCGTACGACTCCGACGACCGGATCAGCGCGCTGCTGCTCGACCACCTCGGCGTCGAGCGCCTGCCCTCCGACATGATCCTGGAGGGCGGCGCGATCACCGTCGACGGCGAGGGCACGCTGATCACCACCGAGCAGTGCCTGCTCCACCCCAACCGCAACCCGGACCTGAGCCGCGCGGAGATCGAGGCCGAACTGAAGTCCCTGCTCGGGGTCGAGAAGGTGATCTGGCTTCCGTACGGCGGGCTGCTCGACACCGAGACGGACGGGCACGTCGACGGGGTCTGCGCGTTCGCCGCCCCCGGCAAGGTCGTCGTCTCCCTGCCCGCGGACCCGGCACACGCCGACCACGCCCGGATGCGCGCCAACCGCGCCGTCCTGGCGGCCAGCACCGACGCCAAGGGCCGCCCCCTGGAGATCGTCGACGTGCCGCAGACCGTGTTCACCGAGGTGACCGGTGGCGAGGTCGAGGTGTCGTACCTCAACTACTACGTCGCCAACGGCGGTGTCGTCGTGCCGGTCGCCGGGCTGCCCGCCGACGAGGACGCGCTCGCGGTGATCGCCGCCGCGTACCCCGGCCGCAAGGTCGTCGGCGTGCGGGCGGCCGCCGTCGCCTACGGCGGCGGGGGAGTCCACTGCATCACCCAGCAGATCCCCGCCGCCCGCCCCAGCGCGTGA	MTAYRMPAEWSEHEGCLMAWPTRVDLWDGVLDQVQGEYAQVARAIAEFEPVTMVAPPGYGDAARARCGDGVDVLELPLDDSWFRDSAPLFVLDGDGHRAGVDFRFNAWGRKHHPYDSDDRISALLLDHLGVERLPSDMILEGGAITVDGEGTLITTEQCLLHPNRNPDLSRAEIEAELKSLLGVEKVIWLPYGGLLDTETDGHVDGVCAFAAPGKVVVSLPADPAHADHARMRANRAVLAASTDAKGRPLEIVDVPQTVFTEVTGGEVEVSYLNYYVANGGVVVPVAGLPADEDALAVIAAAYPGRKVVGVRAAAVAYGGGGVHCITQQIPAARPSA	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	89.15	gnl|BL_ORD_ID|4802|hsp_num:0	3797			213	375	tetracycline; minocycline; oxytetracycline
BGC0000703.1|Kanamycin_169 # 177358 # 178068 # -1 # ID=1_169;partial=00;start_type=ATG;rbs_motif=AGCGA;rbs_spacer=11bp;gc_cont=0.734	BGC0000703.1|Kanamycin_169 	177358	178068	-	Loose	1000	25.0238	MCR-4.3	36.67	3004695	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCCGCTGACCCCCACCGAACGTGACCGGCTCCTGCTGTTCACGGCCGCCGAACTCGCGCGGTCCCGGCACGCCCGCGGCCTCGGGCTCAACGTCCCCGAGGCCACCGCGCTGATCGCCGACACCGTCTGCGAGGCCGCGCGGGACGGGCTCCGCCTCGCCGAGGCCGTCGAGCGCGGCCGTGCCGTCCTCCGCCCCGACGACGTCCTGCCCGGCGTCGCCGACGTGGTCACCGAGATCCAGGTCGAGGCCGTCTTCGACGACGGCACGCGGCTGGCGGTCATCAGCGAACCGTTCGGTGCGTGGCCCCGGCGCGACGACGCCCCCGGTGCCGTACTCCCGGCGACGGAGGTCGCTGCGCCCGAGCCGGTCGTGACGCTGGGCGTGCGCAACACCGCGACCGTGCCCGTCTCCGTGACGTCGCACTTCCACTTCTTCGAGGCCAATCCGCGGCTCGACTTCGACCGTGCGGCGGCGTACGGGATGCGGCTTGCGGTGCCCGCGGGCTCCTCGGTGCGTTTCGGTCCCGGCGAGAGTGTTGAGGTGGGGCTGTTGCCCATCGGCGGCGAGCGGATCGCGATCGGTTTCGCGGGTCTGGTGGACGGCCCGCTGGATGCGCCGGGCGCGAAGAAAGACGCCCTGCGCAAGGCGGTGGCCTGCGGCTACCTGGGTGCGAGCAGTACCGAAAGCCCGGCAGGAGTACGCGCATGA	MPLTPTERDRLLLFTAAELARSRHARGLGLNVPEATALIADTVCEAARDGLRLAEAVERGRAVLRPDDVLPGVADVVTEIQVEAVFDDGTRLAVISEPFGAWPRRDDAPGAVLPATEVAAPEPVVTLGVRNTATVPVSVTSHFHFFEANPRLDFDRAAAYGMRLAVPAGSSVRFGPGESVEVGLLPIGGERIAIGFAGLVDGPLDAPGAKKDALRKAVACGYLGASSTESPAGVRA	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFGRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	43.62	gnl|BL_ORD_ID|2271|hsp_num:0	3393			675	765	colistin A; colistin B
BGC0000703.1|Kanamycin_170 # 178219 # 178800 # -1 # ID=1_170;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=9bp;gc_cont=0.720	BGC0000703.1|Kanamycin_170 	178219	178800	-	Loose	375	45.0542	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	40.0	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGCCTCGCACTACTCAGATCCTCGAAGCGGCCGCACGGCTGATCGCCCGTCGCGGTGTCCGCGGCCTGCGCGTCGAAGAACTCGCGGCCGAAGCGGGCGTCTCGACCGGGTTGATCTACTACCACTTCAAGGACCGCACGGGGATCCTGCGCCACACCCTGGAGTTCATCAACGACCGCGCCGAGCGCTACACCACGGGGCGCGACCCCGAGGCCGAACCCCTGGCCCCCCGCGAGGAGTTGGAGGAGATCCTCCTGCTCGAACTGCAGGACACCCCGGAGGTCAGGGAGAACAGCTCCGCCTGGGGCGAGCTGCGGGCCAGCGCCGTCTTCGACGAGGTGCTTCGCGAGGACCTCGCCAGGGCGACGCTGGTGTGGGTGCAGGAGGTCGCCGCCCTGCTCGGGCAGGTGCGGCCGATGACCCCGGCGCCCGCTCTCGCCGCGGCGGGCGAGCGGCTCACCGCGCTCCTGGAGGGGCTCAGCATGCGCTGGCTCAGCGGTGGACTCCAGCTCGATCACGCGCGCGACCTGGTGCGCGGCGCCATCGACGCCGAGCTGGCGCTGCTGCGCGGGAAGTAG	MAPRTTQILEAAARLIARRGVRGLRVEELAAEAGVSTGLIYYHFKDRTGILRHTLEFINDRAERYTTGRDPEAEPLAPREELEEILLLELQDTPEVRENSSAWGELRASAVFDEVLREDLARATLVWVQEVAALLGQVRPMTPAPALAAAGERLTALLEGLSMRWLSGGLQLDHARDLVRGAIDAELALLRGK	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	89.77	gnl|BL_ORD_ID|2090|hsp_num:0	2306			42	192	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000703.1|Kanamycin_171 # 178889 # 180610 # -1 # ID=1_171;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000703.1|Kanamycin_171 	178889	180610	-	Loose	500	30.4166	APH(3')-Va	33.33	3002649	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTCCCCTCAGCCTCCCGGCGTGCCCGGCCCGCCCGGCGCGCCGACCGCCCACGCGCCCCTGTCGGCCGACGACCCCCGCGAGATCGGCGGCTACCGCCTGCACGCCAGGCTCGGCGCCGGTGGCATGGGGGTCGTGTACCTCGCCCACACGCCGGGCGGGCGGCCCATCGCCCTGAAAGCGGTGCGGGACGAGTTCGCCGCCGACCCCGAGTTCCGCAGGCGCTTCGCCCACGAAGTGGCCAGCGCACGGAGCATCCACGGGCTGTTCACCGCGCAGGTGGTCGACTCCGGAGTGGACGCCCCCACACCGTGGCTCGCCACCGCGTACGTACCCGGACTCTCCCTCCAGGAGGTGGTACGACGACACGGCCCGCTGCCCGTACGGACGGTGCTCCTGCTCGTCGCGGGCATCGCGGAGGCGCTCCAGGCCATCCACTGGGCCGGGGTCGTCCACCGGGACCTCAAACCGGCCAACGTGCTGATCGCCGAGGACGGCCCCCGCGTCATCGACTTCGGCATCGCACGCGCGGCCGATGCCACGGGCCTGACCGGCACCGGACTGCGGATCGGCACCGCCGCGTACATGGCGCCCGAGCAGGCGCGGGGCTTGGCCGTGACCCCGGCGACCGACGTCTTCGCGCTCGGCGCGCTCGCCGCGTACGTGGCCGGGGGAGTGCTCGCCTTCGGGGACGGGCCCGAATCGGCAGCGCTGTACCGGGTGGTCCACGAGGCGCCCGACCTGTCCAGGGTGCCCCACGACCTGCACGAGCTGCTGGGACGCTGCCTGGCCAAGCGCCCGGAGGACCGCCCTGACCCGGCCGAACTGATCACGGCGGCGCGGGCGCATCCCGTCATGGGAGCACGTCCCGAATTCACGGAGGGGTGGCTGCCGCGGGGGGTCAGCAGCGAACTCGCCGGGCGCGACGGGGCGCCGGAACCGGCACCGGGGCCTGGTCCCGGCTCTGGGCCCGGTCCGGGTCCTGGGTCCGGTCCCGGTCCTGGGCCCGGCGGTCACGCGCCGACGCACGCCCAGCCGACACTCGCCGCTGCCTCCGCCGCCTCTGCCGCCTCTGCCGAACCCGCCACCGGCCCCGAACCGCGCCGGACCCGCCGTGGCCGCGGCGGCCGACGGCGCGGGGCCGGGGCGGCCCTGGTGGTCGCGGCGGTGCTCCTCGTCTCGGTCGGCGGCGCGGCGTACTACTTCCTCGACCGTCGCGGAGACCCGGCACGAGACCCCTCCGGTTCCTCGGATTCCGCCGATTCCTCCGACACCTCCCACCAACCCCACACGCCGTCCCCCCGGCCCTCGTCGAAGCCGTCGTCGCCCGCCCCCTCGTCCGAGGGCGCGTACGTGCCGGACTACACGGACGCCGAACTCACCGCCCCCGACCCCGACTACGAGTTCGACCTCTCGGCGGGCAAGGTCGTTCCCGCCGAGACCGCGGACTGGTACCTGGAGCGGACCGACACCGAGTTCGTCCTGTCCGACGACAGCGACGCCTTCGTGGCCGCCGGATACGTGCTGAGTCCCGCCGACTGCGTACGCGGGATCGAGACGGAACCGGTGACCGAGCTCCCCTTCGACGACCTCGCCGACGAACGTCCCTTCTGCGTCCGCAGCCCGGACGGGAAGAGCGTCGTCATCGCGCGCCTCGTCGAGGCCGTGCCCGGCGAAGGGCCCGTCACGGTGGTCATGAGCCGCCACAACCAGGGCGGCTGA	MSPQPPGVPGPPGAPTAHAPLSADDPREIGGYRLHARLGAGGMGVVYLAHTPGGRPIALKAVRDEFAADPEFRRRFAHEVASARSIHGLFTAQVVDSGVDAPTPWLATAYVPGLSLQEVVRRHGPLPVRTVLLLVAGIAEALQAIHWAGVVHRDLKPANVLIAEDGPRVIDFGIARAADATGLTGTGLRIGTAAYMAPEQARGLAVTPATDVFALGALAAYVAGGVLAFGDGPESAALYRVVHEAPDLSRVPHDLHELLGRCLAKRPEDRPDPAELITAARAHPVMGARPEFTEGWLPRGVSSELAGRDGAPEPAPGPGPGSGPGPGPGSGPGPGPGGHAPTHAQPTLAAASAASAASAEPATGPEPRRTRRGRGGRRRGAGAALVVAAVLLVSVGGAAYYFLDRRGDPARDPSGSSDSADSSDTSHQPHTPSPRPSSKPSSPAPSSEGAYVPDYTDAELTAPDPDYEFDLSAGKVVPAETADWYLERTDTEFVLSDDSDAFVAAGYVLSPADCVRGIETEPVTELPFDDLADERPFCVRSPDGKSVVIARLVEAVPGEGPVTVVMSRHNQGG	MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEADRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARALHELPVEDCPSDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAYAERFLERYGAHRVDKEKLAFYQLLDEFF	213.81	gnl|BL_ORD_ID|30|hsp_num:0	38			204	366	neomycin; ribostamycin; paromomycin
BGC0000703.1|Kanamycin_172 # 180792 # 181403 # 1 # ID=1_172;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.722	BGC0000703.1|Kanamycin_172 	180792	181403	+	Loose	375	40.4318	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	30.56	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACGTGGGGGCGGACCGCAGGACGGTCATCCTGAGAGGGGCGGCCCGGGTCATCGCCCGGCACGGCGTACGGGGCCTGCGGGTGTCGGAGGTCGCCGCCGAAGCGGGCGTCTCCACGGCGCTCGTCTACTACCACTTCAAGGACCGCGCGGGCATCCTGCACCGGACCCTGGAGTTCATCAGCGACCGGGCCGAGCGCTACACCGCGGGACATCCGCGGCGGGAGCGCGACAGCGACCCGCGCCGCGACCTCGAAAGCTCCCTGCTCCTTGAGTTCCAGGACCGGCCCGAGGTGCGCGAGAACAGCACCGCCTGGGGCGAGTTGCAGGCCACCTCGGTCTTCGACCCCGAGCTCCGCGACGCGCTCGCGGAGGCCCGGCTGATCTGGATCGGCGAGCTGACCCACACCCTCGGCCGCATCCAGCCGACCGCTCCCGCGCCCGCGCTCACCGAGTCCGCCGAGCGGCTCACCGCCACCTTGGAGGGGCTCAGCACGCGCTGGCTCAGCGAGCTGCTGCCCTTGGGGCACGCGCGTGAGCTGATGCGGGACGCCATGGCGGTGGAGCTCGCCCAGTTGGCCAGGCGCGCCAGTCCCACACTTTTTGACTGA	MDVGADRRTVILRGAARVIARHGVRGLRVSEVAAEAGVSTALVYYHFKDRAGILHRTLEFISDRAERYTAGHPRRERDSDPRRDLESSLLLEFQDRPEVRENSTAWGELQATSVFDPELRDALAEARLIWIGELTHTLGRIQPTAPAPALTESAERLTATLEGLSTRWLSELLPLGHARELMRDAMAVELAQLARRASPTLFD	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	94.42	gnl|BL_ORD_ID|2090|hsp_num:0	2306			30	246	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000703.1|Kanamycin_173 # 181599 # 182753 # 1 # ID=1_173;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.692	BGC0000703.1|Kanamycin_173 	181599	182753	+	Loose	600	26.1794	SGM-5	32.0	3006991	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SGM beta-lactamase	GTGTCCCACCTCCTCCCCTCCCGCCGTTCCGCCCTCCGCGCGATCGCCGGAATCGGCGCCGTCGTCCTGGGCGCTTCGGCCTGCGGACCCGGCGACTCCGTGGCCGGGGCGAGCACCGCGGGCGACGAGGACGCGGTGACCGAGGGACGCCGGATGGGCGCCGAGTGGGAGAGCCACGCGCGCACCTTCATGTCGTGGCCCGCCCTGGAGTCGGTGTGGGAGGACGACCTGCGCTACGTGCGCGAGGACATCGCCCGCATCGCCCGCTCCATCGCGGAGTACGAGTACGTCGTGATGATGGCGAGGCCCGACCAGCTGAAGGCCGCCCAGAAGGCGTGCGGGCGCGACGTCGAGGTCATCCCGCTCGCCGTGGACGACCTGTGGGCCCGCGACACGGTGCCGGTGTTCGTGGAGGACGACGGCAAGGTCACCGGCATCGACTTCAACTTCAACGGGTGGGGCAACAAGCAGGAGCACGACAACGACGGCCAGGTGGGCCGCAAGCTCCTGGCCGAGTACGACATCCCCCGCAAGAAGGCCCCGCTGGTCGCCGAGGGCGGCTCGTTCGAGACCGACGGCGAGGGCACGCTCCTGATCACCGAGAGCTCGATCGTCAACGACAACCGCAACCGCGGCAAGAGCCGGGACCAGATCGAGGACGAGCTCAAGCGGACGCTCGGGATCAAGAAGGTCATCTGGCTGGCCGGTGTGCGCGGGCAGGACATCACCGACGCGCACGTGGACAGCCTCGTACGGTTCACCGCGCCGGGCGTGGTGCTCCTGGACCGGGCGCACCCCGACACGCCCGCCGACTCCTGGTCGCGCGCGGCTGACCAAGCGAAGTCCGTGCTGAGCGAGGCGACCGACGCCAGAGGCAAGCCCTTCGAGATCATCGACCTGCCGCAGCCCGACCTGTACGAGATCACCGGCGAGGGCGACGACTTCGTGTCGACGTACGCCAACTTCTACGTCGCCAACGACTCGGTGTTCATCCCCAAGTTCGGCGACCGCAAGGCCGACAAGCGGGCGAAGAGCATCCTCCAGGAGCACTTCCCCAAGCGTGACGTGGTGCAGATCAACATCGACACCATCGCCTCCGGTGGCGGCGGCATCCACTGCTCCACGCACGACGAGCCGGGCAAGCCGGTCGACTGA	MSHLLPSRRSALRAIAGIGAVVLGASACGPGDSVAGASTAGDEDAVTEGRRMGAEWESHARTFMSWPALESVWEDDLRYVREDIARIARSIAEYEYVVMMARPDQLKAAQKACGRDVEVIPLAVDDLWARDTVPVFVEDDGKVTGIDFNFNGWGNKQEHDNDGQVGRKLLAEYDIPRKKAPLVAEGGSFETDGEGTLLITESSIVNDNRNRGKSRDQIEDELKRTLGIKKVIWLAGVRGQDITDAHVDSLVRFTAPGVVLLDRAHPDTPADSWSRAADQAKSVLSEATDARGKPFEIIDLPQPDLYEITGEGDDFVSTYANFYVANDSVFIPKFGDRKADKRAKSILQEHFPKRDVVQINIDTIASGGGGIHCSTHDEPGKPVD	MAVRKSLSFAALTACLLVAMPLSAAPKKKAPAKKAEDVPVLPTQLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCSTFKAPLAAAVLIGAEGGKFGLDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVSDNSAANLLLPMLGGPEGLTAFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLMSRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDQKAAEAAIAEAAHSALEFVSKAKKSGLD	117.79	gnl|BL_ORD_ID|4578|hsp_num:0	5648			291	441	
BGC0000703.1|Kanamycin_174 # 182786 # 183661 # 1 # ID=1_174;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.720	BGC0000703.1|Kanamycin_174 	182786	183661	+	Loose	1900	29.6462	MexI	30.38	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGCGACGCCCCACCCGGTCCCGCGGCAGACTGCTGATCGCGGGCCTGGTGCTCTGCGCCGTGGCGGCGGCCGTCACCGTCGGGGTCTGGCTCCAGTTCGGCGAACGCCATGACCTGGACACCCGCTACCGCGCGGGCGGCGATGCCCCCGACCGGGTGGACATCACCGCGTCGGTCCAGCGGGTCGACGCGGCGGGCCGGGAGCTGACCCTGCGCCTCCTGGTCACCCCGCGCGGAGACCTGGCGGAGGCGGGCGGCGTCGCCCCCGCCGAGTCCCTGACCCTGCAGACGTCGGCCGACGTGCGGGGAGATCTCACCTTCCCCGCGCACAGCCGGATCTCGACGGTGGACGTGCCGGTCACCCTGACGGCGGGCTCGATCACCGACTATCCGTTCGACGCGTACGACACGGATCTCGAATTCGGCGCCGTACAGGGTGGCGAGGCCGTGCCCGTCCGCATGACGCTGACCAACAACGACGCGCTGTTCGCGGCCACGGTCGAGGCCTCCGAGGCGAACGGCGCCGCCGTCTTCTACGTCGGGATCGGCCGCTCCACCAGCGTCCTGATCTTCGCCGTCTTCATGATGGCCGCGATGTGGGCGCTGGCCATCGCCGTACTCATCGGCGCGTGGTTCCTGCTCTCCCGGCGCAAGGGCCTGACCTGGCCCGCGCTCGGCTGGATGGCCGCCACGCTCTTCGCGCTCGCCGCCTTCCGCAACACCGCGCCCGGCGCACCGCCCATCGGCTCCCTCCTCGACTACATCGCCTTCCTGTGGGCGGAGACGGTCATCGCGTTCTGCGTCATCACGGTGGTCGTCATGGGGATGCGGGCGGAGTCCCACCCGTCGCCGGATCCGCCCGCGTCCCCCTGA	MMRRPTRSRGRLLIAGLVLCAVAAAVTVGVWLQFGERHDLDTRYRAGGDAPDRVDITASVQRVDAAGRELTLRLLVTPRGDLAEAGGVAPAESLTLQTSADVRGDLTFPAHSRISTVDVPVTLTAGSITDYPFDAYDTDLEFGAVQGGEAVPVRMTLTNNDALFAATVEASEANGAAVFYVGIGRSTSVLIFAVFMMAAMWALAIAVLIGAWFLLSRRKGLTWPALGWMAATLFALAAFRNTAPGAPPIGSLLDYIAFLWAETVIAFCVITVVVMGMRAESHPSPDPPASP	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	28.28	gnl|BL_ORD_ID|4683|hsp_num:0	1647			1950	2184	acriflavine; tetracycline; norfloxacin
BGC0000703.1|Kanamycin_176 # 184113 # 185009 # -1 # ID=1_176;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=6bp;gc_cont=0.727	BGC0000703.1|Kanamycin_176 	184113	185009	-	Loose	890	25.0238	smeF	33.33	3003057	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGAACCAGCAGGCAGAGCACACCCCTGTGACGGTCATCGGCCTCGGCCTCATGGGCCAGGCCCTCGCCGGGGCGTTCCTGGGCGCGGGACACCCCACGACCGTGTGGAACCGGACGGCGGCGAAGGCCGAACCGCTCGTCGCCCGGGGCGCGAAGAGCGCGGGATCGGTCGCCGAAGCGGTCGCCGCGAGCCCGCTGGTGGTCGTCTGCGTCTCGGACTACGACGCCGTGCACGCGCTCCTCGACCCGCTCGACGGCACGGCCCTCCAGGGGCGCACCCTGGTGAACCTGACCTCCGGCACCTCGGCCCAGGCCCGCGAGCGCGCCGCGTGGGCGGACGGCCGCGGCGCCGACTACCTCGACGGCGCGATCCTGGCGGGACCCGCCGCGATCGGCACGGCGGACGCCGTCGTCCTCCTCAGCGGGCCCCGGTCGGCCTTCGACCCGCACGCGTCTGCCCTCGGCGGCCTCGGCGCGGGAACGACGTACCTCGGCGCCGACCACGGTCTCGCGTCGCTGTACGACGCGGCGGGCCTCGTCATGATGTGGAGCATCCTGAACGGCTTCCTGCAAGGCGCCGCGCTGCTCGGCACGGCCGGTGTGGACGCCACGACGTTCGCCCCGTTCATCACCCAGGGAATAGGAACCGTCGCCGACTGGTTGCCCGGCTACGCGCGACAGATCGACGACGGCGCGTACCCCGCCGACGACGCCGCCATCGACACCCATCTGGCCACCATGGAACACCTCATCCACGAGAGCGAGTTCCTCGGAGTGAACGCCGAACTCCCCAGGTTCATCAAGGCCCTCGCCGACCGGGCCGTGGCCGACGGGCACGGCGGCAGCGGCTACCCGGCGCTGATCGAACAGTTCCGCACGCACTCAGGGAAGTGA	MRNQQAEHTPVTVIGLGLMGQALAGAFLGAGHPTTVWNRTAAKAEPLVARGAKSAGSVAEAVAASPLVVVCVSDYDAVHALLDPLDGTALQGRTLVNLTSGTSAQARERAAWADGRGADYLDGAILAGPAAIGTADAVVLLSGPRSAFDPHASALGGLGAGTTYLGADHGLASLYDAAGLVMMWSILNGFLQGAALLGTAGVDATTFAPFITQGIGTVADWLPGYARQIDDGAYPADDAAIDTHLATMEHLIHESEFLGVNAELPRFIKALADRAVADGHGGSGYPALIEQFRTHSGK	MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG	63.95	gnl|BL_ORD_ID|577|hsp_num:0	634			879	1017	tetracycline; chloramphenicol
BGC0000703.1|Kanamycin_177 # 185093 # 185452 # 1 # ID=1_177;partial=00;start_type=GTG;rbs_motif=AGGGGG;rbs_spacer=7bp;gc_cont=0.689	BGC0000703.1|Kanamycin_177 	185093	185452	+	Loose	200	39.2762	Pseudomonas aeruginosa soxR	31.25	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGATCGGAGAACTGAGCGGACGGACCGGCGTGCACACGCACCAACTGCGGTACTACGAGGCCCAGGGCCTGCTCACACCCGACCGCGGCAGCAACGGCTACCGCGACTACGGCGAGGACGCCGTGCTGACCGTGCGGCAGATCAGGAGCCTGCTCGAAGCCGGTCTCTCGACGCAGGAGATCGCGTACATGCTGCCCTGCGCCGTGGGCACAGGACCCGACTTCTACTTCTGCCCCGATCTCCTGGACGTGCTGCGGGGGCGCCTGCGCGGCCTCGACGACAACATCGACACGCTCACGCGCTCGCGCGACGTGCTCCACGACTTCATCGACGCGACCGAGCGGCGGGCGGCGTAG	MLIGELSGRTGVHTHQLRYYEAQGLLTPDRGSNGYRDYGEDAVLTVRQIRSLLEAGLSTQEIAYMLPCAVGTGPDFYFCPDLLDVLRGRLRGLDDNIDTLTRSRDVLHDFIDATERRAA	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	76.28	gnl|BL_ORD_ID|2395|hsp_num:0	2775			33	225	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
BGC0000703.1|Kanamycin_178 # 185558 # 186343 # 1 # ID=1_178;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.711	BGC0000703.1|Kanamycin_178 	185558	186343	+	Loose	700	25.7942	ADC-150	21.54	3006324	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGAAGATTCTCTGGATATCCGCCCACCCCGAACAGCGCTCCCTGAACGGCCGCCTGATGACCGAGGGACTGCGCGTGCTGACCGAGCTCGGGCACGAGCGCCGCGTCAGCGATCTGTACGCCATGGACTGGAAGCCGATCGTGGACGCCGGTGACTTCGGGGGCGCGTCGCGCGAGCGGCTCTTCATCGGGCGCGAGCAGGAACGCGCGTACGGCAGCGGGGAGTTGAGCGAGGACATCCGCGCCGAGCAGGAGAAGCTCGCCTGGGCGGACGTGGTCGTCTTCCAGTTCCCGCTCTGGTGGCTCGGACCGCCCGCGATCCTCAAGGGCTGGTTCGACCGCGTCCTGGTCCAGGGCTTCGGATTCGGCATCAAGGATCCCGAAGGGCAGGCGCTGCGGTACGGCGACGGGGGCCTGGCAGGGAAGCGCGCCCTGGTCGTCACGTCCATCGGTGCCCGGGAGTCCAGCTTCGGCCCGCGCGGCATCCACGGACCCCTTGAGGAGGTCCTGTTCCCGCTGCTGCACGGCACGTTCTGGTACACCGGCATGGCCGCGCTCCCGCCGTTCGCGGTGTACGGCGCCGACCGGCTCACGGCGGCGGGCTTCTCGCGCGCCACGGCGGACCTGCGCGAACGCCTGCGCACCCTGGACACCACGGAGCCCCTGCCCTTCCGGCACGAGAACGGCGGGGAGTACGACGAGGATCTGACACTGCGGCCGGACGTCGCGGCGGGGCTCACGGGCGTCGGAGTGCACCGCGCGCAGGACGGCCGCGCACACCGCTGA	MKILWISAHPEQRSLNGRLMTEGLRVLTELGHERRVSDLYAMDWKPIVDAGDFGGASRERLFIGREQERAYGSGELSEDIRAEQEKLAWADVVVFQFPLWWLGPPAILKGWFDRVLVQGFGFGIKDPEGQALRYGDGGLAGKRALVVTSIGARESSFGPRGIHGPLEEVLFPLLHGTFWYTGMAALPPFAVYGADRLTAAGFSRATADLRERLRTLDTTEPLPFRHENGGEYDEDLTLRPDVAAGLTGVGVHRAQDGRAHR	MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNGIKK	68.15	gnl|BL_ORD_ID|3182|hsp_num:0	4220			84	258	
BGC0000703.1|Kanamycin_179 # 186345 # 187316 # -1 # ID=1_179;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.746	BGC0000703.1|Kanamycin_179 	186345	187316	-	Loose	2200	26.5646	rpoB2	26.87	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAAGCTGTACCAGGAGGCCCCGGCCGGGCCCCGCCCGTCGGGCCGAGGGCCCGGGCGAACGGGCGTGGGCACCGCGTTCGGCACCTTCGGCGAACTGCTCCAGGGCCAACTGCCCGAGGAGGACGGGGACTTCCTCGTGACCCTGCCCGTCGCCCGCTGGACCATGGCGACCTTCCGGCCGGGCTCCGCGTCCGGCGACATCGAGGTCCGCCCGCGCCACAAGGCCAAGGCGCTGCGCCTCGCCCGGATGATCGCCGAAGCGGCACCGGCGGGGGCGCGGACCGCACGGGGCGGCGTGCTCACGGTGAGCAGCGTGATCCCTGAGGGCAAGGGGCTCGCCAGCTCCTCCGCCGACCTCGTCGCCACCGCGCGGGCGGTCGGCCGCGCCCTCGACGTGCCCATGCCGCCCGCCAGGATCGAGCGCCTGCTGTCCCGGATAGAACCCACCGACGGCGTGCTCTACCCCGCGATCGTCGCCTTCCACCACCGCGCCGTCCGCCTTCGCGCGGTCCTCGGCGCGCTGCCCGCCATGGCCGTGGTCGGCATCGACGAGGGCGGGTCGGTCGACACGGTGGACTTCAACCGCATCCCCAAGCCGTTCACGCCCGCCGACCGGCGCGCCTACGCGGAGCTGCTCGCACGGCTCACCGACGCGGTGCGCACGCACGACCTCGCGGAGGTCGGCAGGATCGCGACCCGCAGCGCCCTGCTGAACCAACGCCTCAGGCACAAGCGCTCGTTGGAGCCGATGCGGGCGATCTGCCGCGAGGTCGGCGGCCTGGGCGTAGCGGTCGGACACAGCGGTACGACACTGGGCGTACTGCTCGACGCCACGGACCCCTCGTACACGCGACGCGTCACGGCGGCGGCCCAGGCGTGCGAGGAACTGACGGGCGGTGGGTGCGGCGGCGGGGGCGTGCAGGTCTACCGGACCCTGAGCTTTCGCACCGGGGGCGGTCCGGGTTCGTGA	MKLYQEAPAGPRPSGRGPGRTGVGTAFGTFGELLQGQLPEEDGDFLVTLPVARWTMATFRPGSASGDIEVRPRHKAKALRLARMIAEAAPAGARTARGGVLTVSSVIPEGKGLASSSADLVATARAVGRALDVPMPPARIERLLSRIEPTDGVLYPAIVAFHHRAVRLRAVLGALPAMAVVGIDEGGSVDTVDFNRIPKPFTPADRRAYAELLARLTDAVRTHDLAEVGRIATRSALLNQRLRHKRSLEPMRAICREVGGLGVAVGHSGTTLGVLLDATDPSYTRRVTAAAQACEELTGGGCGGGGVQVYRTLSFRTGGGPGS	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	27.80	gnl|BL_ORD_ID|2431|hsp_num:0	2831			738	927	rifampin; rifaximin; rifabutin; rifapentine
BGC0000703.1|Kanamycin_180 # 187501 # 188493 # 1 # ID=1_180;partial=00;start_type=ATG;rbs_motif=GGGGGA;rbs_spacer=8bp;gc_cont=0.700	BGC0000703.1|Kanamycin_180 	187501	188493	+	Loose	675	28.4906	emrA	28.33	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCACGCGCACATCGCCGAAGCGGTGAAGAAACCCGACCTCATATCCCTCGCGCCGGACCTGGCCTGCCTCCGGTTCGAGACCATGAAGATCTACTCGGCCCTCGGCGCCGTCCGGCAGCTGCTCGCATCGGGCGCCGTCGAACCGGGCGACACCCTCATCGACAGCTCCAGCGGCATCTACGCGCAGGCCCTGGCCCTGGCCTGCCACCGCTACGGAATGAAGTGCCACATCGTGGGCTCCACGACCGTGGACCGCTCCACGCGGGTCCAGCTGGAGATACTCGGCGCCACCCTCGAACAGGTCCCGCCGTCCCGGAACCTCCGCCTGGACCAGGAACTGAGGGTGCGCAGGATCGCCGAGATCCTGGCCGCCAACCCCTCGTACCACTGGATGCGCCAGTACCACGACGACATCCACTACAGCGGCTACCGCGAGGTCGCCGAGGCCATCGGCAAGGACCTGCCCACAGGACCGCTCGCGCTGGTCGGCGGCGTGGGGTCGGGGGCGTCGACCGGCGCCATCGCCTCGTATCTGCGCGCGGCGGGCCGCGACGTCTCACTCGTCGGCGTGCAGCCCTTCGGCAGCGTCACCTTCGGCTCCGAGCACGTCGCCGACCCCGACATGATCATCGCCGGGATCGGCAGCGCCATCGAGTTCGAGAACGTCCGGCACGAGCTGTACGACCGGGTGCACTGGGTCAACTTCGAGTGCGCCGTGTCCGGCGCGGTCGCGCTCCTGCGCACCAGCGGCATCTTCGCCGGGCTCTCGGCGGGCGCCGCCTACCTCGGCGCGCTGTGGGAGCGGCGCAGGGACGACTCGCGCACCTACGTCTTCATCGCGGCCGACACCGGTCACCGCTACGTCGAGAGCGCCTACGCCCGGCACGAACAGGCCCTGGACATCGAGACGTTGAAGCCGCACGAGATCACCTCGCTCGACCAGCTGCGCCACCCCTGGTCCACCGCGCCGTGGCCCGCCACCACCTCCTGA	MHAHIAEAVKKPDLISLAPDLACLRFETMKIYSALGAVRQLLASGAVEPGDTLIDSSSGIYAQALALACHRYGMKCHIVGSTTVDRSTRVQLEILGATLEQVPPSRNLRLDQELRVRRIAEILAANPSYHWMRQYHDDIHYSGYREVAEAIGKDLPTGPLALVGGVGSGASTGAIASYLRAAGRDVSLVGVQPFGSVTFGSEHVADPDMIIAGIGSAIEFENVRHELYDRVHWVNFECAVSGAVALLRTSGIFAGLSAGAAYLGALWERRRDDSRTYVFIAADTGHRYVESAYARHEQALDIETLKPHEITSLDQLRHPWSTAPWPATTS	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	84.62	gnl|BL_ORD_ID|1610|hsp_num:0	1757			726	891	nalidixic acid
BGC0000703.1|Kanamycin_181 # 188530 # 189369 # 1 # ID=1_181;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=8bp;gc_cont=0.726	BGC0000703.1|Kanamycin_181 	188530	189369	+	Loose	800	24.6386	ParS	31.71	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGTCACACCCCACACCCCGGACCGTCGCCGAACTCACCGACGCCGTCCTCGCGGGCGCCCACGGACCCGACCCCAGGGACCTGACGGTCACCAGCGCCTTCTGGCTGTACAACACGACCCGCCTGGCAGGCGGCGACGTCACGTACCACAACCACTACTTGCTGCTCCGCGTCGGCGACGCGTTCGGCGCCTGCTCCTTCGAAGCCGGTGAACTCTCCCCGGAGTTCTGCGAGAACGCCTCAGGGCACTCCCTGGACAAGCTCCTGCGTCACGAGTGCGCGCCCGTGCGGACCGCCGCGCTCGACGCCTATCTGGCCCGGGCCCGGCCGCACCGCGACACCGACGACGCCGAGCGCGTGCTCCTGCCCGCCGGTACGCCCGAGGTCAGGGCCGAGGCCCGCGACGCCGCGATCGCCGGTCTGCTCGACATCGCGCCCGGCGCGCGGGTCGCCCTGATCGGCGTCGTCAACCCGCTGGTGGCCGCGATACGGGAGCGGGGCGGCGTCTGCCTGCCCTGCGACCTGAACCTGCGCACCACCGCGTGGGGCGAGCCCGTCAGCGACGACATGACCGAGGTGCTCGCGAGCGCCGACGCGGTGGTCGCCACCGGCATGACGCTCAGCAACGGCACCTTCGACCTGATCCTCGCGCACTGCGTCGAGCACGCGGTGCCGCTGGTCGTCTACGCCCAGAGCGGCAGCGCCGTGGCCCGCGCCTTCCTCGGCGCGGGGGTCACCGGACTCAACGCGGAGCCGTTCACGTTCTCCCAGTTCAGCGCCGACCCCACACCCATGTACCGGTACCGCGCCGGCCTCGCGTCGAACGGAGCGGGTGCGTGA	MSHPTPRTVAELTDAVLAGAHGPDPRDLTVTSAFWLYNTTRLAGGDVTYHNHYLLLRVGDAFGACSFEAGELSPEFCENASGHSLDKLLRHECAPVRTAALDAYLARARPHRDTDDAERVLLPAGTPEVRAEARDAAIAGLLDIAPGARVALIGVVNPLVAAIRERGGVCLPCDLNLRTTAWGEPVSDDMTEVLASADAVVATGMTLSNGTFDLILAHCVEHAVPLVVYAQSGSAVARAFLGAGVTGLNAEPFTFSQFSADPTPMYRYRAGLASNGAGA	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	65.19	gnl|BL_ORD_ID|2790|hsp_num:0	3805			921	1044	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000703.1|Kanamycin_182 # 189366 # 190634 # 1 # ID=1_182;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.731	BGC0000703.1|Kanamycin_182 	189366	190634	+	Loose	500	41.2022	bcr-1	31.53	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGCGTCGACGCCGTCAAGAACTCCGCGGCAAACGAAGCCGAGGAGCCGATACCCGGCGATCTGCGCATGGCACGGACACTGTGGCCCGTGCTCCTCGCCTCCGCCGTGGGCCTGCTGCCGTTCACCGTCTTCAGTACGTATCTGGTGCCCATCGCCGACGAGGCGGGCAGCAGCGTCGCCGCGATGGGCGGACTGCGCGGACTCGGCGGTCTGGCCGCCCTGTTGGTGGGCACCGCGCTCGCGCCGCTCATCGACCGGGTGCCGAGGCGGTGGGCGGCGGCGGGCGGGCTCGCCGCGCTCGGGCTCTCCGCGGCGCTCGGCGCGAGCGGCGACTTCGTGCTGCTCGCCGTGTTCTGTCTGCTCGTCGGCGCCAGTACGTCCGTGCTGAACCCGGCGCTCACCGCCGCGGCCGCCGACCGCTTCGGCACCGGCAGGGCGGCGGGCCGTGCGGCGACCCTGGTGACCGCCACCCAGTCGATGACGGCGATGCTCGCGGCGCCGGTGATCGCGCTGCCCGCGCTGTTCTGGGGCTGGCGGGGCGACCTGTTCGCGGTGACCGCGCTCTCGCTGCTGCTCGCGGTGGTGTTCGTGGTGCGCCGCGAGGACACCGAGGACGCGGGTGATGCCGCCTCTGGCGGTCAACGCCTGGGCTACGTCGCCTCGTTCAAGGCCCTGGGCGCCGTGCGCGGCGTCGTGCCGCTGCTGCTCATCGCGCTCCTGCGCACCGCCGTGTTCATGGGATACCTGTCGTACCTGGCGGCGTTCTACGAGGAGCGGTTCGACCTGGACGCCGGACTCTTCGCGTTCGTCTGGACGCTGAGCGGCGCGTCGTTCTTCGTCAGCAACCTCCTCACCGGGCGGCTCACCAACGCGGCCGAGCCGCGCATCCGCACCGAACGGCTGTTGTTCATCGGCCTGTTGGCGGCGCTCGTCTCCGTCATGGGCTTCTACTTCACACACTGGCTGCCGCTCGCGCTCGCGCTGACCTCGCTGCACGCGGCGAGCCACGCCGTCGTCGCGGCCTGCGCGGTCAGCCTCATCGTGCGGCGCTGCGGGCCAGGACTGCGCGGTGCGGCGCTCGGGATCAACGCCGCCGGGATGAGCCTCGGCGTCTTCGTCGGCGCCGCGCTCGGTGGCGCGGGGCTCGGCATCGCCGGATATCCGGGCGTGGCCGTCGTGTTCGGCGTGCTCGTCGTCGTCGCCGTCGGCGCCGCGGTGCTCGTCCTGCGCGCACGGCCCGTGCGGGAGGGGGCGGACTCCGTATGA	MSVDAVKNSAANEAEEPIPGDLRMARTLWPVLLASAVGLLPFTVFSTYLVPIADEAGSSVAAMGGLRGLGGLAALLVGTALAPLIDRVPRRWAAAGGLAALGLSAALGASGDFVLLAVFCLLVGASTSVLNPALTAAAADRFGTGRAAGRAATLVTATQSMTAMLAAPVIALPALFWGWRGDLFAVTALSLLLAVVFVVRREDTEDAGDAASGGQRLGYVASFKALGAVRGVVPLLLIALLRTAVFMGYLSYLAAFYEERFDLDAGLFAFVWTLSGASFFVSNLLTGRLTNAAEPRIRTERLLFIGLLAALVSVMGFYFTHWLPLALALTSLHAASHAVVAACAVSLIVRRCGPGLRGAALGINAAGMSLGVFVGAALGGAGLGIAGYPGVAVVFGVLVVVAVGAAVLVLRARPVREGADSV	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	104.98	gnl|BL_ORD_ID|2332|hsp_num:0	2303			216	849	bicyclomycin
BGC0000703.1|Kanamycin_184 # 191742 # 192515 # 1 # ID=1_184;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=8bp;gc_cont=0.736	BGC0000703.1|Kanamycin_184 	191742	192515	+	Loose	650	101.679	tetA(58)	32.27	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAACTGCGCATCGAAGGGCTCGGCGTCGACATCGACGGCAGGAGCCTGGTGCACGACCTGTCGCTCGACGTGCGCGGCGGCGAGGTGGTGGGCCTCGTAGGACCGAACGGCAGCGGCAAGTCCACCGCGCTGCGCTGCGTGTACCGCGCGCTGCGCCAGGACCGCGGCACCGTCCGGGTCGGCGCCGACGACATCGGCCGTCTGCCGATGCGCCGCAGCGCGCAGCTCGTCGCCGCCATGACGCAGGACGGCGCCGTCGACCTGGACTTCACCGTCGAGGAGGTCGTCGCGCTCGGCCGTGCGCCGCACCAGCGGGGCAACCAGGCGCTCGGCGAGCGTGAACGGGCCCTGTGCGCACGGGCGATGGAGCGGCTCGGCATCCACCACCTGGCGGGGCGCGGCGTCCTCACCCTGTCCGGCGGGGAGCGCCAGCGCGTGCTGCTCGCCCGCGCCCTCGTCCAGGAGCCGGAGATCCTGGTGCTCGACGAGCCGACCAACCACCTCGACGTACGCCACCAGGTCGAGGTCCTCTCCCACCTGCGCGGCGCGGGACCCACCGTCCTGGTCGTGCTGCACGACCTGAACCTCGCGGCGGCCGCCTGCGACCGGCTCTGCGTGCTGTCCCAGGGCCGTCTGGTCGCGTCGGGGACGCCCTCGGAGGTCCTCACCGAGGAGCTGGTGGCCGAGGTGTTCGGCGTCCGCGCCACCGTCGTCCCGCACCCGCTGACGGGCGACCCGCAGCTTCTGTACTCACTGCACCACACCCCCTGA	MELRIEGLGVDIDGRSLVHDLSLDVRGGEVVGLVGPNGSGKSTALRCVYRALRQDRGTVRVGADDIGRLPMRRSAQLVAAMTQDGAVDLDFTVEEVVALGRAPHQRGNQALGERERALCARAMERLGIHHLAGRGVLTLSGGERQRVLLARALVQEPEILVLDEPTNHLDVRHQVEVLSHLRGAGPTVLVVLHDLNLAAAACDRLCVLSQGRLVASGTPSEVLTEELVAEVFGVRATVVPHPLTGDPQLLYSLHHTP	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	74.93	gnl|BL_ORD_ID|2243|hsp_num:0	2517			84	705	tetracycline
BGC0000703.1|Kanamycin_185 # 192531 # 193529 # 1 # ID=1_185;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.654	BGC0000703.1|Kanamycin_185 	192531	193529	+	Loose	1100	27.335	oleB	34.48	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGTCCCACACCCGATCCATCGCCCTGGGATCCGCGCTCGCGGCCGCCTTGGTCCTGAGCGGCTGCGGCGCCGACGTCGCGTCCGACGCCGACGCCAAGGGCGCGAAGAAGACCACCGTGAAGCGCTGCGGCGAGGACGTCACTTACAAGGTCCCTCGGCGCGCGGTGGCGTACGAGGGCGGCAGCGCCGACAAACTGTTCAGCCTGGGCCTGACCAAGCACGTGCACGGGTACGTGATGCCGCCCGCCAACCCGCCCGTGAGCGAGTCCCCTTGGGCGTCCGAGTACGCCAAGGTGAAGATGCTCGGCGACGACCTCCTCAACAAGGAACTCGTCGTCCAGGCCAAGTCCGACTTCGTCGTCGCGGGCTGGAACTCCGGCTTCAGCGACCAGCGCGGCATCACCCCGAAGATCCTCGACAAGCTCGGCATCCAGAGCTTCATGCACACGGAGAGCTGCTTCAACTACCCGGGGTTTCCGCAGAAGGTCACCCCGTTCAACGCGCTCTACAGCGACCTGGAGCGGCTCGGGAAGATCTTCCAGGTCGAGAAGAAGGCGGACCGGGTCGTCGGCGATCTCAAGAAGCGCGTGGCCGCGGTGGCGGCGAAGGCGCCCAAGGGCGGCAGCCCCGTGCCGGTCTTCCTCTACGACTCCGGCACGGACAAGCCGTTCACGGCGGGCAGCCAGGTGCCGCCCAACGACATCATCAAGACGGCTGGCGGCAGGAACATCTTCGACGGACTCGACGAGCGCTGGACGCAGGTGAGTTGGGAGTCCGTGACCAAGGCCGAGCCCGAGGTCGTCATCATCTTCGACTACGGCGACAAGCCCGCGAAGGAGAAGATCGACTTCCTGAAGAACTCCCCGCACACCAAGGAGCTGCCCGCCGTCAAGAAGAACAACTTCTTCGTACTCGACTACAACGAAGGCATCAGCGGGCCGCGGAACGTCGACGGTCTGGAGAAGTTCGGGAAGTACCTCGCAGGGCTCAAGGGCTGA	MSHTRSIALGSALAAALVLSGCGADVASDADAKGAKKTTVKRCGEDVTYKVPRRAVAYEGGSADKLFSLGLTKHVHGYVMPPANPPVSESPWASEYAKVKMLGDDLLNKELVVQAKSDFVVAGWNSGFSDQRGITPKILDKLGIQSFMHTESCFNYPGFPQKVTPFNALYSDLERLGKIFQVEKKADRVVGDLKKRVAAVAAKAPKGGSPVPVFLYDSGTDKPFTAGSQVPPNDIIKTAGGRNIFDGLDERWTQVSWESVTKAEPEVVIIFDYGDKPAKEKIDFLKNSPHTKELPAVKKNNFFVLDYNEGISGPRNVDGLEKFGKYLAGLKG	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	58.35	gnl|BL_ORD_ID|1272|hsp_num:0	1388			72	159	oleandomycin
BGC0000703.1|Kanamycin_186 # 193531 # 194382 # -1 # ID=1_186;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.751	BGC0000703.1|Kanamycin_186 	193531	194382	-	Loose	550	36.5798	vgbC	26.0	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGGGCCGCGCGTACGAGGTGGCGGTGCGCGAGCAGGCCGCACTCGGCGAAGGCCCCACCTGGGACCCCGCCGCCGAACACCTCATCTGGGTCGACATCCTCGCCTCCCGGATCCACACGTATGCCCCCGCGAGCGGCCGGCGCACGGTCATGGCCACGGAGCAGCACGTCGGCGCCGCCAAGCCGCGCGCGGGCGGCGGCCTCGTGGTCAACCTCAGGGACGGCGTCGGCCTGTACGGCCCCGGAGGGTCGTCCTTCGGCTGGCTGGTGCGCGACCCGGTGCCCGGCAGGCGCGGCAACGACGCGGCCGTCGCCCCCGACGGCGCGCTCTGGGCGGGCACGATGCGCTACGACGAGGCTCCGGGCGGCGGCAGCCTCGCCCGCGTCGCCCCCGACGGCACCGTCACCGAACAGTCCGGCGAGGTGTCCGTCAGCAACGGCACGGGCTGGAGCCCGGACGGACGGCTCATGTACTACGTGGACAGCCCCACGCGCCGCATCGACGTCTTCGACTACGAGGGTCAACATGCCCTGAACCGAAGGCCGTTCGCGCACATCGAGGCGGGCGCGGGATTCCCCGACGGGCTCACCGTCGACGCCGAGGGATGCGTCTGGGTGGCGCTCTGGGACGGCGCGGCGATCCGCCGCTACACGCCCGACGGGCGGCTCGACCGGACCGTCGAACTCCCGGTGCGCCGCCCCACCGCCTGCGCCTTCGGCGGCCCTGACCTGCGGGACCTCTACGTCACCACGGCCCGCACCGGGCTCGTCCGCCCGCACCCCTTGTCGGGCTCGGTCCTGGTCGTGCCGGACGCGGGCCGTGGCCTGCCGGGCGTCGCCTTCGCGGGCTAG	MGRAYEVAVREQAALGEGPTWDPAAEHLIWVDILASRIHTYAPASGRRTVMATEQHVGAAKPRAGGGLVVNLRDGVGLYGPGGSSFGWLVRDPVPGRRGNDAAVAPDGALWAGTMRYDEAPGGGSLARVAPDGTVTEQSGEVSVSNGTGWSPDGRLMYYVDSPTRRIDVFDYEGQHALNRRPFAHIEAGAGFPDGLTVDAEGCVWVALWDGAAIRRYTPDGRLDRTVELPVRRPTACAFGGPDLRDLYVTTARTGLVRPHPLSGSVLVVPDAGRGLPGVAFAG	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	95.61	gnl|BL_ORD_ID|2244|hsp_num:0	2526			408	801	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000703.1|Kanamycin_187 # 194382 # 195167 # -1 # ID=1_187;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.716	BGC0000703.1|Kanamycin_187 	194382	195167	-	Loose	800	25.0238	cprS	35.19	3005064	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	GTGGGAGAGGCCGAACTCATGGGACGACTGGTGCCCGCGGTGACCAGGTCGCTGGACATACTCGAACTGTTCCTTGAGGGCGAGGGCACGCTCTCCGCACCCGAGGTCACCCGCAAGCTCCAGCTGCCGCGCACCACGGTGCACGAGTTGCTCACCACCCTGGCCGCCCGCTCGTATCTCGTCCAGCTCCCCGACCAGCCGGGCCGCTACCGCCTGGGCGTGCGCACCTACCAGCTCGGCAGCAGGTACGCGGAGCAGCTCGACCTCGCGGCCGAGGGGCAGCAGGTGGCCCGCGAGGTCGCAGAGACCTGCGACGAGACCGTCCACGTCGCCATCCTGGAGGACACCGACGTCATCTACATCGCCAAGGTCGACTCCACGCACGCCGTGCGCATGGTCTCCGCGGCGGGCCGCAGGCTGCCCGCGCACTGCACGTCCGTCGGCAAGATGCTGCTCGCCTCGCTGCCCGAGGACCAGCTCGAATCCCGCCTCCGGGGTCGGGAGTTCACCGCGATGACCCCGGCCAGCATCACCGATCCGACGGAGCTGCTCGCCGCGCTCGCCGGGATCAGGGAGCGCGGTGTGGCGGTCGAGCACCAGGAGTCCAACCCGGACGTCAGCTGTGTGGCCGCGCCGGTGCGGGACCGCTCGGGCCGGGTCGTCGCGGCGCTCTCCATCTCCGTACCGATGATCCGCTGGAGCGAGGAGCGCGAGGGCGAACTGGCCGGGCTCGCCGCCAAGGGCGCCGCTGATCTGTCCGTCCGCCTCGGCCACCGGGGCGCGTGA	MGEAELMGRLVPAVTRSLDILELFLEGEGTLSAPEVTRKLQLPRTTVHELLTTLAARSYLVQLPDQPGRYRLGVRTYQLGSRYAEQLDLAAEGQQVAREVAETCDETVHVAILEDTDVIYIAKVDSTHAVRMVSAAGRRLPAHCTSVGKMLLASLPEDQLESRLRGREFTAMTPASITDPTELLAALAGIRERGVAVEHQESNPDVSCVAAPVRDRSGRVVAALSISVPMIRWSEEREGELAGLAAKGAADLSVRLGHRGA	MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD	60.56	gnl|BL_ORD_ID|2789|hsp_num:0	3804			636	798	polymyxin B; colistin A; colistin B
BGC0000703.1|Kanamycin_188 # 195378 # 196583 # 1 # ID=1_188;partial=00;start_type=TTG;rbs_motif=AGGGG;rbs_spacer=8bp;gc_cont=0.711	BGC0000703.1|Kanamycin_188 	195378	196583	+	Loose	1250	31.9574	mecC	21.33	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	TTGCGCATTACGGGAATCAGCACGCACGTGGTCGGCACGCCCTGGCGCAATCTCACCTACGTCCAGGTGCACACCGACGAGGGCCTGACCGGCATCGGCGAGACCCGCATGCTCGGCCGCACCGACGCGCTCATCGGGTATCTCCGCGAGGCGGAGGCCAACCACATCGCCGGGTCCGATCCGTTCGCGATCGAGGACCTGGTGCGCAGGATGAAGTACGGCGACTACGGCAGGGCGGGCGAGATCGTCATGTCGGGCATCGCCGTCGTCGAGATGGCCTGCTGGGACATCAAGGGCAAGGCGCTCGGCGTGCCCGTCTGGCAGCTGCTCGGCGGCAAGGTCACCGACCGCGTGAAGGCGTACGCGAACGGCTGGTACACCACGGAGCGCACCCCGGAGGCGTACCACGAGGCCGCCCGCGGGGTCATGGAGCGCGGCTACCGGGCGCTGAAGATCGACCCCTTCGGGACGGGCCACTTCGAGCTCGACCACGAACAGACCCGGTACGCCGTGTCGTTGATCGAGGCGGTGCGCGACGCGATCGGGCCCGACGCCGAGCTGATGCTGGAGATGCACGGCAGGTTCTCGCCCGCCACGGCGATCCGGCTCGCCCGCGACCTCGCGCCGTTCCGGCCCGCGTGGCTGGAGGAACCGGTGCCGCCGGAGAACCTCAAGGCCCTGGCGAAGGTCGCGGCGCGGGTGGACATGCCGGTGGCGACGGGCGAGCGGATCCACGACCGGATCGAGTTCCGCGAGCTGTTCGAGAGCCAGGCGGCCGACGTCCTGCAGCCCGACGTGGGCCACATCGGCGGCATCTGGGAGACCCGGAAGCTCGCGGCCACCGCCGAGACGCACTACATGCTGGTCGCCCCGCACAACGTCGGCGGCCCGGTGCTCACCGCCGCATCGCTCCAAGTCGGCTTCACCACGCCGAACTTCAAGATCCTGGAGCACTTCAACGACTTCGCGGACGCCGACATCAAGAAGGTCGTCAAGGGCGCCCCGCGGGTCGACCCGGCGACGGGCTGCTTCGAGCTGTCGCACGCGCCCGGCCTCGGCGTCGAGCTCGACGTCGACGCGGCGGCGGAGTTCCCGCAGCAGCAGGCGCGGTTCGACCTGTGGGCCGAGGGCTGGGAGAAGCGTTCACCAAGCGCGGCGGCGGGCGGGGCGGCGGGCGGCGCCCCGGGCCCGGGGAGTGCGGAGTGA	MRITGISTHVVGTPWRNLTYVQVHTDEGLTGIGETRMLGRTDALIGYLREAEANHIAGSDPFAIEDLVRRMKYGDYGRAGEIVMSGIAVVEMACWDIKGKALGVPVWQLLGGKVTDRVKAYANGWYTTERTPEAYHEAARGVMERGYRALKIDPFGTGHFELDHEQTRYAVSLIEAVRDAIGPDAELMLEMHGRFSPATAIRLARDLAPFRPAWLEEPVPPENLKALAKVAARVDMPVATGERIHDRIEFRELFESQAADVLQPDVGHIGGIWETRKLAATAETHYMLVAPHNVGGPVLTAASLQVGFTTPNFKILEHFNDFADADIKKVVKGAPRVDPATGCFELSHAPGLGVELDVDAAAEFPQQQARFDLWAEGWEKRSPSAAAGGAAGGAPGPGSAE	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	60.30	gnl|BL_ORD_ID|742|hsp_num:0	810			1074	1293	methicillin
BGC0000703.1|Kanamycin_189 # 196580 # 197593 # 1 # ID=1_189;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=7bp;gc_cont=0.757	BGC0000703.1|Kanamycin_189 	196580	197593	+	Loose	660	32.7278	MexS	40.0	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCAGCCGCGCGATCGTCGTCGAGCGGCCCGGCGCACACCGCCTGGTCACCCGGGGCACCCCCACCCCCGGCCCCGGCGAGGTCCTCGTCCGCGTGGCCGCCGCGGGCATCTGCGGGAGCGACCGCGAGGTGTACGACGGACACCGCGACGCCGCGTACGTGCGCTACCCCGTGATCCCCGGCCACGAGTGGTCGGGGACCGTCGCTGCGGTCGGCGAGGGCGTCGACCCCGGGCTGCTCGGGCGCAGGACCGTCGCCGAGGGGTTCCGGGCGTGCGGTGTCTGCGAGCGGTGCCGGTGCGCGGAGACGAACCTGTGCACCGGCGGGTACGCGGAGACCGGGTTCACCGAGCCCGGCGCCTTCGCCGACCATCTGACCGTGCCCGCACGGCTGTTGCACCTCCTGCGCGACGACGCCGACCTGCGGGCCGCGGCGCTCCTGGAACCGGCCGCGGTGGTCGCGGCGGCGGTGCGGGCGGGCGGCCTCCGGCCGGGTGAGCGCGTCGCGGTGGTCGGGGCGGGGACGCTCGGGCTGCTCGCGGTGCAGTTGCTCGCGGCTTCCGGCCCCGGTGAGCTGGTGGTGGTCGATCCGCGCGGGGCGCGGGGTGCGCGGGCCCGGGAGTGCGGGGCGACCTCGGCGCTCTCCCCCGTCGCGGCCGAATCCGTACGCGGTTCGTTCGACCTCGTCGTGGAGACCGCGGGGGCGCCGACCACCGCCGCCTCGTCGTGTCTGCTCGCCCGGCGCGGCGGGCGGGTCGTGCTCACCGGGATGTTCACGGAGGGGGCCGTGGGGATCGACCCCGTGCATCTCTCCCTCAGTCAGCTGGAGGTGCGGTCCGTCTTCGGGGCGTCGTCCGCGGCGTGGGGCGATGCGGTGCGGGCGTTCGGGCTCGGGCTGATCGACCCCGCGGCGCTGATCACGCACGAGTTTCCTCTGGAGCGGTTCGGAGAGGCGGTTTCTCTCGTCGGTGGGGGTGACCCCAAGACCGGGAAGGTGCTTTTGCGTCCTTGA	VSSRAIVVERPGAHRLVTRGTPTPGPGEVLVRVAAAGICGSDREVYDGHRDAAYVRYPVIPGHEWSGTVAAVGEGVDPGLLGRRTVAEGFRACGVCERCRCAETNLCTGGYAETGFTEPGAFADHLTVPARLLHLLRDDADLRAAALLEPAAVVAAAVRAGGLRPGERVAVVGAGTLGLLAVQLLAASGPGELVVVDPRGARGARARECGATSALSPVAAESVRGSFDLVVETAGAPTTAASSCLLARRGGRVVLTGMFTEGAVGIDPVHLSLSQLEVRSVFGASSAAWGDAVRAFGLGLIDPAALITHEFPLERFGEAVSLVGGGDPKTGKVLLRP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	99.41	gnl|BL_ORD_ID|1039|hsp_num:0	1041			66	258	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000703.1|Kanamycin_190 # 197711 # 198685 # 1 # ID=1_190;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.741	BGC0000703.1|Kanamycin_190 	197711	198685	+	Loose	450	28.8758	ANT(4')-IIa	37.78	3002624	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	GTGATCGACACTTCTTCCGTACGTCCCCGTCGCCCCGGCGAACCCGCCCTCGCCCTCGTCGGGCTCGGCGCGCCCCGCCCCGACCCCGGCGACGCCTCGCCCCACGCCTTCCCCGACGGTGGCACCTGGCGCACCGAGATCCCCTCGGTGGAGGGGCCCGAGGCGCTCGCCGTCGTGCTCAAGGAGAGTGCGCGCCTCGACGTGCCCGTGCACCGGGTCAGCCAGGGCAGCGGCGTCTGGATGCTCACCGACGCCGAGATCACCGAGATGACGGAGTCCTGCGCCGAGCGGGACATCGAGCTCTGTCTGTTCACCGGGCCGCGCGGCACCTGGGACATCGGGGGCTCCACGCGCACCGAATCCGGCGGTGCCGGGCTCCGCGCCCGGGGCCACGACGCGCTCGCGGGGTGCGTCGAAGACGCTCTGCGCGCGGCCGAGTTGGGCGTGCGGTGCCTGCTCGTCGCCGATGAGGGCGTGCTGTGGACCCTGCACCGGCTGCGCGCCGTGGGCGCGCTGCCCGCCGACACCACGTTCAAGCTGTCCGCCCTGTCGGGGCCGGTCAATCCCGCCTCGTACGCGGTGTACGAGCGGCTCGGCGCCGACTCCCTGAACGTGCCGTCCGACCTGACGGCGGACCACCTCACCGAGATCCGCCGGGTCAGCCGAGCCCCCATGGACCTGTACGTCGAGGCGCCCGACGACCTCGGCGGCTACATCCGGATGTACGAGGTCGCCGAGCTGATCAGGCGCGGCGCCCCGCTGTACGTGAAGTTCGGCCTCAGCAAGTCGCCCGGCATCTATCCCTACGGTGCCCAGCTGCGCGAGCACACCCTCGCCACCGCCCGCGAGCGCGTGCGCCGCGGCCGCCTCGTCCTCGATCTGCTCGCCCGGCACGGCGCGGACGGCGGCATGTCGCCGCTCGGCTCGCGGCTCCCCGGCGAGCTGCGCCGATTCCCCACCCCGGAAGGGGACTGA	MIDTSSVRPRRPGEPALALVGLGAPRPDPGDASPHAFPDGGTWRTEIPSVEGPEALAVVLKESARLDVPVHRVSQGSGVWMLTDAEITEMTESCAERDIELCLFTGPRGTWDIGGSTRTESGGAGLRARGHDALAGCVEDALRAAELGVRCLLVADEGVLWTLHRLRAVGALPADTTFKLSALSGPVNPASYAVYERLGADSLNVPSDLTADHLTEIRRVSRAPMDLYVEAPDDLGGYIRMYEVAELIRRGAPLYVKFGLSKSPGIYPYGAQLREHTLATARERVRRGRLVLDLLARHGADGGMSPLGSRLPGELRRFPTPEGD	MHLTITYWIDRLREAYPHAVAILLKGSYARGEASAWSDIDFDVLVSDEEVEEYRTWIEPVGERLVHISVAVEWVTGWERDSADPSSWSYGLPTQETTQLLWAADENIRRRLDRPFKVHPAAEPEVEDTVEALGKIRNAMVRGDDLAVYQAAQVVGKLIPTLLVPINPPTYARFAREAIDRILAFPNVPEGFAADWLTCMGLVDRRTHDPQPTRPNEWCAARSRFCRRMRTSSVRISRGCWKQDWYLRISART	128.57	gnl|BL_ORD_ID|1162|hsp_num:0	1266			489	624	amikacin; tobramycin; isepamicin
BGC0000703.1|Kanamycin_192 # 199796 # 201361 # 1 # ID=1_192;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.688	BGC0000703.1|Kanamycin_192 	199796	201361	+	Loose	1280	78.1814	macB	29.69	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAGCGCACCGATCCTGGAGATGCGCGCCATCACCAAGACGTTCCCCGGCGTCACGGCGCTCTCCGACGTGAACCTGACGGTGCGCCCCGGGGAGATCCACGCGATCTGCGGGGAGAACGGCGCGGGCAAGTCGACGCTGATGAAGGTCCTCAGCGGCGTCCATCCGCACGGGAGTTACGACGGGGAGATCCTCTTCGAGGGCGAGCCGATGGCCTTCAAGGACATCCGGGCCAGCGAGCGCCGGGGCATCGTGATCATCCATCAGGAGCTGGCACTCGTCCCCCACTTGTCGATCGCGGAGAACATCTTCCTCGGCAACGAGCAGGCGCGCGGCGGCTTCGTCGACTGGAACGGCACCCTGCGCAGGGCGGGCGCACTCCTGAAGCGGGTCGGTCTGCGCGAGAAGCCGCAGACGCCGGTCGCCGACATCGGCGTGGGCAAACAGCAGCTCGTGGAGATCGCCAAGGCCCTGTCGAAGGAGGTGCGGCTGCTCATCCTGGACGAGCCGACAGCCGCGCTCAACGACGACGACAGCGCGAAGCTGCTCGGCCTCATCGGGGAACTGCGCGAGCAGGGCATCGCCTGCATCATCATCTCGCACAAGCTGAACGAGATCCGGGCCGTCACCGACGCGGTGACCATCCTGCGCGACGGGCGCACCGTCGAAACCCTGACGGTCCGTGAGACTCCGGACGCCGAGGCCGAGTTGTCGGAGGACCGCATCATCCGCGGCATGGTCGGCCGCGACCTCGACCACCGCTTCCCCGACCGTACGCCCTATGCGGGCGAGGACGCGGGCACGCTCGCGCTGTCCGTCGCGGGATGGACCGTGCGGCACCCGGTCGACCAGCAGCGCACGGTCGTCGACGACGTGTCGCTGACCGTGCGGCGCGGCGAGATCGTCGGCATCGCGGGCCTGATGGGCGCGGGCCGCACCGAACTCGCGATGTCCGTCTTCGGGCGCTCGTACGGCGTCTACGTCGCCGGGGACGTGGCGGTGAACGGCCGCCCGGTGGTGACGCGGACCGTCCCCGCCGCGGTCGACGCGGGCATCGCGTACGTCACTGAGGACCGCAAGCGGTACGGCCTCAACCTCATCGACGACATCAACCGCAACGTCTCCCTGGCCTCGCTGCCCGGCATGCGGCGCCGGGGCGTCGTGGACGAGCACCACGAGCGCTCGGTCGCCGAGCGCTACCGCAAGGCCATGAACATCAAGGCGCCCACCGTCTTCGAGGAGGTGGGCAGGCTCTCCGGCGGCAATCAGCAGAAAGTCGTCCTGAGCAAGTGGATCCACGCCGACCCCGAGGTGCTGATCCTCGACGAGCCGACGCGCGGCATCGACGTGGGCGCCAAGTACGAGATCTACACGGTCATCGACGAGCTCGCCGCGCAGGGCAAGGCCGTCCTGTTCATCTCCTCCGAACTCCCCGAGCTGCTCGGGATGTGCGACCGGATCTACACGATGGCCGAGGGCCGCCTGACCGGTGAGGTCACGCGCGCGGAGGCCACCCAGGAAGTCCTGATGCGCCACATGACCCAGACCAGAAGCCCCAAGAGCTGA	MSAPILEMRAITKTFPGVTALSDVNLTVRPGEIHAICGENGAGKSTLMKVLSGVHPHGSYDGEILFEGEPMAFKDIRASERRGIVIIHQELALVPHLSIAENIFLGNEQARGGFVDWNGTLRRAGALLKRVGLREKPQTPVADIGVGKQQLVEIAKALSKEVRLLILDEPTAALNDDDSAKLLGLIGELREQGIACIIISHKLNEIRAVTDAVTILRDGRTVETLTVRETPDAEAELSEDRIIRGMVGRDLDHRFPDRTPYAGEDAGTLALSVAGWTVRHPVDQQRTVVDDVSLTVRRGEIVGIAGLMGAGRTELAMSVFGRSYGVYVAGDVAVNGRPVVTRTVPAAVDAGIAYVTEDRKRYGLNLIDDINRNVSLASLPGMRRRGVVDEHHERSVAERYRKAMNIKAPTVFEEVGRLSGGNQQKVVLSKWIHADPEVLILDEPTRGIDVGAKYEIYTVIDELAAQGKAVLFISSELPELLGMCDRIYTMAEGRLTGEVTRAEATQEVLMRHMTQTRSPKS	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	80.90	gnl|BL_ORD_ID|446|hsp_num:0	487			6	666	erythromycin
BGC0000703.1|Kanamycin_193 # 201370 # 202611 # 1 # ID=1_193;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.683	BGC0000703.1|Kanamycin_193 	201370	202611	+	Loose	950	27.7202	msrE	29.79	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGACGACCACGACCACTCCCCCGGGCTCCTCCCGGGACGCGTCCGACGCCCCGCCACCCGCGCGGTGGCCGGCGGGCGCGCTGCTGCTGCGAAGCGTGCGCTCCAACACGCGCCAGTACGGCATGCTCATCGCCCTGGCGTTCCTCGTCGTGCTGTTCCAGATCTGGACCGACGGGACGCTGCTGCTCCCGAACAACGTCTCCAACCTGATCCAGCAGAACGGCTACATCCTCATCCTGGCCATCGGCATGATGATCGTCATCATCGCGGGCCACATCGACCTCTCCGTGGGCTCGTTGGTCGCCTTCGTCGGCGCCATGTCGGCGGTCATGATGGTCAAGCACGACATGCCCTGGGTGCTCGCCCTGGTCCTCTCGCTCCTGATCGGCGCGGTCGCGGGGGCCTGGCAGGGCTTCTTCATCGCGTACGTCGGCATCCCCTCGTTCATCGTGACGCTGGCCGGGATGCTGCTCTTCCGCGGACTCACCCAGATCGTCCTTGAGGGCCAGTCGCTCGCGCCGTTCCCCGACGGGTTCCAGAACATCGCCAAGGGCTTCATCCCGGAGATGGGCCCCTACACCCAGTACCACAACCCGACGCTCGTCCTCGGCCTGCTCGCCGTCGCGTTGCTGCTCCTGCGTGAACGGCGCGCTCGCAAGCGCCAGTTGGCGTACGAGCTCGATGTCCTGCCGACCGGTCTGTGGGCGGCCAAGTGCGTGGCGATGACCGCGGCCGTGGTGGCGTTCACCCTCACCCTCGCCAGCTTCCACGGCGTGCCCGTCGTCATGCTCATCATGTGCGGCCTGCTCATCGCGCTGGGCTATGTCATGCGCAACGCCGTCATCGGCCGCCATGTGTACGCCCTCGGCGGCAACAAGGCCGCGGCGAAGCTGTCGGGCGTCAAGGACAAGCGGGTCACCCTCCTGGTCTTCGTGAACATGGGCGTCCTCGCGGCGCTCGCGGGCTGCGTGTACGCGGCGCGCCTGAACGCGGGCACCCCGCAGGCCGGGCTCAACTTCGAACTGGAGGCGATCGCCGCCTCGTTCATCGGCGGCGCGTCGATGAGCGGCGGCGTCGGCACGGTCCTTGGCGCGGTCATCGGCGGCCTCGTCCTCGGCGTCCTGAACAACGGCATGTCCCTGGTCGGCATCGGCACGGACTACCAGCAGGTCATCAAGGGGCTCGTACTGCTCGCCGCGGTCGGCTTCGACGTCTGGAACAAGCGCAAGGCGGGCCGCTAG	MTTTTTPPGSSRDASDAPPPARWPAGALLLRSVRSNTRQYGMLIALAFLVVLFQIWTDGTLLLPNNVSNLIQQNGYILILAIGMMIVIIAGHIDLSVGSLVAFVGAMSAVMMVKHDMPWVLALVLSLLIGAVAGAWQGFFIAYVGIPSFIVTLAGMLLFRGLTQIVLEGQSLAPFPDGFQNIAKGFIPEMGPYTQYHNPTLVLGLLAVALLLLRERRARKRQLAYELDVLPTGLWAAKCVAMTAAVVAFTLTLASFHGVPVVMLIMCGLLIALGYVMRNAVIGRHVYALGGNKAAAKLSGVKDKRVTLLVFVNMGVLAALAGCVYAARLNAGTPQAGLNFELEAIAASFIGGASMSGGVGTVLGAVIGGLVLGVLNNGMSLVGIGTDYQQVIKGLVLLAAVGFDVWNKRKAGR	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	84.11	gnl|BL_ORD_ID|27|hsp_num:0	33			402	543	erythromycin
BGC0000703.1|Kanamycin_194 # 202831 # 203904 # -1 # ID=1_194;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=7bp;gc_cont=0.724	BGC0000703.1|Kanamycin_194 	202831	203904	-	Loose	400	27.7202	salD	30.61	3007028	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	GTGGCGAACGGTGGAACCGGAGCGGCGGATGCCGGGGGCGTAACGGGGGCGGGGGACGGGGCGGACCCCAGGCAACTGGTCCAGCTCGTCTTCGGGAGCATGGCGGCGCAGACGCTGCGCGCGGCCGCCCGGATGCGGGTGGTCGAGCTGATCGGCGACAAGGAGCGGACCGCCGCCGAGGTCGCCGCAGAGGCCGGGGCCCGCCCCGAGGGCATGATCCGGCTGCTGCGCGCGCTCGCGGGCATCGGCGTGGTGGCGGAGCGGACGCCGGGCGTCTTCGCGGTGACGCCCACGGGCGCCCTGCTCGACTCGCGACGACCCGGCAACGTCGCGTCCCTGGTGCTCATGATGTCCGACCCGACGATGCTGCGCGGCTGGGAACACCTCGACGAGGTCGTACGGACGGGTGAGCCCGCCTTCGACACGGTGTTCGGCACGGACTTCTTCGGCCACCTCAGGGAGCATCCCGAGGAGTCCGCCCGGTTCAACGAGGCGATGAGTCAGAGCACCGGGGCGGCGGCCGCCACGCTGCCCCGCGCCTTCGACTTCACCAGGTTCGCCACCGTCGCCGACGTCGGCGGCGGCGACGGCACGCTGCTCTCCGCCGTACTGAAGGAGCACACGGGCCTCACGGGCATCATCTACGACACGGCGGAGGGCCTGGCCCAGGCACCCGCGACGCTGGAGCGGCACGGGCTCACCGAGCGGTGCTCGTCGGTGGCCGGTGACTTCTTCCAGTCGGCCCCCAAGGGCGCCGACCTCTACCTCCTGAAGAGCATCCTGCACGACTGGCCGGACGAGCGGGCGGTGACCATCCTGAGCCACTGTCGCGCGGTGCTGCCGCCCGAGGGCCGGGTGCTGATCCTGGAGCACGTCCTGCCCGAGGCCGTCGACCCGGCGGCCCCGGGGTTCGCGTATCTGAGCGATCTGAACATGCTCGTGAACCTGGGCGGCAGGGAACGCACCCGGGCCGATTTCGACGAGCTCTGCGGCAGGGCCGGGCTCTCCATCGTGTCCGTGACGCCGATGGGGGCGCCGAACCCGCTCTCGATGATCGAGGTGGCGGCCGCCTGA	MANGGTGAADAGGVTGAGDGADPRQLVQLVFGSMAAQTLRAAARMRVVELIGDKERTAAEVAAEAGARPEGMIRLLRALAGIGVVAERTPGVFAVTPTGALLDSRRPGNVASLVLMMSDPTMLRGWEHLDEVVRTGEPAFDTVFGTDFFGHLREHPEESARFNEAMSQSTGAAAATLPRAFDFTRFATVADVGGGDGTLLSAVLKEHTGLTGIIYDTAEGLAQAPATLERHGLTERCSSVAGDFFQSAPKGADLYLLKSILHDWPDERAVTILSHCRAVLPPEGRVLILEHVLPEAVDPAAPGFAYLSDLNMLVNLGGRERTRADFDELCGRAGLSIVSVTPMGAPNPLSMIEVAAA	MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN	65.62	gnl|BL_ORD_ID|4727|hsp_num:0	5739			1089	1236	lincomycin; virginiamycin M1; tiamulin; retapamulin
BGC0000703.1|Kanamycin_195 # 204131 # 204967 # 1 # ID=1_195;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.729	BGC0000703.1|Kanamycin_195 	204131	204967	+	Loose	2090	25.0238	smeB	28.57	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGACCCGGCGTCCACCGCACTGCAGCAGGAGATCGCCCGGGATCTCCAGGTGTCCGCGAGCTTCGACCCGGCGCGCGAGATCGAGCGCCGCGTCGCCTTCCTCACCGAGCGGCTGACCTCGACGGGGCTGCGCTCGCTGGTGCTCGGCATCAGCGGAGGGGTGGACTCCACGACCGCGGGACGGCTGTGCCAGCTCGCCGTCGAGCGGGCCCGCACCGCCGGGCACGAGGCGACCTTCTACGCCATGCGCCTGCCCTACGGCGTCCAGGCCGACGAGAAGGACGCGCAGCTCGCACTGGGCTTCATCGCCGCCGACCAGGTCCTGACCGTGGACGTGAAGGCCGCGAGCGACGCCGCGCTGGAGGCCGCGCTCACCGGCGGGGTCGTCTTCAGGGACGAGCGCCACCAGGACTTCGTGCAGGGCAACATCAAGGCCCGGCAGCGGATGATCGCCCAGTACGCGGTCGCGGGCGCGCGGGACGGTCTGGTGGTCGGCACCGACCACGCGGCCGAGGCGGTCTCCGGGTTCTTCACCAAGTTCGGCGACGGCGCGGCCGACGTCGTGCCGCTGACCGGTCTGACCAAGCGCCGGGTGCGGGCGGTCGCCGACGCGCTCGGCGCCCCTGCCGAGCTGGTGTGGAAGGTCCCGACGGCGGACCTGGAGACGCTCGACCCCGGCAAGCCGGACGAGGACGCGCTCGGCGTGACGTACGACGAGATCGACGACTTCCTGGAGGGGAAGCCGGTGTCCGACGCGTCGTTCCGGTCGATCGTCGGCCGCTACCGCCTCACGGACCACAAGCGCAGGCTGCCGATCGCGCCGACGGCCTGA	MTDPASTALQQEIARDLQVSASFDPAREIERRVAFLTERLTSTGLRSLVLGISGGVDSTTAGRLCQLAVERARTAGHEATFYAMRLPYGVQADEKDAQLALGFIAADQVLTVDVKAASDAALEAALTGGVVFRDERHQDFVQGNIKARQRMIAQYAVAGARDGLVVGTDHAAEAVSGFFTKFGDGAADVVPLTGLTKRRVRAVADALGAPAELVWKVPTADLETLDPGKPDEDALGVTYDEIDDFLEGKPVSDASFRSIVGRYRLTDHKRRLPIAPTA	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	26.50	gnl|BL_ORD_ID|1813|hsp_num:0	1960			2184	2352	
BGC0000703.1|Kanamycin_196 # 205033 # 205446 # -1 # ID=1_196;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000703.1|Kanamycin_196 	205033	205446	-	Loose	700	24.2534	LHK-2	27.66	3006936	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LHK beta-lactamase	ATCGAGGTCAGGGCGTTGTTGGAGAGCCGTGCCGACGCCGCGCAGGCGAAGGACATCGACCGGCTCATGCCGCTTTTCGCGCCGGACGTCGTCTACTTCGACGTCGTGCCGCCGATGCGGTTCGCGGGGCACGGCGAAGTGCGCAAGAACTTCGTGCGGTGGTTCGAGGGCTATGAGGGGCCCATCACGCTGGAGACGCGGGAGCTCACCGTCGCGGTCGGGGACGACGTCGCGTTCGCCCACATGCTGCACCTGGATTCCGGAACCCGTACGAACGGGATGCAGAGCGCGATGCTGGTGCGGTCGACCGTGTGCTGTCGGCGGGTGAGCGGCACGTGGCTGATCACGCACGAGCACATCTCGCTGCCGATCGACCCGGCGACGCTGCAGGCCTGGATGCCGCCCCAGGCGTGA	IEVRALLESRADAAQAKDIDRLMPLFAPDVVYFDVVPPMRFAGHGEVRKNFVRWFEGYEGPITLETRELTVAVGDDVAFAHMLHLDSGTRTNGMQSAMLVRSTVCCRRVSGTWLITHEHISLPIDPATLQAWMPPQA	MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGVDAMVQTVMQAHQIPGMAIAIIQPGKTSYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADMLAYYQHWQPVHPAGTTRLYSNPSIGLMGLAASQATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVRVSPGPLDEETYGIKSTTADMAGFLLAHMDPARSKDALRSALQQRAPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNEPDVWVNKTGSTAGFGAYAVFLPARQTGIVILANRNYPITDRIRLAHGILTALH	35.22	gnl|BL_ORD_ID|3677|hsp_num:0	4747			729	867	
